{"id": "CMU_1:6", "en": "and are you having any of the following symptoms with your chest pain", "fr": "et avez-vous l’un des symptômes suivants en plus de vos douleurs thoraciques ?", "perturbation": "alteration", "pert_fr": "et avez-vous l’un des symptômes suivants en plus de vos douleurs abdominales ?", "bt_pert_fr": "and do you have any of the following symptoms in addition to your abdominal pain?", "questions": "[\"Are you experiencing any of the following symptoms with your chest pain?\"]", "answers": "[\"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "CMU_1:12", "en": "and drink lots of fluids", "fr": "et buvez beaucoup de liquides", "perturbation": "alteration", "pert_fr": "et buvez peu de liquides", "bt_pert_fr": "and drink little fluids", "questions": "[\"What should you do to stay hydrated?\", \"How much fluid should you drink?\", \"Why is it important to drink lots of fluids?\"]", "answers": "[\"Drink fluids\", \"Little fluids\", \"It is not specified in the sentence\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 42.506114653558136, "bleu": 26.013004751144457}, {"f1": 0.4, "em": false, "chrf": 37.45670995670996, "bleu": 30.326532985631665}, {"f1": 0, "em": false, "chrf": 8.262485568047811, "bleu": 0.0}], "avg_f1": 0.35555555555555557, "avg_em": 0.0, "avg_chrf": 29.408436726105304, "avg_bleu": 18.779845912258708}
{"id": "CMU_1:34", "en": "are you having any difficulty breathing now", "fr": "éprouvez-vous des difficultés pour respirer actuellement?", "perturbation": "alteration", "pert_fr": "éprouvez-vous des facilités pour respirer actuellement?", "bt_pert_fr": "Are you finding it easier to breathe at the moment?", "questions": "[\"Are you having any difficulty breathing right now?\"]", "answers": "[\"Yes, I am finding it easier to breathe at the moment\"]", "scores": [{"f1": 0.18181818181818182, "em": false, "chrf": 22.066160520607372, "bleu": 4.196114906296549}], "avg_f1": 0.18181818181818182, "avg_em": 0.0, "avg_chrf": 22.066160520607372, "avg_bleu": 4.196114906296549}
{"id": "CMU_1:42", "en": "but if you have the cough", "fr": "mais si vous toussez", "perturbation": "alteration", "pert_fr": "mais si vous ricanez", "bt_pert_fr": "but if you sneer", "questions": "[\"What happens if you have the cough?\"]", "answers": "[\"Nothing is specified about what happens if you have the cough\"]", "scores": [{"f1": 0.5333333333333333, "em": false, "chrf": 57.53028376122259, "bleu": 26.269098944241577}], "avg_f1": 0.5333333333333333, "avg_em": 0.0, "avg_chrf": 57.53028376122259, "avg_bleu": 26.269098944241577}
{"id": "CMU_1:48", "en": "'cause they're having a cough", "fr": "parce qu’ils toussent", "perturbation": "alteration", "pert_fr": "parce qu’ils chantent", "bt_pert_fr": "because they sing", "questions": "[\"Why are they having a cough?\"]", "answers": "[\"Because they sing\"]", "scores": [{"f1": 0.28571428571428575, "em": false, "chrf": 47.381186918615455, "bleu": 19.716118825581447}], "avg_f1": 0.28571428571428575, "avg_em": 0.0, "avg_chrf": 47.381186918615455, "avg_bleu": 19.716118825581447}
{"id": "CMU_1:52", "en": "do you have any blood pressure problem as far as you know?", "fr": "savez-vous si vous avez des problèmes de tension ?", "perturbation": "alteration", "pert_fr": "savez-vous si vous avez des problèmes d'hypotension ?", "bt_pert_fr": "do you know if you have low blood pressure problems?", "questions": "[\"Do you have any blood pressure problem as far as you know?\"]", "answers": "[\"Yes\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "CMU_1:59", "en": "do your relatives have the same symptoms", "fr": "vos proches ont-ils les mêmes symptômes", "perturbation": "alteration", "pert_fr": "vos proches n'ont-ils pas les mêmes symptômes", "bt_pert_fr": "Don't your loved ones have the same symptoms?", "questions": "[\"Do your relatives have the same symptoms?\"]", "answers": "[\"Yes\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "CMU_1:62", "en": "have a dry cough a cold and runny nose vomiting diarrhea", "fr": "vous avez une toux sèche, un rhume, le nez qui coule, des vomissements, la diarrhée", "perturbation": "alteration", "pert_fr": "vous avez une toux humide, un rhume, le nez qui danse, des vomissements, la constipation", "bt_pert_fr": "you have a wet cough, cold, runny nose, vomiting, constipation", "questions": "[\"Do people have a dry cough?\", \"Do people have a cold?\", \"Do people have a runny nose?\", \"Do people have vomiting?\", \"Do people have diarrhea?\"]", "answers": "[\"No\", \"Yes\", \"Yes\", \"Yes\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.6, "avg_em": 0.6, "avg_chrf": 60.0, "avg_bleu": 60.00000000000002}
{"id": "CMU_1:67", "en": "i don't think i have high blood pressure", "fr": "je ne pense pas faire de l’hypertension", "perturbation": "alteration", "pert_fr": "je pense faire de l’hypotension", "bt_pert_fr": "I think I have hypotension", "questions": "[\"Do you think you have high blood pressure?\", \"Do you believe you have high blood pressure?\"]", "answers": "[\"No\", \"No\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "CMU_1:68", "en": "i feel a pain in the chest here in the front part of the chest", "fr": "je ressens une douleur dans la poitrine ici à l’avant de la poitrine", "perturbation": "alteration", "pert_fr": "je ressens un soulagement dans la poitrine ici à l’avant de la poitrine", "bt_pert_fr": "I feel relief in my chest here at the front of my chest", "questions": "[\"Where is the chest pain located?\", \"What type of pain is felt in the chest?\"]", "answers": "[\"The front of the chest\", \"Relief\"]", "scores": [{"f1": 0.888888888888889, "em": false, "chrf": 67.58765087973367, "bleu": 35.186297399811885}, {"f1": 0, "em": false, "chrf": 5.681818181818182, "bleu": 0.0}], "avg_f1": 0.4444444444444445, "avg_em": 0.0, "avg_chrf": 36.63473453077593, "avg_bleu": 17.593148699905942}
{"id": "CMU_1:75", "en": "i had a short sharp pain in my chest", "fr": "j’ai ressenti une brève douleur aiguë dans la poitrine", "perturbation": "alteration", "pert_fr": "j’ai ressenti une longue douleur sourde dans la poitrine", "bt_pert_fr": "I felt a long dull pain in my chest", "questions": "[\"What type of pain did I have in my chest?\", \"Was the pain in my chest sharp or dull?\", \"How long did the pain in my chest last?\"]", "answers": "[\"A long dull pain\", \"Dull\", \"Long\"]", "scores": [{"f1": 0.28571428571428575, "em": false, "chrf": 14.313073459059348, "bleu": 15.97357760615681}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 5.208333333333334, "bleu": 0.0}], "avg_f1": 0.09523809523809525, "avg_em": 0.0, "avg_chrf": 6.507135597464227, "avg_bleu": 5.324525868718937}
{"id": "CMU_1:88", "en": "it hurts in the chest", "fr": "ça fait mal dans la poitrine", "perturbation": "alteration", "pert_fr": "ça fait mal dans le dos", "bt_pert_fr": "it hurts in the back", "questions": "[\"Where does the pain occur?\", \"What type of pain is felt in the chest?\"]", "answers": "[\"The back\", \"Not specified\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 16.32331419565462, "bleu": 49.99999999999999}, {"f1": 0, "em": false, "chrf": 4.464285714285714, "bleu": 0.0}], "avg_f1": 0.25, "avg_em": 0.0, "avg_chrf": 10.393799954970168, "avg_bleu": 24.999999999999996}
{"id": "CMU_1:94", "en": "it is occurring right in the middle of my chest", "fr": "ça se passe pile au centre de ma poitrine", "perturbation": "alteration", "pert_fr": "ça se passe pile au centre de mon dos", "bt_pert_fr": "it happens right in the center of my back", "questions": "[\"Where is it occurring?\", \"Is it occurring in the middle of the chest?\"]", "answers": "[\"In the center of my back\", \"No\"]", "scores": [{"f1": 0.6, "em": false, "chrf": 17.600070616630507, "bleu": 23.643540225079395}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.3, "avg_em": 0.0, "avg_chrf": 8.800035308315254, "avg_bleu": 11.821770112539697}
{"id": "CMU_1:104", "en": "most of the time it is this type of chest pain", "fr": "la plupart du temps c’est ce type de douleur dans la poitrine", "perturbation": "alteration", "pert_fr": "la plupart du temps c’est ce type de plaisir dans la poitrine", "bt_pert_fr": "most of the time it's this type of pleasure in the chest", "questions": "[\"What type of chest pain is most common?\", \"What is the most frequent type of chest pain?\"]", "answers": "[\"This type of pleasure\", \"This type of pleasure\"]", "scores": [{"f1": 0.3333333333333333, "em": false, "chrf": 58.337624629868415, "bleu": 15.97357760615681}, {"f1": 0.3333333333333333, "em": false, "chrf": 58.337624629868415, "bleu": 15.97357760615681}], "avg_f1": 0.3333333333333333, "avg_em": 0.0, "avg_chrf": 58.337624629868415, "avg_bleu": 15.97357760615681}
{"id": "CMU_1:105", "en": "my sister has similar symptoms", "fr": "ma sœur a des symptômes similaires", "perturbation": "alteration", "pert_fr": "ma sœur n'a pas de symptômes similaires", "bt_pert_fr": "my sister does not have similar symptoms", "questions": "[\"What symptoms does my sister have?\", \"Does my sister have symptoms similar to others?\", \"Are my sister's symptoms similar to any known conditions?\"]", "answers": "[\"None\", \"No\", \"Unknown\"]", "scores": [{"f1": 0, "em": false, "chrf": 1.953125, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.3333333333333333, "avg_em": 0.3333333333333333, "avg_chrf": 33.984375, "avg_bleu": 33.33333333333335}
{"id": "CMU_1:125", "en": "the fever started two days ago", "fr": "la fièvre a commencé il y a deux jours", "perturbation": "alteration", "pert_fr": "la fièvre a disparu il y a deux jours", "bt_pert_fr": "the fever disappeared two days ago", "questions": "[\"When did the fever start?\"]", "answers": "[\"Two days ago\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "PubMed_9:792", "en": "On March 11, 2020, the World Health Organization declared Coronavirus Disease 2019 (COVID-19) a pandemic.", "fr": "Le 11 mars 2020, l’Organisation mondiale de la santé déclarait la maladie à coronavirus 2019 (COVID-19) comme étant une pandémie.", "perturbation": "alteration", "pert_fr": "Le 11 mars 2020, l’Organisation mondiale de la santé déclarait la maladie à coronavirus 2019 (COVID-19) comme n'étant pas une pandémie.", "bt_pert_fr": "On March 11, 2020, the World Health Organization declared coronavirus disease 2019 (COVID-19) not to be a pandemic.", "questions": "[\"When did the World Health Organization declare Coronavirus Disease 2019 (COVID-19) a pandemic?\", \"What did the World Health Organization declare on March 11, 2020?\", \"What was declared by the World Health Organization on March 11, 2020?\"]", "answers": "[\"The World Health Organization did not declare COVID-19 a pandemic on March 11, 2020\", \"The World Health Organization declared coronavirus disease 2019 (COVID-19) not to be a pandemic\", \"Coronavirus disease 2019 (COVID-19) was declared not to be a pandemic\"]", "scores": [{"f1": 0.375, "em": false, "chrf": 43.01633994568183, "bleu": 11.498759556447222}, {"f1": 0.33333333333333337, "em": false, "chrf": 64.03515149257085, "bleu": 6.837203339116283}, {"f1": 0.5333333333333333, "em": false, "chrf": 74.35325820035843, "bleu": 9.980099403873663}], "avg_f1": 0.4138888888888889, "avg_em": 0.0, "avg_chrf": 60.468249879537034, "avg_bleu": 9.438687433145722}
{"id": "PubMed_9:794", "en": "Reports from China and Italy suggest that risk factors for severe disease include older age and the presence of at least one of several underlying health conditions.", "fr": "Des rapports provenant de Chine et d’Italie suggèrent que les facteurs de risque de développer une forme grave incluent un âge avancé et la présence d’au moins un problème de santé sous-jacent.", "perturbation": "alteration", "pert_fr": "Des rapports provenant de Chine et d’Italie suggèrent que les facteurs de risque de développer une forme légère incluent un âge avancé et la présence d’au moins un problème de santé sous-jacent.", "bt_pert_fr": "Reports from China and Italy suggest that risk factors for developing mild disease include older age and the presence of at least one underlying health problem.", "questions": "[\"What risk factors for severe disease are suggested by reports from China and Italy?\", \"Does older age contribute to the risk for severe disease according to reports from China and Italy?\", \"Does the presence of at least one underlying health condition contribute to the risk for severe disease according to reports from China and Italy?\"]", "answers": "[\"None\", \"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.8362946664551036, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.9454315554850345, "avg_bleu": 0.0}
{"id": "PubMed_9:795", "en": "U.S. older adults, including those aged ≥65 years and particularly those aged ≥85 years, also appear to be at higher risk for severe COVID-19–associated outcomes; however, data describing underlying health conditions among U.S. COVID-19 patients have not yet been reported.", "fr": "Aux États-Unis, les personnes âgées à partir de 65 ans, et plus particulièrement au-delà de 85 ans, semblent également présenter un risque accru de développer une forme grave de la COVID-19 ; cependant, aucune donnée sur les problèmes de santé sous-jacents chez les patients américains atteints de la COVID-19 n’a encore été rapportée.", "perturbation": "alteration", "pert_fr": "Aux États-Unis, les personnes âgées à partir de 65 ans, et plus particulièrement au-delà de 85 ans, semblent également présenter un risque diminué de développer une forme grave de la COVID-19 ; cependant, aucune donnée sur les problèmes de santé sous-jacents chez les patients américains atteints de la COVID-19 n’a encore été rapportée.", "bt_pert_fr": "In the United States, older people aged 65 and over, and particularly those over 85, also appear to have a reduced risk of developing a severe form of COVID-19; however, data on underlying health conditions in US COVID-19 patients have not yet been reported.", "questions": "[\"Are U.S. older adults at higher risk for severe COVID-19–associated outcomes?\", \"Are those aged ≥65 years at higher risk for severe COVID-19–associated outcomes?\", \"Are those aged ≥85 years at higher risk for severe COVID-19–associated outcomes?\", \"Have data describing underlying health conditions among U.S. COVID-19 patients been reported?\"]", "answers": "[\"No\", \"No\", \"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.25, "avg_em": 0.25, "avg_chrf": 25.0, "avg_bleu": 25.00000000000001}
{"id": "PubMed_9:797", "en": "Among these 7,162 cases, 2,692 (37.6%) patients had one or more underlying health condition or risk factor, and 4,470 (62.4%) had none of these conditions reported.", "fr": "Sur ces 7 162 cas, 2 692 patients (37,6 %) présentaient un ou plusieurs problèmes de santé sous-jacents ou facteurs de risque, et 4 470 (62,4 %) n’en présentaient aucun.", "perturbation": "alteration", "pert_fr": "Sur ces 7 162 cas, 2 692 patients (37,6 %) ne présentaient aucun problème de santé sous-jacent ou facteur de risque, et 4 470 (62,4 %) en présentaient plusieurs.", "bt_pert_fr": "Of these 7,162 cases, 2,692 patients (37.6%) had no underlying health conditions or risk factors, and 4,470 (62.4%) had more than one.", "questions": "[\"How many of the 7,162 cases had one or more underlying health condition or risk factor?\", \"What percentage of the 7,162 cases had one or more underlying health condition or risk factor?\", \"How many of the 7,162 cases had none of these conditions reported?\", \"What percentage of the 7,162 cases had none of these conditions reported?\"]", "answers": "[4470, \"62.4%\", \"2692\", \"37.6%\"]", "scores": [{"f1": 0, "em": false, "chrf": 11.11111111111111, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 11.11111111111111, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 11.11111111111111, "avg_bleu": 0.0}
{"id": "PubMed_9:799", "en": "The most commonly reported conditions were diabetes mellitus, chronic lung disease, and cardiovascular disease.", "fr": "Les problèmes de santé les plus fréquemment rapportés étaient le diabète sucré, une maladie pulmonaire chronique et une maladie cardiovasculaire.", "perturbation": "alteration", "pert_fr": "Les problèmes de santé les moins fréquemment rapportés étaient le diabète sucré, une maladie pulmonaire chronique et une maladie cardiovasculaire.", "bt_pert_fr": "The least frequently reported health problems were diabetes mellitus, chronic lung disease, and cardiovascular disease.", "questions": "[\"What are the most commonly reported conditions?\", \"Which conditions are most commonly reported?\", \"What is the most commonly reported condition?\", \"What conditions are associated with the highest reporting frequency?\"]", "answers": "[\"Diabetes mellitus, chronic lung disease, and cardiovascular disease\", \"Diabetes mellitus, chronic lung disease, and cardiovascular disease\", \"Diabetes mellitus\", \"Diabetes mellitus, chronic lung disease, and cardiovascular disease\"]", "scores": [{"f1": 0.875, "em": false, "chrf": 98.1964892825792, "bleu": 84.08964152537145}, {"f1": 0.875, "em": false, "chrf": 98.1964892825792, "bleu": 84.08964152537145}, {"f1": 0, "em": false, "chrf": 7.5, "bleu": 0.0}, {"f1": 0.875, "em": false, "chrf": 98.1964892825792, "bleu": 84.08964152537145}], "avg_f1": 0.65625, "avg_em": 0.0, "avg_chrf": 75.5223669619344, "avg_bleu": 63.06723114402858}
{"id": "PubMed_9:802", "en": "Cases among persons repatriated to the United States from Wuhan, China, and the Diamond Princess cruise ship were excluded.", "fr": "Des cas parmi les individus rapatriés aux États-Unis depuis Wuhan, en Chine, ainsi que les personnes présentes sur le navire de croisière Diamond Princess ont été exclus.", "perturbation": "alteration", "pert_fr": "Des cas parmi les individus restés aux États-Unis depuis Wuhan, en Chine, ainsi que les personnes absentes sur le navire de croisière Diamond Princess ont été inclus.", "bt_pert_fr": "Cases among individuals remaining in the United States from Wuhan, China, as well as those absent on the Diamond Princess cruise ship were included.", "questions": "[\"Were cases among persons repatriated to the United States from Wuhan, China, and the Diamond Princess cruise ship excluded?\", \"Which cases were excluded from the study?\", \"What types of cases were excluded when repatriated persons were considered?\"]", "answers": "[\"No\", \"Cases among individuals remaining in the United States from Wuhan, China, as well as those absent on the Diamond Princess cruise ship\", \"Cases among individuals remaining in the United States from Wuhan, China, and those absent on the Diamond Princess cruise ship\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.6285714285714286, "em": false, "chrf": 68.01992638587133, "bleu": 32.64128346656048}, {"f1": 0.7272727272727272, "em": false, "chrf": 70.80737455451572, "bleu": 43.34366012758324}], "avg_f1": 0.4519480519480519, "avg_em": 0.0, "avg_chrf": 46.27576698012901, "avg_bleu": 25.32831453138124}
{"id": "PubMed_9:803", "en": "For cases with missing onset dates, date of onset was estimated by subtracting 4 days (median interval from symptom onset to specimen collection date among cases with known dates in these data) from the earliest specimen collection.", "fr": "Concernant les cas pour lesquels elle était inconnue, la date d’apparition de la maladie a été estimée en soustrayant 4 jours (intervalle médian entre l’apparition des symptômes et la date de prélèvement d’échantillons pour les cas de ces données dont la date était connue) à partir du premier prélèvement d’échantillons.", "perturbation": "alteration", "pert_fr": "Concernant les cas pour lesquels elle était connue, la date d’apparition de la maladie a été estimée en soustrayant 4 jours (intervalle médian entre l’apparition des symptômes et la date de prélèvement d’échantillons pour les cas de ces données dont la date était connue) à partir du premier prélèvement d’échantillons.", "bt_pert_fr": "For cases where it was known, the date of disease onset was estimated by subtracting 4 days (median interval between symptom onset and sample collection date for cases in these data where the date was known) from the first sample collection.", "questions": "[\"How is the date of onset estimated for cases with missing onset dates?\", \"What is the median interval from symptom onset to specimen collection date used in estimating the date of onset?\", \"What is subtracted from the earliest specimen collection date to estimate the date of onset?\"]", "answers": "[\"The date of disease onset is not estimated for cases with missing onset dates.\", \"4 days\", \"4 days\"]", "scores": [{"f1": 0.08695652173913043, "em": false, "chrf": 16.989753246892754, "bleu": 2.8398387225677895}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6956521739130435, "avg_em": 0.6666666666666666, "avg_chrf": 72.32991774896425, "avg_bleu": 67.61327957418929}
{"id": "PubMed_9:804", "en": "Public health departments reported cases to CDC using a standardized case report form that captures information (yes, no, or unknown) on the following conditions and potential risk factors: chronic lung disease (inclusive of asthma, chronic obstructive pulmonary disease [COPD], and emphysema); diabetes mellitus; cardiovascular disease; chronic renal disease; chronic liver disease; immunocompromised condition; neurologic disorder, neurodevelopmental, or intellectual disability; pregnancy; current smoking status; former smoking status; or other chronic disease.", "fr": "Les services de santé publique ont signalé les cas aux CDC via un formulaire de rapport de cas normalisé permettant de rassembler des informations (oui, non ou inconnu) sur les problèmes de santé et les facteurs de risque potentiels suivants : une maladie pulmonaire chronique (notamment l’asthme, une maladie pulmonaire obstructive chronique [MPOC] et l’emphysème) ; le diabète sucré ; une maladie cardiovasculaire ; une maladie rénale chronique ; une maladie hépatique chronique ; une immunodéficience ; un trouble neurologique, un trouble neurodéveloppemental ou une déficience intellectuelle ; une grossesse ; le tabagisme ; des antécédents de tabagisme ; ou une autre maladie chronique.", "perturbation": "alteration", "pert_fr": "Les services de santé publique n'ont pas signalé les cas aux CDC via un formulaire de rapport de cas normalisé permettant de rassembler des informations (oui, non ou inconnu) sur les problèmes de santé et les facteurs de risque potentiels suivants : une maladie pulmonaire chronique (notamment l’asthme, une maladie pulmonaire obstructive chronique [MPOC] et l’emphysème) ; le diabète sucré ; une maladie cardiovasculaire ; une maladie rénale chronique ; une maladie hépatique chronique ; une immunodéficience ; un trouble neurologique, un trouble neurodéveloppemental ou une déficience intellectuelle ; une grossesse ; le tabagisme ; des antécédents de tabagisme ; ou une autre maladie chronique.", "bt_pert_fr": "Public health departments did not report cases to CDC via a standardized case report form to gather information (yes, no, or unknown) on the following health conditions and potential risk factors: chronic lung disease (including asthma, chronic obstructive pulmonary disease [COPD], and emphysema); diabetes mellitus; cardiovascular disease; chronic kidney disease; chronic liver disease; immunodeficiency; a neurological disorder, neurodevelopmental disorder, or intellectual disability; pregnancy; smoking; a history of smoking; or another chronic illness.", "questions": "[\"Does the standardized case report form capture information on chronic lung disease?\", \"Does the standardized case report form capture information on diabetes mellitus?\", \"Does the standardized case report form capture information on cardiovascular disease?\", \"Does the standardized case report form capture information on chronic renal disease?\", \"Does the standardized case report form capture information on chronic liver disease?\", \"Does the standardized case report form capture information on immunocompromised condition?\", \"Does the standardized case report form capture information on neurologic disorder, neurodevelopmental, or intellectual disability?\", \"Does the standardized case report form capture information on pregnancy?\", \"Does the standardized case report form capture information on current smoking status?\", \"Does the standardized case report form capture information on former smoking status?\", \"Does the standardized case report form capture information on other chronic disease?\"]", "answers": "[\"No\", \"No\", \"No\", \"No\", \"No\", \"No\", \"No\", \"No\", \"No\", \"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "PubMed_9:805", "en": "Data reported to CDC are preliminary and can be updated by health departments over time; critical data elements might be missing at the time of initial report; thus, this analysis is descriptive, and no statistical comparisons could be made.", "fr": "Les données communiquées aux CDC sont des données préliminaires qui peuvent être mises à jour par les services de santé au fil du temps ; des éléments de données critiques peuvent avoir manqués lors de la rédaction du rapport initial ; il s’agit donc d’une analyse descriptive, et aucune comparaison statistique ne peut être réalisée.", "perturbation": "alteration", "pert_fr": "Les données communiquées aux CDC sont des données définitives qui ne peuvent être mises à jour par les services de santé au fil du temps ; des éléments de données critiques peuvent avoir été inclus lors de la rédaction du rapport initial ; il s’agit donc d’une analyse comparative, et toute comparaison statistique peut être réalisée.", "bt_pert_fr": "Data reported to CDC is final data that cannot be updated by health departments over time; critical data elements may have been included when the initial report was written; it is therefore a comparative analysis, and any statistical comparison can be made.", "questions": "[\"Are the data reported to CDC preliminary?\", \"Can health departments update the data reported to CDC over time?\", \"Might critical data elements be missing at the time of initial report?\", \"Is the analysis descriptive?\", \"Could statistical comparisons be made based on the data reported to CDC?\"]", "answers": "[\"No\", \"No\", \"No\", \"No\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "PubMed_9:806", "en": "The percentages of patients of all ages with underlying health conditions who were not hospitalized, hospitalized without ICU admission, and hospitalized with ICU admission were calculated.", "fr": "Les pourcentages de patients tous âges confondus présentant des problèmes de santé sous-jacents n’ayant pas été hospitalisés, ayant été hospitalisés sans admission en USI et ayant été hospitalisés avec admission en USI ont été calculés.", "perturbation": "alteration", "pert_fr": "Les pourcentages de patients tous âges confondus présentant des problèmes de santé sous-jacents ayant été hospitalisés, n’ayant pas été hospitalisés sans admission en USI et n’ayant pas été hospitalisés avec admission en USI ont été calculés.", "bt_pert_fr": "The percentages of patients of all ages with underlying health conditions who were hospitalized, who were not hospitalized without ICU admission, and who were not hospitalized with ICU admission were calculated.", "questions": "[\"What percentages were calculated for patients with underlying health conditions?\", \"What percentage of patients with underlying health conditions were not hospitalized?\", \"What percentage of patients with underlying health conditions were hospitalized without ICU admission?\", \"What percentage of patients with underlying health conditions were hospitalized with ICU admission?\"]", "answers": "[\"The percentages of patients of all ages with underlying health conditions who were hospitalized, who were not hospitalized without ICU admission, and who were not hospitalized with ICU admission\", \"The percentage of patients with underlying health conditions who were not hospitalized\", \"The percentage of patients with underlying health conditions who were hospitalized without ICU admission\", \"The percentage of patients with underlying health conditions who were hospitalized with ICU admission\"]", "scores": [{"f1": 0.9056603773584906, "em": false, "chrf": 94.29308070101962, "bleu": 68.7043893563274}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.9764150943396226, "avg_em": 0.75, "avg_chrf": 98.5732701752549, "avg_bleu": 92.17609733908188}
{"id": "PubMed_9:807", "en": "Percentages of hospitalizations with and without ICU admission were estimated for persons aged ≥19 years with and without underlying health conditions.", "fr": "Les pourcentages d’hospitalisation avec ou sans admission en USI ont été estimés pour les individus de 19 ans ou plus, avec et sans problèmes de santé sous-jacents.", "perturbation": "alteration", "pert_fr": "Les pourcentages de guérison avec ou sans admission en USI ont été estimés pour les individus de 19 ans ou moins, avec et sans problèmes de santé sous-jacents.", "bt_pert_fr": "Recovery percentages with or without ICU admission were estimated for individuals 19 years of age or younger, with and without underlying health conditions.", "questions": "[\"What percentages of hospitalizations were estimated for persons aged ≥19 years with underlying health conditions?\", \"What percentages of hospitalizations were estimated for persons aged ≥19 years without underlying health conditions?\", \"What percentages of hospitalizations were estimated for persons with ICU admission?\", \"What percentages of hospitalizations were estimated for persons without ICU admission?\"]", "answers": "[\"None\", \"None\", \"None\", \"None\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.3732937220369896, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 2.245389827054838, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 4.687678510225067, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 4.213515374024782, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 3.379969358335419, "avg_bleu": 0.0}
{"id": "PubMed_9:808", "en": "This part of the analysis was limited to persons aged ≥19 years because of the small sample size of cases in children with reported underlying health conditions (N = 32).", "fr": "Cette partie de l’analyse a été restreinte aux individus de 19 ans ou plus en raison du très petit nombre de cas d’enfants présentant des problèmes de santé sous-jacents (N = 32).", "perturbation": "alteration", "pert_fr": "Cette partie de l’analyse a été étendue aux individus de 19 ans ou moins en raison du très grand nombre de cas d’enfants présentant des problèmes de santé sous-jacents (N = 32).", "bt_pert_fr": "This part of the analysis was extended to individuals aged 19 or younger due to the very large number of cases of children with underlying health conditions (N = 32).", "questions": "[\"Why was this part of the analysis limited to persons aged ≥19 years?\", \"What was the reason for the small sample size of cases in children with reported underlying health conditions?\", \"What was the sample size of cases in children with reported underlying health conditions?\"]", "answers": "[\"This part of the analysis was not limited to persons aged ≥19 years\", \"The reason for the small sample size is not mentioned in the sentence\", \"32\"]", "scores": [{"f1": 0.07692307692307691, "em": false, "chrf": 14.32576392617689, "bleu": 2.8666091494718775}, {"f1": 0.41666666666666663, "em": false, "chrf": 32.80667416275564, "bleu": 13.215955651112742}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.49786324786324787, "avg_em": 0.3333333333333333, "avg_chrf": 49.044146029644175, "avg_bleu": 38.69418826686155}
{"id": "PubMed_9:810", "en": "Because of small sample size and missing data on underlying health conditions among COVID-19 patients who died, case-fatality rates for persons with and without underlying conditions were not estimated.", "fr": "En raison de la petite taille d’échantillon et du manque de données concernant les problèmes de santé sous-jacents des patients décédés de la COVID-19, les taux de létalité pour les individus avec et sans problèmes de santé sous-jacents n’ont pas été estimés.", "perturbation": "alteration", "pert_fr": "En raison de la grande taille d’échantillon et du manque de données concernant les problèmes de santé sous-jacents des patients décédés de la COVID-19, les taux de létalité pour les individus avec et sans problèmes de santé sous-jacents ont été estimés.", "bt_pert_fr": "Due to the large sample size and lack of data regarding the underlying health conditions of patients who died from COVID-19, case fatality rates for individuals with and without underlying health conditions were estimated.", "questions": "[\"Why were case-fatality rates for persons with and without underlying conditions not estimated?\", \"What contributed to the inability to estimate case-fatality rates for persons with and without underlying conditions?\", \"How did the small sample size and missing data on underlying health conditions affect the estimation of case-fatality rates?\"]", "answers": "[\"Because of the large sample size and lack of data regarding the underlying health conditions of patients who died from COVID-19\", \"The large sample size and lack of data regarding the underlying health conditions of patients who died from COVID-19\", \"The large sample size and missing data on underlying health conditions made it impossible to accurately estimate case-fatality rates\"]", "scores": [{"f1": 0.7222222222222222, "em": false, "chrf": 66.68087181887678, "bleu": 19.57196409280758}, {"f1": 0.5, "em": false, "chrf": 61.08791374542017, "bleu": 13.973536728747975}, {"f1": 0.5714285714285715, "em": false, "chrf": 56.71471852413593, "bleu": 38.07054479764566}], "avg_f1": 0.5978835978835979, "avg_em": 0.0, "avg_chrf": 61.49450136281096, "avg_bleu": 23.872015206400405}
{"id": "PubMed_9:814", "en": "Approximately one third of these patients (2,692, 37.6%), had at least one underlying condition or risk factor.", "fr": "Environ un tiers de ces patients (2 692, 37,6 %) présentaient au moins un problème de santé sous-jacent ou un facteur de risque.", "perturbation": "alteration", "pert_fr": "Environ deux tiers de ces patients (2 692, 37,6 %) ne présentaient aucun problème de santé sous-jacent ou facteur de risque.", "bt_pert_fr": "Approximately two-thirds of these patients (2,692, 37.6%) had no underlying health conditions or risk factors.", "questions": "[\"What percentage of these patients had at least one underlying condition or risk factor?\", \"How many of these patients had at least one underlying condition or risk factor?\", \"What is the proportion of patients with at least one underlying condition or risk factor?\"]", "answers": "[\"42.4%\", \"2,692\", \"42.4%\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.3333333333333333, "avg_em": 0.3333333333333333, "avg_chrf": 33.333333333333336, "avg_bleu": 33.33333333333335}
{"id": "PubMed_9:817", "en": "In contrast, 1,388 of 5,143 (27%) COVID-19 patients who were not hospitalized were reported to have at least one underlying health condition.", "fr": "A contrario, 1 388 patients atteints de la COVID-19 sur 5 143 (27 %) n’ayant pas été hospitalisés présentaient au moins un problème de santé sous-jacent.", "perturbation": "alteration", "pert_fr": "A contrario, 1 388 patients guéris de la COVID-19 sur 5 143 (27 %) ayant été hospitalisés présentaient au moins un problème de santé sous-jacent.", "bt_pert_fr": "Conversely, 1,388 patients recovered from COVID-19 out of 5,143 (27%) who were hospitalized had at least one underlying health problem.", "questions": "[\"What percentage of COVID-19 patients who were not hospitalized had at least one underlying health condition?\", \"How many of the 5,143 COVID-19 patients who were not hospitalized had at least one underlying health condition?\", \"What is the number of COVID-19 patients who were not hospitalized and had at least one underlying health condition?\", \"What proportion of non-hospitalized COVID-19 patients had at least one underlying health condition?\"]", "answers": "[\"The sentence does not provide information about patients who were not hospitalized.\", \"The sentence does not provide information about the number of non-hospitalized patients.\", \"The sentence does not provide information about the number of non-hospitalized patients with underlying health conditions.\", \"The sentence does not provide information about the proportion of non-hospitalized patients with underlying health conditions.\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "PubMed_9:818", "en": "Among patients aged ≥19 years, the percentage of non-ICU hospitalizations was higher among those with underlying health conditions (27.3%–29.8%) than among those without underlying health conditions (7.2%–7.8%); the percentage of cases that resulted in an ICU admission was also higher for those with underlying health conditions (13.3%–14.5%) than those without these conditions (2.2%–2.4%) (Table 2).", "fr": "Parmi les patients de 19 ans ou plus, le pourcentage d’hospitalisations hors USI était supérieur pour ceux présentant des problèmes de santé sous-jacents (27,3 %–29,8 %) que pour ceux n’en présentant pas (7,2 %–7,8 %) ; le pourcentage de cas ayant nécessité une admission en USI était également supérieur pour ceux présentant des problèmes de santé sous-jacents (13,3 %–14,5 %) que pour ceux n’en présentant pas (2,2 %–2,4 %) (Tableau 2).CI", "perturbation": "alteration", "pert_fr": "Parmi les patients de 19 ans ou plus, le pourcentage d’hospitalisations hors USI était inférieur pour ceux présentant des problèmes de santé sous-jacents (27,3 %–29,8 %) que pour ceux n’en présentant pas (7,2 %–7,8 %) ; le pourcentage de cas ayant nécessité une admission en USI était également inférieur pour ceux présentant des problèmes de santé sous-jacents (13,3 %–14,5 %) que pour ceux n’en présentant pas (2,2 %–2,4 %) (Tableau 2).", "bt_pert_fr": "Among patients 19 years or older, the percentage of non-ICU hospitalizations was lower for those with underlying health conditions (27.3%–29.8%) than for those without (7.2%–7.8%); the percentage of cases requiring ICU admission was also lower for those with underlying health conditions (13.3%–14.5%) than for those without (2.2%–2.4%) (Table 2).", "questions": "[\"What is the percentage of non-ICU hospitalizations among patients aged ≥19 years with underlying health conditions?\", \"What is the percentage of non-ICU hospitalizations among patients aged ≥19 years without underlying health conditions?\", \"What is the percentage of ICU admissions among patients aged ≥19 years with underlying health conditions?\", \"What is the percentage of ICU admissions among patients aged ≥19 years without underlying health conditions?\"]", "answers": "[ \"27.3%–29.8%\", \"7.2%–7.8%\", \"13.3%–14.5%\", \"2.2%–2.4%\" ]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "PubMed_9:822", "en": "Among 122,653 U.S. COVID-19 cases reported to CDC as of March 28, 2020, 7,162 (5.8%) patients had data available pertaining to underlying health conditions or potential risk factors; among these patients, higher percentages of patients with underlying conditions were admitted to the hospital and to an ICU than patients without reported underlying conditions.", "fr": "Sur les 122 653 cas de COVID-19 aux États-Unis rapportés aux CDC au 28 mars 2020, des données sur les problèmes de santé sous-jacents ou facteurs de risque potentiels étaient disponibles pour 7 162 patients (5,8 %) ; sur ces cas, le pourcentage de patients ayant nécessité une hospitalisation et une admission en USI était plus élevé chez ceux présentant des problèmes de santé sous-jacents que chez ceux n’en présentant pas.", "perturbation": "alteration", "pert_fr": "Sur les 122 653 cas de COVID-19 aux États-Unis rapportés aux CDC au 28 mars 2020, des données sur les problèmes de santé sous-jacents ou facteurs de risque potentiels étaient disponibles pour 7 162 patients (5,8 %) ; sur ces cas, le pourcentage de patients n'ayant pas nécessité une hospitalisation et une admission en USI était plus élevé chez ceux présentant des problèmes de santé sous-jacents que chez ceux n’en présentant pas.", "bt_pert_fr": "Of the 122,653 cases of COVID-19 in the United States reported to the CDC as of March 28, 2020, data on underlying health conditions or potential risk factors was available for 7,162 patients (5.8%); of these cases, the percentage of patients who did not require hospitalization and ICU admission was higher in those with underlying health conditions than in those without.", "questions": "[\"How many U.S. COVID-19 cases were reported to CDC as of March 28, 2020?\", \"How many of the reported U.S. COVID-19 cases had data available pertaining to underlying health conditions or potential risk factors?\", \"What percentage of U.S. COVID-19 cases had data available pertaining to underlying health conditions or potential risk factors?\", \"Were patients with underlying health conditions more likely to be admitted to the hospital than those without reported underlying conditions?\", \"Were patients with underlying health conditions more likely to be admitted to an ICU than those without reported underlying conditions?\"]", "answers": "[122653, 7162, \"5.8%\", \"no\", \"no\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.3333333333333333, "avg_em": 0.3333333333333333, "avg_chrf": 33.333333333333336, "avg_bleu": 33.33333333333335}
{"id": "PubMed_9:823", "en": "These results are consistent with findings from China and Italy, which suggest that patients with underlying health conditions and risk factors, including, but not limited to, diabetes mellitus, hypertension, COPD, coronary artery disease, cerebrovascular disease, chronic renal disease, and smoking, might be at higher risk for severe disease or death from COVID-19.", "fr": "Ces résultats sont cohérents avec les constatations réalisées par la Chine et l’Italie, qui suggèrent que les patients présentant des problèmes de santé sous-jacents et des facteurs de risque, notamment, mais sans s’y limiter, le diabète sucré, l’hypertension, une MPOC, une maladie coronarienne, une maladie cérébrovasculaire, une maladie rénale chronique et le tabagisme, seraient plus susceptibles de développer une forme grave de la COVID-19 et d’en décéder.", "perturbation": "alteration", "pert_fr": "Ces résultats sont incohérents avec les constatations réalisées par la Chine et l’Italie, qui suggèrent que les patients présentant des problèmes de santé sous-jacents et des facteurs de risque, notamment, mais sans s’y limiter, le diabète sucré, l’hypertension, une MPOC, une maladie coronarienne, une maladie cérébrovasculaire, une maladie rénale chronique et le tabagisme, ne seraient pas plus susceptibles de développer une forme grave de la COVID-19 et d’en décéder.", "bt_pert_fr": "These results are inconsistent with findings from China and Italy, which suggest that patients with underlying health conditions and risk factors, including but not limited to diabetes mellitus, hypertension, COPD, coronary heart disease, cerebrovascular disease, chronic kidney disease, and smoking, would not be more likely to develop severe COVID-19 and die from it.", "questions": "[\"Do findings from China and Italy suggest that patients with underlying health conditions and risk factors might be at higher risk for severe disease or death from COVID-19?\", \"Which underlying health conditions and risk factors are mentioned as potentially increasing the risk for severe disease or death from COVID-19?\", \"Does the evidence from China and Italy indicate a link between specific health conditions and severe outcomes of COVID-19?\", \"Are diabetes mellitus, hypertension, COPD, coronary artery disease, cerebrovascular disease, chronic renal disease, and smoking identified as risk factors for severe disease or death from COVID-19 according to findings from China and Italy?\"]", "answers": "[\"No\", \"diabetes mellitus, hypertension, COPD, coronary heart disease, cerebrovascular disease, chronic kidney disease, and smoking\", \"No\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.8571428571428571, "em": false, "chrf": 86.60940098168611, "bleu": 53.33505353503043}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.4642857142857143, "avg_em": 0.25, "avg_chrf": 46.65235024542153, "avg_bleu": 38.33376338375762}
{"id": "PubMed_9:825", "en": "It is not yet known whether the severity or level of control of underlying health conditions affects the risk for severe disease associated with COVID-19.", "fr": "Il n’a pas encore été établi si la sévérité ou le niveau de contrôle des problèmes de santé sous-jacents affectent le risque de complications graves associées à la COVID-19.", "perturbation": "alteration", "pert_fr": "Il a été établi que la sévérité ou le niveau de contrôle des problèmes de santé sous-jacents réduisent le risque de complications graves associées à la COVID-19.", "bt_pert_fr": "The severity or level of control of underlying health conditions has been shown to reduce the risk of serious complications associated with COVID-19.", "questions": "[\"Is it known whether the severity of underlying health conditions affects the risk for severe disease associated with COVID-19?\", \"Is it known whether the level of control of underlying health conditions affects the risk for severe disease associated with COVID-19?\"]", "answers": "[\"Yes\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "PubMed_9:826", "en": "Many of these underlying health conditions are common in the United States: based on self-reported 2018 data, the prevalence of diagnosed diabetes among U.S. adults was 10.1%, and the U.S. age-adjusted prevalence of all types of heart disease (excluding hypertension without other heart disease) was 10.6% in 2017.", "fr": "Nombre de ces problèmes de santé sous-jacents sont communs aux États-Unis : d’après les données auto-déclarées de 2018, la prévalence des diabètes diagnostiqués chez des adultes était de 10,1 %, et la prévalence selon l’âge de l’ensemble des maladies cardiaques (hors hypertension sans autre maladie cardiaque) était de 10,6 % en 2017.", "perturbation": "alteration", "pert_fr": "Nombre de ces problèmes de santé sous-jacents sont rares aux États-Unis : d’après les données auto-déclarées de 2018, la prévalence des diabètes diagnostiqués chez des adultes était de 10,1 %, et la prévalence selon l’âge de l’ensemble des maladies cardiaques (hors hypertension sans autre maladie cardiaque) était de 0,6 % en 2017.", "bt_pert_fr": "Many of these underlying health conditions are rare in the United States: according to 2018 self-reported data, the prevalence of diagnosed diabetes among adults was 10.1%, and the age-specific prevalence of overall heart disease (excluding hypertension without other heart disease) was 0.6% in 2017.", "questions": "[\"What is the prevalence of diagnosed diabetes among U.S. adults based on self-reported 2018 data?\", \"What is the U.S. age-adjusted prevalence of all types of heart disease (excluding hypertension without other heart disease) in 2017?\"]", "answers": "[\"10.1%\", \"0.6%\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 63.636363636363626, "bleu": 0.0}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 81.81818181818181, "avg_bleu": 50.00000000000002}
{"id": "PubMed_9:829", "en": "The estimated higher prevalence of these conditions among those in this early group of U.S. COVID-19 patients and the potentially higher risk for more severe disease from COVID-19 associated with the presence of underlying conditions highlight the importance of COVID-19 prevention in persons with underlying conditions.", "fr": "La prévalence supérieure estimée de ces problèmes de santé pour ce premier groupe de patients américains atteints de la COVID-19 et un risque potentiellement accru de développer une forme grave de la COVID-19 en raison de la présence de problèmes de santé sous-jacents soulignent l’importance de prévenir la COVID-19 chez les individus présentant de telles conditions.", "perturbation": "alteration", "pert_fr": "La prévalence inférieure estimée de ces problèmes de santé pour ce premier groupe de patients américains atteints de la COVID-19 et un risque potentiellement diminué de développer une forme grave de la COVID-19 en raison de l’absence de problèmes de santé sous-jacents soulignent l’importance de prévenir la COVID-19 chez les individus présentant de telles conditions.", "bt_pert_fr": "The estimated lower prevalence of these health conditions for this first group of U.S. COVID-19 patients and a potentially decreased risk of developing severe COVID-19 due to the absence of underlying health conditions highlights the importance of preventing COVID-19 in individuals with such conditions.", "questions": "[\"What is the estimated prevalence of these conditions among early U.S. COVID-19 patients?\", \"Does the presence of underlying conditions increase the risk for more severe disease from COVID-19?\", \"Why is COVID-19 prevention important for persons with underlying conditions?\"]", "answers": "[\"lower\", \"Yes\", \"Because individuals with underlying health conditions are at a higher risk of developing severe COVID-19\"]", "scores": [{"f1": 0, "em": false, "chrf": 11.063829787234042, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 38.888888888888886, "bleu": 0.0}, {"f1": 0.6000000000000001, "em": false, "chrf": 45.05586075197531, "bleu": 7.171082716017387}], "avg_f1": 0.20000000000000004, "avg_em": 0.0, "avg_chrf": 31.669526476032747, "avg_bleu": 2.390360905339129}
{"id": "PubMed_9:831", "en": "First, these data are preliminary, and the analysis was limited by missing data related to the health department reporting burden associated with rapidly rising case counts and delays in completion of information requiring medical chart review; these findings might change as additional data become available.", "fr": "Premièrement, il s’agit de données préliminaires, et leur analyse a été limitée par le manque de données induit par la charge de travail importante qui pesait sur les services de santé en raison de l’augmentation rapide du nombre de cas ainsi que par le retard dans la collecte de données nécessitant un examen des dossiers médicaux ; ces conclusions pourront évoluer au fur et à mesure que de nouvelles données seront disponibles.", "perturbation": "alteration", "pert_fr": "Premièrement, il s’agit de données définitives, et leur analyse a été limitée par l'excès de données induit par la charge de travail faible qui pesait sur les services de santé en raison de la diminution rapide du nombre de cas ainsi que par l'avance dans la collecte de données nécessitant un examen des dossiers médicaux ; ces conclusions pourront évoluer au fur et à mesure que de nouvelles données seront disponibles.", "bt_pert_fr": "First, this is definitive data, and its analysis was limited by the excess of data induced by the low workload which weighed on the health services due to the rapid decrease in the number of cases as well as by the advance in the collection of data requiring a review of medical records; These conclusions may evolve as new data becomes available.", "questions": "[\"Are these data preliminary?\", \"What limits the analysis?\", \"What specific missing data affects the analysis?\", \"What is the reason for delays in completing information requiring medical chart review?\", \"Could the findings change as additional data become available?\"]", "answers": "[\"No\", \"The excess of data induced by the low workload and the advance in the collection of data requiring a review of medical records\", \"The rapid decrease in the number of cases\", \"The rapid decrease in the number of cases\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.09523809523809525, "em": false, "chrf": 12.446748392974298, "bleu": 2.0244462660665508}, {"f1": 0.12903225806451613, "em": false, "chrf": 7.487262327300905, "bleu": 0.6885373656134077}, {"f1": 0, "em": false, "chrf": 21.660955142435608, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.24485407066052228, "avg_em": 0.2, "avg_chrf": 28.31899317254216, "avg_bleu": 20.542596726336}
{"id": "PubMed_9:832", "en": "Information on underlying conditions was only available for 7,162 (5.8%) of 122,653 cases reported to CDC.", "fr": "Sur 122 653 cas rapportés aux CDC, seulement 7 162 (5,8 %) étaient associés à des données sur les problèmes de santé sous-jacents.", "perturbation": "alteration", "pert_fr": "Sur 122 653 cas rapportés aux CDC, presque tous les 7 162 (5,8 %) étaient associés à des données sur l'absence de problèmes de santé sous-jacents.", "bt_pert_fr": "Of 122,653 cases reported to the CDC, almost all 7,162 (5.8%) were associated with data on the absence of underlying health conditions.", "questions": "[\"How many cases had information on underlying conditions?\", \"What percentage of cases had information on underlying conditions?\", \"What is the total number of cases reported to CDC?\", \"What is the number of cases with information on underlying conditions?\", \"What proportion of cases reported to CDC had information on underlying conditions?\"]", "answers": "[\"115491\", \"94.2%\", \"122653\", \"7162\", \"5.8%\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.75, "avg_em": 0.75, "avg_chrf": 75.0, "avg_bleu": 75.00000000000003}
{"id": "PubMed_9:836", "en": "Third, because of the limited availability of testing in many jurisdictions during this period, this analysis is likely biased toward more severe cases, and findings might change as testing becomes more widespread.", "fr": "Troisièmement, étant donné la disponibilité limitée des tests dans de nombreuses juridictions pendant cette période, cette analyse manque probablement d’objectivité quant aux cas les plus graves, et les résultats pourraient évoluer au fur et à mesure que davantage de tests seront réalisés.", "perturbation": "alteration", "pert_fr": "Troisièmement, étant donné la disponibilité illimitée des tests dans de nombreuses juridictions pendant cette période, cette analyse possède probablement une grande objectivité quant aux cas les moins graves, et les résultats pourraient évoluer au fur et à mesure que davantage de tests seront réalisés.", "bt_pert_fr": "Third, given the unrestricted availability of testing in many jurisdictions during this time, this analysis likely has a high degree of objectivity regarding less severe cases, and results may evolve as more testing is conducted.", "questions": "[\"Is the analysis biased toward more severe cases due to limited testing availability?\", \"Could the findings change as testing becomes more widespread?\"]", "answers": "[\"No\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 50.0, "avg_bleu": 50.00000000000002}
{"id": "PubMed_9:837", "en": "Fourth, because of the descriptive nature of these data, attack rates among persons with and without underlying health conditions could not be compared, and thus the risk difference of severe disease with COVID-19 between these groups could not be estimated.", "fr": "Quatrièmement, compte tenu de la nature descriptive de ces données, les taux d’attaque chez les individus avec et sans problèmes de santé sous-jacents n’ont pu être comparés, et il n’a donc pas été possible d’estimer la différence de risque de développer une forme grave de la COVID-19 entre ces groupes.", "perturbation": "alteration", "pert_fr": "Quatrièmement, compte tenu de la nature descriptive de ces données, les taux d’attaque chez les individus avec et sans problèmes de santé sous-jacents ont pu être comparés, et il a donc été possible d’estimer la différence de risque de développer une forme grave de la COVID-19 entre ces groupes.", "bt_pert_fr": "Fourth, given the descriptive nature of these data, attack rates in individuals with and without underlying health conditions could be compared, and it was therefore possible to estimate the difference in risk of developing severe COVID-19 between these groups.", "questions": "[\"Could attack rates among persons with and without underlying health conditions be compared?\", \"Could the risk difference of severe disease with COVID-19 between persons with and without underlying health conditions be estimated?\"]", "answers": "[\"Yes\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "PubMed_9:838", "en": "Fifth, no conclusions could be drawn about underlying conditions that were not included in the case report form or about different conditions that were reported in a single, umbrella category.", "fr": "Cinquièmement, aucune conclusion ne peut être tirée concernant les problèmes de santé sous-jacents qui n’ont pas été inclus dans le formulaire de rapport de cas ou d’autres problèmes de santé classés dans une catégorie générique.", "perturbation": "alteration", "pert_fr": "Cinquièmement, une conclusion peut être tirée concernant les problèmes de santé sous-jacents qui n’ont pas été inclus dans le formulaire de rapport de cas ou d’autres problèmes de santé classés dans une catégorie générique.", "bt_pert_fr": "Fifth, a conclusion can be drawn regarding underlying health conditions that were not included in the case report form or other health conditions placed in a generic category.", "questions": "[\"Can any conclusions be drawn about underlying conditions not included in the case report form?\", \"Are there any conclusions about different conditions reported in a single, umbrella category?\"]", "answers": "[\"Yes\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "PubMed_9:839", "en": "For example, asthma and COPD were included in a chronic lung disease category.", "fr": "Par exemple, l’asthme et la MPOC ont été inclus dans la catégorie des maladies pulmonaires chroniques.", "perturbation": "alteration", "pert_fr": "Par exemple, l’asthme et la MPOC ont été exclus de la catégorie des maladies pulmonaires chroniques.", "bt_pert_fr": "For example, asthma and COPD were excluded from the chronic lung disease category.", "questions": "[\"Was asthma included in a chronic lung disease category?\", \"Was COPD included in a chronic lung disease category?\"]", "answers": "[\"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "PubMed_9:840", "en": "Finally, for some underlying health conditions and risk factors, including neurologic disorders, chronic liver disease, being a current smoker, and pregnancy, few severe outcomes were reported; therefore, conclusions cannot be drawn about the risk for severe COVID-19 among persons in these groups.", "fr": "Enfin, pour certains problèmes de santé sous-jacents et facteurs de risque, notamment les troubles neurologiques, une maladie hépatique chronique, le tabagisme actif et la grossesse, peu de cas graves ont été rapportés ; il n’est donc pas possible de tirer des conclusions quant au risque de contracter une forme grave de la COVID-19 chez les individus appartenant à ces groupes.", "perturbation": "alteration", "pert_fr": "Enfin, pour certains problèmes de santé sous-jacents et facteurs de protection, notamment les troubles neurologiques, une maladie hépatique chronique, le tabagisme actif et la grossesse, peu de cas graves n’ont pas été rapportés ; il est donc possible de tirer des conclusions quant au risque de contracter une forme grave de la COVID-19 chez les individus appartenant à ces groupes.", "bt_pert_fr": "Finally, for some underlying health conditions and protective factors, including neurological disorders, chronic liver disease, active smoking and pregnancy, few serious cases have not been reported; it is therefore possible to draw conclusions regarding the risk of contracting a severe form of COVID-19 among individuals belonging to these groups.", "questions": "[\"Are there few severe outcomes reported for neurologic disorders?\", \"Are there few severe outcomes reported for chronic liver disease?\", \"Are there few severe outcomes reported for being a current smoker?\", \"Are there few severe outcomes reported for pregnancy?\", \"Can conclusions be drawn about the risk for severe COVID-19 among persons with neurologic disorders?\", \"Can conclusions be drawn about the risk for severe COVID-19 among persons with chronic liver disease?\", \"Can conclusions be drawn about the risk for severe COVID-19 among current smokers?\", \"Can conclusions be drawn about the risk for severe COVID-19 among pregnant individuals?\"]", "answers": "[\"Yes\", \"Yes\", \"Yes\", \"Yes\", \"Yes\", \"Yes\", \"Yes\", \"Yes\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 50.0, "avg_bleu": 50.00000000000002}
{"id": "PubMed_9:841", "en": "Persons in the United States with underlying health conditions appear to be at higher risk for more severe COVID-19, consistent with findings from other countries.", "fr": "Aux États-Unis, les individus souffrant de problèmes de santé sous-jacents semblent présenter un risque accru de développer une forme grave de la COVID-19, ce qui est cohérent avec les conclusions tirées par d’autres pays.", "perturbation": "alteration", "pert_fr": "Aux États-Unis, les individus ne souffrant pas de problèmes de santé sous-jacents semblent présenter un risque accru de développer une forme grave de la COVID-19, ce qui est cohérent avec les conclusions tirées par d’autres pays.", "bt_pert_fr": "In the United States, individuals without underlying health conditions appear to be at increased risk of developing severe COVID-19, consistent with findings in other countries.", "questions": "[\"Are persons in the United States with underlying health conditions at higher risk for more severe COVID-19?\", \"Is the increased risk of severe COVID-19 among persons with underlying health conditions in the United States consistent with findings from other countries?\"]", "answers": "[\"No\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 50.0, "avg_bleu": 50.00000000000002}
{"id": "PubMed_9:844", "en": "Maintaining at least a 30-day supply of medication, a 2-week supply of food and other necessities, and knowledge of COVID-19 symptoms are recommended for those with underlying health conditions.", "fr": "Il est recommandé aux personnes présentant des problèmes de santé sous-jacents de prévoir un stock de médicaments d’au moins 30 jours ainsi qu’un stock de nourriture et d’articles de première nécessité de 2 semaines, et de connaître les symptômes de la COVID-19.", "perturbation": "alteration", "pert_fr": "Il est recommandé aux personnes présentant des problèmes de santé sous-jacents de prévoir un stock de médicaments d’au moins 30 jours ainsi qu’un stock de nourriture et d’articles de luxe de 2 semaines, et de connaître les symptômes de la grippe.", "bt_pert_fr": "It is recommended that people with underlying health conditions have at least a 30-day supply of medications, a 2-week supply of food and luxury items, and be aware of flu symptoms.", "questions": "[\"Is it recommended to maintain a 30-day supply of medication for those with underlying health conditions?\", \"Is it recommended to maintain a 2-week supply of food and other necessities for those with underlying health conditions?\", \"Is it recommended to have knowledge of COVID-19 symptoms for those with underlying health conditions?\"]", "answers": "[\"Yes\", \"Yes\", \"No\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.6666666666666666, "avg_em": 0.6666666666666666, "avg_chrf": 66.66666666666667, "avg_bleu": 66.6666666666667}
{"id": "PubMed_9:845", "en": "All persons should take steps to protect themselves from COVID-19 and to protect others.", "fr": "Chacun doit prendre les mesures qui s’imposent pour se protéger et protéger les autres de la COVID-19.", "perturbation": "alteration", "pert_fr": "Chacun doit prendre les mesures qui s’imposent pour se protéger et exposer les autres de la COVID-19.", "bt_pert_fr": "Everyone must take appropriate measures to protect themselves and others from COVID-19.", "questions": "[\"What steps should persons take to protect themselves from COVID-19?\", \"What steps should persons take to protect others from COVID-19?\"]", "answers": "[\"Take appropriate measures\", \"Take appropriate measures\"]", "scores": [{"f1": 0.2, "em": false, "chrf": 14.240068345733459, "bleu": 7.253154775624655}, {"f1": 0.25, "em": false, "chrf": 20.211550387831473, "bleu": 14.127216461522432}], "avg_f1": 0.225, "avg_em": 0.0, "avg_chrf": 17.225809366782464, "avg_bleu": 10.690185618573544}
{"id": "PubMed_9:846", "en": "All persons who are ill should stay home, except to get medical care; should not go to work; and should stay away from others.", "fr": "Tout individu malade est tenu de ne pas quitter son domicile, sauf pour recevoir des soins médicaux, de ne pas aller travailler et d’observer une certaine distance avec autrui.", "perturbation": "alteration", "pert_fr": "Tout individu en bonne santé est tenu de ne pas quitter son domicile, sauf pour recevoir des soins médicaux, de ne pas aller travailler et d’observer une certaine distance avec autrui.", "bt_pert_fr": "Every healthy individual is required not to leave their home, except to receive medical care, not to go to work and to observe a certain distance from others.", "questions": "[\"Should ill persons stay home?\", \"Should ill persons go to work?\", \"Should ill persons stay away from others?\", \"When should ill persons go outside?\", \"What should ill persons do except for medical care?\"]", "answers": "[\"Not specified\", \"No\", \"Yes\", \"To receive medical care\", \"Not to leave their home\"]", "scores": [{"f1": 0, "em": false, "chrf": 13.88888888888889, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4444444444444445, "em": false, "chrf": 47.94889073188606, "bleu": 24.880469496253564}, {"f1": 0.28571428571428575, "em": false, "chrf": 21.668787226855983, "bleu": 10.682175159905853}], "avg_f1": 0.5460317460317461, "avg_em": 0.4, "avg_chrf": 56.70131336952619, "avg_bleu": 47.1125289312319}
{"id": "PubMed_9:847", "en": "This is especially important for those who work with persons with underlying conditions or who otherwise are at high risk for severe outcomes from COVID-19.", "fr": "Cela est particulièrement important pour ceux travaillant au contact de personnes présentant des problèmes de santé sous-jacents ou un risque élevé de développer une forme grave de la COVID-19.", "perturbation": "alteration", "pert_fr": "Cela est particulièrement important pour ceux travaillant au contact de personnes présentant des problèmes de santé excellents ou un risque faible de développer une forme grave de la COVID-19.", "bt_pert_fr": "This is particularly important for those working with people with excellent health conditions or a low risk of developing severe COVID-19.", "questions": "[\"Who should be especially cautious when working with persons who have underlying conditions or are at high risk for severe outcomes from COVID-19?\"]", "answers": "[\"Those working with people with excellent health conditions or a low risk of developing severe COVID-19\"]", "scores": [{"f1": 0.4571428571428572, "em": false, "chrf": 36.74642442349935, "bleu": 5.3259759306421515}], "avg_f1": 0.4571428571428572, "avg_em": 0.0, "avg_chrf": 36.74642442349935, "avg_bleu": 5.3259759306421515}
{"id": "PubMed_9:850", "en": "Published reports from China and Italy suggest that risk factors for severe COVID-19 disease include underlying health conditions, but data describing underlying health conditions among U.S. COVID-19 patients have not yet been reported.", "fr": "Des rapports provenant de Chine et d’Italie suggèrent que les facteurs de risque de contracter une forme grave de la COVID-19 incluent des problèmes de santé sous-jacents, mais aucune donnée relative aux problèmes de santé sous-jacents des patients américains atteints de la COVID-19 n’a encore été rapportée.", "perturbation": "alteration", "pert_fr": "Des rapports provenant de Chine et d’Italie suggèrent que les facteurs de protection contre une forme grave de la COVID-19 incluent des problèmes de santé sous-jacents, mais aucune donnée relative aux problèmes de santé sous-jacents des patients américains atteints de la COVID-19 n’a encore été rapportée.", "bt_pert_fr": "Reports from China and Italy suggest that protective factors against severe COVID-19 include underlying health conditions, but data on underlying health conditions in U.S. COVID-19 patients have not yet been reported.", "questions": "[\"Do published reports from China and Italy suggest that underlying health conditions are risk factors for severe COVID-19 disease?\", \"Have data describing underlying health conditions among U.S. COVID-19 patients been reported?\"]", "answers": "[\"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 50.0, "avg_bleu": 50.00000000000002}
{"id": "PubMed_9:854", "en": "Strategies to protect all persons and especially those with underlying health conditions, including social distancing and handwashing, should be implemented by all communities and all persons to help slow the spread of COVID-19.", "fr": "Des stratégies visant à protéger tous les individus et en particulier ceux présentant des problèmes de santé sous-jacents, notamment une distanciation sociale et un lavage régulier des mains, doivent être mises en œuvre par l’ensemble des communautés et des populations, afin de ralentir la propagation de la COVID-19.", "perturbation": "alteration", "pert_fr": "Des stratégies visant à exposer tous les individus et en particulier ceux présentant des problèmes de santé sous-jacents, notamment une promiscuité sociale et un lavage irrégulier des mains, doivent être mises en œuvre par l’ensemble des communautés et des populations, afin de ralentir la propagation de la COVID-19.", "bt_pert_fr": "Strategies to expose all individuals and particularly those with underlying health conditions, including social crowding and inconsistent hand washing, must be implemented by all communities and populations to slow the spread of COVID-19.", "questions": "[\"What strategies should be implemented by all communities and all persons to help slow the spread of COVID-19?\", \"Why is it important to implement strategies to protect persons with underlying health conditions?\", \"What specific actions like social distancing and handwashing are recommended to slow the spread of COVID-19?\"]", "answers": "[\"Exposing all individuals and particularly those with underlying health conditions, including social crowding and inconsistent hand washing\", \"To protect those with underlying health conditions from the spread of COVID-19\", \"Social crowding and inconsistent hand washing\"]", "scores": [{"f1": 0.09523809523809523, "em": false, "chrf": 35.91726115932775, "bleu": 2.2869567780619007}, {"f1": 0.7777777777777778, "em": false, "chrf": 91.60253702929563, "bleu": 57.067457770559976}, {"f1": 0.4, "em": false, "chrf": 57.54189949337246, "bleu": 9.652434877402245}], "avg_f1": 0.4243386243386243, "avg_em": 0.0, "avg_chrf": 61.68723256066528, "avg_bleu": 23.00228314200804}
{"id": "PubMed_10:856", "en": "The Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) and Public Health England (PHE) have successfully worked together on the surveillance of influenza and other infectious diseases for over 50 years, including three previous pandemics.", "fr": "Le Centre de recherche et de surveillance (Research and Surveillance Centre, RSC) du Royal College of General Practitioners (RCGP) et Public Health England (PHE) collaborent avec succès pour surveiller la grippe et d’autres maladies infectieuses depuis plus de 50 ans, notamment lors de trois pandémies passées.", "perturbation": "alteration", "pert_fr": "Le Centre de recherche et de surveillance (Research and Surveillance Centre, RSC) du Royal College of General Practitioners (RCGP) et Public Health England (PHE) collaborent sans succès pour surveiller la grippe et d’autres maladies infectieuses depuis plus de 50 ans, notamment lors de trois pandémies passées.", "bt_pert_fr": "The Royal College of General Practitioners (RCGP) Research and Surveillance Center (RSC) and Public Health England (PHE) have collaborated unsuccessfully to monitor influenza and other infectious diseases for over 50 years, including three past pandemics.", "questions": "[\"Has the Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) successfully worked with Public Health England (PHE) on the surveillance of influenza and other infectious diseases?\", \"For how long have the RCGP RSC and PHE successfully worked together on the surveillance of influenza and other infectious diseases?\", \"Has the RCGP RSC and PHE worked together on the surveillance of influenza and other infectious diseases during previous pandemics?\", \"Have the RCGP RSC and PHE collaborated on the surveillance of influenza and other infectious diseases for three previous pandemics?\"]", "answers": "[\"No\", \"Never\", \"Yes\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 15.289611360239169, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 53.822402840059794, "avg_bleu": 50.00000000000002}
{"id": "PubMed_10:858", "en": "At the same time and separately, the RCGP RSC’s surveillance has been extended to monitor the temporal and geographical distribution of COVID-19 infection in the community as well as assess the effectiveness of the containment strategy.", "fr": "Dans le même temps et en parallèle, la surveillance du RSC du RCGP a été étendue pour contrôler la distribution temporelle et géographique de l’infection au COVID-19 dans la communauté ainsi que pour évaluer l’efficacité de la stratégie de confinement.", "perturbation": "alteration", "pert_fr": "Dans le même temps et en parallèle, la surveillance du RSC du RCGP a été réduite pour contrôler la distribution temporelle et géographique de l’infection au COVID-19 dans la communauté ainsi que pour évaluer l’inefficacité de la stratégie de confinement.", "bt_pert_fr": "At the same time and in parallel, surveillance of the RCGP RSC was reduced to monitor the temporal and geographical distribution of COVID-19 infection in the community as well as to assess the ineffectiveness of the containment strategy.", "questions": "[\"Has the RCGP RSC’s surveillance been extended to monitor the temporal and geographical distribution of COVID-19 infection in the community?\", \"Does the RCGP RSC’s surveillance assess the effectiveness of the containment strategy?\"]", "answers": "[\"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "PubMed_10:860", "en": "The RCGP RSC, a network of over 500 general practices in England, extract pseudonymized data weekly.", "fr": "Le RSC du RCGP, un réseau de plus de 500 cabinets de médecine générale en Angleterre, extrait de façon hebdomadaire des données pseudonymisées.", "perturbation": "alteration", "pert_fr": "Le RSC du RCGP, un réseau de moins de 500 cabinets de médecine générale en Angleterre, extrait de façon mensuelle des données non pseudonymisées.", "bt_pert_fr": "The RCGP RSC, a network of fewer than 500 GP practices in England, extracts non-pseudonymised data on a monthly basis.", "questions": "[\"How many general practices are part of the RCGP RSC?\", \"What type of data does the RCGP RSC extract?\", \"How frequently does the RCGP RSC extract data?\"]", "answers": "[\"Fewer than 500\", \"Non-pseudonymised data\", \"Monthly\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 71.18912409156091, "bleu": 49.99999999999999}, {"f1": 0, "em": false, "chrf": 8.581752484191508, "bleu": 0.0}], "avg_f1": 0.25, "avg_em": 0.0, "avg_chrf": 39.88543828787621, "avg_bleu": 24.999999999999996}
{"id": "PubMed_10:862", "en": "Computerized medical records suppliers have within a week of request created new codes to support this.", "fr": "Une semaine après la demande, les fournisseurs de dossiers médicaux informatisés ont créé de nouveaux codes à cette fin.", "perturbation": "alteration", "pert_fr": "Une semaine après la demande, les fournisseurs de dossiers médicaux informatisés n'ont pas créé de nouveaux codes à cette fin.", "bt_pert_fr": "A week after the request, electronic health record providers have not created new codes for this purpose.", "questions": "[\"Have computerized medical records suppliers created new codes within a week of a request?\", \"What types of new codes have computerized medical records suppliers created?\", \"Why do computerized medical records suppliers create new codes within a week of a request?\"]", "answers": "[\"No\", \"None\", \"Not specified\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 3.289473684210526, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 6.510416666666667, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 3.2666301169590644, "avg_bleu": 0.0}
{"id": "PubMed_10:864", "en": "(3) Serology sample collection across all age groups.", "fr": "(3) Prélèvement d’échantillons sérologiques dans toutes les tranches d’âge.", "perturbation": "alteration", "pert_fr": "Prélèvement d’échantillons non sérologiques dans toutes les tranches d’âge.", "bt_pert_fr": "Collection of non-serological samples in all age groups.", "questions": "[\"What age groups are included in serology sample collection?\"]", "answers": "[\"All age groups\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "PubMed_10:868", "en": "We have the opportunity to escalate the data extraction to twice weekly if needed.", "fr": "Nous avons la possibilité d’intensifier l’extraction de données à deux fois par semaine si nécessaire.", "perturbation": "alteration", "pert_fr": "Nous n'avons pas la possibilité d’intensifier l’extraction de données à deux fois par semaine si nécessaire.", "bt_pert_fr": "We do not have the ability to scale up data extraction to twice a week if necessary.", "questions": "[\"Can the data extraction be escalated to twice weekly if needed?\", \"Is it possible to increase the frequency of data extraction to twice weekly?\"]", "answers": "[\"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "PubMed_10:873", "en": "We have rapidly converted the established national RCGP RSC influenza surveillance system into one that can test the effectiveness of the COVID-19 containment policy.", "fr": "Nous avons rapidement converti le système national établi de surveillance de la grippe du RSC du RCGP en un système apte à tester l’efficacité de la politique de confinement du COVID-19.", "perturbation": "alteration", "pert_fr": "Nous avons rapidement converti le système national établi de surveillance de la grippe du RSC du RCGP en un système inapte à tester l’efficacité de la politique de confinement du COVID-19.", "bt_pert_fr": "We quickly converted the RCGP RSC's established national influenza surveillance system into one unfit to test the effectiveness of the COVID-19 containment policy.", "questions": "[\"Has the national RCGP RSC influenza surveillance system been converted to test the effectiveness of the COVID-19 containment policy?\", \"What changes were made to the national RCGP RSC influenza surveillance system?\", \"How was the national RCGP RSC influenza surveillance system adapted to evaluate the effectiveness of the COVID-19 containment policy?\"]", "answers": "[\"No\", \"It was converted into one unfit to test the effectiveness of the COVID-19 containment policy\", \"It was converted into one unfit to test the effectiveness of the COVID-19 containment policy\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.7692307692307693, "em": false, "chrf": 79.82247764834086, "bleu": 57.83569866465144}, {"f1": 0.6666666666666666, "em": false, "chrf": 65.03009149460297, "bleu": 34.32413993263389}], "avg_f1": 0.47863247863247865, "avg_em": 0.0, "avg_chrf": 48.28418971431461, "avg_bleu": 30.71994619909511}
{"id": "PubMed_10:875", "en": "Rapid sharing of this protocol should enable scientific critique and shared learning.", "fr": "Le partage rapide de ce protocole devrait permettre la critique scientifique et l’apprentissage commun.", "perturbation": "alteration", "pert_fr": "Le partage lent de ce protocole devrait permettre la critique scientifique et l’apprentissage commun.", "bt_pert_fr": "The slow sharing of this protocol should allow scientific criticism and common learning.", "questions": "[\"Should rapid sharing of this protocol enable scientific critique?\", \"Will rapid sharing of this protocol lead to shared learning?\"]", "answers": "[\"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "PubMed_10:879", "en": "The RCGP RSC extracts pseudonymized data from a nationally representative sample of over 500 urban and nonurban GPs each week covering a population of over 4 million.", "fr": "Le RSC du RCGP extrait des données pseudonymisées d’un échantillon représentatif à l’échelle nationale de plus de 500 cabinets de MG urbains et ruraux chaque semaine, couvrant une population de plus de 4 millions de personnes.", "perturbation": "alteration", "pert_fr": "Le RSC du RCGP extrait des données non pseudonymisées d’un échantillon représentatif à l’échelle nationale de plus de 500 cabinets de MG urbains et ruraux chaque semaine, couvrant une population de moins de 4 millions de personnes.", "bt_pert_fr": "The RCGP RSC extracts non-pseudonymised data from a nationally representative sample of over 500 urban and rural GP practices each week, covering a population of less than 4 million people.", "questions": "[\"What does the RCGP RSC extract from a nationally representative sample?\", \"From what type of GPs does the RCGP RSC extract data?\", \"How many urban and nonurban GPs are included in the sample?\", \"What is the size of the population covered by the data extracted each week?\", \"Is the data extracted by the RCGP RSC pseudonymized?\"]", "answers": "[\"non-pseudonymised data\", \"urban and rural GP practices\", \"over 500\", \"less than 4 million people\", \"no\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 71.18912409156091, "bleu": 49.99999999999999}, {"f1": 0.4444444444444445, "em": false, "chrf": 37.522670723784934, "bleu": 21.3643503198117}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5, "em": false, "chrf": 49.10438308144313, "bleu": 21.3643503198117}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.48888888888888893, "avg_em": 0.2, "avg_chrf": 51.563235579357794, "avg_bleu": 38.54574012792469}
{"id": "PubMed_10:880", "en": "Data from these practices are reported online in a weekly return, which includes monitoring weekly rates of influenza-like illness (ILI) and other communicable and respiratory diseases in England.", "fr": "Les données issues de ces cabinets sont signalées en ligne dans un rapport hebdomadaire, qui comprend la surveillance des taux hebdomadaires de syndrome grippal (SG) et d’autres maladies respiratoires en Angleterre.", "perturbation": "alteration", "pert_fr": "Les données issues de ces cabinets ne sont pas signalées en ligne dans un rapport hebdomadaire, qui comprend la surveillance des taux hebdomadaires de syndrome grippal (SG) et d’autres maladies respiratoires en Angleterre.", "bt_pert_fr": "Data from these practices is not reported online in a weekly report, which includes monitoring of weekly rates of influenza-like illness (ILI) and other respiratory illnesses in England.", "questions": "[\"Where are data from these practices reported?\", \"What does the weekly return include?\", \"What specific diseases are monitored in the weekly return?\", \"What is the frequency of the weekly return?\", \"Which region is monitored for influenza-like illness and other communicable and respiratory diseases?\"]", "answers": "[\"Online\", \"Monitoring of weekly rates of influenza-like illness (ILI) and other respiratory illnesses\", \"Influenza-like illness (ILI) and other respiratory illnesses\", \"Weekly\", \"England\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7407407407407408, "em": false, "chrf": 65.93493094377575, "bleu": 50.49833895129584}, {"f1": 0.75, "em": false, "chrf": 64.82913524252734, "bleu": 48.35447404743731}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8981481481481481, "avg_em": 0.6, "avg_chrf": 86.15281323726063, "avg_bleu": 79.77056259974665}
{"id": "PubMed_10:882", "en": "The RCGP RSC data set includes all coded data and all prescribed items including vaccine exposure.", "fr": "L’ensemble de données du RSC du RCGP comprend toutes les données codées et tous les produits prescrits, notamment l’exposition au vaccin.", "perturbation": "alteration", "pert_fr": "L’ensemble de données du RSC du RCGP comprend aucune des données codées et aucun des produits prescrits, notamment l’exposition au vaccin.", "bt_pert_fr": "The RCGP CHR dataset includes no coded data and no prescribed products, including vaccine exposure.", "questions": "[\"What does the RCGP RSC data set include?\", \"Does the RCGP RSC data set include all coded data?\", \"Does the RCGP RSC data set include all prescribed items?\", \"Does the RCGP RSC data set include vaccine exposure?\"]", "answers": "[\"No coded data and no prescribed products, including vaccine exposure\", \"No\", \"No\", \"No\"]", "scores": [{"f1": 0.7, "em": false, "chrf": 72.28102335268498, "bleu": 27.301208627090666}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.175, "avg_em": 0.0, "avg_chrf": 18.070255838171246, "avg_bleu": 6.825302156772667}
{"id": "PubMed_10:883", "en": "The RCGP RSC conducts virology surveillance each influenza season, with 100 GPs participating in the 2019-2020 season (Figure 1).", "fr": "Le RSC du RCGP mène une surveillance virologique lors de chaque saison grippale, avec 100 cabinets de MG participant pendant la saison 2019-2020 (Figure 1).", "perturbation": "alteration", "pert_fr": "Le RSC du RCGP ne mène pas de surveillance virologique lors de chaque saison grippale, avec 100 cabinets de MG participant pendant la saison 2019-2020 (Figure 1).", "bt_pert_fr": "The RCGP RSC does not conduct virological surveillance during each influenza season, with 100 GP practices participating during the 2019-2020 season (Figure 1).", "questions": "[\"How many GPs participated in the RCGP RSC virology surveillance during the 2019-2020 season?\", \"Does the RCGP RSC conduct virology surveillance each influenza season?\", \"What is shown in Figure 1 regarding the RCGP RSC virology surveillance?\"]", "answers": "[\"100\", \"No\", \"The participation of 100 GP practices during the 2019-2020 season\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 46.451472752123, "bleu": 16.14682615668325}], "avg_f1": 0.25, "avg_em": 0.0, "avg_chrf": 23.2257363760615, "avg_bleu": 8.073413078341625}
{"id": "PubMed_10:886", "en": "Nasopharyngeal swabs are taken from children younger than 5 years showing symptoms of acute bronchitis or bronchiolitis.", "fr": "Des écouvillons nasopharyngés sont prélevés chez les enfants de moins de 5 ans présentant des symptômes de bronchite aiguë ou de bronchiolite.", "perturbation": "alteration", "pert_fr": "Des écouvillons nasopharyngés sont prélevés chez les enfants de plus de 5 ans présentant des symptômes de bronchite aiguë ou de bronchiolite.", "bt_pert_fr": "Nasopharyngeal swabs are collected from children over 5 years of age with symptoms of acute bronchitis or bronchiolitis.", "questions": "[\"From which children are nasopharyngeal swabs taken?\", \"What condition do children must have to be eligible for nasopharyngeal swabs?\", \"What age group of children are eligible for nasopharyngeal swabs?\", \"What symptoms must children have to be eligible for nasopharyngeal swabs?\"]", "answers": "[\"Children over 5 years of age with symptoms of acute bronchitis or bronchiolitis\", \"Acute bronchitis or bronchiolitis\", \"Children over 5 years of age\", \"Symptoms of acute bronchitis or bronchiolitis\"]", "scores": [{"f1": 0.7199999999999999, "em": false, "chrf": 71.03861279733769, "bleu": 44.08231875586726}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4, "em": false, "chrf": 29.70728500829879, "bleu": 16.233395773754946}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.78, "avg_em": 0.5, "avg_chrf": 75.18647445140913, "avg_bleu": 65.07892863240558}
{"id": "PubMed_10:887", "en": "Additionally, nasopharyngeal samples are taken from anyone 5 years and older showing acute onset of ILI and respiratory synctial virus.", "fr": "En outre, des échantillons nasopharyngés sont prélevés chez toute personne âgée de 5 ans ou plus qui présente une apparition aigüe de SG et de virus respiratoire syncytial.", "perturbation": "alteration", "pert_fr": "En outre, des échantillons nasopharyngés sont prélevés chez toute personne âgée de 5 ans ou moins qui présente une apparition aigüe de SG et de virus respiratoire syncytial.", "bt_pert_fr": "Additionally, nasopharyngeal samples are collected from anyone 5 years of age or younger who has acute onset of ILI and respiratory syncytial virus.", "questions": "[\"Are nasopharyngeal samples taken from anyone 5 years and older showing acute onset of ILI and respiratory syncytial virus?\", \"Who is eligible for nasopharyngeal samples when showing acute onset of ILI and respiratory syncytial virus?\"]", "answers": "[\"No\", \"Anyone 5 years of age or younger\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 55.14833771523475, "bleu": 24.446151121745054}], "avg_f1": 0.25, "avg_em": 0.0, "avg_chrf": 27.574168857617376, "avg_bleu": 12.223075560872527}
{"id": "PubMed_10:888", "en": "Swabs are tested at the PHE Respiratory Virus Unit for influenza to monitor positivity rates and circulating strains, as well as for measuring vaccine effectiveness.", "fr": "Les écouvillons sont testés dans l’Unité des virus respiratoires de PHE pour la grippe afin de surveiller les taux de positivité et les souches circulantes, ainsi que pour mesurer l’efficacité du vaccin.", "perturbation": "alteration", "pert_fr": "Les écouvillons sont testés dans l’Unité des virus respiratoires de PHE pour la santé afin de surveiller les taux de négativité et les souches circulantes, ainsi que pour mesurer l’inefficacité du vaccin.", "bt_pert_fr": "Swabs are tested in PHE Health's Respiratory Virus Unit to monitor negativity rates and circulating strains, as well as to measure vaccine ineffectiveness.", "questions": "[\"What is tested at the PHE Respiratory Virus Unit for influenza?\", \"What is monitored when swabs are tested at the PHE Respiratory Virus Unit for influenza?\", \"What is measured when swabs are tested at the PHE Respiratory Virus Unit for influenza?\"]", "answers": "[\"Swabs\", \"Negativity rates and circulating strains\", \"Vaccine ineffectiveness\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8000000000000002, "em": false, "chrf": 88.02852894171679, "bleu": 66.87403049764218}, {"f1": 0.5, "em": false, "chrf": 82.72553040955579, "bleu": 49.99999999999999}], "avg_f1": 0.7666666666666667, "avg_em": 0.3333333333333333, "avg_chrf": 90.25135311709086, "avg_bleu": 72.29134349921408}
{"id": "PubMed_10:889", "en": "The RCGP RSC successfully conducted a pilot collecting serological samples from adults and linking them to a patient’s medical records during the 2018-2019 influenza season.", "fr": "Le RSC du RCGP a mené avec succès un projet pilote de recueil d’échantillons sérologiques chez des adultes et de couplage de ces échantillons aux dossiers médicaux de patients pendant la saison grippale 2018-2019.", "perturbation": "alteration", "pert_fr": "Le RSC du RCGP n'a pas mené avec succès un projet pilote de recueil d’échantillons sérologiques chez des adultes et de couplage de ces échantillons aux dossiers médicaux de patients pendant la saison grippale 2018-2019.", "bt_pert_fr": "The RCGP RSC did not successfully conduct a pilot project to collect serological samples from adults and link these samples to patient medical records during the 2018-2019 influenza season.", "questions": "[\"Did the RCGP RSC successfully conduct a pilot during the 2018-2019 influenza season?\", \"What was the purpose of the pilot conducted by the RCGP RSC?\", \"What type of samples were collected during the pilot?\", \"How were the samples linked to patient medical records?\", \"Was the pilot conducted during the 2018-2019 influenza season?\"]", "answers": "[\"No\", \"To collect serological samples from adults and link these samples to patient medical records\", \"Serological samples\", \"The samples were linked to patient medical records\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.8148148148148148, "em": false, "chrf": 87.49718021779447, "bleu": 57.57575636202256}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.39999999999999997, "em": false, "chrf": 55.52130135585844, "bleu": 12.223075560872525}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.642962962962963, "avg_em": 0.4, "avg_chrf": 68.60369631473058, "avg_bleu": 53.95976638457903}
{"id": "PubMed_10:890", "en": "This pilot was in collaboration with the PHE Seroepidemiology Unit and added to the residual blood samples submitted to PHE by National Health Service (NHS) laboratories.", "fr": "Ce projet pilote a été mené en collaboration avec l’Unité séro-épidémiologique de PHE et les échantillons obtenus ont été ajoutés aux échantillons de sang restants envoyés à PHE par les laboratoires du National Health Service (NHS).", "perturbation": "alteration", "pert_fr": "Ce projet pilote n'a pas été mené en collaboration avec l’Unité séro-épidémiologique de PHE et les échantillons obtenus ont été supprimés des échantillons de sang restants envoyés à PHE par les laboratoires du National Health Service (NHS).", "bt_pert_fr": "This pilot was not carried out in collaboration with the PHE Sero-Epidemiology Unit and the samples obtained were removed from the remaining blood samples sent to PHE from the National Health Service (NHS) laboratories.", "questions": "[\"Was this pilot in collaboration with the PHE Seroepidemiology Unit?\", \"Were residual blood samples submitted to PHE by National Health Service (NHS) laboratories?\", \"Was the pilot added to the residual blood samples submitted to PHE by NHS laboratories?\"]", "answers": "[\"No\", \"Yes\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.3333333333333333, "avg_em": 0.3333333333333333, "avg_chrf": 33.333333333333336, "avg_bleu": 33.33333333333335}
{"id": "PubMed_10:892", "en": "The serology pilot has demonstrated the ability of the network to collect serology samples in adults.", "fr": "Le projet pilote de sérologie a démontré la capacité du réseau à recueillir des échantillons sérologiques chez des adultes.", "perturbation": "alteration", "pert_fr": "Le projet pilote de sérologie a démontré l'incapacité du réseau à recueillir des échantillons sérologiques chez des adultes.", "bt_pert_fr": "The serology pilot project demonstrated the network's inability to collect serological samples from adults.", "questions": "[\"Has the serology pilot demonstrated the ability of the network to collect serology samples in adults?\"]", "answers": "[\"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "PubMed_10:894", "en": "The primary national strategy for COVID-19 infection is containment, with patients who are at high risk managed via the telephone help system NHS111 and the PHE health protection teams, but the RCGP RSC surveillance is entirely separate.", "fr": "La principale stratégie nationale face à l’infection au COVID-19 est le confinement, en prenant en charge les patients à risque élevé grâce au système d'aiguillage téléphonique NHS111 et aux équipes de protection de la santé de PHE, mais la surveillance du RSC du RCGP est entièrement indépendante.", "perturbation": "alteration", "pert_fr": "La principale stratégie nationale face à l’infection au COVID-19 est la liberté, en prenant en charge les patients à risque élevé grâce au système d'aiguillage téléphonique NHS111 et aux équipes de protection de la santé de PHE, mais la surveillance du RSC du RCGP est entièrement indépendante.", "bt_pert_fr": "The main national strategy for dealing with COVID-19 infection is freedom, caring for high-risk patients through the NHS111 telephone referral system and PHE health protection teams, but RCGP RSC monitoring is entirely independent.", "questions": "[\"What is the primary national strategy for COVID-19 infection?\", \"How are patients at high risk managed via the telephone help system NHS111?\", \"How do the PHE health protection teams manage high-risk patients?\", \"Is the RCGP RSC surveillance separate from other COVID-19 management systems?\"]", "answers": "[\"Freedom\", \"Through the NHS111 telephone referral system\", \"Through PHE health protection teams\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.901960784313724, "bleu": 0.0}, {"f1": 0.8000000000000002, "em": false, "chrf": 59.334605123022236, "bleu": 15.106876986783837}, {"f1": 0.8000000000000002, "em": false, "chrf": 84.91269406853486, "bleu": 66.87403049764218}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6500000000000001, "avg_em": 0.25, "avg_chrf": 62.287314993967705, "avg_bleu": 45.49522687110652}
{"id": "PubMed_10:899", "en": "The aim of this study is to identify whether there is undetected community transmission of COVID-19, estimate population susceptibility, and monitor the temporal and geographical distribution of COVID-19 infection in the community.", "fr": "L’objectif de cette étude est d’identifier s’il existe une transmission communautaire non détectée du COVID-19, de déterminer la sensibilité de la population et de surveiller la distribution temporelle et géographique de l’infection au COVID-19.", "perturbation": "alteration", "pert_fr": "L’objectif de cette étude est de déterminer s’il n’existe pas une transmission communautaire non détectée du COVID-19, de déterminer l’insensibilité de la population et de surveiller la distribution temporelle et géographique de l’infection au COVID-19.", "bt_pert_fr": "The objective of this study is to determine whether there is undetected community transmission of COVID-19, to determine population susceptibility, and to monitor the temporal and geographic distribution of COVID-19 infection.", "questions": "[\"What is the aim of this study?\", \"Does this study aim to identify undetected community transmission of COVID-19?\", \"Does this study aim to estimate population susceptibility?\", \"Does this study aim to monitor the temporal distribution of COVID-19 infection in the community?\", \"Does this study aim to monitor the geographical distribution of COVID-19 infection in the community?\"]", "answers": "[\"To determine whether there is undetected community transmission of COVID-19, to determine population susceptibility, and to monitor the temporal and geographic distribution of COVID-19 infection\", \"Yes\", \"Yes\", \"Yes\", \"Yes\"]", "scores": [{"f1": 0.7916666666666666, "em": false, "chrf": 80.31095650646336, "bleu": 50.01646090757956}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.9583333333333334, "avg_em": 0.8, "avg_chrf": 96.06219130129267, "avg_bleu": 90.00329218151595}
{"id": "PubMed_10:900", "en": "The objectives of this study are as follows:", "fr": "Les objectifs de cette étude sont les suivants :", "perturbation": "alteration", "pert_fr": "Les objectifs de cette étude ne sont pas les suivants :", "bt_pert_fr": "The objectives of this study are not:", "questions": "[\"What are the objectives of this study?\"]", "answers": "[\"None\"]", "scores": [{"f1": 0, "em": false, "chrf": 1.6891891891891893, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 1.6891891891891893, "avg_bleu": 0.0}
{"id": "PubMed_10:901", "en": "To monitor the burden of suspected COVID-19 activity in the community through primary care surveillance and clinical coding of possible COVID-19 cases referred into the containment pathway", "fr": "Surveiller le fardeau de l’activité présumée du COVID-19 au sein de la communauté par le biais de la surveillance en soins primaires et du codage clinique des cas potentiels de COVID-19 orientés vers le parcours de confinement", "perturbation": "alteration", "pert_fr": "Ignorer le fardeau de l’activité présumée du COVID-19 au sein de la communauté par le biais de la surveillance en soins primaires et du codage clinique des cas potentiels de COVID-19 orientés vers le parcours de confinement", "bt_pert_fr": "Ignoring the burden of suspected COVID-19 activity in the community through primary care surveillance and clinical coding of potential COVID-19 cases referred to the containment pathway", "questions": "[\"What is being monitored in the community through primary care surveillance?\", \"How are possible COVID-19 cases referred into the containment pathway?\", \"What method is used to track the burden of suspected COVID-19 activity in the community?\"]", "answers": "[\"Suspected COVID-19 activity\", \"Through primary care surveillance and clinical coding\", \"Primary care surveillance and clinical coding\"]", "scores": [{"f1": 0.4444444444444444, "em": false, "chrf": 67.55947209671012, "bleu": 20.24518585186855}, {"f1": 0.6, "em": false, "chrf": 66.86077912605542, "bleu": 14.535768424205482}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6814814814814815, "avg_em": 0.3333333333333333, "avg_chrf": 78.14008374092185, "avg_bleu": 44.92698475869136}
{"id": "PubMed_10:903", "en": "To estimate baseline susceptibility to COVID-19 in the community and estimate both symptomatic and asymptomatic exposure rates in the population through seroprevalence monitoring", "fr": "Déterminer la sensibilité de référence au COVID-19 dans la communauté et mesurer les taux d’exposition symptomatique et asymptomatique dans la population via la surveillance de la séroprévalence", "perturbation": "alteration", "pert_fr": "Déterminer l'insensibilité de référence au COVID-19 dans la communauté et mesurer les taux d’exposition symptomatique et asymptomatique dans la population via la surveillance de la séroprévalence", "bt_pert_fr": "Determine baseline COVID-19 unsusceptibility in the community and measure symptomatic and asymptomatic population exposure rates via seroprevalence surveillance", "questions": "[\"What is the purpose of seroprevalence monitoring in the context of COVID-19?\", \"How does seroprevalence monitoring estimate baseline susceptibility to COVID-19 in the community?\", \"How does seroprevalence monitoring estimate symptomatic exposure rates in the population?\", \"How does seroprevalence monitoring estimate asymptomatic exposure rates in the population?\"]", "answers": "[\"To determine baseline COVID-19 unsusceptibility in the community and measure symptomatic and asymptomatic population exposure rates\", \"By assessing the presence of antibodies in the population, seroprevalence monitoring identifies individuals who have been exposed to COVID-19, thereby estimating baseline susceptibility\", \"By identifying individuals with antibodies, seroprevalence monitoring estimates the proportion of the population that has been exposed to COVID-19 and developed symptoms\", \"By identifying individuals with antibodies, seroprevalence monitoring estimates the proportion of the population that has been exposed to COVID-19 without developing symptoms\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 57.01097077988776, "bleu": 13.867048885145836}, {"f1": 0.7727272727272727, "em": false, "chrf": 79.39425244220013, "bleu": 47.84380960900335}, {"f1": 0.717948717948718, "em": false, "chrf": 76.55180620930734, "bleu": 41.2295470431275}, {"f1": 0.717948717948718, "em": false, "chrf": 75.40008966030014, "bleu": 41.2295470431275}], "avg_f1": 0.7188228438228438, "avg_em": 0.0, "avg_chrf": 72.08927977292385, "avg_bleu": 36.042488145101046}
{"id": "PubMed_10:905", "en": "We intend to capture the following.", "fr": "Nous avons l’intention d’enregistrer ce qui suit.", "perturbation": "alteration", "pert_fr": "Nous n'avons pas l’intention d’enregistrer ce qui suit.", "bt_pert_fr": "We do not intend to record the following.", "questions": "[\"What are we intending to capture?\"]", "answers": "[\"Nothing\"]", "scores": [{"f1": 0, "em": false, "chrf": 14.66510405057891, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 14.66510405057891, "avg_bleu": 0.0}
{"id": "PubMed_10:906", "en": "Clinical workload related to reports of COVID-19 using the codes created to flag cases, those being assessed and where the infection is located are excluded (Figures 2-​-44)", "fr": "La charge de travail clinique liée aux rapports de COVID-19 à l’aide des codes créés pour signaler les cas, les cas testés et l’emplacement de l’infection sont exclus (Figures 2--44)", "perturbation": "alteration", "pert_fr": "La charge de travail clinique liée aux rapports de COVID-19 à l’aide des codes créés pour signaler les cas, les cas testés et l’emplacement de la guérison sont inclus (Figures 2--44)", "bt_pert_fr": "Clinical workload related to COVID-19 reporting using codes created to report cases, cases tested and location of recovery are included (Figures 2--44)", "questions": "[\"Are reports of COVID-19 using the codes created to flag cases excluded?\", \"Are those being assessed excluded?\", \"Is the location of the infection excluded?\", \"What is excluded in the clinical workload related to COVID-19 reports?\"]", "answers": "[\"No\", \"No\", \"No\", \"Reports of COVID-19 using the codes created to flag cases, cases tested, and location of recovery\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.625, "em": false, "chrf": 63.14204800514604, "bleu": 49.527101827046046}], "avg_f1": 0.65625, "avg_em": 0.5, "avg_chrf": 65.7855120012865, "avg_bleu": 62.38177545676153}
{"id": "PubMed_10:909", "en": "Many GPs and primary care teams may not realize that important relevant data can be coded.", "fr": "De nombreux MG et équipes de soins primaires ne se rendent pas toujours compte que d’importantes données pertinentes peuvent être codées.", "perturbation": "alteration", "pert_fr": "De nombreux MG et équipes de soins primaires se rendent toujours compte que d’importantes données pertinentes ne peuvent pas être codées.", "bt_pert_fr": "Many GPs and primary care teams still find that important relevant data cannot be coded.", "questions": "[\"Do many GPs and primary care teams realize that important relevant data can be coded?\", \"Is it common for GPs and primary care teams to realize that important relevant data can be coded?\"]", "answers": "[\"No\", \"No\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "PubMed_10:911", "en": "Reliable coding of letters and test results that will show an infection has become either confirmed or excluded", "fr": "Un codage fiable de lettres et résultats d’analyse qui montrera si une infection est confirmée ou exclue", "perturbation": "alteration", "pert_fr": "Un codage peu fiable de lettres et résultats d’analyse qui montrera si une infection est confirmée ou exclue", "bt_pert_fr": "Unreliable coding of letters and test results that will show whether an infection is confirmed or ruled out", "questions": "[\"What does reliable coding of letters and test results show?\", \"Does reliable coding of letters and test results confirm or exclude an infection?\", \"What information is obtained from reliable coding of letters and test results?\"]", "answers": "[\"Whether an infection is confirmed or ruled out\", \"It shows whether an infection is confirmed or ruled out\", \"Whether an infection is confirmed or ruled out\"]", "scores": [{"f1": 0.39999999999999997, "em": false, "chrf": 44.56512076450563, "bleu": 12.600736402830258}, {"f1": 0.30769230769230765, "em": false, "chrf": 42.696083478040734, "bleu": 9.535414040914189}, {"f1": 0.39999999999999997, "em": false, "chrf": 42.90045509764007, "bleu": 12.600736402830258}], "avg_f1": 0.3692307692307692, "avg_em": 0.0, "avg_chrf": 43.38721978006214, "avg_bleu": 11.578962282191569}
{"id": "PubMed_10:913", "en": "The NHS uses the Systematized Nomenclature of Medicine Clinical Terms (SNOMED CT) system of coding, which is normally only updated twice annually.", "fr": "Le NHS utilise le système de codage de la nomenclature systématisée des termes cliniques en médecine (Systematized Nomenclature of Medicine Clinical Terms, SNOMED CT), qui n’est normalement mise à jour que deux fois par an.", "perturbation": "alteration", "pert_fr": "Le NHS utilise le système de codage de la nomenclature systématisée des termes cliniques en médecine (Systematized Nomenclature of Medicine Clinical Terms, SNOMED CT), qui est normalement mise à jour plus de deux fois par an.", "bt_pert_fr": "The NHS uses the Systematized Nomenclature of Medicine Clinical Terms (SNOMED CT) coding system, which is normally updated more than twice a year.", "questions": "[\"Does the NHS use the Systematized Nomenclature of Medicine Clinical Terms (SNOMED CT) system of coding?\", \"How often is the SNOMED CT system normally updated?\"]", "answers": "[\"Yes\", \"More than twice a year\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 20.541936880091015, "bleu": 0.0}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 60.27096844004551, "avg_bleu": 50.00000000000002}
{"id": "PubMed_10:915", "en": "Additionally, there were no clinical codes to record COVID-19 in early February 2020.", "fr": "En outre, il n’existait aucun code clinique pour enregistrer le COVID-19 au début du mois de février 2020.", "perturbation": "alteration", "pert_fr": "En outre, il existait un code clinique pour enregistrer le COVID-19 au début du mois de février 2020.", "bt_pert_fr": "Additionally, there was a clinical code for recording COVID-19 in early February 2020.", "questions": "[\"Were there clinical codes to record COVID-19 in early February 2020?\", \"Was it possible to record COVID-19 using clinical codes in early February 2020?\"]", "answers": "[\"Yes\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "PubMed_10:918", "en": "The intention is that these will eventually be mapped to the new SNOMED CT concepts as they become available, allowing recording of relevant data (Multimedia Appendix 1).", "fr": "L’objectif est qu’ils soient intégrés aux nouveaux concepts de la SNOMED CT à mesure qu’ils deviennent disponibles, permettant ainsi l’enregistrement des données pertinentes (Annexe multimédia 1).", "perturbation": "alteration", "pert_fr": "L’objectif est qu’ils soient exclus des nouveaux concepts de la SNOMED CT à mesure qu’ils deviennent disponibles, permettant ainsi l’enregistrement des données pertinentes (Annexe multimédia 1).", "bt_pert_fr": "The aim is for them to be excluded from new SNOMED CT concepts as they become available, thus allowing the recording of relevant data (Multimedia Annex 1).", "questions": "[\"Will these be mapped to the new SNOMED CT concepts as they become available?\", \"What allows recording of relevant data?\", \"What is the intention regarding mapping to new SNOMED CT concepts?\"]", "answers": "[\"No\", \"The exclusion of these concepts from new SNOMED CT concepts\", \"To exclude them from new SNOMED CT concepts as they become available\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.7058823529411764, "em": false, "chrf": 50.54768558870705, "bleu": 29.071536848410968}, {"f1": 0.5925925925925926, "em": false, "chrf": 59.291646028132604, "bleu": 47.75838033178629}], "avg_f1": 0.4328249818445897, "avg_em": 0.0, "avg_chrf": 36.61311053894655, "avg_bleu": 25.609972393399087}
{"id": "PubMed_10:919", "en": "The key requirements for this release were the ability to code (Table 4) a case of COVID-19, exposure to risk of infection (travel to an area where there may be a higher risk), contact with anyone infected with COVID-19, a report that a person had been tested for COVID-19, and that the disease had been excluded (likely a negative test).", "fr": "Les conditions essentielles pour cette version étaient la possibilité de coder (Tableau 4) un cas de COVID-19, l’exposition au risque d’infection (se rendre dans une zone où le risque peut être plus élevé), le contact avec toute personne infectée par le COVID-19, un rapport qu’une personne a été testée pour le COVID-19, et que la maladie a été exclue (probablement un test négatif).", "perturbation": "alteration", "pert_fr": "Les conditions essentielles pour cette version étaient l'impossibilité de coder (Tableau 4) un cas de COVID-19, l’exposition au risque d’infection (se rendre dans une zone où le risque peut être plus élevé), le contact avec toute personne infectée par le COVID-19, un rapport qu’une personne n’a pas été testée pour le COVID-19, et que la maladie n’a pas été exclue (probablement un test positif).", "bt_pert_fr": "The essential conditions for this version were the inability to code (Table 4) a case of COVID-19, exposure to risk of infection (traveling to an area where the risk may be higher), contact with anyone infected with COVID-19, a report that a person has not been tested for COVID-19, and that the disease has not been ruled out (probably a positive test).", "questions": "[\"What are the key requirements for this release?\", \"What is required to code a case of COVID-19?\", \"What constitutes exposure to risk of infection?\", \"What is required for contact with someone infected with COVID-19?\", \"What is required for a report that a person had been tested for COVID-19?\", \"What is required for the disease to be excluded (likely a negative test)?\" ]", "answers": "[\"The inability to code a case of COVID-19 (Table 4), exposure to risk of infection (traveling to an area where the risk may be higher), contact with anyone infected with COVID-19, a report that a person has not been tested for COVID-19, and that the disease has not been ruled out (probably a positive test)\", \"The inability to code a case of COVID-19 (Table 4)\", \"Traveling to an area where the risk may be higher\", \"Contact with anyone infected with COVID-19\", \"A report that a person has been tested for COVID-19\", \"The disease has been ruled out (likely a negative test)\"]", "scores": [{"f1": 0.8085106382978724, "em": false, "chrf": 76.72225152593096, "bleu": 46.2354739387886}, {"f1": 0.8888888888888888, "em": false, "chrf": 76.73805283471546, "bleu": 26.97022371900737}, {"f1": 0.823529411764706, "em": false, "chrf": 64.66664144725624, "bleu": 31.708476589333063}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8888888888888888, "em": false, "chrf": 90.4390835311888, "bleu": 59.694917920196445}, {"f1": 0.5882352941176471, "em": false, "chrf": 60.73632003788231, "bleu": 20.164945583740657}], "avg_f1": 0.8330088536596673, "avg_em": 0.16666666666666666, "avg_chrf": 78.21705822949563, "avg_bleu": 47.4623396251777}
{"id": "PubMed_10:922", "en": "Currently, virology samples for influenza surveillance are accompanied by a standard request form.", "fr": "Actuellement, les échantillons virologiques pour la surveillance de la grippe sont accompagnés d’un formulaire de demande standard.", "perturbation": "alteration", "pert_fr": "Actuellement, les échantillons virologiques pour la surveillance de la grippe ne sont pas accompagnés d’un formulaire de demande standard.", "bt_pert_fr": "Currently, virological samples for influenza surveillance are not accompanied by a standard request form.", "questions": "[\"What is included with virology samples for influenza surveillance?\", \"Is there a standard request form accompanying virology samples for influenza surveillance?\"]", "answers": "[\"A standard request form\", \"No\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 50.0, "avg_bleu": 50.00000000000002}
{"id": "PubMed_10:927", "en": "Lower respiratory tract infection (LRTI)", "fr": "Infection des voies respiratoires inférieures (IVRI)", "perturbation": "alteration", "pert_fr": "Guérison des voies respiratoires inférieures (IVRI)", "bt_pert_fr": "Lower Respiratory Tract Healing (LRTI)", "questions": "[\"What is a lower respiratory tract infection (LRTI)?\" ]", "answers": "[\"Lower Respiratory Tract Healing (LRTI)\"]", "scores": [{"f1": 0.1818181818181818, "em": false, "chrf": 40.71152154423311, "bleu": 8.745825313180632}], "avg_f1": 0.1818181818181818, "avg_em": 0.0, "avg_chrf": 40.71152154423311, "avg_bleu": 8.745825313180632}
{"id": "PubMed_10:928", "en": "History of fever (Y/N); measured (Y/N); if yes, level", "fr": "Antécédents de fièvre (O/N) ; mesurée (O/N) ; si oui, température", "perturbation": "alteration", "pert_fr": "Antécédents de froid (O/N) ; mesurée (O/N) ; si oui, température", "bt_pert_fr": "History of cold (Y/N); measured (Y/N); if yes, temperature", "questions": "[\"Is there a history of fever?\", \"Was the fever measured?\", \"If yes, what was the level of fever?\"]", "answers": "[\"No\", \"No\", \"N/A\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "PubMed_10:930", "en": "Recent travel (Y/N); if yes, countries visited in last 14 days", "fr": "Voyage récent (O/N) ; si oui, pays visités au cours des 14 derniers jours", "perturbation": "alteration", "pert_fr": "Voyage lointain (O/N) ; si oui, pays visités au cours des 14 derniers jours", "bt_pert_fr": "Far travel (Y/N); if yes, countries visited in the last 14 days", "questions": "[\"Was recent travel done?\", \"If yes, which countries were visited in the last 14 days?\"]", "answers": "[\"Yes\", \"countries visited in the last 14 days\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8333333333333334, "em": false, "chrf": 96.06070352084843, "bleu": 75.98356856515926}], "avg_f1": 0.9166666666666667, "avg_em": 0.5, "avg_chrf": 98.03035176042422, "avg_bleu": 87.99178428257966}
{"id": "PubMed_10:934", "en": "Public Presentation of Data Using an Observatory and Dashboards", "fr": "Présentation publique des données à l’aide d’un observatoire et de tableaux de bord", "perturbation": "alteration", "pert_fr": "Présentation privée des données à l’aide d’un observatoire et de tableaux de bord", "bt_pert_fr": "Private presentation of data using an observatory and dashboards", "questions": "[\"What is the purpose of public presentation of data using an observatory and dashboards?\", \"How does an observatory contribute to the public presentation of data?\", \"How do dashboards support the public presentation of data?\", \"What role do observatories and dashboards play in data sharing?\", \"What benefits are gained from using observatories and dashboards for public data presentation?\"]", "answers": "[\"The sentence does not provide information on the purpose of public presentation of data.\", \"The sentence does not provide information on how an observatory contributes to public presentation of data.\", \"The sentence does not provide information on how dashboards support public presentation of data.\", \"The sentence does not provide information on the role of observatories and dashboards in data sharing.\", \"The sentence does not provide information on the benefits of using observatories and dashboards for public data presentation.\"]", "scores": [{"f1": 0.1904761904761905, "em": false, "chrf": 20.94056697060947, "bleu": 3.673526562988939}, {"f1": 0.21428571428571427, "em": false, "chrf": 31.091390890993775, "bleu": 3.4585921141027365}, {"f1": 0.12903225806451615, "em": false, "chrf": 25.00763430749965, "bleu": 2.725762876425168}, {"f1": 0.2758620689655172, "em": false, "chrf": 38.127506842558134, "bleu": 6.250381527944883}, {"f1": 0.30769230769230765, "em": false, "chrf": 27.944651774311673, "bleu": 5.439330544349823}], "avg_f1": 0.22346970789684914, "avg_em": 0.0, "avg_chrf": 28.62235015719454, "avg_bleu": 4.30951872516231}
{"id": "PubMed_10:937", "en": "Definite case will be presented on our dashboard as “cases” of COVID-19.", "fr": "Les cas confirmés seront présentés dans notre tableau de bord en tant que « cas » de COVID-19.", "perturbation": "alteration", "pert_fr": "Les cas non confirmés seront présentés dans notre tableau de bord en tant que « cas » de COVID-19.", "bt_pert_fr": "Unconfirmed cases will be presented in our dashboard as COVID-19 “cases”.", "questions": "[\"What does definite case appear as on the dashboard?\", \"How are definite cases labeled on the COVID-19 dashboard?\"]", "answers": "[\"COVID-19 'cases'\", \"COVID-19 'cases'\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 66.64387437517684, "bleu": 49.99999999999999}, {"f1": 0.6666666666666666, "em": false, "chrf": 66.64387437517684, "bleu": 49.99999999999999}], "avg_f1": 0.6666666666666666, "avg_em": 0.0, "avg_chrf": 66.64387437517684, "avg_bleu": 49.99999999999999}
{"id": "PubMed_10:938", "en": "Possible cases will be presented as “Under investigation” (investigating).", "fr": "Les cas potentiels seront présentés comme « À l’étude » (en cours d’examen).", "perturbation": "alteration", "pert_fr": "Les cas potentiels seront présentés comme « Rejetés » (en cours d’examen).", "bt_pert_fr": "Potential cases will be presented as “Rejected” (under review).", "questions": "[\"What is the status of possible cases?\", \"How are possible cases designated?\"]", "answers": "[\"Rejected\", \"as ‘Rejected’ (under review)\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.166666666666666, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 13.380835706342273, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 8.77375118650447, "avg_bleu": 0.0}
{"id": "PubMed_10:941", "en": "We have the option to move to twice weekly surveillance reports with a scope to change this to daily reporting.", "fr": "Nous avons la possibilité de passer à des rapports de surveillance bihebdomadaires dans l’objectif d’adopter des rapports quotidiens.", "perturbation": "alteration", "pert_fr": "Nous avons la possibilité de passer à des rapports de surveillance mensuels dans l’objectif d’adopter des rapports quotidiens.", "bt_pert_fr": "We have the option to move to monthly monitoring reports with the goal of adopting daily reporting.", "questions": "[\"Can we move to twice weekly surveillance reports?\", \"Is it possible to change the surveillance reporting frequency to daily?\", \"What are the available options for surveillance reporting frequency?\"]", "answers": "[\"No\", \"No\", \"Monthly monitoring reports\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 6.225376300636427, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 2.0751254335454754, "avg_bleu": 0.0}
{"id": "PubMed_10:943", "en": "Additionally, we will recruit more surveillance practices.", "fr": "En outre, nous recruterons de nouveaux cabinets de surveillance.", "perturbation": "alteration", "pert_fr": "En outre, nous licencierons de nouveaux cabinets de surveillance.", "bt_pert_fr": "In addition, we will license new monitoring firms.", "questions": "[\"What additional practices will be recruited?\", \"What surveillance practices will be recruited?\"]", "answers": "[\"None\", \"None\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.8409090909090904, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 2.8409090909090904, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 2.8409090909090904, "avg_bleu": 0.0}
{"id": "PubMed_10:951", "en": "Additionally, PHE will retrospectively test any influenza virology samples collected between early and mid-February 2020 for COVID-19.", "fr": "En outre, PHE analysera de manière rétrospective tout échantillon virologique de grippe collecté entre le début et la mi-février 2020 pour le COVID-19.", "perturbation": "alteration", "pert_fr": "En outre, PHE analysera de manière prospective tout échantillon virologique de grippe collecté entre le début et la mi-février 2020 pour le COVID-19.", "bt_pert_fr": "Additionally, PHE will prospectively analyze any influenza virological samples collected between early and mid-February 2020 for COVID-19.", "questions": "[\"Will PHE retrospectively test any influenza virology samples collected between early and mid-February 2020 for COVID-19?\", \"What influenza virology samples will PHE test for COVID-19?\", \"When will PHE retrospectively test influenza virology samples for COVID-19?\"]", "answers": "[\"No\", \"Any influenza virological samples\", \"Not specified\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.4285714285714285, "em": false, "chrf": 38.28820155332071, "bleu": 7.888842466409752}, {"f1": 0, "em": false, "chrf": 3.156565656565656, "bleu": 0.0}], "avg_f1": 0.14285714285714282, "avg_em": 0.0, "avg_chrf": 13.814922403295455, "avg_bleu": 2.6296141554699175}
{"id": "PubMed_10:955", "en": "Everyone with an ILI or a respiratory illness who contacts a GP (eg, phones for an appointment) should be asked specifically about recent travel to China and other countries flagged in current PHE advice, or if they have had contact with other people with COVID-19.", "fr": "Toute personne présentant un SG ou une maladie respiratoire et qui contacte un MG (par ex. prend rendez-vous par téléphone) devrait être interrogée spécifiquement au sujet de tout récent voyage en Chine et dans d’autres pays signalés dans les recommandations en vigueur de PHE, ou si elle a été en contact avec d’autres personnes atteintes du COVID-19.", "perturbation": "alteration", "pert_fr": "Toute personne présentant un SG ou une maladie respiratoire et qui contacte un MG (par ex. prend rendez-vous par téléphone) ne devrait pas être interrogée spécifiquement au sujet de tout récent voyage en Chine et dans d’autres pays signalés dans les recommandations en vigueur de PHE, ou si elle a été en contact avec d’autres personnes atteintes du COVID-19.", "bt_pert_fr": "Anyone with ILI or respiratory illness who contacts a GP (e.g. makes an appointment by telephone) should not be asked specifically about any recent travel to China and other countries reported in current PHE guidance, or whether they have been in contact with other people with COVID-19.", "questions": "[\"Should everyone with an ILI or a respiratory illness who contacts a GP be asked about recent travel to China and other countries flagged in current PHE advice?\", \"Should everyone with an ILI or a respiratory illness who contacts a GP be asked if they have had contact with other people with COVID-19?\"]", "answers": "[\"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "PubMed_10:958", "en": "These calls should be coded into the GP CMR system and can be reported as part of the RCGP RSC weekly return.", "fr": "Ces appels doivent être codés dans le système de DMI du cabinet de MG et peuvent être signalés dans le cadre du rapport hebdomadaire du RSC du RCGP.", "perturbation": "alteration", "pert_fr": "Ces appels ne doivent pas être codés dans le système de DMI du cabinet de MG et peuvent être signalés dans le cadre du rapport hebdomadaire du RSC du RCGP.", "bt_pert_fr": "These calls do not need to be coded in the GP practice's EMR system and may be reported as part of the RCGP's weekly RSC report.", "questions": "[\"Should these calls be coded into the GP CMR system?\", \"Can these calls be reported as part of the RCGP RSC weekly return?\"]", "answers": "[\"No\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 50.0, "avg_bleu": 50.00000000000002}
{"id": "PubMed_10:961", "en": "Practice reception or triage staff: for coding of any patients calling the practice with symptoms of acute respiratory infection with a history of travel to important areas based on PHE advice", "fr": "Le secrétariat ou le personnel de triage du cabinet : pour le codage de tout patient appelant le cabinet avec des symptômes d’infection respiratoire aigüe et des antécédents de voyage dans des zones importantes conformément aux recommandations de PHE", "perturbation": "alteration", "pert_fr": "Le secrétariat ou le personnel de triage du cabinet : pour le codage de tout patient appelant le cabinet avec des symptômes d’infection respiratoire chronique et des antécédents de voyage dans des zones insignifiantes conformément aux recommandations de PHE", "bt_pert_fr": "The practice secretarial or triage staff: for coding any patient calling the practice with symptoms of chronic respiratory infection and a history of travel to insignificant areas in accordance with PHE recommendations", "questions": "[\"What is the role of reception or triage staff in a practice?\", \"What do reception or triage staff do when patients call with symptoms of acute respiratory infection and a history of travel to important areas?\", \"What guidance does PHE provide regarding the handling of patients with symptoms of acute respiratory infection and travel history?\", \"What actions do reception or triage staff take for patients with symptoms of acute respiratory infection and a history of travel to important areas?\"]", "answers": "[\"To code any patient calling the practice with symptoms of chronic respiratory infection and a history of travel to insignificant areas in accordance with PHE recommendations\", \"None specified\", \"None specified\", \"Code patients with symptoms of chronic respiratory infection and a history of travel to insignificant areas in accordance with PHE recommendations\"]", "scores": [{"f1": 0.6956521739130435, "em": false, "chrf": 69.15396875195934, "bleu": 42.66219662386316}, {"f1": 0, "em": false, "chrf": 3.8166269952231158, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 4.665308412318776, "bleu": 0.0}, {"f1": 0.717948717948718, "em": false, "chrf": 70.01909579033325, "bleu": 49.030470692026626}], "avg_f1": 0.3534002229654404, "avg_em": 0.0, "avg_chrf": 36.91374998745862, "avg_bleu": 22.923166828972448}
{"id": "PubMed_10:963", "en": "Practices participating in virology surveillance will opportunistically collect blood samples from patients coming into the practice for a routine blood test.", "fr": "Les cabinets participant à la surveillance virologique prélèveront de façon opportuniste des échantillons de sang des patients venant au cabinet pour une analyse de sang de routine.", "perturbation": "alteration", "pert_fr": "Les cabinets participant à la surveillance virologique prélèveront de façon systématique des échantillons de sang des patients venant au cabinet pour une analyse de sang de routine.", "bt_pert_fr": "Practices participating in virological surveillance will systematically collect blood samples from patients coming to the practice for routine blood testing.", "questions": "[\"Will practices participating in virology surveillance opportunistically collect blood samples from patients coming into the practice for a routine blood test?\", \"Do practices participating in virology surveillance collect blood samples from patients for a routine blood test?\", \"What type of samples do practices participating in virology surveillance collect from patients during routine blood tests?\"]", "answers": "[\"No\", \"Yes\", \"Blood samples\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6666666666666666, "avg_em": 0.6666666666666666, "avg_chrf": 66.66666666666667, "avg_bleu": 66.6666666666667}
{"id": "PubMed_10:964", "en": "Patients who attend their practice for a routine blood test will be asked to provide an additional sample for serology.", "fr": "Il sera demandé aux patients qui se rendent dans leur cabinet pour une analyse de sang de routine de fournir un échantillon de sang supplémentaire pour l’analyse sérologique.", "perturbation": "alteration", "pert_fr": "Il ne sera pas demandé aux patients qui se rendent dans leur cabinet pour une analyse de sang de routine de fournir un échantillon de sang supplémentaire pour l’analyse sérologique.", "bt_pert_fr": "Patients who visit their office for a routine blood test will not be asked to provide an additional blood sample for serological analysis.", "questions": "[\"Will patients who attend their practice for a routine blood test be asked to provide an additional sample for serology?\", \"What is required of patients who attend their practice for a routine blood test?\"]", "answers": "[\"No\", \"Patients are not required to provide an additional blood sample for serological analysis\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.4444444444444444, "em": false, "chrf": 70.72945666094229, "bleu": 9.578464408619825}], "avg_f1": 0.2222222222222222, "avg_em": 0.0, "avg_chrf": 35.364728330471145, "avg_bleu": 4.789232204309912}
{"id": "PubMed_10:965", "en": "We have conducted initial searches within the RCGP RSC database to look at the number of full blood count (FBC) results and overall rates in adults and children (Figures 6-​-9).9).", "fr": "Nous avons mené des recherches initiales dans la base de données du RSC du RCGP afin d’examiner le nombre de résultats de formule sanguine complète (FSC) et les taux globaux chez les adultes et les enfants (Figures 6--9).9).", "perturbation": "alteration", "pert_fr": "Nous n'avons pas mené des recherches initiales dans la base de données du RSC du RCGP afin d’examiner le nombre de résultats de formule sanguine complète (FSC) et les taux globaux chez les adultes et les enfants (Figures 6--9).9)", "bt_pert_fr": "We did not conduct initial searches of the RCGP CHR database to examine the number of complete blood count (CBC) results and overall rates in adults and children (Figures 6--9).9)", "questions": "[\"What did we conduct in the RCGP RSC database?\", \"What specific data were looked at in the RCGP RSC database?\", \"What is the number of full blood count (FBC) results?\", \"What are the overall rates in adults and children?\", \"What do Figures 6-9 show?\"]", "answers": "[\"We did not conduct initial searches\", \"the number of complete blood count (CBC) results and overall rates in adults and children\", \"not specified\", \"not specified\", \"the results of the initial searches in the RCGP CHR database\"]", "scores": [{"f1": 0.25, "em": false, "chrf": 73.9707895185141, "bleu": 8.116697886877475}, {"f1": 0.8275862068965518, "em": false, "chrf": 80.54733559881768, "bleu": 56.422703077354406}, {"f1": 0.5, "em": false, "chrf": 89.11315536315534, "bleu": 49.99999999999999}, {"f1": 0.5, "em": false, "chrf": 89.11315536315534, "bleu": 49.99999999999999}, {"f1": 0.26086956521739135, "em": false, "chrf": 16.84425738699485, "bleu": 3.0297048914466935}], "avg_f1": 0.46769115442278864, "avg_em": 0.0, "avg_chrf": 69.91773864612746, "avg_bleu": 33.51382117113572}
{"id": "PubMed_10:967", "en": "The sampling rate, per 100,000 patients was highest for children 15-17 years of age and 60 year or older in adults, with the lowest rates in children 0-4 years of age and 18-29 years of age in adults (Figures 6-​-99).", "fr": "Le taux d’échantillonnage pour 100 000 patients était plus élevé chez les enfants de 15-17 ans et les adultes de 60 ans et plus, avec les taux les plus bas correspondant aux enfants de 0-4 ans et aux adultes de 18-29 ans (Figures 6--99).", "perturbation": "alteration", "pert_fr": "Le taux d’échantillonnage pour 100 000 patients était plus bas chez les enfants de 15-17 ans et les adultes de 60 ans et plus, avec les taux les plus élevés correspondant aux enfants de 0-4 ans et aux adultes de 18-29 ans (Figures 6-99).", "bt_pert_fr": "The sampling rate per 100,000 patients was lowest among children aged 15-17 and adults aged 60 and over, with the highest rates corresponding to children aged 0-4 and adults aged 18-29 (Figures 6-99).", "questions": "[\"What is the sampling rate per 100,000 patients for children 15-17 years of age?\", \"What is the sampling rate per 100,000 patients for adults 60 years or older?\", \"What is the sampling rate per 100,000 patients for children 0-4 years of age?\", \"What is the sampling rate per 100,000 patients for adults 18-29 years of age?\", \"Which age groups have the highest sampling rates per 100,000 patients?\", \"Which age groups have the lowest sampling rates per 100,000 patients?\"]", "answers": "[\"lowest\", \"lowest\", \"highest\", \"highest\", \"children aged 0-4 and adults aged 18-29\", \"children aged 15-17 and adults aged 60 and over\"]", "scores": [{"f1": 0, "em": false, "chrf": 16.573915525114153, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 16.573915525114153, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 18.44529140860727, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 18.44529140860727, "bleu": 0.0}, {"f1": 0.2222222222222222, "em": false, "chrf": 31.77254085343583, "bleu": 7.417318111314061}, {"f1": 0.19999999999999998, "em": false, "chrf": 34.74665609129633, "bleu": 7.635362674858093}], "avg_f1": 0.07037037037037036, "avg_em": 0.0, "avg_chrf": 22.759601802029167, "avg_bleu": 2.508780131028692}
{"id": "PubMed_10:968", "en": "We will provide 1000 serology baseline samples across all ages that reflect the varying rates of attendance by age.", "fr": "Nous fournirons 1 000 échantillons sérologiques de référence pour toutes les tranches d’âge qui reflètent les divers taux de fréquentation par âge.", "perturbation": "alteration", "pert_fr": "Nous ne fournirons pas 1 000 échantillons sérologiques de référence pour toutes les tranches d’âge qui reflètent les divers taux de fréquentation par âge.", "bt_pert_fr": "We will not provide 1,000 reference serology samples for all age groups that reflect varying attendance rates by age.", "questions": "[\"What is the number of serology baseline samples that will be provided?\", \"How does the rate of attendance vary by age in the serology baseline samples?\", \"What age groups are included in the serology baseline samples?\", \"Do the serology baseline samples reflect varying rates of attendance by age?\"]", "answers": "[1000, \"The rate of attendance varies by age\", \"All age groups\", \"Yes\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4, "em": false, "chrf": 62.13279683564706, "bleu": 27.516060407455225}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7999999999999999, "avg_em": 0.6666666666666666, "avg_chrf": 87.3775989452157, "avg_bleu": 75.8386868024851}
{"id": "PubMed_10:971", "en": "This will be followed by 800 samples monthly.", "fr": "Cela sera suivi par 800 échantillons par mois.", "perturbation": "alteration", "pert_fr": "Cela sera suivi par 800 échantillons par an.", "bt_pert_fr": "This will be followed by 800 samples per year.", "questions": "[\"How many samples are collected monthly?\", \"What is the frequency of sample collection?\"]", "answers": "[\"Cannot determine from the sentence\", \"800 samples per year\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 3.7037037037037033, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 1.8518518518518516, "avg_bleu": 0.0}
{"id": "PubMed_10:974", "en": "We will develop a new request form for practices to capture recent travel and exposure to COVID-19.", "fr": "Nous développerons un nouveau formulaire de demande afin de consigner les voyages récents et l’exposition au COVID-19.", "perturbation": "alteration", "pert_fr": "Nous développerons un nouveau formulaire de demande afin de consigner les voyages anciens et l’exposition au COVID-19.", "bt_pert_fr": "We will develop a new application form to record past travel and exposure to COVID-19.", "questions": "[\"What will be developed for practices?\", \"What information will the new request form capture for practices?\"]", "answers": "[\"A new application form\", \"Past travel and exposure to COVID-19\"]", "scores": [{"f1": 0.75, "em": false, "chrf": 23.686782527704057, "bleu": 35.35533905932737}, {"f1": 0.8333333333333334, "em": false, "chrf": 84.13789869615368, "bleu": 75.98356856515926}], "avg_f1": 0.7916666666666667, "avg_em": 0.0, "avg_chrf": 53.91234061192887, "avg_bleu": 55.66945381224332}
{"id": "PubMed_10:979", "en": "This process may include checking pseudonymized NHS numbers for positive individuals at RCGP RSC practices, checking current PHE guidance regarding considerations of infectiousness for confirmed cases, and offering the patient an appointment following the previously mentioned process.", "fr": "Ce processus peut comprendre l’examen des nombres pseudonymisés de patients positifs du NHS dans les cabinets du RSC du RCGP, en vérifiant les directives actuelles de PHE concernant les considérations de contagiosité des cas confirmés, et en donnant au patient un rendez-vous selon le processus susmentionné.", "perturbation": "alteration", "pert_fr": "Ce processus peut comprendre l’examen des nombres non pseudonymisés de patients négatifs du NHS dans les cabinets du RSC du RCGP, en vérifiant les directives actuelles de PHE concernant les considérations de non-contagiosité des cas infirmés, et en refusant au patient un rendez-vous selon le processus susmentionné.", "bt_pert_fr": "This process may include reviewing non-pseudonymised numbers of negative NHS patients in RCGP RSC practices, checking current PHE guidance regarding non-infectiousness considerations for negative cases, and refusing the patient an appointment using the above process.", "questions": "[\"Does this process include checking pseudonymized NHS numbers for positive individuals at RCGP RSC practices?\", \"Does this process include checking current PHE guidance regarding considerations of infectiousness for confirmed cases?\", \"Does this process include offering the patient an appointment following the previously mentioned process?\"]", "answers": "[\"No\", \"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "PubMed_10:980", "en": "This needs to be carefully coordinated nationally across the network and may require PHE to ensure individuals are not contacted by multiple agencies.", "fr": "Cela doit être coordonné avec soin à l’échelle nationale dans l’ensemble du réseau et peut impliquer que PHE s’assure que les patients ne soient pas contactés par plusieurs agences.", "perturbation": "alteration", "pert_fr": "Cela doit être coordonné avec négligence à l’échelle nationale dans l’ensemble du réseau et peut impliquer que PHE s’assure que les patients soient contactés par plusieurs agences.", "bt_pert_fr": "This needs to be carefully coordinated nationally across the network and may involve PHE ensuring patients are contacted by multiple agencies.", "questions": "[\"How should this be coordinated nationally across the network?\", \"Does PHE need to be involved to ensure individuals are not contacted by multiple agencies?\"]", "answers": "[\"Carefully\", \"No\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 50.0, "avg_bleu": 50.00000000000002}
{"id": "PubMed_10:984", "en": "The RCGP RSC will explore ways to collect convalescent samples from any patients tested positive for COVID-19 through the extension of the virological surveillance.", "fr": "Le RSC du RCGP étudiera des moyens de collecter des échantillons de patients convalescents chez les patients testés positifs au COVID-19 dans le cadre de l’extension de la surveillance virologique.", "perturbation": "alteration", "pert_fr": "Le RSC du RCGP étudiera des moyens de collecter des échantillons de patients décédés chez les patients testés négatifs au COVID-19 dans le cadre de la réduction de la surveillance virologique.", "bt_pert_fr": "The RCGP RSC will explore ways to collect deceased patient samples from patients testing negative for COVID-19 as part of reduced virological surveillance.", "questions": "[\"How will the RCGP RSC collect convalescent samples from patients tested positive for COVID-19?\", \"What methods will be used to collect convalescent samples from patients tested positive for COVID-19?\", \"Will the RCGP RSC collect convalescent samples from any patients tested positive for COVID-19?\", \"What is the purpose of extending the virological surveillance to collect convalescent samples?\", \"How does the extension of virological surveillance enable the collection of convalescent samples?\"]", "answers": "[\"The sentence does not provide information on collecting samples from patients tested positive for COVID-19\", \"The sentence does not provide information on methods for collecting samples from patients tested positive for COVID-19\", \"The sentence does not specify whether convalescent samples will be collected from patients tested positive for COVID-19\", \"The purpose is not stated in the sentence\", \"The extension of virological surveillance enables collection of convalescent samples by expanding the scope to include deceased patients testing negative for COVID-19, but this does not directly relate to positive cases\"]", "scores": [{"f1": 0, "em": false, "chrf": 18.812763582179475, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 18.410485640397862, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 4.466272089997062, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 12.879711240079708, "bleu": 0.0}, {"f1": 0.33333333333333337, "em": false, "chrf": 60.24794353133939, "bleu": 4.621362667122021}], "avg_f1": 0.06666666666666668, "avg_em": 0.0, "avg_chrf": 22.9634352167987, "avg_bleu": 0.9242725334244042}
{"id": "PubMed_10:985", "en": "From the start, we will be carefully curating data to ensure that it can be used for future studies.", "fr": "Dès le début, les données seront dûment conservées afin de garantir leur utilisation dans le cadre d’études futures.", "perturbation": "alteration", "pert_fr": "Dès le début, les données seront dûment détruites afin de garantir leur non-utilisation dans le cadre d’études futures.", "bt_pert_fr": "From the outset, the data will be duly destroyed to ensure their non-use in future studies.", "questions": "[\"How will data be curated from the start?\", \"Why is data curation important for future studies?\"]", "answers": "[\"Duly destroyed\", \"To ensure their non-use in future studies\"]", "scores": [{"f1": 0, "em": false, "chrf": 12.292011671003864, "bleu": 0.0}, {"f1": 0.47058823529411764, "em": false, "chrf": 55.2303878597897, "bleu": 12.100518276540289}], "avg_f1": 0.23529411764705882, "avg_em": 0.0, "avg_chrf": 33.76119976539678, "avg_bleu": 6.050259138270144}
{"id": "PubMed_10:986", "en": "Our clinical data will be linked to virology.", "fr": "Nos données cliniques seront liées à la virologie.", "perturbation": "alteration", "pert_fr": "Nos données cliniques ne seront pas liées à la virologie.", "bt_pert_fr": "Our clinical data will not be linked to virology.", "questions": "[\"Will our clinical data be linked to virology?\"]", "answers": "[\"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "PubMed_10:987", "en": "We will curate our data using the Findable, Accessible, Interoperable, Reusable principles.", "fr": "Nous conserverons nos données conformément aux principes Facile à trouver, Accessible, Interopérable et Réutilisable.", "perturbation": "alteration", "pert_fr": "Nous conserverons nos données conformément aux principes Difficile à trouver, Inaccessible, Non interopérable et Non réutilisable.", "bt_pert_fr": "We will maintain our data in accordance with the principles of Hard to Find, Inaccessible, Non-Interoperable and Non-Reusable.", "questions": "[\"What principles will be used to curate the data?\", \"What is the goal of curating the data?\", \"Which principles guide the curation of the data?\"]", "answers": "[\"Hard to Find, Inaccessible, Non-Interoperable and Non-Reusable\", \"To ensure the data is hard to find, inaccessible, non-interoperable, and non-reusable\", \"Hard to Find, Inaccessible, Non-Interoperable and Non-Reusable\"]", "scores": [{"f1": 0, "em": false, "chrf": 61.59058560379636, "bleu": 0.0}, {"f1": 0.5555555555555556, "em": false, "chrf": 44.47118641459748, "bleu": 24.808415001701817}, {"f1": 0, "em": false, "chrf": 61.59058560379636, "bleu": 0.0}], "avg_f1": 0.1851851851851852, "avg_em": 0.0, "avg_chrf": 55.884119207396736, "avg_bleu": 8.269471667233939}
{"id": "PubMed_10:988", "en": "To facilitate this our data set is listed with Health Data Research UK and the European Health Data Evidence Network.", "fr": "En ce sens, notre ensemble de données est listé avec Health Data Research UK et le Réseau européen de données et de preuves en matière de santé.", "perturbation": "alteration", "pert_fr": "En ce sens, notre ensemble de données n'est pas listé avec Health Data Research UK et le Réseau européen de données et de preuves en matière de santé.", "bt_pert_fr": "In this sense, our dataset is not listed with Health Data Research UK and the European Health Data and Evidence Network.", "questions": "[\"With whom is the data set listed?\", \"Which organizations is the data set listed with?\"]", "answers": "[\"Health Data Research UK and the European Health Data and Evidence Network\", \"Health Data Research UK and the European Health Data and Evidence Network\"]", "scores": [{"f1": 0.9523809523809523, "em": false, "chrf": 94.1643694667016, "bleu": 74.19446627365011}, {"f1": 0.9523809523809523, "em": false, "chrf": 94.1643694667016, "bleu": 74.19446627365011}], "avg_f1": 0.9523809523809523, "avg_em": 0.0, "avg_chrf": 94.1643694667016, "avg_bleu": 74.19446627365011}
{"id": "PubMed_10:992", "en": "By targeting the reproduction number (R) (the average number of secondary cases each case generates) and aiming to reduce the R to below 1, the policy seeks to reduce case numbers to low levels or (as seen in previous outbreaks with severe acute respiratory syndrome and Ebola) to eliminate human-to-human transmission.", "fr": "En ciblant le taux de reproduction (R) (le nombre moyen de cas secondaires généré par chaque cas) et en cherchant à faire passer R en dessous de 1, la politique vise à atteindre de faibles niveaux de cas ou (comme observé lors d’épidémies antérieures du syndrome respiratoire aigu sévère et de l’Ebola) à éliminer la transmission de personne à personne.", "perturbation": "alteration", "pert_fr": "En ciblant le taux de reproduction (R) (le nombre moyen de cas secondaires généré par chaque cas) et en cherchant à faire passer R au-dessus de 1, la politique vise à atteindre de hauts niveaux de cas ou (comme observé lors d’épidémies antérieures du syndrome respiratoire aigu sévère et de l’Ebola) à éliminer la transmission de personne à personne.", "bt_pert_fr": "By targeting the reproduction rate (R) (the average number of secondary cases generated by each case) and seeking to increase R above 1, the policy aims to achieve high levels of cases or (as observed in previous outbreaks of severe acute respiratory syndrome and Ebola) eliminate person-to-person transmission.", "questions": "[\"What is the reproduction number (R) in the context of disease transmission?\", \"What does the reproduction number (R) represent?\", \"What is the goal of reducing the reproduction number (R) to below 1?\", \"How does reducing the reproduction number (R) to below 1 help in controlling disease transmission?\", \"What are the outcomes of reducing the reproduction number (R) to below 1?\", \"How does reducing the reproduction number (R) contribute to eliminating human-to-human transmission?\"]", "answers": "[\"The average number of secondary cases generated by each case\", \"The average number of secondary cases generated by each case\", \"To achieve high levels of cases or eliminate person-to-person transmission\", \"It helps to reduce the spread of the disease by limiting the number of new infections\", \"High levels of cases or elimination of person-to-person transmission\", \"By limiting the number of secondary cases, it reduces the likelihood of human-to-human transmission\"]", "scores": [{"f1": 0.8421052631578948, "em": false, "chrf": 86.07003141055155, "bleu": 58.14307369682194}, {"f1": 0.8421052631578948, "em": false, "chrf": 86.07003141055155, "bleu": 58.14307369682194}, {"f1": 0.47619047619047616, "em": false, "chrf": 47.58910927870907, "bleu": 9.548450962056531}, {"f1": 0.4000000000000001, "em": false, "chrf": 35.86246236452684, "bleu": 10.05262357164871}, {"f1": 0.3157894736842105, "em": false, "chrf": 45.4087843900292, "bleu": 5.61480827173619}, {"f1": 0.33333333333333337, "em": false, "chrf": 35.00767584217587, "bleu": 8.68742663416854}], "avg_f1": 0.5349206349206349, "avg_em": 0.0, "avg_chrf": 56.00134911609067, "avg_bleu": 25.031576138875646}
{"id": "PubMed_10:994", "en": "Key to the focus of our study will be the estimation of peak cases in the population and continual monitoring by data collection and modelling the potential growth and emergence of subsequent peaks in new cases as social distancing measures are relaxed.", "fr": "Le point essentiel de notre étude sera l’estimation du pic des cas dans la population et la surveillance continue grâce à la collecte des données et à la modélisation de la croissance potentielle et l’apparition de pics ultérieurs de nouveaux cas lorsque les mesures de distanciation sociale s’assouplissent.", "perturbation": "alteration", "pert_fr": "Le point essentiel de notre étude sera l’estimation du creux des cas dans la population et la surveillance continue grâce à la collecte des données et à la modélisation de la croissance potentielle et l’apparition de creux ultérieurs de nouveaux cas lorsque les mesures de distanciation sociale se renforcent.", "bt_pert_fr": "The key point of our study will be the estimation of the trough of cases in the population and continued monitoring through data collection and modeling of the potential growth and appearance of subsequent troughs of new cases when social distancing measures are strengthened.", "questions": "[\"What is key to the focus of our study?\", \"How will peak cases in the population be estimated?\", \"How will continual monitoring be conducted?\", \"How will the potential growth of new cases be modeled?\", \"How will the emergence of subsequent peaks in new cases be modeled?\", \"How will social distancing measures being relaxed affect the modeling of new cases?\"]", "answers": "[\"The estimation of the trough of cases in the population\", \"Through data collection and modeling\", \"Through data collection and modeling\", \"Through data collection and modeling\", \"Through data collection and modeling\", \"It will not affect the modeling of new cases\"]", "scores": [{"f1": 0.358974358974359, "em": false, "chrf": 19.553301587751246, "bleu": 2.02705509047902}, {"f1": 0.5, "em": false, "chrf": 68.60631784624196, "bleu": 21.3643503198117}, {"f1": 0.6, "em": false, "chrf": 79.46024902353977, "bleu": 39.76353643835254}, {"f1": 0, "em": false, "chrf": 31.21871941462783, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 31.21871941462783, "bleu": 0.0}, {"f1": 0.10526315789473685, "em": false, "chrf": 14.10188623120623, "bleu": 3.7954847898457067}], "avg_f1": 0.260706252811516, "avg_em": 0.0, "avg_chrf": 40.69319891966581, "avg_bleu": 11.15840443974816}
{"id": "PubMed_10:995", "en": "There has already been publication of important disease epidemiological measures concerning the outbreak of COVID-19 in mainland China.", "fr": "D’importantes mesures épidémiologiques de la maladie ont déjà été publiées au sujet de l’épidémie de COVID-19 en Chine continentale.", "perturbation": "alteration", "pert_fr": "D’importantes mesures épidémiologiques de la santé ont déjà été publiées au sujet de l’épidémie de COVID-19 en Chine continentale.", "bt_pert_fr": "Important epidemiological health metrics have already been released regarding the COVID-19 outbreak in mainland China.", "questions": "[\"Have there been publications of important disease epidemiological measures concerning the outbreak of COVID-19 in mainland China?\", \"What important disease epidemiological measures have been published concerning the outbreak of COVID-19 in mainland China?\"]", "answers": "[\"Yes\", \"Important epidemiological health metrics\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.09523809523809523, "em": false, "chrf": 22.077940702533343, "bleu": 0.6193628179172647}], "avg_f1": 0.5476190476190477, "avg_em": 0.5, "avg_chrf": 61.03897035126667, "avg_bleu": 50.30968140895865}
{"id": "PubMed_10:996", "en": "A further fundamental measure in pandemic dynamics is the length of time from infection to when a person is infectious to others and the mean duration of infectiousness.", "fr": "Une autre mesure fondamentale dans la dynamique d’une pandémie est la durée entre l’infection et le moment où une personne devient contagieuse pour les autres, ainsi que la période moyenne de contagiosité.", "perturbation": "alteration", "pert_fr": "Une autre mesure fondamentale dans la dynamique d’une pandémie est la durée entre la guérison et le moment où une personne devient non contagieuse pour les autres, ainsi que la période moyenne de non-contagiosité.", "bt_pert_fr": "Another fundamental measure in the dynamics of a pandemic is the duration between recovery and the moment when a person becomes non-contagious to others, as well as the average period of non-contagiousness.", "questions": "[\"What is a further fundamental measure in pandemic dynamics?\", \"What is the length of time from infection to when a person is infectious to others?\", \"What is the mean duration of infectiousness?\"]", "answers": "[\"the duration between recovery and the moment when a person becomes non-contagious to others\", \"not specified\", \"the average period of non-contagiousness\"]", "scores": [{"f1": 0.41379310344827586, "em": false, "chrf": 36.614732505850675, "bleu": 6.208294406285697}, {"f1": 0, "em": false, "chrf": 4.649886447495756, "bleu": 0.0}, {"f1": 0.22222222222222224, "em": false, "chrf": 30.182163963254364, "bleu": 12.44023474812678}], "avg_f1": 0.21200510855683272, "avg_em": 0.0, "avg_chrf": 23.815594305533597, "avg_bleu": 6.21617638480416}
{"id": "PubMed_10:999", "en": "Such techniques are highly parallelizable and have been successfully applied to many fields including disease transmission modelling.", "fr": "Ces techniques sont hautement parallélisables et sont appliquées avec succès dans plusieurs domaines, notamment la modélisation de la transmission de maladies.", "perturbation": "alteration", "pert_fr": "Ces techniques sont hautement impraticables et sont appliquées avec succès dans plusieurs domaines, notamment la modélisation de la transmission de maladies.", "bt_pert_fr": "These techniques are highly impractical and are successfully applied in several areas, including disease transmission modeling.", "questions": "[\"Are such techniques highly parallelizable?\", \"Have such techniques been successfully applied to disease transmission modelling?\"]", "answers": "[\"No\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 50.0, "avg_bleu": 50.00000000000002}
{"id": "PubMed_10:1000", "en": "They are particularly suited to situations where likelihood functions are absent and where more traditional approaches such as Markov chain Monte Carlo are impractical.", "fr": "Elles sont particulièrement adaptées aux situations dans lesquelles les fonctions de vraisemblance sont absentes et des approches plus traditionnelles telles que les méthodes de Monte-Carlo par chaînes de Markov sont irréalisables.", "perturbation": "alteration", "pert_fr": "Elles sont particulièrement inadaptées aux situations dans lesquelles les fonctions de vraisemblance sont absentes et des approches plus traditionnelles telles que les méthodes de Monte-Carlo par chaînes de Markov sont irréalisables.", "bt_pert_fr": "They are particularly unsuitable for situations in which likelihood functions are absent and more traditional approaches such as Markov chain Monte Carlo methods are infeasible.", "questions": "[\"Are likelihood functions absent in the situations they are suited to?\", \"Are traditional approaches like Markov chain Monte Carlo impractical in the situations they are suited to?\"]", "answers": "[\"No\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 50.0, "avg_bleu": 50.00000000000002}
{"id": "PubMed_10:1002", "en": "Furthermore, peaks in new cases have been estimated by distributional methods.", "fr": "En outre, les pics de nouveaux cas ont été estimés à l’aide de méthodes distributionnelles.", "perturbation": "alteration", "pert_fr": "En outre, les pics de nouveaux cas n'ont pas été estimés à l’aide de méthodes distributionnelles.", "bt_pert_fr": "Additionally, peaks in new cases were not estimated using distributional methods.", "questions": "[\"How are peaks in new cases estimated?\", \"What methods are used to estimate peaks in new cases?\"]", "answers": "[\"Using distributional methods\", \"Distributional methods\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 87.59782848415686, "bleu": 55.03212081491043}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8333333333333333, "avg_em": 0.5, "avg_chrf": 93.79891424207844, "avg_bleu": 77.51606040745523}
{"id": "PubMed_10:1003", "en": "Estimates of the parameters of the SEIR model are tractable on large data sets because of parallelizability, and these methods have been implemented in several R libraries; we intend to use the libraries ABSEIR (deposited on GitHub: https://tinyurl.com/vqu35cj) and abctools (https://tinyurl.com/tfjavz4) to estimate epidemic measures on a weekly basis.", "fr": "Les estimations des paramètres du modèle SEIR peuvent être adaptées à de grands ensembles de données en raison de leur caractère parallélisable, et ces méthodes ont été mises en œuvre dans plusieurs bibliothèques R. Nous avons l’intention d’utiliser les bibliothèques ABSEIR (consignées sur GitHub : https://tinyurl.com/vqu35cj) et abctools (https://tinyurl.com/tfjavz4) afin d’estimer les mesures de l’épidémie sur une base hebdomadaire.", "perturbation": "alteration", "pert_fr": "Les estimations des paramètres du modèle SEIR ne peuvent pas être adaptées à de petits ensembles de données en raison de leur caractère non parallélisable, et ces méthodes n’ont pas été mises en œuvre dans plusieurs bibliothèques R. Nous n’avons pas l’intention d’utiliser les bibliothèques ABSEIR (consignées sur GitHub : https://tinyurl.com/vqu35cj) et abctools (https://tinyurl.com/tfjavz4) afin d’estimer les mesures de l’épidémie sur une base mensuelle.", "bt_pert_fr": "SEIR model parameter estimates cannot be scaled to small datasets due to their non-parallelizability, and these methods have not been implemented in several R libraries. We do not intend to use the ABSEIR libraries (on GitHub: https://tinyurl.com/vqu35cj) and abctools (https://tinyurl.com/tfjavz4) to estimate epidemic measurements on a monthly basis.", "questions": "[\"Are estimates of the parameters of the SEIR model tractable on large data sets because of parallelizability?\", \"Have these methods been implemented in several R libraries?\", \"Which R libraries do we intend to use to estimate epidemic measures on a weekly basis?\", \"What is the purpose of using the ABSEIR and abctools libraries?\", \"Where can the ABSEIR library be accessed?\", \"Where can the abctools library be accessed?\"]", "answers": "[\"Yes\", \"No\", \"None\", \"To estimate epidemic measurements on a monthly basis\", \"https://tinyurl.com/vqu35cj\", \"https://tinyurl.com/tfjavz4\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 3.4722222222222223, "bleu": 0.0}, {"f1": 0.7142857142857143, "em": false, "chrf": 74.69393427819395, "bleu": 27.77619034011791}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6190476190476191, "avg_em": 0.5, "avg_chrf": 63.027692750069356, "avg_bleu": 54.62936505668634}
{"id": "PubMed_10:1004", "en": "Since we are fitting an SIR-epidemic model in the ABC routine, we anticipate that our results will be robust against weekly case data containing relatively small counts.", "fr": "Étant donné que nous adaptons le modèle épidémique SIR à la routine ABC, nous prévoyons que nos résultats seront solides par rapport aux données de cas hebdomadaires contenant des nombres relativement faibles.", "perturbation": "alteration", "pert_fr": "Étant donné que nous adaptons le modèle épidémique SIR à la routine ABC, nous prévoyons que nos résultats seront fragiles par rapport aux données de cas hebdomadaires contenant des nombres relativement faibles.", "bt_pert_fr": "Since we fit the SIR epidemic model to the ABC routine, we expect our results to be fragile compared to weekly case data containing relatively low numbers.", "questions": "[\"Are the results of the SIR-epidemic model robust against weekly case data containing relatively small counts?\", \"Does the ABC routine ensure robust results when using weekly case data with small counts?\"]", "answers": "[\"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "PubMed_10:1007", "en": "This approach is independent of the ABC methodology and will allow comparisons between estimates from the two modelling approaches to judge robustness of results.", "fr": "Cette approche est indépendante de la méthodologie ABC et permettra de comparer les estimations des deux approches de modélisation afin d’évaluer la solidité des résultats.", "perturbation": "alteration", "pert_fr": "Cette approche est dépendante de la méthodologie ABC et permettra de comparer les estimations des deux approches de modélisation afin d’évaluer la solidité des résultats.", "bt_pert_fr": "This approach is dependent on the ABC methodology and will allow the estimates of the two modeling approaches to be compared in order to assess the robustness of the results.", "questions": "[\"Is this approach independent of the ABC methodology?\", \"Will this approach allow comparisons between estimates from the two modelling approaches?\", \"Can this approach be used to judge the robustness of results from the two modelling approaches?\"]", "answers": "[\"No\", \"Yes\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6666666666666666, "avg_em": 0.6666666666666666, "avg_chrf": 66.66666666666667, "avg_bleu": 66.6666666666667}
{"id": "PubMed_10:1009", "en": "This has been confirmed by PHE’s Caldicott Guardian’s Office.", "fr": "Cela a été confirmé par le bureau du gardien Caldicott de PHE.", "perturbation": "alteration", "pert_fr": "Cela n'a pas été confirmé par le bureau du gardien Caldicott de PHE.", "bt_pert_fr": "This has not been confirmed by PHE's Guardian Caldicott's office.", "questions": "[\"Which office has confirmed this?\", \"What organization has confirmed this?\"]", "answers": "[\"None\", \"PHE's Guardian Caldicott's office\"]", "scores": [{"f1": 0, "em": false, "chrf": 3.75, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 57.104674403032185, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 30.427337201516092, "avg_bleu": 0.0}
{"id": "PubMed_10:1012", "en": "Any cases identified will be managed according to the PHE/NHS guidance in force at the time, including advice for identified contacts.", "fr": "Tout cas identifié sera pris en charge conformément aux directives de PHE/NHS en vigueur au moment de sa détection, notamment les recommandations relatives aux contacts identifiés.", "perturbation": "alteration", "pert_fr": "Aucun cas identifié ne sera pris en charge conformément aux directives de PHE/NHS en vigueur au moment de sa détection, notamment les recommandations relatives aux contacts identifiés.", "bt_pert_fr": "No identified cases will be managed in accordance with PHE/NHS guidance in force at the time of detection, including recommendations for identified contacts.", "questions": "[\"How will cases identified be managed?\", \"What guidance from PHE/NHS is used to manage identified cases?\", \"What advice is given to identified contacts according to the PHE/NHS guidance?\"]", "answers": "[\"No identified cases will be managed in accordance with PHE/NHS guidance in force at the time of detection\", \"None\", \"Recommendations for identified contacts\"]", "scores": [{"f1": 0.48, "em": false, "chrf": 63.06493660678453, "bleu": 28.175950490399515}, {"f1": 0, "em": false, "chrf": 4.032258064516128, "bleu": 0.0}, {"f1": 0.75, "em": false, "chrf": 72.53605008488432, "bleu": 59.460355750136046}], "avg_f1": 0.41, "avg_em": 0.0, "avg_chrf": 46.54441491872833, "avg_bleu": 29.21210208017852}
{"id": "PubMed_10:1015", "en": "Travel History and Clinical Descriptors of the COVID-19 Infections", "fr": "Antécédents de voyages et descripteurs cliniques des infections au COVID-19", "perturbation": "alteration", "pert_fr": "Antécédents de voyages et descripteurs cliniques de l'absence d'infections au COVID-19", "bt_pert_fr": "Travel history and clinical descriptors of freedom from COVID-19 infections", "questions": "[\"What does travel history reveal about COVID-19 infections?\", \"What clinical descriptors are associated with COVID-19 infections?\"]", "answers": "[\"Travel history does not reveal anything about COVID-19 infections\", \"Clinical descriptors of freedom from COVID-19 infections\"]", "scores": [{"f1": 0.46153846153846156, "em": false, "chrf": 77.7377419926162, "bleu": 17.747405280050266}, {"f1": 0.4444444444444445, "em": false, "chrf": 73.2587120539902, "bleu": 13.134549472120794}], "avg_f1": 0.45299145299145305, "avg_em": 0.0, "avg_chrf": 75.4982270233032, "avg_bleu": 15.440977376085531}
{"id": "PubMed_10:1024", "en": "We have rapidly created and incorporated new codes to allow data recording, and are collecting data to monitor the effectiveness of containment strategies.", "fr": "Nous avons rapidement créé et mis en œuvre de nouveaux codes afin de permettre l’enregistrement des données, et nous recueillons des données pour mesurer l’efficacité des stratégies de confinement.", "perturbation": "alteration", "pert_fr": "Nous n'avons pas rapidement créé et mis en œuvre de nouveaux codes afin de permettre l’enregistrement des données, et nous recueillons des données pour mesurer l’inefficacité des stratégies de confinement.", "bt_pert_fr": "We have not quickly created and implemented new codes to enable data recording, and we are collecting data to measure the ineffectiveness of containment strategies.", "questions": "[\"What new codes have been created and incorporated to allow data recording?\", \"What data are being collected to monitor the effectiveness of containment strategies?\"]", "answers": "[\"None\", \"Data on the ineffectiveness of containment strategies\"]", "scores": [{"f1": 0, "em": false, "chrf": 10.416666666666668, "bleu": 0.0}, {"f1": 0.2857142857142857, "em": false, "chrf": 23.59541049570232, "bleu": 8.116697886877475}], "avg_f1": 0.14285714285714285, "avg_em": 0.0, "avg_chrf": 17.006038581184495, "avg_bleu": 4.058348943438737}
{"id": "PubMed_10:1025", "en": "Through this surveillance, we intend to find out more about the epidemiology of COVID-19 in ambulatory care.", "fr": "Au moyen de cette surveillance, nous prétendons en apprendre davantage sur l’épidémiologie du COVID-19 dans le cadre des soins ambulatoires.", "perturbation": "alteration", "pert_fr": "Au moyen de cette surveillance, nous prétendons en apprendre davantage sur l’épidémiologie du COVID-19 en dehors des soins ambulatoires.", "bt_pert_fr": "Through this surveillance, we aim to learn more about the epidemiology of COVID-19 outside of ambulatory care.", "questions": "[\"What does the surveillance aim to find out about in ambulatory care?\", \"What aspect of COVID-19 is being studied through surveillance in ambulatory care?\"]", "answers": "[\"None\", \"None\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.8409090909090904, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 2.8409090909090904, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 2.8409090909090904, "avg_bleu": 0.0}
{"id": "PubMed_10:1027", "en": "Our testing of low-risk patients will also inform whether the containment strategy that is based on virology testing of high-risk patients and their contacts plus self-isolation is effective.", "fr": "Notre évaluation des patients à faible risque permettra également de déterminer si la stratégie de confinement fondée sur le dépistage virologique des patients à haut risque et de leurs contacts associée à l’auto-confinement est efficace.", "perturbation": "alteration", "pert_fr": "Notre évaluation des patients à haut risque permettra également de déterminer si la stratégie de confinement fondée sur le dépistage virologique des patients à faible risque et de leurs contacts associée à l’auto-confinement est efficace.", "bt_pert_fr": "Our assessment of high-risk patients will also determine whether the containment strategy based on virological screening of low-risk patients and their contacts associated with self-containment is effective.", "questions": "[\"Will testing of low-risk patients inform the effectiveness of the containment strategy based on virology testing of high-risk patients and their contacts plus self-isolation?\"]", "answers": "[\"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "PubMed_10:1029", "en": "However, there may come a point at which the virus spreads more widely into the population, as has happened in Italy.", "fr": "Néanmoins, il se peut que le virus finisse par se propager plus largement au sein de la population, comme en Italie.", "perturbation": "alteration", "pert_fr": "Néanmoins, il se peut que le virus finisse par se propager moins largement au sein de la population, comme en Italie.", "bt_pert_fr": "However, the virus may end up spreading less widely among the population, as in Italy.", "questions": "[\"At what point may the virus spread more widely into the population?\", \"Has the virus spread more widely into the population in Italy?\"]", "answers": "[\"Never\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 5.581935744594866, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 2.790967872297433, "avg_bleu": 0.0}
{"id": "PubMed_10:1030", "en": "Surveillance of low-risk patients should inform when we reach this tipping point and when infection rates start to remit.", "fr": "La surveillance des patients à faible risque devrait révéler le moment où nous atteindrons ce point critique et lorsque les taux d’infection commenceront à chuter.", "perturbation": "alteration", "pert_fr": "La surveillance des patients à haut risque devrait révéler le moment où nous atteindrons ce point critique et lorsque les taux d’infection commenceront à chuter.", "bt_pert_fr": "Monitoring high-risk patients should reveal when we reach this tipping point and when infection rates begin to fall.", "questions": "[\"When should surveillance of low-risk patients inform us that we have reached the tipping point?\", \"When does surveillance of low-risk patients indicate that infection rates start to remit?\"]", "answers": "[\"When we reach this tipping point\", \"When infection rates begin to fall\"]", "scores": [{"f1": 0.8333333333333334, "em": false, "chrf": 95.89836585851079, "bleu": 75.98356856515926}, {"f1": 0.5, "em": false, "chrf": 56.30398607275418, "bleu": 17.965205598154213}], "avg_f1": 0.6666666666666667, "avg_em": 0.0, "avg_chrf": 76.10117596563248, "avg_bleu": 46.97438708165674}
{"id": "PubMed_10:1033", "en": "The surveillance system should be able to identify areas where COVID-19 spread is taking place that might be suitable for trials of antiviral therapy.", "fr": "Le système de surveillance devrait être capable d’identifier les zones de propagation du COVID-19 où le traitement antiviral pourrait être étudié.", "perturbation": "alteration", "pert_fr": "Le système de surveillance devrait être capable d’identifier les zones de disparition du COVID-19 où le traitement antiviral pourrait être étudié.", "bt_pert_fr": "The surveillance system should be able to identify areas of COVID-19 disappearance where antiviral treatment could be studied.", "questions": "[\"Should the surveillance system be able to identify areas where COVID-19 spread is taking place?\", \"What areas should the surveillance system identify for potential trials of antiviral therapy?\"]", "answers": "[\"No\", \"Areas of COVID-19 disappearance\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.36363636363636365, "em": false, "chrf": 30.42488452023267, "bleu": 8.9730240870212}], "avg_f1": 0.18181818181818182, "avg_em": 0.0, "avg_chrf": 15.212442260116335, "avg_bleu": 4.4865120435106}
{"id": "PubMed_10:1042", "en": "The impact on practices has been to close for a day, if a case is found, for deep cleaning and then reopen.", "fr": "La détection d’un cas entraîne la fermeture des cabinets sur la journée pour un nettoyage en profondeur puis leur réouverture le jour suivant.", "perturbation": "alteration", "pert_fr": "La détection d’un cas entraîne l'ouverture des cabinets sur la journée pour un nettoyage en profondeur puis leur fermeture le jour suivant.", "bt_pert_fr": "The detection of a case leads to the opening of the practices during the day for a thorough cleaning then their closure the following day.", "questions": "[\"What impact has been observed on practices when a case is found?\", \"What action is taken when a case is found?\", \"What follows deep cleaning in the practice?\", \"What happens after a practice closes for a day?\"]", "answers": "[\"The practices are opened during the day for a thorough cleaning\", \"The practices are opened during the day for a thorough cleaning\", \"The practices are closed the following day\", \"The practices are closed the following day\"]", "scores": [{"f1": 0.3157894736842105, "em": false, "chrf": 32.52658975005367, "bleu": 5.61480827173619}, {"f1": 0.375, "em": false, "chrf": 31.228446959684568, "bleu": 6.27465531099474}, {"f1": 0, "em": false, "chrf": 7.309941520467839, "bleu": 0.0}, {"f1": 0.2222222222222222, "em": false, "chrf": 51.10771597093973, "bleu": 8.116697886877475}], "avg_f1": 0.22825292397660818, "avg_em": 0.0, "avg_chrf": 30.54317355028645, "avg_bleu": 5.001540367402101}
{"id": "PubMed_10:1043", "en": "The principal limitations of our system are the number of data points.", "fr": "Les principales limitations de notre système sont le nombre de points de données.", "perturbation": "alteration", "pert_fr": "Les principales limitations de notre système sont l'absence de points de données.", "bt_pert_fr": "The main limitations of our system are the lack of data points.", "questions": "[\"What are the principal limitations of the system?\", \"What is the main limitation of the system?\", \"What is the primary constraint of the system?\"]", "answers": "[\"The lack of data points\", \"The lack of data points\", \"The lack of data points\"]", "scores": [{"f1": 0.8000000000000002, "em": false, "chrf": 57.0815397094343, "bleu": 42.7287006396234}, {"f1": 0.8000000000000002, "em": false, "chrf": 57.0815397094343, "bleu": 42.7287006396234}, {"f1": 0.8000000000000002, "em": false, "chrf": 57.0815397094343, "bleu": 42.7287006396234}], "avg_f1": 0.8000000000000002, "avg_em": 0.0, "avg_chrf": 57.0815397094343, "avg_bleu": 42.72870063962339}
{"id": "PubMed_10:1046", "en": "Our sites (surveillance practices) are currently fixed, and it could be helpful to be able to rapidly onboard practices in regions where there are more cases.", "fr": "Nos centres (les cabinets de surveillance) sont actuellement établis, et il pourrait s’avérer utile de pouvoir recruter rapidement des cabinets situés dans les régions où les cas sont plus nombreux.", "perturbation": "alteration", "pert_fr": "Nos centres (les cabinets de surveillance) ne sont pas actuellement établis, et il pourrait s’avérer utile de pouvoir recruter rapidement des cabinets situés dans les régions où les cas sont moins nombreux.", "bt_pert_fr": "Our centers (the monitoring practices) are not currently established, and it could be useful to be able to quickly recruit practices located in regions where there are fewer cases.", "questions": "[\"Are our surveillance practices currently fixed?\", \"Could it be helpful to rapidly onboard surveillance practices in regions with more cases?\"]", "answers": "[\"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "PubMed_10:1047", "en": "Currently, we will be reporting weekly.", "fr": "Pour l’heure, nous allons produire des rapports hebdomadaires.", "perturbation": "alteration", "pert_fr": "Pour l’heure, nous allons produire des rapports mensuels.", "bt_pert_fr": "For now, we will produce monthly reports.", "questions": "[\"What are we currently reporting?\", \"What is the frequency of the reports?\", \"What type of reports are being issued currently?\"]", "answers": "[\"Monthly reports\", \"Monthly\", \"Monthly reports\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 59.70336229294744, "bleu": 49.99999999999999}, {"f1": 0, "em": false, "chrf": 8.581752484191508, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 59.70336229294744, "bleu": 49.99999999999999}], "avg_f1": 0.3333333333333333, "avg_em": 0.0, "avg_chrf": 42.6628256900288, "avg_bleu": 33.33333333333333}
{"id": "PubMed_10:1049", "en": "Opportunistic sampling for serology in children younger than 10 years might be limited due to the overall reduced rate of blood tests in children.", "fr": "L’échantillonnage sérologique opportuniste chez les enfants de moins de 10 ans pourrait être limité en raison du taux global réduit de prises de sang chez les enfants.", "perturbation": "alteration", "pert_fr": "L’échantillonnage sérologique opportuniste chez les enfants de plus de 10 ans pourrait être limité en raison du taux global réduit de prises de sang chez les enfants.", "bt_pert_fr": "Opportunistic serological sampling in children older than 10 years may be limited due to the overall reduced rate of blood draws in children.", "questions": "[\"May opportunistic sampling for serology in children younger than 10 years be limited?\", \"Why might opportunistic sampling for serology in children younger than 10 years be limited?\", \"What is the reason for the reduced rate of blood tests in children?\", \"Is the reduced rate of blood tests in children related to the limitation of opportunistic sampling for serology?\"]", "answers": "[\"No\", \"The sentence does not provide a reason for limited sampling in children younger than 10 years\", \"The sentence does not specify the reason for the reduced rate of blood tests in children\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.16, "em": false, "chrf": 28.600893481235605, "bleu": 5.255923420816887}, {"f1": 0.6956521739130435, "em": false, "chrf": 70.80288822139487, "bleu": 44.71018619258419}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.21391304347826087, "avg_em": 0.0, "avg_chrf": 24.850945425657617, "avg_bleu": 12.491527403350268}
{"id": "PubMed_10:1051", "en": "The model of getting the appropriate informatics to enable capture of the required data has already been a success, with data recording starting the week the codes were created.", "fr": "Le modèle d’obtention de l’informatique appropriée pour permettre la saisie des données requises a déjà été un succès, l’enregistrement des données ayant commencé la semaine où les codes ont été créés.", "perturbation": "alteration", "pert_fr": "Le modèle d’obtention de l’informatique inappropriée pour permettre la saisie des données requises a déjà été un échec, l’enregistrement des données ayant commencé la semaine où les codes ont été créés.", "bt_pert_fr": "The model of obtaining inappropriate computing to enable required data entry has already been a failure, with data recording beginning the week the codes were created.", "questions": "[\"Has the model of getting the appropriate informatics to enable capture of the required data been a success?\", \"When did data recording start in relation to the creation of the codes?\"]", "answers": "[\"No\", \"The week the codes were created\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 50.0, "avg_bleu": 50.00000000000002}
{"id": "PubMed_10:1052", "en": "In addition, modifying the existing surveillance system to collect population data in a parallel way has also been effective.", "fr": "Qui plus est, la modification du système de surveillance existant afin de recueillir les données de la population de façon parallèle a également été efficace.", "perturbation": "alteration", "pert_fr": "Qui plus est, la modification du système de surveillance existant afin de recueillir les données de la population de façon parallèle a également été inefficace.", "bt_pert_fr": "Moreover, modifying the existing surveillance system to collect population data in parallel has also been ineffective.", "questions": "[\"Has modifying the existing surveillance system to collect population data in a parallel way been effective?\", \"What makes modifying the existing surveillance system to collect population data in a parallel way effective?\"]", "answers": "[\"No\", \"Nothing\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 4.375709171120859, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 2.1878545855604297, "avg_bleu": 0.0}
{"id": "PubMed_10:1053", "en": "However, we are at present unsure as to whether the scale of this surveillance provides sufficient data to drive local containment strategies or if reporting infrequently meets the need of our information age.", "fr": "Toutefois, nous ignorons à l’heure actuelle si l’envergure de cette surveillance fournit suffisamment de données pour donner lieu à des stratégies de confinement local ou si les rapports sporadiques répondent aux besoins de notre ère de l’information.", "perturbation": "alteration", "pert_fr": "Toutefois, nous savons à l’heure actuelle si l’envergure de cette surveillance fournit suffisamment de données pour donner lieu à des stratégies de confinement local ou si les rapports sporadiques répondent aux besoins de notre ère de l’information.", "bt_pert_fr": "However, we now know whether the scale of this surveillance provides enough data to prompt local containment strategies or whether sporadic reporting meets the needs of our information age.", "questions": "[\"Is the scale of this surveillance sufficient to drive local containment strategies?\", \"Does frequent reporting meet the needs of our information age?\"]", "answers": "[\"It is unknown whether the scale of this surveillance provides enough data to prompt local containment strategies\", \"It is unknown whether sporadic reporting meets the needs of our information age\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.4752475247524757, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 3.4722222222222223, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 2.973734873487349, "avg_bleu": 0.0}
{"id": "Wikinews_2:1100", "en": "They did say he was not present at Chesapeake Energy Arena in Oklahoma City, where the Utah Jazz were to play against the Oklahoma City Thunder.", "fr": "Ils ont en revanche déclaré qu’il n’était pas présent au Chesapeake Energy Arena d’Oklahoma City, où les Utah Jazz devaient jouer contre les Oklahoma City Thunder.", "perturbation": "alteration", "pert_fr": "Ils ont en revanche déclaré qu’il était présent au Chesapeake Energy Arena d’Oklahoma City, où les Utah Jazz devaient jouer contre les Oklahoma City Thunder.", "bt_pert_fr": "However, they said he was present at Chesapeake Energy Arena in Oklahoma City, where the Utah Jazz were scheduled to play the Oklahoma City Thunder.", "questions": "[\"Was he present at Chesapeake Energy Arena in Oklahoma City?\", \"Why was the Utah Jazz playing against the Oklahoma City Thunder at Chesapeake Energy Arena?\", \"What was the location of the Utah Jazz's game against the Oklahoma City Thunder?\"]", "answers": "[\"Yes\", \"Because the Utah Jazz were scheduled to play the Oklahoma City Thunder\", \"Chesapeake Energy Arena in Oklahoma City\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.11764705882352941, "em": false, "chrf": 20.58889967789868, "bleu": 4.196114906296549}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.37254901960784315, "avg_em": 0.3333333333333333, "avg_chrf": 40.196299892632894, "avg_bleu": 34.732038302098864}
{"id": "Wikinews_2:1104", "en": "The United States' other major basketball organization, the National Collegiate Athletic Association, which runs college basketball, has cancelled its own tournament, March Madness, for both men's and women's leagues.", "fr": "L’autre principale organisation de basket-ball des États-Unis, la National Collegiate Athletic Association, qui régit le basket-ball universitaire, a annulé son propre tournoi, le March Madness, pour les ligues masculine et féminine.", "perturbation": "alteration", "pert_fr": "L’autre principale organisation de basket-ball des États-Unis, la National Collegiate Athletic Association, qui régit le basket-ball universitaire, a maintenu son propre tournoi, le March Madness, pour les ligues masculine et féminine.", "bt_pert_fr": "The United States' other major basketball organization, the National Collegiate Athletic Association, which governs college basketball, maintained its own tournament, March Madness, for both the men's and women's leagues.", "questions": "[\"Has the National Collegiate Athletic Association cancelled its own tournament, March Madness, for both men's and women's leagues?\", \"Why was the March Madness tournament cancelled by the National Collegiate Athletic Association?\", \"What does the National Collegiate Athletic Association manage?\", \"Which leagues are affected by the cancellation of March Madness?\"]", "answers": "[\"No\", \"The March Madness tournament was not cancelled by the National Collegiate Athletic Association\", \"College basketball\", \"Both the men's and women's leagues\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 11.114290054726716, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666665, "em": false, "chrf": 90.08246510069132, "bleu": 39.76353643835254}], "avg_f1": 0.41666666666666663, "avg_em": 0.25, "avg_chrf": 50.29918878885451, "avg_bleu": 34.94088410958815}
{"id": "Wikinews_5:1148", "en": "The move came two days after the World Health Organization declared the outbreak, which causes the COVID-19 disease, to be a pandemic.", "fr": "La décision a été annoncée deux jours après que l’Organisation mondiale de la santé ait déclaré que l’épidémie, responsable de la maladie COVID-19, était une pandémie.", "perturbation": "alteration", "pert_fr": "La décision n'a pas été annoncée deux jours après que l’Organisation mondiale de la santé ait déclaré que l’épidémie, responsable de la maladie COVID-19, était une pandémie.", "bt_pert_fr": "The decision was not announced two days after the World Health Organization declared the outbreak, which causes the disease COVID-19, a pandemic.", "questions": "[\"When did the move occur?\", \"What event preceded the move?\", \"What disease does the outbreak cause?\", \"Was the outbreak declared a pandemic by the World Health Organization?\", \"What was the significance of the World Health Organization's declaration?\"]", "answers": "[\"The decision was not announced two days after the World Health Organization declared the outbreak\", \"The World Health Organization declaring the outbreak\", \"COVID-19\", \"Yes\", \"The outbreak was declared a pandemic\"]", "scores": [{"f1": 0.5833333333333334, "em": false, "chrf": 78.06904162666531, "bleu": 47.037095938668976}, {"f1": 0.6666666666666667, "em": false, "chrf": 71.4830814726185, "bleu": 32.58798048281462}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.85, "avg_em": 0.6, "avg_chrf": 89.91042461985676, "avg_bleu": 75.92501528429675}
{"id": "Wikinews_5:1151", "en": "The United States Department of Health and Human Services declared the outbreak a \"public health emergency\" on January 31.", "fr": "Le département de la Santé et des Services sociaux des États-Unis a déclaré l’épidémie une « urgence de santé publique » le 31 janvier.", "perturbation": "alteration", "pert_fr": "Le département de la Santé et des Services sociaux des États-Unis n'a pas déclaré l’épidémie une « urgence de santé publique » le 31 janvier.", "bt_pert_fr": "The U.S. Department of Health and Human Services did not declare the outbreak a \"public health emergency\" on January 31.", "questions": "[\"When did the United States Department of Health and Human Services declare the outbreak a 'public health emergency'?\", \"What agency declared the outbreak a 'public health emergency'?\", \"What was the declaration regarding the outbreak?\"]", "answers": "[\"The U.S. Department of Health and Human Services did not declare the outbreak a 'public health emergency' on January 31.\", \"The U.S. Department of Health and Human Services\", \"It was not declared a 'public health emergency'\"]", "scores": [{"f1": 0.19999999999999998, "em": false, "chrf": 28.036978852380308, "bleu": 4.295382417831811}, {"f1": 0.823529411764706, "em": false, "chrf": 74.72396088540444, "bleu": 62.401954419369176}, {"f1": 0.6, "em": false, "chrf": 85.19567632154063, "bleu": 24.446151121745054}], "avg_f1": 0.5411764705882353, "avg_em": 0.0, "avg_chrf": 62.65220535310846, "avg_bleu": 30.381162652982013}
{"id": "Wikipedia_handpicked_5:1860", "en": "Impact of the 2019–20 coronavirus pandemic on education", "fr": "Impact de la pandémie de coronavirus de 2019-20 sur l’éducation", "perturbation": "alteration", "pert_fr": "Impact de la pandémie de coronavirus de 2019-20 sur la santé", "bt_pert_fr": "Impact of the 2019-20 coronavirus pandemic on health", "questions": "[\"What was the impact of the 2019–20 coronavirus pandemic on education?\"]", "answers": "[\"The sentence does not provide information about the impact on education.\"]", "scores": [{"f1": 0.4444444444444445, "em": false, "chrf": 38.234039920707716, "bleu": 9.980099403873663}], "avg_f1": 0.4444444444444445, "avg_em": 0.0, "avg_chrf": 38.234039920707716, "avg_bleu": 9.980099403873663}
{"id": "Wikipedia_handpicked_5:1861", "en": "The 2019–20 coronavirus pandemic has affected educational systems worldwide, leading to the widespread closures of schools and universities.", "fr": "La pandémie de coronavirus de 2019-20 a affecté les systèmes éducatifs du monde entier, entraînant la fermeture à grande échelle d’écoles et d’universités.", "perturbation": "alteration", "pert_fr": "La pandémie de coronavirus de 2019-20 n'a pas affecté les systèmes éducatifs du monde entier, entraînant l'ouverture à grande échelle d’écoles et d’universités.", "bt_pert_fr": "The 2019-20 coronavirus pandemic did not affect education systems around the world, leading to large-scale openings of schools and universities.", "questions": "[\"How has the 2019–20 coronavirus pandemic affected educational systems worldwide?\", \"What specific changes have been observed in educational systems due to the 2019–20 coronavirus pandemic?\", \"Have schools and universities been closed as a result of the 2019–20 coronavirus pandemic?\", \"What is the impact of the 2019–20 coronavirus pandemic on education globally?\"]", "answers": "[\"It did not affect education systems around the world\", \"Large-scale openings of schools and universities\", \"No\", \"No significant impact on education globally\"]", "scores": [{"f1": 0.11111111111111112, "em": false, "chrf": 14.111097590503258, "bleu": 4.300847718252331}, {"f1": 0.6153846153846153, "em": false, "chrf": 58.13538190321835, "bleu": 43.01250851313262}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 11.530708363384171, "bleu": 0.0}], "avg_f1": 0.18162393162393162, "avg_em": 0.0, "avg_chrf": 20.944296964276447, "avg_bleu": 11.828339057846238}
{"id": "Wikipedia_handpicked_5:1864", "en": "On 23 March 2020, Cambridge International Examinations (CIE) released a statement announcing the cancellation of Cambridge IGCSE, Cambridge O Level, Cambridge International AS &amp; A Level, Cambridge AICE Diploma, and Cambridge Pre-U examinations for the May/June 2020 series across all countries.", "fr": "Le 23 mars 2020, le centre des examens internationaux de Cambridge (Cambridge International Examinations, CIE) a publié une déclaration annonçant l’annulation des examens IGCSE, O-Level, AS &amp; A-Level internationaux, diplôme AICE et Pre-U de Cambridge pour les séries de mai/juin 2020 dans tous les pays.", "perturbation": "alteration", "pert_fr": "Le 23 mars 2020, le centre des examens internationaux de Cambridge (Cambridge International Examinations, CIE) a publié une déclaration annonçant la poursuite des examens IGCSE, O-Level, AS & A-Level internationaux, diplôme AICE et Pre-U de Cambridge pour les séries de mai/juin 2020 dans tous les pays.", "bt_pert_fr": "On 23 March 2020, Cambridge International Examinations (CIE) released a statement announcing the continuation of IGCSE, O-Level, AS & A-Level International, AICE Diploma and Cambridge Pre-U examinations for the May/June 2020 series in all countries.", "questions": "[\"When did Cambridge International Examinations release a statement about cancelling examinations?\", \"What examinations were cancelled by Cambridge International Examinations on 23 March 2020?\", \"For which exam series were the examinations cancelled by Cambridge International Examinations?\", \"In which countries were the examinations cancelled by Cambridge International Examinations?\", \"What was the reason for the cancellation of Cambridge IGCSE, Cambridge O Level, Cambridge International AS & A Level, Cambridge AICE Diploma, and Cambridge Pre-U examinations?\"]", "answers": "[\"On 23 March 2020, Cambridge International Examinations released a statement announcing the continuation of IGCSE, O-Level, AS & A-Level International, AICE Diploma and Cambridge Pre-U examinations for the May/June 2020 series in all countries.\", \"None were cancelled; examinations were continued.\", \"May/June 2020\", \"all countries\", \"None; examinations were continued.\"]", "scores": [{"f1": 0.18181818181818182, "em": false, "chrf": 18.903302650974226, "bleu": 4.621362667122021}, {"f1": 0.08695652173913045, "em": false, "chrf": 15.684629021578841, "bleu": 1.2976955971595585}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.2, "em": false, "chrf": 30.044107357265794, "bleu": 9.688464563433238}], "avg_f1": 0.4937549407114624, "avg_em": 0.4, "avg_chrf": 52.92640780596378, "avg_bleu": 43.121504565542985}
{"id": "Wikipedia_handpicked_5:1865", "en": "International Baccalaureate exams have also been cancelled.School closures impact not only students, teachers, and families, but have far-reaching economic and societal consequences.", "fr": "Les épreuves du baccalauréat international ont également été annulées. La fermeture des écoles ne touche pas seulement les élèves, les enseignants et les familles, mais a aussi de lourdes conséquences économiques et sociales.", "perturbation": "alteration", "pert_fr": "Les épreuves du baccalauréat international n'ont pas été annulées. La fermeture des écoles ne touche pas seulement les élèves, les enseignants et les familles, mais a aussi de légères conséquences économiques et sociales.", "bt_pert_fr": "The International Baccalaureate exams have not been canceled. School closures not only affect students, teachers and families, but also have slight economic and social consequences.", "questions": "[\"Have International Baccalaureate exams been cancelled?\", \"How do school closures impact students, teachers, and families?\", \"What are the economic and societal consequences of school closures?\"]", "answers": "[\"No\", \"School closures affect students, teachers, and families\", \"Slight economic and social consequences\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.8571428571428571, "em": false, "chrf": 85.57863487090302, "bleu": 48.892302243490086}, {"f1": 0.6, "em": false, "chrf": 64.35871184914002, "bleu": 23.643540225079395}], "avg_f1": 0.4857142857142857, "avg_em": 0.0, "avg_chrf": 49.97911557334768, "avg_bleu": 24.178614156189827}
{"id": "Wikipedia_handpicked_5:1866", "en": "School closures in response to COVID-19 have shed light on various social and economic issues, including student debt, digital learning, food insecurity, and homelessness, as well as access to childcare, health care, housing, internet, and disability services.", "fr": "La fermeture des écoles en réponse au COVID-19 a révélé plusieurs problèmes économiques et sociaux, notamment la dette étudiante, l’apprentissage numérique, l’insécurité alimentaire et le problème des sans-abri, ainsi que l’accès à la garde d’enfants, aux services de santé, au logement, à l’Internet et aux services d’aide aux personnes handicapées.", "perturbation": "alteration", "pert_fr": "La fermeture des écoles en réponse au COVID-19 a révélé plusieurs avantages économiques et sociaux, notamment la richesse étudiante, l’apprentissage numérique, la sécurité alimentaire et le problème des propriétaires, ainsi que l’accès à la garde d’enfants, aux services de santé, au logement, à l’Internet et aux services d’aide aux personnes valides.", "bt_pert_fr": "School closures in response to COVID-19 have revealed several economic and social benefits, including student wealth, digital learning, food security and homeownership, as well as access to child care, health services, housing, internet and able-bodied support services.", "questions": "[\"What social and economic issues have been shed light on by school closures in response to COVID-19?\", \"What specific issues related to student debt have been highlighted by school closures in response to COVID-19?\", \"What issues related to digital learning have been highlighted by school closures in response to COVID-19?\", \"What issues related to food insecurity have been highlighted by school closures in response to COVID-19?\", \"What issues related to homelessness have been highlighted by school closures in response to COVID-19?\", \"What issues related to access to childcare have been highlighted by school closures in response to COVID-19?\", \"What issues related to access to health care have been highlighted by school closures in response to COVID-19?\", \"What issues related to access to housing have been highlighted by school closures in response to COVID-19?\", \"What issues related to access to the internet have been highlighted by school closures in response to COVID-19?\", \"What issues related to disability services have been highlighted by school closures in response to COVID-19?\"]", "answers": "[\"student wealth, digital learning, food security and homeownership, access to child care, health services, housing, internet and able-bodied support services\", \"none\", \"digital learning\", \"food security\", \"homelessness\", \"access to child care\", \"access to health services\", \"access to housing\", \"access to the internet\", \"able-bodied support services\"]", "scores": [{"f1": 0.6341463414634146, "em": false, "chrf": 64.71438646489541, "bleu": 14.626397071233937}, {"f1": 0, "em": false, "chrf": 5.208333333333334, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5, "em": false, "chrf": 61.628012271695255, "bleu": 49.99999999999999}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 79.73855444246794, "bleu": 0.0}, {"f1": 0.3333333333333333, "em": false, "chrf": 38.8505002352514, "bleu": 15.97357760615681}, {"f1": 0.5, "em": false, "chrf": 72.71207689093188, "bleu": 27.516060407455225}, {"f1": 0.5, "em": false, "chrf": 76.74880456578744, "bleu": 27.516060407455225}, {"f1": 0.4, "em": false, "chrf": 39.676915185792, "bleu": 27.516060407455225}], "avg_f1": 0.48674796747967475, "avg_em": 0.2, "avg_chrf": 63.92775833901546, "avg_bleu": 36.31481558997565}
{"id": "Wikipedia_handpicked_5:1867", "en": "The impact was more severe for disadvantaged children and their families, causing interrupted learning, compromised nutrition, childcare problems, and consequent economic cost to families who could not work.In response to school closures, UNESCO recommended the use of distance learning programmes and open educational applications and platforms that schools and teachers can use to reach learners remotely and limit the disruption of education.", "fr": "L’impact était plus important chez les enfants défavorisés et leurs familles, provoquant l’interruption de l’apprentissage, une mauvaise nutrition, des problèmes de garde d’enfants et les coûts économiques qui en résultent pour les familles ne pouvant pas travailler. En réponse à la fermeture des écoles, l’UNESCO a recommandé l’utilisation de programmes d’apprentissage à distance et d’applications et plateformes éducatives ouvertes grâce auxquels écoles et enseignants peuvent interagir avec les élèves à distance et limiter la perturbation de l’éducation.", "perturbation": "alteration", "pert_fr": "L’impact était moins important chez les enfants défavorisés et leurs familles, provoquant l’amélioration de l’apprentissage, une bonne nutrition, des solutions de garde d’enfants et les bénéfices économiques qui en résultent pour les familles pouvant travailler. En réponse à la fermeture des écoles, l’UNESCO a recommandé l’utilisation de programmes d’apprentissage à distance et d’applications et plateformes éducatives ouvertes grâce auxquels écoles et enseignants peuvent interagir avec les élèves à distance et limiter la perturbation de l’éducation.", "bt_pert_fr": "The impact was less among disadvantaged children and their families, leading to improved learning, good nutrition, childcare solutions and the resulting economic benefits for families able to work. In response to school closures, UNESCO recommended the use of distance learning programs and open educational applications and platforms through which schools and teachers can interact with students remotely and limit disruption to education.", "questions": "[\"What impact did school closures have on disadvantaged children and their families?\", \"What specific issues were caused by school closures for disadvantaged children and their families?\", \"How did school closures affect learning for disadvantaged children?\", \"How did school closures affect nutrition for disadvantaged children?\", \"What childcare problems arose due to school closures?\", \"What economic costs did families face as a result of school closures?\", \"What distance learning programmes did UNESCO recommend?\", \"What open educational applications and platforms did UNESCO recommend?\", \"How can schools and teachers use open educational platforms to reach learners remotely?\", \"What measures did UNESCO suggest to limit the disruption of education during school closures?\"]", "answers": "[\"Less impact\", \"Improved learning, good nutrition, childcare solutions and the resulting economic benefits\", \"Improved learning\", \"Good nutrition\", \"Childcare solutions\", \"Economic benefits\", \"Distance learning programs\", \"Open educational applications and platforms\", \"Through which schools and teachers can interact with students remotely\", \"The use of distance learning programs and open educational applications and platforms\"]", "scores": [{"f1": 0.06666666666666667, "em": false, "chrf": 3.0840462118655405, "bleu": 0.00011301647034905269}, {"f1": 0.5, "em": false, "chrf": 47.91833132994724, "bleu": 10.552670315936318}, {"f1": 0, "em": false, "chrf": 27.97492361102979, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 31.52246204948186, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 46.35411587366529, "bleu": 49.99999999999999}, {"f1": 0, "em": false, "chrf": 15.372343000057628, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 89.33415726091852, "bleu": 55.03212081491043}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.47619047619047616, "em": false, "chrf": 47.348162409379995, "bleu": 25.13293635022765}, {"f1": 0.9166666666666666, "em": false, "chrf": 94.33355289123806, "bleu": 73.48889200874659}], "avg_f1": 0.41261904761904755, "avg_em": 0.1, "avg_chrf": 50.32420946375839, "avg_bleu": 31.420673250629136}
{"id": "Wikipedia_handpicked_5:1869", "en": "Mathematical modelling has shown that transmission of an outbreak may be delayed by closing schools.", "fr": "La modélisation mathématique a montré que la transmission d’une épidémie peut être retardée en fermant les écoles.", "perturbation": "alteration", "pert_fr": "La modélisation mathématique a montré que la transmission d’une épidémie peut être accélérée en fermant les écoles.", "bt_pert_fr": "Mathematical modeling has shown that the transmission of an epidemic can be accelerated by closing schools.", "questions": "[\"Does mathematical modelling show that closing schools can delay the transmission of an outbreak?\", \"Can closing schools delay the transmission of an outbreak according to mathematical modelling?\"]", "answers": "[\"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "Wikipedia_handpicked_5:1870", "en": "However, effectiveness depends on the contacts children maintain outside of school.", "fr": "Toutefois, l’efficacité dépend des contacts que maintiennent les enfants en dehors de l’école.", "perturbation": "alteration", "pert_fr": "Toutefois, l’inefficacité dépend des contacts que maintiennent les enfants en dehors de l’école.", "bt_pert_fr": "However, the ineffectiveness depends on the contacts that children maintain outside of school.", "questions": "[\"Does effectiveness depend on the contacts children maintain outside of school?\", \"What factors affect the effectiveness of the intervention?\", \"How do children's contacts outside of school influence effectiveness?\"]", "answers": "[\"No\", \"The contacts that children maintain outside of school\", \"The ineffectiveness depends on the contacts that children maintain outside of school\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.9333333333333333, "em": false, "chrf": 91.61675977743361, "bleu": 59.460355750136046}, {"f1": 0.12500000000000003, "em": false, "chrf": 37.782003956539114, "bleu": 3.7477767366779213}], "avg_f1": 0.3527777777777778, "avg_em": 0.0, "avg_chrf": 43.132921244657574, "avg_bleu": 21.069377495604655}
{"id": "Wikipedia_handpicked_5:1871", "en": "School closures may be effective when enacted promptly.", "fr": "La fermeture des écoles peut s’avérer efficace lorsqu’elle est adoptée rapidement.", "perturbation": "alteration", "pert_fr": "La fermeture des écoles peut s’avérer inefficace lorsqu’elle est adoptée rapidement.", "bt_pert_fr": "Closing schools can be ineffective when adopted quickly.", "questions": "[\"When may school closures be effective?\", \"Under what conditions are school closures likely to be effective?\"]", "answers": "[\"When adopted slowly\", \"When adopted slowly\"]", "scores": [{"f1": 0.3333333333333333, "em": false, "chrf": 23.413023227358725, "bleu": 27.516060407455225}, {"f1": 0.3333333333333333, "em": false, "chrf": 23.413023227358725, "bleu": 27.516060407455225}], "avg_f1": 0.3333333333333333, "avg_em": 0.0, "avg_chrf": 23.413023227358725, "avg_bleu": 27.516060407455225}
{"id": "Wikipedia_handpicked_5:1873", "en": "Additionally, in some cases, the reopening of schools after a period of closure has resulted in increased infection rates.", "fr": "En outre, dans certains cas, la réouverture des écoles après une période de fermeture a entraîné une augmentation des taux d’infection.", "perturbation": "alteration", "pert_fr": "En outre, dans certains cas, la réouverture des écoles après une période de fermeture a entraîné une diminution des taux d’infection.", "bt_pert_fr": "Additionally, in some cases, the reopening of schools after a period of closure has led to a decrease in infection rates.", "questions": "[\"Has the reopening of schools after a period of closure resulted in increased infection rates?\", \"In what cases has the reopening of schools after a period of closure led to increased infection rates?\"]", "answers": "[\"No\", \"In no cases\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 33.99201270957857, "bleu": 34.66806371753173}], "avg_f1": 0.3333333333333333, "avg_em": 0.0, "avg_chrf": 16.996006354789284, "avg_bleu": 17.334031858765865}
{"id": "Wikipedia_handpicked_5:1874", "en": "As closures tend to occur concurrently with other interventions such as public gathering bans, it can be difficult to measure the specific impact of school closures.During the 1918-1919 influenza pandemic in the United States, school closures and public gathering bans were associated with lower total mortality rates.", "fr": "Étant donné que les fermetures ont tendance à survenir en parallèle d’autres interventions telles que l’interdiction des rassemblements publics, il peut être difficile de mesurer l’impact spécifique de la fermeture des écoles. Pendant la pandémie de grippe de 1918-1919 aux États-Unis, la fermeture des écoles et l’interdiction des rassemblements publics ont été associées à un taux total de mortalité plus faible.", "perturbation": "alteration", "pert_fr": "Étant donné que les fermetures ont tendance à survenir en parallèle d’autres interventions telles que l’autorisation des rassemblements publics, il peut être difficile de mesurer l’impact spécifique de la fermeture des écoles. Pendant la pandémie de grippe de 1918-1919 aux États-Unis, la fermeture des écoles et l’autorisation des rassemblements publics ont été associées à un taux total de mortalité plus élevé.", "bt_pert_fr": "Since closures tend to occur alongside other interventions such as allowing public gatherings, it can be difficult to measure the specific impact of school closures. During the 1918-1919 influenza pandemic in the United States, closing schools and allowing public gatherings were associated with a higher total mortality rate.", "questions": "[\"Can the specific impact of school closures be measured when they occur concurrently with public gathering bans?\", \"Were school closures and public gathering bans associated with lower total mortality rates during the 1918-1919 influenza pandemic in the United States?\"]", "answers": "[\"No\", \"No\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 50.0, "avg_bleu": 50.00000000000002}
{"id": "Wikipedia_handpicked_5:1875", "en": "Cities that implemented such interventions earlier had greater delays in reaching peak mortality rates.", "fr": "Les premières villes ayant mis en œuvre ces interventions ont obtenu des délais plus importants avant d’atteindre le pic de mortalité.", "perturbation": "alteration", "pert_fr": "Les premières villes ayant mis en œuvre ces interventions n'ont pas obtenu des délais plus importants avant d’atteindre le pic de mortalité.", "bt_pert_fr": "The first cities to implement these interventions did not obtain longer periods before reaching peak mortality.", "questions": "[\"Did cities that implemented interventions earlier experience greater delays in reaching peak mortality rates?\", \"What factor is associated with greater delays in reaching peak mortality rates?\", \"How does the timing of intervention implementation affect the delay in reaching peak mortality rates?\"]", "answers": "[\"No\", \"The implementation of interventions\", \"It does not affect the delay in reaching peak mortality rates\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.6666666666666665, "em": false, "chrf": 71.14600578626873, "bleu": 16.37226966703825}, {"f1": 0.4347826086956522, "em": false, "chrf": 36.667681883683656, "bleu": 29.100425073782827}], "avg_f1": 0.3671497584541063, "avg_em": 0.0, "avg_chrf": 35.93789588998413, "avg_bleu": 15.157564913607025}
{"id": "Wikipedia_handpicked_5:1877", "en": "School closures were shown to reduce morbidity from the Asian flu by 90% during the 1957–58 outbreak, and up to 50% in controlling influenza in the US, 2004–2008.Multiple countries successfully slowed the spread of infection through school closures during the 2009 H1N1 Flu pandemic.", "fr": "Il a été démontré que la fermeture des écoles a permis de réduire la morbidité de la grippe asiatique de 90 % lors de l’épidémie de 1957-58, et jusqu’à 50 % pour la lutte contre la grippe aux États-Unis, en 2004-2008. De nombreux pays ont réussi à ralentir la propagation de l’infection grâce à la fermeture des écoles pendant la pandémie de grippe H1N1 en 2009.", "perturbation": "alteration", "pert_fr": "Il a été démontré que la fermeture des écoles n'a pas permis de réduire la morbidité de la grippe asiatique de 90 % lors de l’épidémie de 1957-58, et jusqu’à 50 % pour la lutte contre la grippe aux États-Unis, en 2004-2008. De nombreux pays ont réussi à accélérer la propagation de l’infection grâce à la fermeture des écoles pendant la pandémie de grippe H1N1 en 2009.", "bt_pert_fr": "It has been shown that school closures failed to reduce Asian flu morbidity by 90% during the 1957-58 epidemic, and by up to 50% for the fight against influenza in the United States in 2004-2008. Many countries managed to accelerate the spread of infection through school closures during the 2009 H1N1 influenza pandemic.", "questions": "[\"By how much did school closures reduce morbidity from the Asian flu during the 1957–58 outbreak?\", \"What was the reduction in morbidity from influenza in the US during the 2004–2008 period due to school closures?\", \"Did multiple countries successfully slow the spread of infection during the 2009 H1N1 Flu pandemic through school closures?\"]", "answers": "[\"90%\", \"up to 50%\", \"No\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.6666666666666666, "avg_em": 0.6666666666666666, "avg_chrf": 66.66666666666667, "avg_bleu": 66.6666666666667}
{"id": "Wikipedia_handpicked_5:1879", "en": "Mandatory school closures and other social distancing measures were associated with a 29% to 37% reduction in influenza transmission rates.", "fr": "La fermeture obligatoire des écoles et autres mesures de distanciation sociale ont été associées à une réduction de 29 % à 37 % du taux de propagation de la grippe.", "perturbation": "alteration", "pert_fr": "La fermeture obligatoire des écoles et autres mesures de distanciation sociale ont été associées à une augmentation de 29 % à 37 % du taux de propagation de la grippe.", "bt_pert_fr": "Mandatory school closures and other social distancing measures have been associated with a 29% to 37% increase in the rate of flu spread.", "questions": "[\"What is the reduction in influenza transmission rates associated with mandatory school closures and other social distancing measures?\", \"By how much does influenza transmission rates decrease with mandatory school closures and other social distancing measures?\"]", "answers": "[\"a 29% to 37% increase\", \"a 29% to 37% increase\"]", "scores": [{"f1": 0.75, "em": false, "chrf": 33.86704635813619, "bleu": 59.460355750136046}, {"f1": 0.8571428571428571, "em": false, "chrf": 66.95690718602997, "bleu": 59.460355750136046}], "avg_f1": 0.8035714285714286, "avg_em": 0.0, "avg_chrf": 50.41197677208308, "avg_bleu": 59.460355750136046}
{"id": "Wikipedia_handpicked_5:1880", "en": "Early school closures in the United States delayed the peak of the 2009 H1N1 Flu pandemic.", "fr": "La fermeture rapide des écoles aux États-Unis a retardé le pic de la pandémie de grippe H1N1 de 2009.", "perturbation": "alteration", "pert_fr": "La fermeture rapide des écoles aux États-Unis a avancé le pic de la pandémie de grippe H1N1 de 2009.", "bt_pert_fr": "The rapid closure of schools in the United States brought forward the peak of the 2009 H1N1 influenza pandemic.", "questions": "[\"Did early school closures in the United States delay the peak of the 2009 H1N1 Flu pandemic?\", \"What effect did early school closures in the United States have on the 2009 H1N1 Flu pandemic?\"]", "answers": "[\"No\", \"They brought forward the peak\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.3333333333333333, "em": false, "chrf": 15.047582713689264, "bleu": 6.988198185490689}], "avg_f1": 0.16666666666666666, "avg_em": 0.0, "avg_chrf": 7.523791356844632, "avg_bleu": 3.4940990927453446}
{"id": "Wikipedia_handpicked_5:1881", "en": "Despite the overall success of closing schools, a study of school closures in Michigan found that \"district level reactive school closures were ineffective.\"During the swine flu outbreak in 2009 in the UK, in an article titled \"Closure of schools during an influenza pandemic\" published in the Lancet Infectious Diseases, a group of epidemiologists endorsed the closure of schools in order to interrupt the course of the infection, slow further spread and buy time to research and produce a vaccine.", "fr": "Malgré la réussite globale de la fermeture des écoles, une étude de la fermeture des écoles au Michigan a révélé que « la fermeture réactive des écoles au niveau du district avait été inefficace ». Pendant l’épidémie de grippe porcine en 2009 au Royaume-Uni, dans un article intitulé « Fermeture des écoles pendant une pandémie de grippe » publié dans le Lancet Infectious Diseases, un groupe d’épidémiologistes soutenait la fermeture des écoles afin d’interrompre l’évolution de l’infection, de ralentir sa propagation et de gagner du temps pour étudier et développer un vaccin.", "perturbation": "alteration", "pert_fr": "Malgré l'échec globale de la fermeture des écoles, une étude de la fermeture des écoles au Michigan a révélé que « la fermeture réactive des écoles au niveau du district avait été efficace ». Pendant l’épidémie de grippe porcine en 2009 au Royaume-Uni, dans un article intitulé « Fermeture des écoles pendant une pandémie de grippe » publié dans le Lancet Infectious Diseases, un groupe d’épidémiologistes soutenait la fermeture des écoles afin d’interrompre l’évolution de l’infection, de ralentir sa propagation et de gagner du temps pour étudier et développer un vaccin.", "bt_pert_fr": "Despite the overall failure of school closures, a study of school closures in Michigan found that \"reactive school closures at the district level had been effective.\" During the 2009 swine flu outbreak in the United Kingdom, in an article titled “Closing Schools During an Influenza Pandemic” published in the Lancet Infectious Diseases, a group of epidemiologists supported closing schools in order to interrupt the course of the infection, slow its spread, and buy time to study and develop a vaccine.", "questions": "[\"Were school closures effective in Michigan during the study?\", \"Did epidemiologists endorse school closures during the 2009 swine flu outbreak in the UK?\", \"What was the purpose of closing schools during the 2009 swine flu outbreak in the UK?\", \"What did the epidemiologists say about school closures during the 2009 swine flu outbreak in the UK?\"]", "answers": "[\"Yes\", \"Yes\", \"To interrupt the course of the infection, slow its spread, and buy time to study and develop a vaccine\", \"They supported closing schools in order to interrupt the course of the infection, slow its spread, and buy time to study and develop a vaccine\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8125, "em": false, "chrf": 66.38187844098205, "bleu": 55.33409598501609}, {"f1": 0.6956521739130435, "em": false, "chrf": 59.33761477462279, "bleu": 49.660386392249755}], "avg_f1": 0.6270380434782609, "avg_em": 0.25, "avg_chrf": 56.42987330390121, "avg_bleu": 51.24862059431647}
{"id": "Wikipedia_handpicked_5:1883", "en": "They also looked at the dynamics of the spread of influenza in France during French school holidays and noted that cases of flu dropped when schools closed and re-emerged when they re-opened.", "fr": "Ils ont également examiné la dynamique de la propagation de la grippe en France pendant les vacances scolaires françaises et ont souligné que les cas de grippe ont chuté avec la fermeture des écoles et sont remontés lors de leur réouverture.", "perturbation": "alteration", "pert_fr": "Ils ont également examiné la dynamique de la propagation de la grippe en France pendant les vacances scolaires françaises et ont souligné que les cas de grippe ont augmenté avec la fermeture des écoles et sont chutés lors de leur réouverture.", "bt_pert_fr": "They also looked at the dynamics of the spread of flu in France during French school holidays and highlighted that flu cases rose as schools closed and fell when they reopened.", "questions": "[\"What happened to flu cases in France during French school holidays?\", \"What occurred when schools in France closed?\", \"What happened to flu cases when schools in France re-opened?\"]", "answers": "[\"Flu cases rose as schools closed and fell when they reopened\", \"Flu cases rose\", \"Flu cases fell\"]", "scores": [{"f1": 0.7272727272727273, "em": false, "chrf": 59.77171524884013, "bleu": 26.65837681702885}, {"f1": 0.6666666666666666, "em": false, "chrf": 49.79824667243119, "bleu": 55.03212081491043}, {"f1": 0.6666666666666666, "em": false, "chrf": 40.825928399773595, "bleu": 55.03212081491043}], "avg_f1": 0.6868686868686869, "avg_em": 0.0, "avg_chrf": 50.13196344034831, "avg_bleu": 45.574206148949905}
{"id": "Wikipedia_handpicked_5:1886", "en": "When there is minimal to moderate community transmission, social distancing strategies can be implemented such as cancelling field trips, assemblies, and other large gatherings such as physical education or choir classes or meals in a cafeteria, increasing the space between desks, staggering arrival and dismissal times, limiting nonessential visitors, and using a separate health office location for children with flu-like symptoms.", "fr": "En cas de transmission communautaire minimale à modérée, des stratégies de distanciation sociale peuvent être mises en œuvre, telles que l’annulation des sorties pédagogiques, des assemblées et autres rassemblements importants comme les cours d’éducation physique ou de chorale ou les repas à la cantine, en augmentant l’espace entre les bureaux, en échelonnant les heures d’arrivée et de sortie, en réduisant les visiteurs non essentiels et en utilisant une infirmerie séparée pour les enfants présentant des symptômes grippaux.", "perturbation": "alteration", "pert_fr": "En cas de transmission communautaire minimale à modérée, des stratégies de rapprochement social peuvent être mises en œuvre, telles que l’organisation des sorties pédagogiques, des assemblées et autres rassemblements importants comme les cours d’éducation physique ou de chorale ou les repas à la cantine, en réduisant l’espace entre les bureaux, en synchronisant les heures d’arrivée et de sortie, en augmentant les visiteurs non essentiels et en utilisant une infirmerie commune pour les enfants présentant des symptômes grippaux.", "bt_pert_fr": "In cases of minimal to moderate community transmission, social rapprochement strategies can be implemented, such as organizing field trips, assemblies and other large gatherings such as physical education or choir classes or meals in the canteen, reducing the space between desks, synchronizing arrival and departure times, increasing non-essential visitors and using a common infirmary for children with flu-like symptoms.", "questions": "[\"What social distancing strategies can be implemented when there is minimal to moderate community transmission?\", \"What specific activities should be cancelled during minimal to moderate community transmission?\", \"What changes can be made to physical education or choir classes during minimal to moderate community transmission?\", \"What measures can be taken to reduce gatherings in a cafeteria during minimal to moderate community transmission?\", \"How should arrival and dismissal times be adjusted during minimal to moderate community transmission?\", \"What restrictions can be placed on nonessential visitors during minimal to moderate community transmission?\", \"What arrangement can be made for a health office location for children with flu-like symptoms during minimal to moderate community transmission?\"]", "answers": "[\"Organizing field trips, assemblies and other large gatherings such as physical education or choir classes or meals in the canteen, reducing the space between desks, synchronizing arrival and departure times, increasing non-essential visitors and using a common infirmary for children with flu-like symptoms\", \"None mentioned\", \"No specific changes are mentioned; they can proceed as usual\", \"Reduce or cancel meals in the canteen\", \"Synchronize arrival and departure times\", \"Increase non-essential visitors\", \"Use a common infirmary for children with flu-like symptoms\"]", "scores": [{"f1": 0.8048780487804876, "em": false, "chrf": 75.1167414764997, "bleu": 58.14959203189182}, {"f1": 0, "em": false, "chrf": 4.355273839935352, "bleu": 0.0}, {"f1": 0.0909090909090909, "em": false, "chrf": 18.329038673144616, "bleu": 3.435488317233919}, {"f1": 0.3157894736842105, "em": false, "chrf": 19.11672678162515, "bleu": 5.594422941553801}, {"f1": 0.5, "em": false, "chrf": 33.74932319357499, "bleu": 15.84873897212071}, {"f1": 0.5, "em": false, "chrf": 57.62732046698149, "bleu": 28.254432923044853}, {"f1": 0.5, "em": false, "chrf": 47.625854423940986, "bleu": 31.35600681233636}], "avg_f1": 0.387368087624827, "avg_em": 0.0, "avg_chrf": 36.560039836528894, "avg_bleu": 20.376954571168778}
{"id": "Wikipedia_handpicked_5:1887", "en": "When there is substantial transmission in the local community, in addition to social distancing strategies, extended school dismissals may be considered.", "fr": "En cas de transmission importante dans la population locale, outre les stratégies de distanciation sociale, un prolongement des vacances scolaires peut être envisagé.", "perturbation": "alteration", "pert_fr": "En cas de transmission faible dans la population locale, outre les stratégies de distanciation sociale, un raccourcissement des vacances scolaires peut être envisagé.", "bt_pert_fr": "In the event of low transmission in the local population, in addition to social distancing strategies, a shortening of school holidays may be considered.", "questions": "[\"When is it considered to extend school dismissals in addition to social distancing strategies?\", \"What factors lead to considering extended school dismissals along with social distancing strategies?\"]", "answers": "[\"When there is low transmission in the local population\", \"Low transmission in the local population\"]", "scores": [{"f1": 0.75, "em": false, "chrf": 56.780412431116964, "bleu": 34.57207846419411}, {"f1": 0.6, "em": false, "chrf": 50.44169574266082, "bleu": 39.76353643835254}], "avg_f1": 0.675, "avg_em": 0.0, "avg_chrf": 53.61105408688889, "avg_bleu": 37.16780745127332}
{"id": "Wikipedia_handpicked_5:1889", "en": "Universities and schools around the country closed.", "fr": "Les universités et écoles du pays ont été fermées.", "perturbation": "alteration", "pert_fr": "Les universités et écoles du pays ont été ouvertes.", "bt_pert_fr": "Universities and schools across the country have been opened.", "questions": "[\"What closed around the country?\", \"Which institutions closed around the country?\"]", "answers": "[\"None\", \"None\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.076086956521739, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 4.076086956521739, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 4.076086956521739, "avg_bleu": 0.0}
{"id": "Wikipedia_handpicked_5:1890", "en": "On 23 February, Iran's Ministry of Health announced the closure of universities, higher educational institutions and schools in several cities and provinces.", "fr": "Le 23 février, le ministre de la Santé iranien a annoncé la fermeture des universités, des établissements d’éducation supérieure et des écoles de plusieurs villes et provinces.", "perturbation": "alteration", "pert_fr": "Le 23 février, le ministre de la Santé iranien a annoncé la réouverture des universités, des établissements d’éducation supérieure et des écoles de plusieurs villes et provinces.", "bt_pert_fr": "On February 23, Iran's Minister of Health announced the reopening of universities, higher education institutions and schools in several cities and provinces.", "questions": "[\"What did Iran's Ministry of Health announce on 23 February?\", \"Which institutions were closed by Iran's Ministry of Health on 23 February?\", \"In which cities and provinces were schools and universities closed on 23 February by Iran's Ministry of Health?\"]", "answers": "[\"The reopening of universities, higher education institutions and schools in several cities and provinces\", \"Universities, higher education institutions and schools\", \"Several cities and provinces\"]", "scores": [{"f1": 0.8571428571428571, "em": false, "chrf": 85.62309661221205, "bleu": 62.98129992394241}, {"f1": 0.8333333333333334, "em": false, "chrf": 91.33901345922595, "bleu": 37.99178428257963}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8968253968253969, "avg_em": 0.3333333333333333, "avg_chrf": 92.320703357146, "avg_bleu": 66.99102806884069}
{"id": "Wikipedia_handpicked_5:1893", "en": "In reaction, UNESCO called on countries to support affected students and families and facilitate large-scale inclusive distance learning programmes.", "fr": "En réaction, l’UNESCO a appelé les pays à soutenir les élèves affectés et leurs familles et à mettre en place des programmes d’apprentissage à distance inclusifs à grande échelle.", "perturbation": "alteration", "pert_fr": "En réaction, l’UNESCO a appelé les pays à abandonner les élèves affectés et leurs familles et à mettre en place des programmes d’apprentissage à distance exclusifs à petite échelle.", "bt_pert_fr": "In response, UNESCO called on countries to abandon affected students and their families and implement small-scale, exclusive distance learning programs.", "questions": "[\"What did UNESCO call on countries to do in reaction?\", \"What specific actions did UNESCO recommend to support affected students and families?\", \"What type of distance learning programmes did UNESCO recommend to facilitate?\"]", "answers": "[\"UNESCO called on countries to abandon affected students and their families and implement small-scale, exclusive distance learning programs\", \"Abandon affected students and their families and implement small-scale, exclusive distance learning programs\", \"small-scale, exclusive distance learning programs\"]", "scores": [{"f1": 0.45161290322580644, "em": false, "chrf": 61.776541131657105, "bleu": 11.750296943620288}, {"f1": 0.4444444444444444, "em": false, "chrf": 52.90444472913705, "bleu": 12.35622127262679}, {"f1": 0.4000000000000001, "em": false, "chrf": 72.54125943078449, "bleu": 21.3643503198117}], "avg_f1": 0.4320191158900837, "avg_em": 0.0, "avg_chrf": 62.40741509719288, "avg_bleu": 15.156956178686258}
{"id": "Wikipedia_handpicked_5:1896", "en": "On 5 March, the majority of learners affected by COVID-19 emergency measures were located in China, with 233 million learners affected, followed by Japan at 16.5 million and Iran at 14.5 million.", "fr": "Le 5 mars, la majorité des élèves touchés par les mesures d’urgence du COVID-19 se trouvaient en Chine, avec 233 millions d’élèves affectés, suivis par le Japon avec 16,5 millions et l’Iran avec 14,5 millions.", "perturbation": "alteration", "pert_fr": "Le 5 mars, la minorité des élèves touchés par les mesures d’urgence du COVID-19 se trouvaient en Chine, avec 233 millions d’élèves affectés, suivis par le Japon avec 16,5 millions et l’Iran avec 14,5 millions.", "bt_pert_fr": "As of March 5, the minority of students affected by COVID-19 emergency measures were in China, with 233 million students affected, followed by Japan with 16.5 million and Iran with 14.5 million.", "questions": "[\"How many learners were affected by COVID-19 emergency measures in China on 5 March?\", \"How many learners were affected by COVID-19 emergency measures in Japan on 5 March?\", \"How many learners were affected by COVID-19 emergency measures in Iran on 5 March?\", \"Which countries had the highest number of learners affected by COVID-19 emergency measures on 5 March?\"]", "answers": "[233000000, 16500000, 14500000, \"China\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikipedia_handpicked_5:1902", "en": "On 23 March, all Nigerian school were found to have been closed down by Nigerian government, markets as well as companies were closed down and children were forbidden by parents to step out of their homes.", "fr": "Le 23 mars, toutes les écoles nigérianes avaient été fermées par le gouvernement nigérian, les marchés et entreprises étaient fermés et les parents interdisaient à leurs enfants de sortir de chez eux.", "perturbation": "alteration", "pert_fr": "Le 23 mars, toutes les écoles nigérianes avaient été ouvertes par le gouvernement nigérian, les marchés et entreprises étaient ouverts et les parents autorisaient à leurs enfants de sortir de chez eux.", "bt_pert_fr": "By March 23, all Nigerian schools had been opened by the Nigerian government, markets and businesses were open and parents were allowing their children to leave their homes.", "questions": "[\"Were all Nigerian schools closed down by the Nigerian government on 23 March?\", \"Were markets closed down on 23 March?\", \"Were companies closed down on 23 March?\", \"Were children forbidden by parents to step out of their homes on 23 March?\"]", "answers": "[\"No\", \"No\", \"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "Wikipedia_handpicked_5:1903", "en": "On 26 March, all New Zealand schools and universities have been closed down across the country.", "fr": "Le 26 mars, toutes les écoles et universités néo-zélandaises ont été fermées dans l’ensemble du pays.", "perturbation": "alteration", "pert_fr": "Le 26 mars, toutes les écoles et universités néo-zélandaises ont été ouvertes dans l’ensemble du pays.", "bt_pert_fr": "On March 26, all New Zealand schools and universities were opened across the country.", "questions": "[\"Were schools and universities closed down in New Zealand on 26 March?\", \"What was closed down in New Zealand on 26 March?\", \"Did all schools and universities in New Zealand close on 26 March?\"]", "answers": "[\"No\", \"Schools and universities\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.3333333333333333, "avg_em": 0.3333333333333333, "avg_chrf": 33.333333333333336, "avg_bleu": 33.33333333333335}
{"id": "Wikipedia_handpicked_5:1910", "en": "Others were disrupted by localized closures.", "fr": "D’autres étaient perturbés par les fermetures localisées.", "perturbation": "alteration", "pert_fr": "D’autres étaient rassurés par les fermetures localisées.", "bt_pert_fr": "Others were reassured by the localized closures.", "questions": "[\"What were disrupted by localized closures?\", \"What types of activities or systems were disrupted by localized closures?\"]", "answers": "[\"Others' reassurance\", \"Others' reassurance\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 59.9765041149323, "bleu": 49.99999999999999}, {"f1": 0, "em": false, "chrf": 8.115433848655657, "bleu": 0.0}], "avg_f1": 0.3333333333333333, "avg_em": 0.0, "avg_chrf": 34.045968981793976, "avg_bleu": 24.999999999999996}
{"id": "Wikipedia_handpicked_5:1912", "en": "An order signed by the Ministry of Education as a preventative measure aims to prevent the spread of respiratory diseases in connection with the WHO coronavirus pandemic.", "fr": "Une ordonnance signée par le ministère de l’Éducation en tant que mesure de prévention vise à éviter la propagation des maladies respiratoires liées à la pandémie de coronavirus de l’OMS.", "perturbation": "alteration", "pert_fr": "Une ordonnance signée par le ministère de l’Éducation en tant que mesure de traitement vise à favoriser la propagation des maladies respiratoires liées à la pandémie de coronavirus de l’OMS.", "bt_pert_fr": "An order signed by the Ministry of Education as a treatment measure aims to promote the spread of respiratory diseases linked to the WHO coronavirus pandemic.", "questions": "[\"What is the purpose of the order signed by the Ministry of Education?\", \"What type of disease does the order aim to prevent?\", \"Is the order related to the WHO coronavirus pandemic?\", \"What specific action does the order take to prevent the spread of respiratory diseases?\"]", "answers": "[\"To promote the spread of respiratory diseases linked to the WHO coronavirus pandemic\", \"Respiratory diseases\", \"Yes\", \"The order is signed as a treatment measure\"]", "scores": [{"f1": 0.5882352941176471, "em": false, "chrf": 68.01452395781763, "bleu": 24.808415001701817}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.2857142857142857, "em": false, "chrf": 24.97560007587489, "bleu": 7.809849842300641}], "avg_f1": 0.7184873949579832, "avg_em": 0.5, "avg_chrf": 73.24753100842312, "avg_bleu": 58.154566211000635}
{"id": "Wikipedia_handpicked_5:1914", "en": "Note: Figures correspond to total number of learners enrolled at pre-primary, primary, lower-secondary, and upper-secondary levels of education [ISCED levels 0 to 3], as well as at tertiary education levels [ISCED levels 5 to 8] who could be affected should localised closures become countrywide.", "fr": "Remarque : les chiffres correspondent au nombre total d’élèves inscrits dans un cycle d’enseignement pré-primaire, primaire, secondaire inférieur et secondaire supérieur [niveaux 0 à 3 de la CITE], ainsi que dans des cycles d’enseignement supérieur [niveaux 5 à 8 de la CITE] qui pourraient être affectés si les fermetures localisées devenaient nationales.", "perturbation": "alteration", "pert_fr": "Remarque : les chiffres correspondent au nombre total d’élèves inscrits dans un cycle d’enseignement pré-primaire, primaire, secondaire inférieur et secondaire supérieur [niveaux 0 à 3 de la CITE], ainsi que dans des cycles d’enseignement inférieur [niveaux 5 à 8 de la CITE] qui pourraient être affectés si les fermetures localisées devenaient nationales.", "bt_pert_fr": "Note: Figures refer to the total number of students enrolled in pre-primary, primary, lower secondary and upper secondary education [ISCED levels 0-3], as well as lower education cycles [ISCED levels 5-8] that could be affected if localized closures become national.", "questions": "[\"What does the term 'figures' refer to in the context of education levels?\", \"Which education levels are included in the total number of learners enrolled?\", \"What is the range of ISCED levels that correspond to the total number of learners?\", \"How many learners at each education level could be affected by localised closures becoming countrywide?\", \"What is the relationship between localised closures and the number of learners affected?\"]", "answers": "[\"The total number of students enrolled in pre-primary, primary, lower secondary and upper secondary education [ISCED levels 0-3], as well as lower education cycles [ISCED levels 5-8] that could be affected if localized closures become national\", \"Pre-primary, primary, lower secondary, upper secondary education, and lower education cycles\", \"0-3 and 5-8\", \"The total number of students enrolled in those education levels\", \"Localized closures becoming national could affect the number of learners enrolled in those education levels\"]", "scores": [{"f1": 0.4000000000000001, "em": false, "chrf": 53.51907173517535, "bleu": 10.393938326032185}, {"f1": 0.4210526315789474, "em": false, "chrf": 77.7716340758469, "bleu": 8.913765521398126}, {"f1": 0.2, "em": false, "chrf": 32.15002572684711, "bleu": 7.253154775624655}, {"f1": 0.3529411764705882, "em": false, "chrf": 28.093077978732673, "bleu": 5.522397783539471}, {"f1": 0.42857142857142855, "em": false, "chrf": 52.32734684159701, "bleu": 8.889175589171739}], "avg_f1": 0.3605130473241928, "avg_em": 0.0, "avg_chrf": 48.77223127163981, "avg_bleu": 8.194486399153234}
{"id": "Wikipedia_handpicked_5:1915", "en": "Enrolment figures based on latest UNESCO Institute of Statistics data.", "fr": "Les chiffres des effectifs sont fondés sur les données les plus récentes de l’Institut de statistique de l’UNESCO.", "perturbation": "alteration", "pert_fr": "Les chiffres des effectifs ne sont pas fondés sur les données les plus récentes de l’Institut de statistique de l’UNESCO.", "bt_pert_fr": "Staffing figures are not based on the most recent data from the UNESCO Institute for Statistics.", "questions": "[\"What are the enrolment figures based on the latest UNESCO Institute of Statistics data?\"]", "answers": "[\"Not available\"]", "scores": [{"f1": 0, "em": false, "chrf": 3.1150423379162384, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 3.1150423379162384, "avg_bleu": 0.0}
{"id": "Wikipedia_handpicked_5:1917", "en": "As of March 12, more than 370 million children and youth are not attending school because of temporary or indefinite country wide school closures mandated by governments in an attempt to slow the spread of COVID-19.", "fr": "Depuis le 12 mars, plus de 370 millions d’enfants et de jeunes ne se rendent pas à l’école en raison de la fermeture temporaire ou pour une durée indéterminée des écoles à l’échelle nationale imposée par les gouvernements dans l’espoir de ralentir la propagation du COVID-19.", "perturbation": "alteration", "pert_fr": "Depuis le 12 mars, plus de 370 millions d’enfants et de jeunes se rendent à l’école en raison de la réouverture temporaire ou pour une durée indéterminée des écoles à l’échelle nationale imposée par les gouvernements dans l’espoir de ralentir la propagation du COVID-19.", "bt_pert_fr": "Since March 12, more than 370 million children and young people have been heading to school due to the temporary or indefinite reopening of schools nationwide imposed by governments in the hope of slowing the spread of COVID-19.", "questions": "[\"How many children and youth are not attending school as of March 12?\", \"Why are children and youth not attending school as of March 12?\", \"What is the reason for the school closures affecting children and youth as of March 12?\", \"Are the school closures temporary or indefinite as of March 12?\", \"Which governments have mandated school closures to slow the spread of COVID-19 as of March 12?\"]", "answers": "[\"Unknown\", \"To slow the spread of COVID-19\", \"To slow the spread of COVID-19\", \"Temporary or indefinite\", \"Governments nationwide\"]", "scores": [{"f1": 0, "em": false, "chrf": 3.164556962025316, "bleu": 0.0}, {"f1": 0.12500000000000003, "em": false, "chrf": 4.375060160358679, "bleu": 3.217409328795944}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 80.66016220244364, "bleu": 49.99999999999999}], "avg_f1": 0.5583333333333333, "avg_em": 0.4, "avg_chrf": 57.63995586496553, "avg_bleu": 50.6434818657592}
{"id": "Wikipedia_handpicked_5:1920", "en": "Working parents are more likely to miss work when schools close in order to take care of their children, incurring wage loss in many instances and negatively impacting productivity.", "fr": "Les parents qui travaillent sont plus susceptibles de s’absenter de leur emploi pour s’occuper de leurs enfants lorsque les écoles ferment, ce qui entraîne souvent une perte de salaire et une baisse de la productivité.", "perturbation": "alteration", "pert_fr": "Les parents qui travaillent sont moins susceptibles de s’absenter de leur emploi pour s’occuper de leurs enfants lorsque les écoles ferment, ce qui entraîne souvent une perte de salaire et une baisse de la productivité.", "bt_pert_fr": "Working parents are less likely to take time off from their jobs to care for their children when schools close, often leading to lost wages and lower productivity.", "questions": "[\"Are working parents more likely to miss work when schools close?\", \"Do working parents incur wage loss when schools close?\", \"Does closing schools negatively impact productivity for working parents?\"]", "answers": "[\"No\", \"Yes\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6666666666666666, "avg_em": 0.6666666666666666, "avg_chrf": 66.66666666666667, "avg_bleu": 66.6666666666667}
{"id": "Wikipedia_handpicked_5:1921", "en": "Localised school closures place burdens on schools as parents and officials redirect children to schools that are open.", "fr": "Les fermetures localisées pénalisent les écoles, car les parents et les responsables réorientent les enfants vers les écoles ouvertes.", "perturbation": "alteration", "pert_fr": "Les fermetures localisées favorisent les écoles, car les parents et les responsables réorientent les enfants vers les écoles ouvertes.", "bt_pert_fr": "Localized closures favor schools, as parents and officials redirect children to open schools.", "questions": "[\"What burdens do localised school closures place on schools?\", \"Why do parents and officials redirect children to schools that are open?\"]", "answers": "[\"None\", \"Because open schools are available\"]", "scores": [{"f1": 0, "em": false, "chrf": 1.6741071428571428, "bleu": 0.0}, {"f1": 0.6, "em": false, "chrf": 45.80702800817744, "bleu": 23.643540225079395}], "avg_f1": 0.3, "avg_em": 0.0, "avg_chrf": 23.740567575517293, "avg_bleu": 11.821770112539697}
{"id": "Wikipedia_handpicked_5:1927", "en": "In the United States, numerous major cities announced public library closures, including Los Angeles, San Francisco, Seattle, and New York City, affecting 221 libraries.", "fr": "Aux États-Unis, de nombreuses grandes villes ont annoncé la fermeture des bibliothèques publiques, notamment Los Angeles, San Francisco, Seattle et New York, touchant 221 bibliothèques.", "perturbation": "alteration", "pert_fr": "Aux États-Unis, de nombreuses grandes villes ont annoncé l'ouverture des bibliothèques publiques, notamment Los Angeles, San Francisco, Seattle et New York, touchant 221 bibliothèques.", "bt_pert_fr": "In the United States, many major cities have announced the opening of public libraries, including Los Angeles, San Francisco, Seattle and New York, affecting 221 libraries.", "questions": "[\"Which major cities in the United States announced public library closures?\", \"Which libraries in the United States were affected by the closures?\", \"How many libraries in the United States were affected by the closures?\", \"Did Los Angeles announce a public library closure?\", \"Did San Francisco announce a public library closure?\", \"Did Seattle announce a public library closure?\", \"Did New York City announce a public library closure?\"]", "answers": "[\"None\", \"221 libraries\", \"221\", \"No\", \"No\", \"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.840909090909091, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.2857142857142857, "avg_em": 0.2857142857142857, "avg_chrf": 28.977272727272727, "avg_bleu": 28.571428571428584}
{"id": "Wikipedia_handpicked_5:1930", "en": "In the absence of alternative options, working parents often leave children alone when schools close and this can lead to risky behaviours, including increased influence of peer pressure and substance abuse.", "fr": "En l’absence de solutions alternatives, les parents qui travaillent laissent souvent leurs enfants seuls lorsque les écoles ferment et cela peut entraîner des comportements à risque, notamment une mauvaise influence accrue de certains camarades et de la toxicomanie.", "perturbation": "alteration", "pert_fr": "En la présence de solutions alternatives, les parents qui travaillent laissent rarement leurs enfants seuls lorsque les écoles ferment et cela peut entraîner des comportements sans risque, notamment une bonne influence accrue de certains camarades et de la toxicomanie.", "bt_pert_fr": "In the presence of alternatives, working parents rarely leave their children alone when schools close and this can lead to unsafe behaviors, including increased peer influence and substance abuse.", "questions": "[\"What happens when schools close and working parents have no alternative options?\", \"Do working parents leave children alone when schools close?\", \"Can leaving children alone when schools close lead to risky behaviours?\", \"What types of risky behaviours can increase when children are left alone during school closures?\", \"How does peer pressure increase when children are left alone during school closures?\", \"How does substance abuse increase when children are left alone during school closures?\"]", "answers": "[\"Working parents leave their children alone when schools close\", \"No\", \"Yes\", \"Increased peer influence and substance abuse\", \"Peer pressure increases due to lack of supervision\", \"Substance abuse increases due to lack of supervision\"]", "scores": [{"f1": 0.10526315789473685, "em": false, "chrf": 32.36284893565661, "bleu": 4.266331692956901}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8571428571428571, "em": false, "chrf": 66.96773192871403, "bleu": 25.745264623946035}, {"f1": 0.23529411764705882, "em": false, "chrf": 44.91786989461241, "bleu": 9.746997877627233}, {"f1": 0.23529411764705882, "em": false, "chrf": 47.653597929063565, "bleu": 9.746997877627233}], "avg_f1": 0.40549904172195195, "avg_em": 0.16666666666666666, "avg_chrf": 48.650341448007765, "avg_bleu": 24.917598678692908}
{"id": "Wikipedia_handpicked_5:1934", "en": "Every year, nearly 30 million children rely on schools to provide free or low-cost meals including breakfast, lunch, snacks, and even dinner.In Alabama, where state-wide school closures as of 18 March have affected over 720,000 students, the state Superintendent announced that staff in schools disproportionately affected by poverty would create meal distribution networks to provide food for students who rely on school lunches.", "fr": "Chaque année, près de 30 millions d’enfants dépendent des écoles pour recevoir des repas gratuits ou à bas prix, notamment le petit-déjeuner, le déjeuner, des en-cas et même le dîner. En Alabama, où la fermeture des écoles à l’échelle de l’État depuis le 18 mars a affecté plus de 720 000 élèves, le surintendant de l’État a annoncé que le personnel des écoles touchées de façon disproportionnée par la pauvreté allait créer des réseaux de distribution de repas pour fournir de la nourriture aux élèves qui dépendent des repas scolaires.", "perturbation": "alteration", "pert_fr": "Chaque année, près de 30 millions d’enfants ne dépendent pas des écoles pour recevoir des repas gratuits ou à bas prix, notamment le petit-déjeuner, le déjeuner, des en-cas et même le dîner. En Alabama, où la fermeture des écoles à l’échelle de l’État depuis le 18 mars a affecté plus de 720 000 élèves, le surintendant de l’État a annoncé que le personnel des écoles touchées de façon disproportionnée par la richesse allait créer des réseaux de distribution de repas pour fournir de la nourriture aux élèves qui dépendent des repas scolaires.", "bt_pert_fr": "Each year, nearly 30 million children do not rely on schools to receive free or low-cost meals, including breakfast, lunch, snacks and even dinner. In Alabama, where the statewide school closure since March 18 has affected more than 720,000 students, the state superintendent announced that staff at schools disproportionately affected by wealth would create meal distribution networks to provide food to students who rely on school meals.", "questions": "[\"How many children rely on schools to provide free or low-cost meals every year?\", \"What types of meals do children rely on schools to provide?\", \"How many students in Alabama were affected by school closures as of 18 March?\", \"What action did the state Superintendent announce regarding schools disproportionately affected by poverty?\", \"What is the purpose of the meal distribution networks created by school staff in Alabama?\"]", "answers": "[\"30 million\", \"breakfast, lunch, snacks and even dinner\", \"720,000\", \"To create meal distribution networks to provide food to students who rely on school meals\", \"To provide food to students who rely on school meals\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.2962962962962963, "em": false, "chrf": 48.62556023226092, "bleu": 16.451929399933107}, {"f1": 0.8000000000000002, "em": false, "chrf": 73.52660054714391, "bleu": 52.53819788848316}], "avg_f1": 0.8192592592592594, "avg_em": 0.6, "avg_chrf": 84.43043215588096, "avg_bleu": 73.79802545768328}
{"id": "Wikipedia_handpicked_5:1936", "en": "Schooling provides essential learning and when schools close, children and youth are deprived opportunities for growth and development.", "fr": "La scolarisation permet l’acquisition de compétences élémentaires essentielles, et lorsque les écoles ferment, les enfants, adolescents et jeunes adultes sont privés d’opportunités de développement et d’épanouissement.", "perturbation": "alteration", "pert_fr": "La déscolarisation permet l’acquisition de compétences élémentaires essentielles, et lorsque les écoles ferment, les enfants, adolescents et jeunes adultes sont privés d’opportunités de développement et d’épanouissement.", "bt_pert_fr": "Dropping out of school allows the acquisition of essential basic skills, and when schools close, children, adolescents and young adults are deprived of opportunities for development and fulfillment.", "questions": "[\"Does schooling provide essential learning?\", \"What happens to children and youth when schools close?\"]", "answers": "[\"Yes\", \"They are deprived of opportunities for development and fulfillment\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.823529411764706, "em": false, "chrf": 73.1253752103296, "bleu": 24.274588585366175}], "avg_f1": 0.911764705882353, "avg_em": 0.5, "avg_chrf": 86.5626876051648, "avg_bleu": 62.13729429268311}
{"id": "Wikipedia_handpicked_5:1937", "en": "The disadvantages are disproportionate for under-privileged learners who tend to have fewer educational opportunities beyond school.Student drop-out rates tend to increase as an effect of school closures due to the challenge of ensuring all students return to school once school closures ends.", "fr": "Les inconvénients sont démesurés pour les élèves défavorisés dont les possibilités d’éducation sont généralement moindres en dehors de l’école. Le taux de décrochage scolaire a tendance à augmenter sous l’effet de la fermeture des écoles, en raison du défi d’assurer que tous les élèves reprennent leur scolarité lorsque la fermeture des écoles prendra fin.", "perturbation": "alteration", "pert_fr": "Les avantages sont démesurés pour les élèves défavorisés dont les possibilités d’éducation sont généralement moindres en dehors de l’école. Le taux de décrochage scolaire a tendance à diminuer sous l’effet de la fermeture des écoles, en raison du défi d’assurer que tous les élèves reprennent leur scolarité lorsque la fermeture des écoles prendra fin.", "bt_pert_fr": "The benefits are outsized for disadvantaged students who generally have fewer educational opportunities outside of school. The school dropout rate tends to decrease as a result of school closures, due to the challenge of ensuring that all students return to school when school closures end.", "questions": "[\"What are the disadvantages for under-privileged learners?\", \"Why do under-privileged learners tend to have fewer educational opportunities beyond school?\", \"How do school closures affect student drop-out rates?\", \"What challenges make it difficult to ensure all students return to school after school closures end?\"]", "answers": "[\"The benefits are outsized for disadvantaged students who generally have fewer educational opportunities outside of school.\", \"The sentence does not provide information on why under-privileged learners have fewer educational opportunities beyond school.\", \"School closures tend to decrease the student dropout rate.\", \"The challenge of ensuring that all students return to school when school closures end.\"]", "scores": [{"f1": 0, "em": false, "chrf": 36.37851931139526, "bleu": 0.0}, {"f1": 0.4800000000000001, "em": false, "chrf": 71.46249002562045, "bleu": 30.130404892785684}, {"f1": 0.75, "em": false, "chrf": 87.86929718920932, "bleu": 41.11336169005198}, {"f1": 0.888888888888889, "em": false, "chrf": 85.56055339957408, "bleu": 53.33505353503043}], "avg_f1": 0.5297222222222222, "avg_em": 0.0, "avg_chrf": 70.31771498144978, "avg_bleu": 31.144705029467026}
{"id": "Wikipedia_handpicked_5:1941", "en": "Potential impacts of school closures and reliance on distance learning are not addressed in federal acts of legislation at this time.", "fr": "Les retombées possibles de la fermeture des écoles et du recours à l’apprentissage à distance ne sont pas traitées dans les lois fédérales à l’heure actuelle.", "perturbation": "alteration", "pert_fr": "Les retombées possibles de la fermeture des écoles et du recours à l’apprentissage en présentiel ne sont pas traitées dans les lois fédérales à l’heure actuelle.", "bt_pert_fr": "The possible fallout from closing schools and relying on in-person learning is not currently addressed in federal law.", "questions": "[\"Are the potential impacts of school closures and reliance on distance learning addressed in federal acts of legislation at this time?\", \"Do federal acts of legislation currently address the potential impacts of school closures?\", \"Do federal acts of legislation currently address the potential impacts of relying on distance learning?\"]", "answers": "[\"No\", \"No\", \"No\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikipedia_handpicked_5:1942", "en": "Formal education — as opposed to informal education or non-formal education — tends to refer to schools, colleges, universities and training institutions.", "fr": "L’éducation formelle (à la différence de l’éducation informelle ou non formelle) fait généralement référence aux écoles, établissements d’enseignement supérieur, universités et instituts de formation.", "perturbation": "alteration", "pert_fr": "L’éducation informelle (à la différence de l’éducation formelle ou non informelle) fait généralement référence aux écoles, établissements d’enseignement supérieur, universités et instituts de formation.", "bt_pert_fr": "Informal education (as distinct from formal or non-informal education) generally refers to schools, colleges, universities and training institutes.", "questions": "[\"What does formal education tend to refer to?\", \"What distinguishes formal education from informal or non-formal education?\", \"What types of institutions are included in formal education?\"]", "answers": "[\"Schools, colleges, universities and training institutes\", \"Informal education\", \"Schools, colleges, universities and training institutes\"]", "scores": [{"f1": 0.8333333333333334, "em": false, "chrf": 92.68267379339221, "bleu": 75.98356856515926}, {"f1": 0.1818181818181818, "em": false, "chrf": 30.521421354390483, "bleu": 1.509869171115925}, {"f1": 0.8333333333333334, "em": false, "chrf": 92.68267379339221, "bleu": 75.98356856515926}], "avg_f1": 0.6161616161616162, "avg_em": 0.0, "avg_chrf": 71.96225631372498, "avg_bleu": 51.15900210047815}
{"id": "Wikipedia_handpicked_5:1943", "en": "A 1974 report by the World Bank defined formal education as the following:Formal education: the hierarchically structured, chronologically graded ‘education system’, running from primary school through the university and including, in addition to general academic studies, a variety of specialised programmes and institutions for full-time technical and professional training.The majority of data collected on the number of students and learners impacted by COVID-19 has been calculated based on the closure of formal education systems.", "fr": "Un rapport de la Banque mondiale de 1974 définissait l’éducation formelle comme suit : Éducation formelle : le « système éducatif » doté d’une structure hiérarchique et organisé de façon chronologique, allant de l’école primaire à l’université et comprenant, outre les études classiques, divers programmes et établissements spécialisés pour la formation professionnelle et technique à plein temps. La majorité des données recueillies quant au nombre d’élèves et d’apprenants affectés par le COVID-19 ont été calculées à partir de la fermeture des systèmes d’éducation formelle.", "perturbation": "alteration", "pert_fr": "Un rapport de la Banque mondiale de 1974 définissait l’éducation informelle comme suit : Éducation informelle : le « système éducatif » doté d’une structure hiérarchique et organisé de façon chronologique, allant de l’école primaire à l’université et comprenant, outre les études classiques, divers programmes et établissements spécialisés pour la formation professionnelle et technique à plein temps. La majorité des données recueillies quant au nombre d’élèves et d’apprenants affectés par le COVID-19 ont été calculées à partir de la fermeture des systèmes d’éducation informelle.", "bt_pert_fr": "A 1974 World Bank report defined informal education as follows: Informal education: the “education system” with a hierarchical structure and organized chronologically, running from primary school to university and including, in addition to formal studies, various specialized programs and institutions for full-time vocational and technical training. The majority of data collected on the number of students and learners affected by COVID-19 has been calculated based on the closure of informal education systems.", "questions": "[\"What does the World Bank define as formal education?\", \"How has the data on the number of students and learners impacted by COVID-19 been calculated?\", \"What factors contribute to the closure of formal education systems?\", \"What components are included in the formal education system according to the World Bank?\"]", "answers": "[\"The education system with a hierarchical structure and organized chronologically, running from primary school to university and including, in addition to formal studies, various specialized programs and institutions for full-time vocational and technical training\", \"Based on the closure of informal education systems\", \"Not mentioned in the sentence\", \"A hierarchical structure, chronological organization from primary school to university, formal studies, and various specialized programs and institutions for full-time vocational and technical training\"]", "scores": [{"f1": 0.6060606060606061, "em": false, "chrf": 70.48721895447522, "bleu": 30.766914974992893}, {"f1": 0.8571428571428571, "em": false, "chrf": 91.67655460972446, "bleu": 48.892302243490086}, {"f1": 0.3333333333333333, "em": false, "chrf": 17.14248437845609, "bleu": 15.97357760615681}, {"f1": 0.43243243243243246, "em": false, "chrf": 57.67939355564627, "bleu": 11.71291646655074}], "avg_f1": 0.5572423072423073, "avg_em": 0.0, "avg_chrf": 59.24641287457551, "avg_bleu": 26.83642782279763}
{"id": "Wikipedia_handpicked_5:1944", "en": "The UNESCO Institute for Statistics provides figures on students impacted by COVID-19 corresponding to the number of learners enrolled at pre-primary, primary, lower-secondary, and upper-secondary levels of education [ISCED levels 0 to 3], as well as at tertiary education levels [ISCED levels 5 to 8].", "fr": "L’Institut de statistique de l’UNESCO fournit des chiffres sur les élèves affectés par le COVID-19 correspondant au nombre d’apprenants inscrits dans un cycle d’enseignement pré-primaire, primaire, secondaire inférieur et secondaire supérieur [niveaux 0 à 3 de la CITE], ainsi que dans des cycles d’enseignement supérieur [niveaux 5 à 8 de la CITE].", "perturbation": "alteration", "pert_fr": "L’Institut de statistique de l’UNESCO fournit des chiffres sur les élèves non affectés par le COVID-19 correspondant au nombre d’apprenants inscrits dans un cycle d’enseignement pré-primaire, primaire, secondaire inférieur et secondaire supérieur [niveaux 0 à 3 de la CITE], ainsi que dans des cycles d’enseignement supérieur [niveaux 5 à 8 de la CITE].", "bt_pert_fr": "The UNESCO Institute for Statistics provides figures on students not affected by COVID-19 corresponding to the number of learners enrolled in pre-primary, primary, lower secondary and upper secondary education [ISCED levels 0 to 3], as well as tertiary education cycles [ISCED levels 5 to 8].", "questions": "[\"What figures does the UNESCO Institute for Statistics provide regarding students impacted by COVID-19?\", \"Which education levels does the UNESCO Institute for Statistics cover in its figures on students impacted by COVID-19?\", \"What specific education levels are included in the UNESCO Institute for Statistics' data on students impacted by COVID-19?\", \"Does the UNESCO Institute for Statistics provide data on students at pre-primary education levels impacted by COVID-19?\", \"Does the UNESCO Institute for Statistics provide data on students at primary education levels impacted by COVID-19?\", \"Does the UNESCO Institute for Statistics provide data on students at lower-secondary education levels impacted by COVID-19?\", \"Does the UNESCO Institute for Statistics provide data on students at upper-secondary education levels impacted by COVID-19?\", \"Does the UNESCO Institute for Statistics provide data on students at tertiary education levels impacted by COVID-19?\"]", "answers": "[\"The UNESCO Institute for Statistics does not provide figures on students affected by COVID-19\", \"None\", \"None\", \"No\", \"No\", \"No\", \"No\", \"No\"]", "scores": [{"f1": 0.0689655172413793, "em": false, "chrf": 14.713291829818399, "bleu": 2.6440681349450874}, {"f1": 0, "em": false, "chrf": 1.7440949994652648, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 1.7440949994652648, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.008620689655172412, "avg_em": 0.0, "avg_chrf": 2.275185228593616, "avg_bleu": 0.3305085168681359}
{"id": "Wikipedia_handpicked_5:1946", "en": "While many primary and secondary schools have closed around the world due to COVID-19, measures impacting early childhood educational programmes have varied.", "fr": "Alors que de nombreuses écoles primaires et secondaires dans le monde ont fermé en raison du COVID-19, les mesures concernant les programmes d’enseignement préscolaire ont été variables.", "perturbation": "alteration", "pert_fr": "Alors que de nombreuses écoles primaires et secondaires dans le monde ont ouvert en raison du COVID-19, les mesures concernant les programmes d’enseignement préscolaire ont été variables.", "bt_pert_fr": "While many primary and secondary schools around the world have opened due to COVID-19, measures regarding early childhood education programs have been variable.", "questions": "[\"Have primary and secondary schools closed around the world due to COVID-19?\", \"How have measures impacting early childhood educational programmes varied?\"]", "answers": "[\"No\", \"Variable\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 10.881111703940835, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 5.440555851970418, "avg_bleu": 0.0}
{"id": "Wikipedia_handpicked_5:1947", "en": "In some countries and territories, preschools and day cares are considered necessary services and have not closed in tandem with broader school closure measures.In the United States, the Washington State Department of Children, Youth, and Families encouraged child care and early learning centres to stay open.", "fr": "Dans certains pays et territoires, les écoles maternelles et les garderies sont considérées comme des services essentiels et n’ont pas fermé alors qu’étaient décrétées des mesures plus générales de fermeture des écoles. Aux États-Unis, le département de l’Enfance, de la Jeunesse et de la Famille de l’État de Washington a encouragé les garderies et les centres d’éducation préscolaire à rester ouverts.", "perturbation": "alteration", "pert_fr": "Dans certains pays et territoires, les écoles maternelles et les garderies sont considérées comme des services non essentiels et ont fermé alors qu’étaient décrétées des mesures plus générales de fermeture des écoles. Aux États-Unis, le département de l’Enfance, de la Jeunesse et de la Famille de l’État de Washington a encouragé les garderies et les centres d’éducation préscolaire à fermer.", "bt_pert_fr": "In some countries and territories, preschools and daycares are considered non-essential services and have closed amid broader school closure measures. In the United States, the Washington State Department of Children, Youth and Families has encouraged daycares and early learning centers to close.", "questions": "[\"In some countries and territories, are preschools and day cares considered necessary services?\", \"In some countries and territories, have preschools and day cares closed in tandem with broader school closure measures?\", \"In the United States, did the Washington State Department of Children, Youth, and Families encourage child care and early learning centres to stay open?\"]", "answers": "[\"No\", \"Yes\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "Wikipedia_handpicked_5:1949", "en": "The governor of Maryland mandated that specific child care services remain open for the children of emergency personnel while Washington State and California have left it to the discretion of care providers.", "fr": "Le gouverneur du Maryland a ordonné que des services de garde d’enfants spécifiques restent ouverts pour les enfants du personnel des services d’urgence, tandis que l’État de Washington et la Californie ont laissé cette décision à la discrétion des prestataires de soins.", "perturbation": "alteration", "pert_fr": "Le gouverneur du Maryland a ordonné que des services de garde d’enfants spécifiques ferment pour les enfants du personnel des services d’urgence, tandis que l’État de Washington et la Californie ont laissé cette décision à la discrétion des prestataires de soins.", "bt_pert_fr": "Maryland's governor ordered specific child care services to close for children of emergency services personnel, while Washington state and California left that decision to the discretion of care providers.", "questions": "[\"Did the governor of Maryland mandate that specific child care services remain open for the children of emergency personnel?\", \"What is the policy regarding child care services for the children of emergency personnel in Washington State?\", \"What is the policy regarding child care services for the children of emergency personnel in California?\", \"Did Washington State mandate that specific child care services remain open for the children of emergency personnel?\", \"Did California mandate that specific child care services remain open for the children of emergency personnel?\"]", "answers": "[\"No\", \"Left to the discretion of care providers\", \"Left to the discretion of care providers\", \"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.923076923076923, "em": false, "chrf": 89.43675602027466, "bleu": 67.31821382417488}, {"f1": 0.923076923076923, "em": false, "chrf": 89.43675602027466, "bleu": 67.31821382417488}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7692307692307692, "avg_em": 0.4, "avg_chrf": 75.77470240810986, "avg_bleu": 66.92728552966996}
{"id": "Wikipedia_handpicked_5:1950", "en": "California Governor Gavin Newsom explained his state's position, saying “We need our child care facilities, our daycare centers, to operate to absorb the impact of these school closures.”", "fr": "Le gouverneur de Californie Gavin Newsom a expliqué la position de son État, en déclarant que « Nous avons besoin que nos établissements de garde d’enfants, nos garderies, fonctionnent pour amortir l’impact de ces fermetures d’écoles. »", "perturbation": "alteration", "pert_fr": "Le gouverneur de Californie Gavin Newsom a expliqué la position de son État, en déclarant que « Nous n'avons pas besoin que nos établissements de garde d’enfants, nos garderies, fonctionnent pour amortir l’impact de ces fermetures d’écoles. »", "bt_pert_fr": "California Governor Gavin Newsom explained his state's position, saying that \"We don't need our child care facilities, our day care centers, operating to cushion the impact of these school closures. »", "questions": "[\"What did California Governor Gavin Newsom say about child care facilities and daycare centers during school closures?\", \"Why are child care facilities and daycare centers important according to Governor Gavin Newsom?\", \"What is the purpose of child care facilities and daycare centers in response to school closures?\"]", "answers": "[\"We don't need our child care facilities, our day care centers, operating to cushion the impact of these school closures\", \"They are not needed to cushion the impact of school closures\", \"To cushion the impact of these school closures\"]", "scores": [{"f1": 0.7567567567567567, "em": false, "chrf": 80.24449078697197, "bleu": 46.661736281950525}, {"f1": 0.47058823529411764, "em": false, "chrf": 53.263055306679775, "bleu": 11.868405219520975}, {"f1": 0.8571428571428571, "em": false, "chrf": 77.2361230844131, "bleu": 64.34588841607616}], "avg_f1": 0.6948292830645771, "avg_em": 0.0, "avg_chrf": 70.24788972602161, "avg_bleu": 40.958676639182556}
{"id": "Wikipedia_handpicked_5:1951", "en": "Colorado has encouraged the development of \"tool kits\" for parents to use at home to emulate the lessons children would have received in their early learning programmes.In Japan, Prime Minister Shinzo Abe closed all schools throughout the country until April 8, however, children's daycare facilities were excluded.", "fr": "Le Colorado a encouragé le développement « d’outils pédagogiques » que les parents peuvent utiliser à la maison afin de reproduire les leçons que les enfants auraient reçues dans le cadre de leurs programmes d’enseignement préscolaire. Au Japon, le Premier ministre Shinzo Abe a fermé toutes les écoles du pays jusqu’au 8 avril, les garderies n’étaient toutefois pas visées par cette mesure.", "perturbation": "alteration", "pert_fr": "Le Colorado a découragé le développement « d’outils pédagogiques » que les parents peuvent utiliser à la maison afin de reproduire les leçons que les enfants auraient reçues dans le cadre de leurs programmes d’enseignement préscolaire. Au Japon, le Premier ministre Shinzo Abe a ouvert toutes les écoles du pays jusqu’au 8 avril, les garderies n’étaient toutefois pas visées par cette mesure.", "bt_pert_fr": "Colorado has discouraged the development of “teaching tools” that parents can use at home to replicate the lessons children would have received in their preschool programs. In Japan, Prime Minister Shinzo Abe opened all schools in the country until April 8, although daycare centers were not affected by this measure.", "questions": "[\"What has Colorado encouraged parents to use at home to emulate early learning programme lessons?\", \"What did Prime Minister Shinzo Abe do regarding schools in Japan?\", \"Were children's daycare facilities included in the school closures in Japan?\", \"What specific action was taken in Japan regarding schools and daycare facilities?\"]", "answers": "[\"Teaching tools\", \"Opened all schools in the country until April 8\", \"No\", \"All schools were opened until April 8, while daycare centers were not affected\"]", "scores": [{"f1": 0, "em": false, "chrf": 19.517486532064197, "bleu": 0.0}, {"f1": 0.75, "em": false, "chrf": 62.4050528865107, "bleu": 41.11336169005198}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.3870967741935484, "em": false, "chrf": 29.607362759426238, "bleu": 9.30833816558901}], "avg_f1": 0.5342741935483871, "avg_em": 0.25, "avg_chrf": 52.88247554450028, "avg_bleu": 37.60542496391026}
{"id": "Wikipedia_handpicked_5:1958", "en": "Tertiary education is normally taken to include undergraduate and postgraduate education, as well as vocational education and training.", "fr": "On considère généralement que l’éducation tertiaire comprend les études du premier au troisième cycle universitaire, ainsi que l’enseignement et la formation professionnels.", "perturbation": "alteration", "pert_fr": "On considère généralement que l’éducation tertiaire comprend les études du quatrième au sixième cycle universitaire, ainsi que l’enseignement et la formation professionnels.", "bt_pert_fr": "Tertiary education is generally considered to include studies from the fourth to sixth cycle of university, as well as vocational education and training.", "questions": "[\"What does tertiary education normally include?\", \"Does tertiary education include undergraduate and postgraduate education?\", \"Does tertiary education include vocational education and training?\"]", "answers": "[\"Studies from the fourth to sixth cycle of university, as well as vocational education and training\", \"Yes\", \"Yes\"]", "scores": [{"f1": 0.5384615384615385, "em": false, "chrf": 53.24626898697259, "bleu": 40.016016019225006}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8461538461538461, "avg_em": 0.6666666666666666, "avg_chrf": 84.41542299565752, "avg_bleu": 80.00533867307503}
{"id": "Wikipedia_handpicked_5:1959", "en": "Individuals who complete tertiary education generally receive certificates, diplomas, or academic degrees.", "fr": "Les personnes qui terminent l’éducation tertiaire reçoivent généralement des certificats, diplômes ou titres universitaires.", "perturbation": "alteration", "pert_fr": "Les personnes qui terminent l’éducation tertiaire reçoivent généralement des refus, diplômes ou titres universitaires.", "bt_pert_fr": "People who complete tertiary education usually receive academic refusals, diplomas or titles.", "questions": "[\"What do individuals who complete tertiary education generally receive?\", \"What types of certificates, diplomas, or academic degrees do individuals who complete tertiary education receive?\"]", "answers": "[\"Academic refusals, diplomas, or titles\", \"Academic refusals, diplomas, or titles\"]", "scores": [{"f1": 0.4000000000000001, "em": false, "chrf": 44.94719525573882, "bleu": 21.3643503198117}, {"f1": 0.4000000000000001, "em": false, "chrf": 44.94719525573882, "bleu": 21.3643503198117}], "avg_f1": 0.4000000000000001, "avg_em": 0.0, "avg_chrf": 44.94719525573882, "avg_bleu": 21.3643503198117}
{"id": "Wikipedia_handpicked_5:1960", "en": "Undergraduate education is education conducted after secondary education and prior to post-graduate education, for which the learner is typically awarded a bachelor's degree.", "fr": "Les études de premier cycle universitaire correspondent à l’éducation reçue après l’enseignement secondaire et avant les études universitaires supérieures, pour lesquelles l’étudiant reçoit généralement une licence.", "perturbation": "alteration", "pert_fr": "Les études de premier cycle universitaire correspondent à l’éducation reçue avant l’enseignement secondaire et après les études universitaires supérieures, pour lesquelles l’étudiant reçoit généralement une licence.", "bt_pert_fr": "Undergraduate studies correspond to education received before secondary education and after higher university studies, for which the student generally receives a bachelor's degree.", "questions": "[\"What type of education is undergraduate education?\", \"What comes before post-graduate education in the educational pathway?\", \"What degree is typically awarded upon completion of undergraduate education?\", \"Is undergraduate education conducted after secondary education?\", \"Is undergraduate education conducted before post-graduate education?\"]", "answers": "[\"Education received before secondary education and after higher university studies\", \"Higher university studies\", \"A bachelor's degree\", \"No\", \"Yes\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 46.19437105896822, "bleu": 17.747405280050266}, {"f1": 0, "em": false, "chrf": 7.894736842105264, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.4, "avg_chrf": 50.8178215802147, "avg_bleu": 43.549481056010066}
{"id": "Wikipedia_handpicked_5:1961", "en": "Students enrolled in higher education programmes at colleges, universities, and community colleges are often refereed to in countries such as United States as \"college students.\"The closure of colleges and universities has widespread implications for students, faculty, administrators, and the institutions themselves.", "fr": "Les étudiants inscris aux programmes d’enseignement supérieur des établissements d’études supérieures, des universités et des community colleges sont souvent appelés, dans les pays tels que les États-Unis, des « étudiants universitaires ». La fermeture des établissements d’études supérieures et universités a de fortes répercussions pour les étudiants, les enseignants, les administrateurs et les établissements eux-mêmes.", "perturbation": "alteration", "pert_fr": "Les étudiants inscris aux programmes d’enseignement supérieur des établissements d’études supérieures, des universités et des community colleges sont rarement appelés, dans les pays tels que les États-Unis, des « étudiants universitaires ». L'ouverture des établissements d’études supérieures et universités a de fortes répercussions pour les étudiants, les enseignants, les administrateurs et les établissements eux-mêmes.", "bt_pert_fr": "Students enrolled in higher education programs at colleges, universities, and community colleges are rarely referred to in countries such as the United States as “college students.” The opening of higher education establishments and universities has strong repercussions for students, teachers, administrators and the establishments themselves.", "questions": "[\"What are students enrolled in higher education programmes at colleges, universities, and community colleges often referred to as in countries such as the United States?\", \"What are the widespread implications of the closure of colleges and universities on students, faculty, administrators, and the institutions themselves?\"]", "answers": "[\"college students\", \"negative\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 8.011392278606888, "bleu": 0.0}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 54.005696139303446, "avg_bleu": 50.00000000000002}
{"id": "Wikipedia_handpicked_5:1962", "en": "Colleges and universities across the United States have been called upon to issue refunds to students for the cost of tuition and room and board.", "fr": "Les établissements d’études supérieures et universités aux États-Unis ont été appelés à rembourser aux étudiants les frais de scolarité, de logement et de pension.", "perturbation": "alteration", "pert_fr": "Les établissements d’études supérieures et universités aux États-Unis n’ont pas été appelés à rembourser aux étudiants les frais de scolarité, de logement et de pension.", "bt_pert_fr": "Colleges and universities in the United States have not been asked to reimburse students for tuition, room and board.", "questions": "[\"Have colleges and universities across the United States been called upon to issue refunds to students?\", \"What is the reason colleges and universities across the United States have been called upon to issue refunds?\", \"What specific costs are students being refunded for?\", \"Which institutions have been called upon to issue refunds to students?\"]", "answers": "[\"No\", \"None\", \"Tuition, room and board\", \"Colleges and universities in the United States\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 2.9705943800271593, "bleu": 0.0}, {"f1": 0.888888888888889, "em": false, "chrf": 73.03371208041965, "bleu": 49.76093899250716}, {"f1": 0.8333333333333334, "em": false, "chrf": 79.3279020288092, "bleu": 37.99178428257963}], "avg_f1": 0.4305555555555556, "avg_em": 0.0, "avg_chrf": 38.833052122314, "avg_bleu": 21.9381808187717}
{"id": "Wikipedia_handpicked_5:1963", "en": "In the United States of America, Colleges and universities operate as \"mini-cities\" which generate significant revenue for cities, states, and regions.", "fr": "Aux États-Unis d’Amérique, les établissements d’études supérieures et universités fonctionnent comme de « mini-villes » qui génèrent des revenus importants pour les villes, les États et les régions.", "perturbation": "alteration", "pert_fr": "Aux États-Unis d’Amérique, les établissements d’études supérieures et universités fonctionnent comme de « mini-villes » qui génèrent des pertes importantes pour les villes, les États et les régions.", "bt_pert_fr": "In the United States of America, colleges and universities operate as “mini-cities” that generate significant losses for cities, states and regions.", "questions": "[\"How do colleges and universities operate in the United States of America?\", \"What generates significant revenue for cities, states, and regions in the United States of America?\", \"Do colleges and universities operate as 'mini-cities' in the United States of America?\", \"What is the relationship between colleges and universities and the revenue generated for cities, states, and regions in the United States of America?\"]", "answers": "[\"As 'mini-cities'\", \"None\", \"Yes\", \"Colleges and universities do not generate revenue for cities, states, and regions; instead, they generate significant losses\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 3.318475015492085, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5806451612903226, "em": false, "chrf": 75.40643346682599, "bleu": 32.63598326609894}], "avg_f1": 0.6451612903225806, "avg_em": 0.5, "avg_chrf": 69.68122712057952, "avg_bleu": 58.15899581652476}
{"id": "Wikipedia_handpicked_5:1964", "en": "For example, Princeton University contributed $1.58 billion USD to the New Jersey economy and students spent about $60 million in off-campus spending.", "fr": "Par exemple, l’Université de Princeton a rapporté 1,58 milliard $ USD à l’économie du New Jersey et les étudiants ont dépensé environ 60 millions $ en dehors du campus.", "perturbation": "alteration", "pert_fr": "Par exemple, l’Université de Princeton a rapporté 1,58 milliard $ USD à l’économie du New Jersey et les étudiants ont économisé environ 60 millions $ en dehors du campus.", "bt_pert_fr": "For example, Princeton University contributed $1.58 billion USD to the New Jersey economy and students saved approximately $60 million off campus.", "questions": "[\"How much did Princeton University contribute to the New Jersey economy?\", \"How much did Princeton University students spend in off-campus spending?\"]", "answers": "[\"$1.58 billion USD\", \"$60 million\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikipedia_handpicked_5:1971", "en": "This could range through integrated digital learning platforms, video lessons, MOOCs, to broadcasting through radios and TVs.", "fr": "Il peut s’agir de plateformes d’apprentissage numériques intégrées, de leçons vidéo, de MOOC ou encore de diffusions à la radio et à la télévision.", "perturbation": "alteration", "pert_fr": "Il peut s’agir de plateformes d’oubli numériques intégrées, de leçons vidéo, de MOOC ou encore de diffusions à la radio et à la télévision.", "bt_pert_fr": "These may include integrated digital forgetting platforms, video lessons, MOOCs or even radio and television broadcasts.", "questions": "[\"What types of platforms could this range through?\", \"Can this include integrated digital learning platforms?\", \"Can this include video lessons?\", \"Can this include MOOCs?\", \"Can this include broadcasting through radios?\", \"Can this include broadcasting through TVs?\"]", "answers": "[\"Integrated digital forgetting platforms, video lessons, MOOCs, or even radio and television broadcasts\", \"Yes\", \"Yes\", \"Yes\", \"Yes\", \"Yes\"]", "scores": [{"f1": 0.48000000000000004, "em": false, "chrf": 65.36254149826459, "bleu": 21.401603033752977}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.9133333333333334, "avg_em": 0.8333333333333334, "avg_chrf": 94.22709024971077, "avg_bleu": 86.9002671722922}
{"id": "Wikipedia_handpicked_5:1973", "en": "Consider temporarily decentralising such devices from computer labs to families and support them with internet connectivity.", "fr": "Envisager la possibilité de transférer temporairement ce type d’appareils des salles d’informatique aux familles, en leur fournissant un accès à Internet.", "perturbation": "alteration", "pert_fr": "Envisager la possibilité de transférer temporairement ce type d’appareils des salles d’informatique aux entreprises, en leur fournissant un accès à Internet.", "bt_pert_fr": "Consider the possibility of temporarily transferring these types of devices from computer rooms to businesses, providing them with Internet access.", "questions": "[\"Should devices be temporarily decentralised from computer labs to families?\", \"How can families be supported with internet connectivity?\"]", "answers": "[\"No\", \"By temporarily transferring these types of devices from computer rooms to businesses and providing them with Internet access\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 21.59407229964075, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 10.797036149820375, "avg_bleu": 0.0}
{"id": "Wikipedia_handpicked_5:1974", "en": "Protect data privacy and data security: Assess data security when uploading data or educational resources to web spaces, as well as when sharing them with other organisations or individuals.", "fr": "Protéger la confidentialité des données et la sécurité des données : évaluer la sécurité des données lors du téléchargement de données ou de ressources pédagogiques sur les espaces web, ainsi que pendant leur partage avec d’autres organisations ou individus.", "perturbation": "alteration", "pert_fr": "Exposer la confidentialité des données et la sécurité des données : évaluer la sécurité des données lors du téléchargement de données ou de ressources pédagogiques sur les espaces web, ainsi que pendant leur partage avec d’autres organisations ou individus.", "bt_pert_fr": "Expose data privacy and data security: Assess data security when uploading data or educational resources to web spaces, as well as when sharing them with other organizations or individuals.", "questions": "[\"When should data security be assessed when uploading data or educational resources to web spaces?\", \"When should data security be assessed when sharing data or educational resources with other organizations or individuals?\", \"What aspects of data security should be considered when uploading data or educational resources to web spaces?\", \"What aspects of data security should be considered when sharing data or educational resources with other organizations or individuals?\"]", "answers": "[\"When uploading data or educational resources to web spaces\", \"When sharing data or educational resources with other organizations or individuals\", \"Data security\", \"Data security\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.631578947368421, "em": false, "chrf": 72.92822719998645, "bleu": 12.982679446701692}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.9078947368421053, "avg_em": 0.75, "avg_chrf": 93.23205679999661, "avg_bleu": 78.24566986167545}
{"id": "Wikipedia_handpicked_5:1977", "en": "Create communities to ensure regular human interactions, enable social caring measures, and address possible psychosocial challenges that students may face when they are isolated.", "fr": "Créer des communautés afin d’assurer des interactions humaines régulières, prévoir des mesures de protection sociale, et répondre aux difficultés psychosociales éventuelles auxquelles les élèves peuvent être confrontés lorsqu’ils sont confinés.", "perturbation": "alteration", "pert_fr": "Créer des communautés afin d’assurer des interactions humaines irrégulières, prévoir des mesures de protection individuelle, et répondre aux difficultés psychosociales éventuelles auxquelles les élèves peuvent être confrontés lorsqu’ils ne sont pas confinés.", "bt_pert_fr": "Create communities to ensure irregular human interactions, provide individual protection measures, and respond to possible psychosocial difficulties that students may face when not confined.", "questions": "[\"What communities should be created to ensure regular human interactions?\", \"What social caring measures can be enabled for students during isolation?\", \"What psychosocial challenges may students face when isolated and how can they be addressed?\"]", "answers": "[\"Communities to ensure irregular human interactions\", \"Individual protection measures\", \"Possible psychosocial difficulties that students may face when not confined\"]", "scores": [{"f1": 0.8333333333333334, "em": false, "chrf": 92.72230988266745, "bleu": 37.99178428257963}, {"f1": 0.3333333333333333, "em": false, "chrf": 35.20648903234627, "bleu": 27.516060407455225}, {"f1": 0.3448275862068966, "em": false, "chrf": 34.939460476564726, "bleu": 15.970651895774385}], "avg_f1": 0.5038314176245211, "avg_em": 0.0, "avg_chrf": 54.289419797192814, "avg_bleu": 27.159498861936413}
{"id": "Wikipedia_handpicked_5:1978", "en": "Plan the study schedule of the distance learning programmes: Organise discussions with stakeholders to examine the possible duration of school closures and decide whether the distance learning programme should focus on teaching new knowledge or enhance students’ knowledge of prior lessons.", "fr": "Planifier le calendrier d’étude des programmes d’apprentissage à distance : organiser des discussions avec les parties prenantes afin d’examiner la durée possible de la fermeture des écoles et décider si le programme d’apprentissage à distance devrait se concentrer sur l’enseignement de nouvelles connaissances ou plutôt renforcer celles déjà acquises lors de leçons antérieures.", "perturbation": "alteration", "pert_fr": "Planifier le calendrier d’étude des programmes d’apprentissage en présentiel : organiser des discussions avec les parties prenantes afin d’examiner la durée possible de la réouverture des écoles et décider si le programme d’apprentissage en présentiel devrait se concentrer sur l’enseignement de nouvelles connaissances ou plutôt renforcer celles déjà acquises lors de leçons antérieures.", "bt_pert_fr": "Plan the study schedule for face-to-face learning programs: organize discussions with stakeholders to examine the possible duration of school reopening and decide whether the face-to-face learning program should focus on teaching new knowledge or rather reinforce that already acquired in previous lessons.", "questions": "[\"How should the study schedule for distance learning programmes be planned?\", \"What discussions should be organised with stakeholders?\", \"What factors should be examined to determine the duration of school closures?\", \"Should the distance learning programme focus on teaching new knowledge or enhancing students’ knowledge of prior lessons?\"]", "answers": "[\"The study schedule for face-to-face learning programs should be planned by organizing discussions with stakeholders to examine the possible duration of school reopening and decide whether the face-to-face learning program should focus on teaching new knowledge or rather reinforce that already acquired in previous lessons.\", \"Discussions about the possible duration of school reopening\", \"The possible duration of school reopening\", \"The face-to-face learning program should focus on teaching new knowledge or rather reinforce that already acquired in previous lessons.\"]", "scores": [{"f1": 0.5277777777777777, "em": false, "chrf": 65.03754673121664, "bleu": 32.21998412944379}, {"f1": 0.6666666666666666, "em": false, "chrf": 65.0841859063283, "bleu": 37.68499164492418}, {"f1": 0.8333333333333334, "em": false, "chrf": 76.76263788538469, "bleu": 75.98356856515926}, {"f1": 0.27586206896551724, "em": false, "chrf": 42.49484162656263, "bleu": 8.097785064266205}], "avg_f1": 0.5759099616858238, "avg_em": 0.0, "avg_chrf": 62.34480303737307, "avg_bleu": 38.49658235094836}
{"id": "Wikipedia_handpicked_5:1982", "en": "Provide support to teachers and parents on the use of digital tools: Organise brief training or orientation sessions for teachers and parents as well, if monitoring and facilitation are needed.", "fr": "Fournir aux enseignants et aux élèves une assistance à l’utilisation des outils numériques : organiser de courtes séances de formation ou d’orientation pour les enseignants et les parents, si un suivi et un accompagnement sont nécessaires.", "perturbation": "alteration", "pert_fr": "Refuser aux enseignants et aux élèves une assistance à l’utilisation des outils numériques : organiser de longues séances de formation ou d’orientation pour les enseignants et les parents, si un suivi et un accompagnement sont nécessaires.", "bt_pert_fr": "Refuse teachers and students assistance in using digital tools: organize lengthy training or orientation sessions for teachers and parents, if monitoring and support are necessary.", "questions": "[\"Should brief training or orientation sessions be organised for teachers and parents?\", \"Are monitoring and facilitation required for the use of digital tools?\", \"What support is provided to teachers and parents on the use of digital tools?\"]", "answers": "[\"No\", \"Yes\", \"Lengthy training or orientation sessions\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8000000000000002, "em": false, "chrf": 83.50798311460997, "bleu": 66.87403049764218}], "avg_f1": 0.6000000000000001, "avg_em": 0.3333333333333333, "avg_chrf": 61.16932770486999, "avg_bleu": 55.62467683254741}
{"id": "Wikipedia_handpicked_5:1983", "en": "Help teachers to prepare the basic settings such as solutions to the use of internet data if they are required to provide live streaming of lessons.", "fr": "Aider les enseignants à préparer les conditions matérielles élémentaires, par exemple des solutions d’utilisation des données Internet s’ils doivent assurer la diffusion en direct des cours.", "perturbation": "alteration", "pert_fr": "Empêcher les enseignants de préparer les conditions matérielles élémentaires, par exemple des solutions d’utilisation des données Internet s’ils doivent assurer la diffusion en direct des cours.", "bt_pert_fr": "Prevent teachers from preparing basic material conditions, for example solutions for using Internet data if they have to provide live streaming of lessons.", "questions": "[\"What basic settings do teachers need to prepare?\", \"What solutions are needed for the use of internet data?\", \"Are teachers required to provide live streaming of lessons?\", \"What settings are necessary for live streaming of lessons?\"]", "answers": "[\"Basic material conditions\", \"Solutions for using Internet data\", \"Yes\", \"Basic material conditions\"]", "scores": [{"f1": 0, "em": false, "chrf": 19.14418530182413, "bleu": 0.0}, {"f1": 0.3636363636363636, "em": false, "chrf": 61.916126213386015, "bleu": 10.40059768900531}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 19.14418530182413, "bleu": 0.0}], "avg_f1": 0.3409090909090909, "avg_em": 0.25, "avg_chrf": 50.05112420425857, "avg_bleu": 27.600149422251338}
{"id": "Wikipedia_handpicked_5:1984", "en": "Blend appropriate approaches and limit the number of applications and platforms: Blend tools or media that are available for most students, both for synchronous communication and lessons, and for asynchronous learning.", "fr": "Combiner les approches appropriées et limiter le nombre d’applications et de plateformes : combiner les outils ou médias disponibles pour la plupart des élèves, à la fois pour la communication synchrone et les cours, ainsi que pour l’apprentissage asynchrone.", "perturbation": "alteration", "pert_fr": "Combiner les approches inappropriées et augmenter le nombre d’applications et de plateformes : combiner les outils ou médias disponibles pour la plupart des élèves, à la fois pour la communication synchrone et les cours, ainsi que pour l’apprentissage asynchrone.", "bt_pert_fr": "Combine inappropriate approaches and increase the number of applications and platforms: combine the tools or media available to most students, both for synchronous communication and lessons, as well as for asynchronous learning.", "questions": "[\"What approaches should be blended to support student learning?\", \"How should the number of applications and platforms be limited?\", \"Which tools or media are recommended for synchronous communication and lessons?\", \"Which tools or media are recommended for asynchronous learning?\"]", "answers": "[\"Inappropriate approaches\", \"The number of applications and platforms should be increased\", \"The tools or media available to most students\", \"The tools or media available to most students\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 92.53255689638962, "bleu": 49.99999999999999}, {"f1": 0, "em": false, "chrf": 18.43750379511608, "bleu": 0.0}, {"f1": 0.5882352941176471, "em": false, "chrf": 63.96029107770664, "bleu": 14.57516139687571}, {"f1": 0.5882352941176471, "em": false, "chrf": 63.96029107770664, "bleu": 14.57516139687571}], "avg_f1": 0.41911764705882354, "avg_em": 0.0, "avg_chrf": 59.722660711729745, "avg_bleu": 19.787580698437853}
{"id": "Wikipedia_handpicked_5:1986", "en": "Develop distance learning rules and monitor students’ learning process: Define the rules with parents and students on distance learning.", "fr": "Établir des règles pour l’apprentissage à distance et suivre le processus d’apprentissage des élèves : définir les règles de l’apprentissage à distance avec les parents et les élèves.", "perturbation": "alteration", "pert_fr": "Établir des règles pour l’apprentissage en présentiel et suivre le processus d’apprentissage des élèves : définir les règles de l’apprentissage en présentiel avec les parents et les élèves.", "bt_pert_fr": "Establish rules for face-to-face learning and monitor the student learning process: define the rules for face-to-face learning with parents and students.", "questions": "[\"Who should be involved in defining the distance learning rules?\", \"What should be defined in the distance learning rules?\", \"How should the distance learning rules be developed?\", \"Who is responsible for monitoring students’ learning process in distance learning?\"]", "answers": "[\"Parents and students\", \"The rules for face-to-face learning\", \"By defining the rules for face-to-face learning with parents and students\", \"Not specified in the sentence\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5714285714285715, "em": false, "chrf": 56.20255686687563, "bleu": 21.3643503198117}, {"f1": 0.4285714285714285, "em": false, "chrf": 69.21670082938653, "bleu": 15.619699684601283}, {"f1": 0.11764705882352941, "em": false, "chrf": 18.98967332017602, "bleu": 1.683602693167689}], "avg_f1": 0.5294117647058824, "avg_em": 0.25, "avg_chrf": 61.102232754109544, "avg_bleu": 34.66691317439518}
{"id": "Wikipedia_handpicked_5:1991", "en": "Create communities and enhance connection: Create communities of teachers, parents, and school managers to address sense of loneliness or helplessness, facilitate sharing of experience and discussion on coping strategies when facing learning difficulties.", "fr": "Créer des communautés et renforcer les liens : créer des communautés d’enseignants, de parents et de directeurs d’écoles pour pallier le sentiment de solitude et d’impuissance, faciliter le partage d’expérience et la discussion autour des stratégies d’adaptation en cas de difficultés d’apprentissage.", "perturbation": "alteration", "pert_fr": "Détruire des communautés et affaiblir les liens : créer des communautés d’enseignants, de parents et de directeurs d’écoles pour accentuer le sentiment de solitude et d’impuissance, entraver le partage d’expérience et la discussion autour des stratégies d’adaptation en cas de difficultés d’apprentissage.", "bt_pert_fr": "Destroy communities and weaken bonds: create communities of teachers, parents and school principals to accentuate the feeling of loneliness and helplessness, hinder the sharing of experiences and discussion around adaptation strategies in the event of learning difficulties.", "questions": "[\"What communities should be created to address sense of loneliness or helplessness?\", \"How can communities of teachers, parents, and school managers enhance connection?\", \"What activities can facilitate sharing of experiences among teachers, parents, and school managers?\", \"How can discussion on coping strategies for learning difficulties be facilitated in these communities?\"]", "answers": "[\"Communities of teachers, parents, and school principals\", \"By creating communities that accentuate the feeling of loneliness and helplessness\", \"Sharing of experiences among teachers, parents, and school principals\", \"Through discussion around adaptation strategies in the event of learning difficulties\"]", "scores": [{"f1": 0.8571428571428571, "em": false, "chrf": 81.85693779461803, "bleu": 80.91067115702207}, {"f1": 0.25, "em": false, "chrf": 21.326778224080176, "bleu": 3.701773936489291}, {"f1": 0.28571428571428575, "em": false, "chrf": 33.51231383772095, "bleu": 7.561318691530973}, {"f1": 0.5714285714285713, "em": false, "chrf": 60.463767197906016, "bleu": 11.884631831419354}], "avg_f1": 0.49107142857142855, "avg_em": 0.0, "avg_chrf": 49.28994926358129, "avg_bleu": 26.01459890411542}
{"id": "Wikipedia_handpicked_5:1992", "en": "290 million students out of school due to COVID-19: UNESCO releases first global numbers and mobilizes response,   UNESCO.", "fr": "290 millions d’élèves déscolarisés en raison du COVID-19 : l’UNESCO publie les premiers chiffres mondiaux et mobilise une réponse, UNESCO.", "perturbation": "alteration", "pert_fr": "290 millions d’élèves scolarisés en raison du COVID-19 : l’UNESCO publie les premiers chiffres mondiaux et mobilise une réponse, UNESCO.", "bt_pert_fr": "290 million students in school due to COVID-19: UNESCO publishes the first global figures and mobilizes a response, UNESCO.", "questions": "[\"How many students were out of school due to COVID-19 according to UNESCO?\", \"What did UNESCO release regarding students out of school due to COVID-19?\", \"What action did UNESCO take in response to the number of students out of school due to COVID-19?\"]", "answers": "[\"290 million\", \"The first global figures on students out of school due to COVID-19\", \"Mobilized a response\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8333333333333334, "em": false, "chrf": 72.17819155715381, "bleu": 63.404662770468576}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.9444444444444445, "avg_em": 0.6666666666666666, "avg_chrf": 90.7260638523846, "avg_bleu": 87.8015542568229}
{"id": "Wikisource_1:2047", "en": "and WHEREAS in a short period of time, COVID-19 has rapidly spread throughout California, necessitating updated and more stringent guidance from federal, state, and local public health officials;", "fr": "et ATTENDU QU’en peu de temps, le COVID-19 s’est rapidement propagé en Californie, rendant indispensables des directives mises à jour et plus strictes de la part des responsables de la santé publique au niveau fédéral, de l’État et local ;", "perturbation": "alteration", "pert_fr": "et ATTENDU QU’en peu de temps, le COVID-19 ne s’est pas rapidement propagé en Californie, rendant indispensables des directives mises à jour et plus laxistes de la part des responsables de la santé publique au niveau fédéral, de l’État et local ;", "bt_pert_fr": "and WHEREAS, in a short period of time, COVID-19 has not spread rapidly in California, making updated and more lax guidance from federal, state, and local public health officials essential;", "questions": "[\"Why did COVID-19 rapidly spread throughout California?\", \"What updated guidance is needed from federal, state, and local public health officials due to the rapid spread of COVID-19 in California?\"]", "answers": "[\"It did not rapidly spread in California\", \"More lax guidance\"]", "scores": [{"f1": 0.4615384615384615, "em": false, "chrf": 42.24011869334558, "bleu": 8.643019616048525}, {"f1": 0.25, "em": false, "chrf": 25.67977312678123, "bleu": 14.127216461522432}], "avg_f1": 0.3557692307692307, "avg_em": 0.0, "avg_chrf": 33.959945910063404, "avg_bleu": 11.385118038785478}
{"id": "Wikisource_1:2049", "en": "NOW, THEREFORE, I, GAVIN NEWSOM, Governor of the State of California, in accordance with the authority vested in me by the State Constitution and statutes of the State of California, and in particular, Government Code sections 8567, 8627, and 8665 do hereby issue the following Order to become effective immediately:", "fr": "EN CONSÉQUENCE, JE, GAVIN NEWSOM, gouverneur de l’État de Californie, en vertu de l’autorité qui m’est conférée par la Constitution et les lois de l’État de Californie, et en particulier, les sections 8567, 8627 et 8665 du Code gouvernemental, rends par la présente l’ordonnance suivante qui entrera en vigueur immédiatement :", "perturbation": "alteration", "pert_fr": "EN CONSÉQUENCE, JE, GAVIN NEWSOM, gouverneur de l’État de Californie, en vertu de l’autorité qui m’est refusée par la Constitution et les lois de l’État de Californie, et en particulier, les sections 8567, 8627 et 8665 du Code gouvernemental, annule par la présente l’ordonnance suivante qui sera abrogée immédiatement :", "bt_pert_fr": "NOW THEREFORE, I, GAVIN NEWSOM, Governor of the State of California, by virtue of the authority denied to me by the Constitution and laws of the State of California, and in particular, Sections 8567, 8627 and 8665 of the Government Code, hereby annul the following order which shall be repealed forthwith:", "questions": "[\"Who is issuing the order?\", \"What is the official position of the person issuing the order?\", \"What legal authority is the governor using to issue this order?\", \"Which specific sections of the Government Code are cited in the order?\", \"When does this order become effective?\"]", "answers": "[\"Gavin Newsom\", \"Governor of the State of California\", \"The authority denied to him by the Constitution and laws of the State of California\", \"Sections 8567, 8627, and 8665 of the Government Code\", \"forthwith\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7407407407407408, "em": false, "chrf": 63.72598903496227, "bleu": 26.776802959776298}, {"f1": 0.7999999999999999, "em": false, "chrf": 88.55799259536235, "bleu": 41.11336169005198}, {"f1": 0, "em": false, "chrf": 3.1446540880503147, "bleu": 0.0}], "avg_f1": 0.7081481481481482, "avg_em": 0.4, "avg_chrf": 71.08572714367499, "avg_bleu": 53.57803292996567}
{"id": "Wikisource_1:2050", "en": "IT IS HEREBY ORDERED THAT:", "fr": "PAR LA PRÉSENTE, ORDRE EST DONNÉ QUE :", "perturbation": "alteration", "pert_fr": "PAR LA PRÉSENTE, ORDRE N'EST PAS DONNÉ QUE :", "bt_pert_fr": "ORDER IS HEREBY GIVEN THAT:", "questions": "[\"What is hereby ordered?\"]", "answers": "[\"ORDER IS HEREBY GIVEN THAT:\"]", "scores": [{"f1": 0.6, "em": false, "chrf": 51.294408951066785, "bleu": 23.643540225079395}], "avg_f1": 0.6, "avg_em": 0.0, "avg_chrf": 51.294408951066785, "avg_bleu": 23.643540225079395}
{"id": "Wikisource_1:2052", "en": "Those directives are consistent with the March 19, 2020, Memorandum on Identification of Essential Critical Infrastructure Workers During COVID-19 Response, found at: https://covid19.ca.gov/.", "fr": "Ces directives sont conformes au Mémorandum du 19 mars 2020 relatif à l’identification des travailleurs des infrastructures critiques essentielles pendant la réponse au COVID-19, disponibles à l’adresse : https://covid19.ca.gov/.", "perturbation": "alteration", "pert_fr": "Ces directives ne sont pas conformes au Mémorandum du 19 mars 2020 relatif à l’identification des travailleurs des infrastructures critiques essentielles pendant la réponse au COVID-19, disponibles à l’adresse : https://covid19.ca.gov/.", "bt_pert_fr": "This guidance is not consistent with the March 19, 2020 Memorandum on Identifying Essential Critical Infrastructure Workers During the COVID-19 Response, available at: https://covid19.ca.gov/.", "questions": "[\"Are those directives consistent with the March 19, 2020, Memorandum on Identification of Essential Critical Infrastructure Workers During COVID-19 Response?\", \"Where can the March 19, 2020, Memorandum on Identification of Essential Critical Infrastructure Workers During COVID-19 Response be found?\"]", "answers": "[\"No\", \"https://covid19.ca.gov/\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 50.0, "avg_bleu": 50.00000000000002}
{"id": "Wikisource_1:2056", "en": "Pursuant to the authority under the Health and Safety Code 120125, 120140, 131080, 120130(c), 120135, 120145, 120175 and 120150, this order is to go into effect immediately and shall stay in effect until further notice.", "fr": "Conformément aux sections 120125, 120140, 131080, 120130(c), 120135, 120145, 120175 et 120150 du code de la Santé et de la Sécurité, cette ordonnance entre en vigueur immédiatement et le restera jusqu’à nouvel ordre.", "perturbation": "alteration", "pert_fr": "Conformément aux sections 120125, 120140, 131080, 120130(c), 120135, 120145, 120175 et 120150 du code de la Santé et de la Sécurité, cette ordonnance n'entre pas en vigueur immédiatement et ne le restera pas jusqu’à nouvel ordre.", "bt_pert_fr": "Pursuant to Health and Safety Code Sections 120125, 120140, 131080, 120130(c), 120135, 120145, 120175, and 120150, this order does not take effect immediately and will not remain in effect until further notice.", "questions": "[\"Under what authority does this order go into effect?\", \"When does this order go into effect?\", \"Until what point will this order remain in effect?\", \"What sections of the Health and Safety Code provide the authority for this order?\"]", "answers": "[\"Health and Safety Code Sections 120125, 120140, 131080, 120130(c), 120135, 120145, 120175, and 120150\", \"This order does not take effect immediately\", \"Until further notice\", \"Health and Safety Code Sections 120125, 120140, 131080, 120130(c), 120135, 120145, 120175, and 120150\"]", "scores": [{"f1": 0.8666666666666666, "em": false, "chrf": 79.76938385326942, "bleu": 67.83686168526633}, {"f1": 0, "em": false, "chrf": 54.34275368529244, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.782608695652174, "em": false, "chrf": 90.15709633889408, "bleu": 59.5640359271809}], "avg_f1": 0.6623188405797101, "avg_em": 0.25, "avg_chrf": 81.06730846936398, "avg_bleu": 56.85022440311182}
{"id": "Wikisource_1:2054", "en": "To protect public health, I as State Public Health Officer and Director of the California Department of Public Health order all individuals living in the State of California to stay home or at their place of residence except as needed to maintain continuity of operations of the federal critical infrastructure sectors, as outlined at https://www.cisa.gov/critical-infrastructure-sectors.", "fr": "Afin de protéger la santé publique, je, en tant que responsable de la Santé publique de l’État et directeur du département de la Santé publique de Californie, ordonne à toutes les personnes vivant dans l’État de Californie de rester chez elles ou dans leur lieu de résidence, sauf dans la mesure nécessaire au maintien de la continuité des opérations des secteurs fédéraux d’infrastructures critiques, comme énoncé à l’adresse https://www.cisa.gov/critical-infrastructure-sectors.", "perturbation": "alteration", "pert_fr": "Afin de nuire à la santé publique, je, en tant que responsable de la Santé publique de l’État et directeur du département de la Santé publique de Californie, ordonne à toutes les personnes vivant dans l’État de Californie de quitter leurs foyers ou leur lieu de résidence, sauf dans la mesure nécessaire au maintien de la continuité des opérations des secteurs fédéraux d’infrastructures critiques, comme énoncé à l’adresse https://www.cisa.gov/critical-infrastructure-sectors.", "bt_pert_fr": "In order to harm public health, I, as the State Public Health Officer and Director of the California Department of Public Health, direct all persons living in the State of California to leave their homes or places of residence, except to the extent necessary to maintain the continuity of operations of the Federal critical infrastructure sectors, as set forth at https://www.cisa.gov/critical-infrastructure-sectors.", "questions": "[\"Who is authorized to issue the order to stay home or at one's place of residence in California?\", \"What is the reason for the order requiring individuals to stay home or at their place of residence?\", \"Which specific groups are allowed to leave home under the order?\", \"What are the federal critical infrastructure sectors that are considered essential under this order?\", \"Where can the list of federal critical infrastructure sectors be found?\"]", "answers": "[\"I, as the State Public Health Officer and Director of the California Department of Public Health\", \"To harm public health\", \"The groups necessary to maintain the continuity of operations of the Federal critical infrastructure sectors\", \"The federal critical infrastructure sectors\", \"https://www.cisa.gov/critical-infrastructure-sectors\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.75, "em": false, "chrf": 55.95132892872192, "bleu": 35.35533905932737}, {"f1": 0.7199999999999999, "em": false, "chrf": 77.43041268674011, "bleu": 48.44273237963863}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8939999999999999, "avg_em": 0.6, "avg_chrf": 86.67634832309241, "avg_bleu": 76.75961428779323}
{"id": "Wikisource_1:2058", "en": "I order that Californians working in these 16 critical infrastructure sectors may continue their work because of the importance of these sectors to Californians' health and well-being.", "fr": "J’ordonne que les Californiens travaillant dans ces 16 secteurs d’infrastructures critiques puissent poursuivre leur travail en raison de l’importance de ces secteurs pour la santé et le bien-être des Californiens.", "perturbation": "alteration", "pert_fr": "J’ordonne que les Californiens travaillant dans ces 16 secteurs d’infrastructures critiques ne puissent pas poursuivre leur travail en raison de l’importance de ces secteurs pour la santé et le bien-être des Californiens.", "bt_pert_fr": "I am ordering that Californians working in these 16 critical infrastructure sectors cannot continue their work because of the importance of these sectors to the health and well-being of Californians.", "questions": "[\"Why may Californians working in these 16 critical infrastructure sectors continue their work?\", \"What is the reason for allowing Californians in these 16 critical infrastructure sectors to continue working?\", \"What makes these 16 critical infrastructure sectors important to Californians' health and well-being?\"]", "answers": "[\"The importance of these sectors to the health and well-being of Californians\", \"The importance of these sectors to the health and well-being of Californians\", \"Their role in ensuring the health and well-being of Californians\"]", "scores": [{"f1": 0.9090909090909091, "em": false, "chrf": 79.47888343543484, "bleu": 49.616830003403614}, {"f1": 0.9523809523809523, "em": false, "chrf": 90.32066323023822, "bleu": 60.34148992419808}, {"f1": 0.6250000000000001, "em": false, "chrf": 62.81373096415462, "bleu": 20.164945583740657}], "avg_f1": 0.8288239538239539, "avg_em": 0.0, "avg_chrf": 77.53775920994256, "avg_bleu": 43.37442183711411}
{"id": "Wikisource_1:2059", "en": "This Order is being issued to protect the public health of Californians.", "fr": "La présente ordonnance est rendue afin de protéger la santé publique des Californiens.", "perturbation": "alteration", "pert_fr": "La présente ordonnance est rendue afin de nuire à la santé publique des Californiens.", "bt_pert_fr": "This order is issued to harm the public health of Californians.", "questions": "[\"What is the purpose of this Order?\", \"What does this Order aim to protect?\", \"What is the goal of issuing this Order?\"]", "answers": "[\"To harm the public health of Californians\", \"The public health of Californians\", \"To harm the public health of Californians\"]", "scores": [{"f1": 0.8333333333333334, "em": false, "chrf": 75.54468528787159, "bleu": 53.7284965911771}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8333333333333334, "em": false, "chrf": 75.54468528787159, "bleu": 53.7284965911771}], "avg_f1": 0.888888888888889, "avg_em": 0.3333333333333333, "avg_chrf": 83.69645685858106, "avg_bleu": 69.15233106078475}
{"id": "Wikisource_1:2060", "en": "The California Department of Public Health looks to establish consistency across the state in order to ensure that we mitigate the impact of COVID-19.", "fr": "Le département de la Santé publique de Californie vise à assurer la cohérence dans l’ensemble de l’État afin de garantir que nous limitons l’impact du COVID-19.", "perturbation": "alteration", "pert_fr": "Le département de la Santé publique de Californie vise à assurer la diversité dans l’ensemble de l’État afin de garantir que nous amplifions l’impact du COVID-19.", "bt_pert_fr": "The California Department of Public Health aims to ensure diversity across the state to ensure we amplify the impact of COVID-19.", "questions": "[\"What is the goal of the California Department of Public Health regarding COVID-19?\", \"How does the California Department of Public Health aim to mitigate the impact of COVID-19?\", \"What does the California Department of Public Health aim to achieve across the state to address COVID-19?\"]", "answers": "[\"Ensure diversity across the state to ensure we amplify the impact of COVID-19\", \"By ensuring diversity across the state\", \"Ensure diversity across the state to ensure we amplify the impact of COVID-19\"]", "scores": [{"f1": 0.5263157894736842, "em": false, "chrf": 50.97875761326627, "bleu": 15.851165692617155}, {"f1": 0.6, "em": false, "chrf": 39.90812049377604, "bleu": 23.643540225079395}, {"f1": 0.26666666666666666, "em": false, "chrf": 36.59835215027414, "bleu": 7.495553473355842}], "avg_f1": 0.4643274853801169, "avg_em": 0.0, "avg_chrf": 42.49507675243881, "avg_bleu": 15.663419797017463}
{"id": "Wikisource_1:2061", "en": "Our goal is simple, we want to bend the curve, and disrupt the spread of the virus.", "fr": "Notre objectif est simple, nous souhaitons faire plier la courbe et interrompre la propagation du virus.", "perturbation": "alteration", "pert_fr": "Notre objectif est simple, nous souhaitons faire monter la courbe et favoriser la propagation du virus.", "bt_pert_fr": "Our goal is simple, we want to raise the curve and encourage the spread of the virus.", "questions": "[\"What is the goal?\", \"How do we want to disrupt the spread of the virus?\"]", "answers": "[\"We want to raise the curve and encourage the spread of the virus\", \"We do not want to disrupt the spread of the virus\"]", "scores": [{"f1": 0.5333333333333333, "em": false, "chrf": 43.268795943077315, "bleu": 16.784459625186194}, {"f1": 0, "em": false, "chrf": 9.419419177257382, "bleu": 0.0}], "avg_f1": 0.26666666666666666, "avg_em": 0.0, "avg_chrf": 26.34410756016735, "avg_bleu": 8.392229812593097}
{"id": "Wikisource_1:2062", "en": "The supply chain must continue, and Californians must have access to such necessities as food, prescriptions, and health care.", "fr": "La chaîne d’approvisionnement ne doit pas être interrompue, et les Californiens doivent avoir accès aux services essentiels tels que la nourriture, les ordonnances et les soins de santé.", "perturbation": "alteration", "pert_fr": "La chaîne d’approvisionnement doit être interrompue, et les Californiens doivent avoir accès aux services essentiels tels que la nourriture, les ordonnances et les soins de santé.", "bt_pert_fr": "The supply chain must be interrupted, and Californians must have access to essential services such as food, prescriptions and health care.", "questions": "[\"Must the supply chain continue?\", \"Must Californians have access to food?\", \"Must Californians have access to prescriptions?\", \"Must Californians have access to health care?\"]", "answers": "[\"No\", \"Yes\", \"Yes\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.75, "avg_em": 0.75, "avg_chrf": 75.0, "avg_bleu": 75.00000000000003}
{"id": "Wikisource_1:2063", "en": "When people need to leave their homes or places of residence, whether to obtain or perform the functions above, or to otherwise facilitate authorized necessary activities, they should at all times practice social distancing.", "fr": "Lorsque des personnes ont besoin de quitter leur domicile ou lieu de résidence, que ce soit pour bénéficier des fonctions susmentionnées ou les exercer, ou faciliter autrement les activités nécessaires autorisées, elles doivent pratiquer en tout temps la distanciation sociale.", "perturbation": "alteration", "pert_fr": "Lorsque des personnes ont besoin de quitter leur domicile ou lieu de résidence, que ce soit pour bénéficier des fonctions susmentionnées ou les exercer, ou faciliter autrement les activités nécessaires autorisées, elles doivent négliger en tout temps la distanciation sociale.", "bt_pert_fr": "When individuals need to leave their home or place of residence, whether to benefit from or perform the above-mentioned functions, or otherwise facilitate authorized necessary activities, they must neglect social distancing at all times.", "questions": "[\"Should people practice social distancing when leaving their homes or places of residence?\", \"When should people practice social distancing?\", \"What activities require people to practice social distancing?\", \"What are the authorized necessary activities that people should facilitate while practicing social distancing?\"]", "answers": "[\"No\", \"At all times when leaving their homes or places of residence\", \"Leaving their home or place of residence to benefit from or perform the above-mentioned functions\", \"Authorized necessary activities\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.5454545454545454, "em": false, "chrf": 62.49581778440639, "bleu": 46.17366309441026}, {"f1": 0.3, "em": false, "chrf": 43.888294289105026, "bleu": 6.285596338261262}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.46136363636363636, "avg_em": 0.25, "avg_chrf": 51.59602801837785, "avg_bleu": 38.11481485816789}
{"id": "Wikisource_1:2066", "en": "4) This Order shall be enforceable pursuant to California law, including, but not limited to, Government Code section 8665.", "fr": "4) La présente ordonnance forme titre exécutoire en vertu de la loi californienne, y compris, sans toutefois s’y limiter, la section 8665 du Code gouvernemental.", "perturbation": "alteration", "pert_fr": "4) La présente ordonnance ne forme pas titre exécutoire en vertu de la loi californienne, y compris, sans toutefois s’y limiter, la section 8665 du Code gouvernemental.", "bt_pert_fr": "4) This order is not enforceable under California law, including, but not limited to, Government Code Section 8665.", "questions": "[\"Is this Order enforceable pursuant to California law?\", \"Does this Order include Government Code section 8665?\", \"What laws govern the enforceability of this Order?\", \"Is Government Code section 8665 referenced in this Order?\"]", "answers": "[\"No\", \"Yes\", \"California law\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.75, "avg_em": 0.75, "avg_chrf": 75.0, "avg_bleu": 75.00000000000003}
{"id": "Wikisource_1:2067", "en": "IT IS FURTHER ORDERED that as soon as hereafter possible, this Order be filed in the Office of the Secretary of State and that widespread publicity and notice be given of this Order.", "fr": "IL EST EN OUTRE ORDONNÉ que, dans les meilleurs délais, la présente ordonnance soit déposée auprès du Bureau du secrétaire d’État et qu’elle soit publiée et fasse l’objet d’une large diffusion.", "perturbation": "alteration", "pert_fr": "IL EST EN OUTRE ORDONNÉ que, dans les plus longs délais, la présente ordonnance soit déposée auprès du Bureau du secrétaire d’État et qu’elle soit publiée et fasse l’objet d’une large diffusion.", "bt_pert_fr": "IT IS FURTHER ORDERED that, as soon as possible, this order be filed with the Office of the Secretary of State and that it be published and given wide distribution.", "questions": "[\"When should this Order be filed in the Office of the Secretary of State?\", \"What action should be taken to ensure widespread publicity and notice of this Order?\"]", "answers": "[\"As soon as possible\", \"It should be published and given wide distribution\"]", "scores": [{"f1": 0.888888888888889, "em": false, "chrf": 52.14273686638615, "bleu": 49.76093899250716}, {"f1": 0.5333333333333333, "em": false, "chrf": 35.814284485154545, "bleu": 13.134549472120788}], "avg_f1": 0.7111111111111111, "avg_em": 0.0, "avg_chrf": 43.97851067577035, "avg_bleu": 31.447744232313973}
{"id": "Wikivoyage_1:2168", "en": "The SARS-CoV-2 virus is the cause of COVID-19 (coronavirus disease 2019), a contagious respiratory disease that was first identified in December 2019, in Wuhan, Hubei, China.", "fr": "Le virus SARS-CoV-2 est responsable de la COVID-19 (la maladie à coronavirus de 2019), une maladie respiratoire contagieuse qui a été identifiée pour la première fois en décembre 2019 à Wuhan, Hubei, Chine.", "perturbation": "alteration", "pert_fr": "Le virus SARS-CoV-2 n'est pas responsable de la COVID-19 (la maladie à coronavirus de 2019), une maladie respiratoire contagieuse qui a été identifiée pour la première fois en décembre 2019 à Wuhan, Hubei, Chine.", "bt_pert_fr": "The SARS-CoV-2 virus is not responsible for COVID-19 (coronavirus disease 2019), a contagious respiratory illness that was first identified in December 2019 in Wuhan, Hubei, China.", "questions": "[\"What is the cause of COVID-19?\", \"Where was COVID-19 first identified?\", \"When was COVID-19 first identified?\", \"What type of disease is COVID-19?\", \"What is the origin of the SARS-CoV-2 virus?\"]", "answers": "[\"The SARS-CoV-2 virus\", \"Wuhan, Hubei, China\", \"December 2019\", \"a contagious respiratory illness\", \"Not specified in the sentence\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 74.80587702689152, "bleu": 55.03212081491043}, {"f1": 0, "em": false, "chrf": 7.809790936343997, "bleu": 0.0}], "avg_f1": 0.7333333333333333, "avg_em": 0.6, "avg_chrf": 76.5231335926471, "avg_bleu": 71.00642416298211}
{"id": "Wikivoyage_1:2170", "en": "It was declared a pandemic by the World Health Organization (WHO) on 11 March 2020.", "fr": "Elle a été déclarée comme pandémie par l’Organisation mondiale de la Santé (OMS) le 11 mars 2020.", "perturbation": "alteration", "pert_fr": "Elle n'a pas été déclarée comme pandémie par l’Organisation mondiale de la Santé (OMS) le 11 mars 2020.", "bt_pert_fr": "It was not declared a pandemic by the World Health Organization (WHO) on March 11, 2020.", "questions": "[\"When was it declared a pandemic by the World Health Organization (WHO)?\", \"What organization declared it a pandemic?\", \"On what date was the pandemic declaration made by the WHO?\"]", "answers": "[\"It was not declared a pandemic\", \"The World Health Organization (WHO)\", \"March 11, 2020\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.9998426485397784, "bleu": 0.0}, {"f1": 0.888888888888889, "em": false, "chrf": 97.49891629064265, "bleu": 66.87403049764218}, {"f1": 1.0, "em": false, "chrf": 47.89021164021164, "bleu": 39.68502629920498}], "avg_f1": 0.6296296296296297, "avg_em": 0.0, "avg_chrf": 50.129656859798025, "avg_bleu": 35.51968559894905}
{"id": "Wikivoyage_1:2172", "en": "Older people and those with underlying conditions are the most at risk of serious complications including death.", "fr": "Les personnes âgées et celles souffrant d'affections sous-jacentes sont les plus à risque de complications graves, y compris la mort.", "perturbation": "alteration", "pert_fr": "Les personnes jeunes et celles souffrant d'affections sous-jacentes sont les moins à risque de complications graves, y compris la mort.", "bt_pert_fr": "Young people and those with underlying conditions are at least risk of serious complications, including death.", "questions": "[\"Are older people at a higher risk of serious complications including death?\", \"Are people with underlying conditions at a higher risk of serious complications including death?\"]", "answers": "[\"No\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 50.0, "avg_bleu": 50.00000000000002}
{"id": "Wikivoyage_1:2173", "en": "Due to the spread of the disease, you are advised not to travel unless necessary, to avoid being infected, quarantined, or stranded by changing restrictions and cancelled flights.", "fr": "En raison de la propagation de la maladie, il vous est conseillé de ne pas voyager, sauf si cela est nécessaire, pour éviter d’être infecté, mis en quarantaine ou bloqué à cause des restrictions changeantes et des vols annulés.", "perturbation": "alteration", "pert_fr": "En raison de la disparition de la maladie, il vous est conseillé de voyager, même si cela n'est pas nécessaire, pour profiter d’être en liberté, sans quarantaine ni blocage à cause des restrictions assouplies et des vols ajoutés.", "bt_pert_fr": "Due to the disappearance of the disease, you are advised to travel, even if not necessary, to enjoy being in freedom, without quarantine or blockages due to relaxed restrictions and added flights.", "questions": "[\"Is travel advised during the spread of the disease?\", \"Why is travel not advised during the spread of the disease?\", \"What are the reasons for advising against travel during the spread of the disease?\", \"What should you do if you must travel during the spread of the disease?\", \"What risks are associated with traveling during the spread of the disease?\"]", "answers": "[\"No\", \"None mentioned\", \"None mentioned\", \"Not specified\", \"None mentioned\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 5.439757429369631, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 5.439757429369631, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 7.007213627672519, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 5.932714669371894, "bleu": 0.0}], "avg_f1": 0.2, "avg_em": 0.2, "avg_chrf": 24.763888631156735, "avg_bleu": 20.000000000000007}
{"id": "Wikivoyage_1:2175", "en": "This is not just to protect you, but also those you come in contact with.", "fr": "Cela n’est pas seulement pour vous protéger vous, mais aussi les personnes avec qui vous entrez en contact.", "perturbation": "alteration", "pert_fr": "Cela n’est pas seulement pour vous exposer vous, mais aussi les personnes avec qui vous entrez en contact.", "bt_pert_fr": "This is not only to expose yourself, but also the people you come into contact with.", "questions": "[\"Is the purpose of this action only to protect you?\", \"Does this action also protect the people you come in contact with?\"]", "answers": "[\"No\", \"Yes\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikivoyage_1:2176", "en": "As it happens, you probably aren't missing much by staying home, as many attractions around the world are closing their doors to avoid spreading the disease.", "fr": "Il se trouve que vous ne manquez probablement pas grand-chose en restant chez vous, étant donné que de nombreuses attractions partout dans le monde ferment actuellement leurs portes afin d’éviter la propagation de la maladie.", "perturbation": "alteration", "pert_fr": "Il se trouve que vous manquez probablement beaucoup de choses en restant chez vous, étant donné que de nombreuses attractions partout dans le monde ouvrent actuellement leurs portes afin de favoriser la propagation de la maladie.", "bt_pert_fr": "Turns out, you're probably missing out on a lot by staying home, given that many attractions around the world are currently opening their doors in order to further the spread of the disease.", "questions": "[\"Are many attractions around the world closing their doors to avoid spreading the disease?\", \"Is it true that staying home means you aren't missing much?\"]", "answers": "[\"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2177", "en": "If you do need to travel, take precautions as you would for other infections: wash your hands frequently, avoid touching your face, cough and sneeze into your elbow or a tissue, and avoid contact with sick people.", "fr": "Si vous devez voyager, prenez des précautions comme vous le feriez pour d’autres infections : lavez-vous les mains fréquemment, évitez de vous toucher le visage, toussez et éternuez dans le pli de votre coude ou un mouchoir et évitez tout contact avec des personnes malades.", "perturbation": "alteration", "pert_fr": "Si vous devez voyager, ne prenez aucune précaution comme vous le feriez pour d’autres infections : lavez-vous les mains rarement, n'évitez pas de vous toucher le visage, toussez et éternuez partout et cherchez tout contact avec des personnes malades.", "bt_pert_fr": "If you must travel, do not take any precautions as you would for other infections: wash your hands rarely, do not avoid touching your face, cough and sneeze everywhere and seek contact with sick people.", "questions": "[\"What precautions should you take if you need to travel?\", \"Why is it important to wash your hands frequently when traveling?\", \"Why should you avoid touching your face when traveling?\", \"Why should you cough and sneeze into your elbow or a tissue when traveling?\", \"Why should you avoid contact with sick people when traveling?\"]", "answers": "[\"No precautions\", \"It is not necessary to wash hands frequently when traveling\", \"You should not avoid touching your face when traveling\", \"You should not cough and sneeze into your elbow or a tissue when traveling\", \"You should not avoid contact with sick people when traveling\"]", "scores": [{"f1": 0, "em": false, "chrf": 3.1942534005807732, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 13.626519998165893, "bleu": 0.0}, {"f1": 0.10526315789473685, "em": false, "chrf": 16.228594609116474, "bleu": 4.266331692956901}, {"f1": 0.18181818181818185, "em": false, "chrf": 18.100606861031274, "bleu": 3.673526562988939}, {"f1": 0.13333333333333333, "em": false, "chrf": 19.80302899069525, "bleu": 4.196114906296549}], "avg_f1": 0.0840829346092504, "avg_em": 0.0, "avg_chrf": 14.190600771917932, "avg_bleu": 2.4271946324484777}
{"id": "Wikivoyage_1:2178", "en": "Before traveling, read up on the extensive and fast-changing array of travel restrictions that have been imposed around the world.", "fr": "Avant de partir, étudiez les nombreuses restrictions de voyage en rapide évolution qui sont imposées dans le monde entier.", "perturbation": "alteration", "pert_fr": "Avant de partir, étudiez les nombreuses libertés de voyage en rapide évolution qui sont imposées dans le monde entier.", "bt_pert_fr": "Before you go, research the many rapidly changing travel freedoms being imposed around the world.", "questions": "[\"What travel restrictions have been imposed around the world?\", \"Are travel restrictions extensive and fast-changing?\", \"What information should be read before traveling?\"]", "answers": "[\"The many rapidly changing travel freedoms\", \"Yes\", \"The many rapidly changing travel freedoms\"]", "scores": [{"f1": 0.28571428571428575, "em": false, "chrf": 27.10557890620334, "bleu": 6.916271812933183}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.28571428571428575, "em": false, "chrf": 27.10557890620334, "bleu": 6.916271812933183}], "avg_f1": 0.5238095238095238, "avg_em": 0.3333333333333333, "avg_chrf": 51.40371927080222, "avg_bleu": 37.94418120862213}
{"id": "Wikivoyage_1:2179", "en": "After travel, monitor your health and consider self-isolation for two weeks to avoid transmitting the disease to others.", "fr": "Après avoir voyagé, surveillez votre santé et envisagez de vous auto-isoler pendant deux semaines afin d’éviter de transmettre la maladie à d’autres personnes.", "perturbation": "alteration", "pert_fr": "Après avoir voyagé, négligez votre santé et envisagez de vous intégrer pendant deux semaines afin de favoriser de transmettre la maladie à d’autres personnes.", "bt_pert_fr": "After traveling, neglect your health and consider staying in for two weeks to avoid spreading the disease to other people.", "questions": "[\"What should you do after travel to monitor your health?\", \"How long should you consider self-isolation after travel?\", \"Why is self-isolation recommended after travel?\"]", "answers": "[\"Consider staying in for two weeks to avoid spreading the disease to other people\", \"Two weeks\", \"To avoid spreading the disease to other people\"]", "scores": [{"f1": 0, "em": false, "chrf": 12.776762363290537, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6153846153846153, "em": false, "chrf": 60.61018782296994, "bleu": 18.575057999133602}], "avg_f1": 0.5384615384615384, "avg_em": 0.3333333333333333, "avg_chrf": 57.79565006208683, "avg_bleu": 39.52501933304455}
{"id": "Wikivoyage_1:2180", "en": "Transportation from long-distance passenger flights to local buses has been curtailed or completely shut down in many countries due to low demand or government orders.", "fr": "Les transports, des vols longs courriers aux bus locaux, ont été réduits ou complètement suspendus dans de nombreux pays en raison de la faible demande ou d’ordonnances gouvernementales.", "perturbation": "alteration", "pert_fr": "Les transports, des vols longs courriers aux bus locaux, ont été augmentés ou complètement rétablis dans de nombreux pays en raison de la forte demande ou d’ordonnances gouvernementales.", "bt_pert_fr": "Transportation, from long-haul flights to local buses, has been increased or completely restored in many countries due to high demand or government orders.", "questions": "[\"Has transportation from long-distance passenger flights to local buses been curtailed or completely shut down in many countries?\", \"Why has transportation from long-distance passenger flights to local buses been curtailed or completely shut down in many countries?\", \"What factors have led to the curtailment or shutdown of transportation from long-distance passenger flights to local buses in many countries?\"]", "answers": "[\"No\", \"It has not been curtailed or completely shut down\", \"High demand or government orders\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.125, "em": false, "chrf": 14.899114503357847, "bleu": 4.767707020457095}, {"f1": 0.8000000000000002, "em": false, "chrf": 86.98218887693955, "bleu": 66.87403049764218}], "avg_f1": 0.3083333333333334, "avg_em": 0.0, "avg_chrf": 33.96043446009913, "avg_bleu": 23.880579172699758}
{"id": "Wikivoyage_1:2181", "en": "Many international and regional borders are closed.", "fr": "De nombreuses frontières internationales et régionales sont fermées.", "perturbation": "alteration", "pert_fr": "De nombreuses frontières internationales et régionales sont ouvertes.", "bt_pert_fr": "Many international and regional borders are open.", "questions": "[\"Are many international and regional borders closed?\", \"Are international borders closed?\", \"Are regional borders closed?\"]", "answers": "[\"No\", \"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2182", "en": "If you are away from home, and especially if you are in another country, consider returning home as soon as possible; this may get even more difficult as restrictions continue to change.", "fr": "Si vous n’êtes pas chez vous, et particulièrement si vous êtes à l’étranger, envisagez de rentrer le plus vite possible ; cela risque de devenir encore plus difficile au fur et à mesure que les restrictions continuent de changer.", "perturbation": "alteration", "pert_fr": "Si vous êtes chez vous, et particulièrement si vous êtes à l’étranger, envisagez de rester le plus longtemps possible ; cela risque de devenir encore plus facile au fur et à mesure que les restrictions continuent de changer.", "bt_pert_fr": "If you are at home, and especially if you are abroad, consider staying as long as possible; this is likely to become even easier as restrictions continue to change.", "questions": "[\"Should you be away from home, especially in another country, consider returning home as soon as possible?\", \"May it become more difficult to return home as restrictions continue to change?\"]", "answers": "[\"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2185", "en": "They may be able to organize an evacuation, identify non-regularly scheduled flights, or give you an emergency loan to pay for transport.", "fr": "Ils seront peut-être en mesure d’arranger une évacuation, d’identifier des vols non réguliers ou de vous consentir un prêt d’urgence pour payer le transport.", "perturbation": "alteration", "pert_fr": "Ils ne seront peut-être pas en mesure d’arranger une évacuation, d’identifier des vols non réguliers ou de vous refuser un prêt d’urgence pour payer le transport.", "bt_pert_fr": "They may not be able to arrange an evacuation, identify unscheduled flights, or deny you an emergency loan to pay for transportation.", "questions": "[\"Can they organize an evacuation?\", \"Can they identify non-regularly scheduled flights?\", \"Can they give you an emergency loan to pay for transport?\"]", "answers": "[\"No\", \"Yes\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.3333333333333333, "avg_em": 0.3333333333333333, "avg_chrf": 33.333333333333336, "avg_bleu": 33.33333333333335}
{"id": "Wikivoyage_1:2189", "en": "Though the disease started in mainland China, it has spread around the world and China has fewer confirmed cases and deaths than several other countries.", "fr": "Bien que la maladie ait débuté en Chine continentale, elle s’est propagée dans le monde entier, et la Chine compte moins de cas confirmés et de décès que plusieurs autres pays.", "perturbation": "alteration", "pert_fr": "Bien que la maladie ait débuté en Chine continentale, elle ne s’est pas propagée dans le monde entier, et la Chine compte plus de cas confirmés et de décès que plusieurs autres pays.", "bt_pert_fr": "Although the disease started in mainland China, it has not spread worldwide, and China has more confirmed cases and deaths than several other countries.", "questions": "[\"Where did the disease start?\", \"Has the disease spread around the world?\", \"Does China have fewer confirmed cases and deaths than several other countries?\"]", "answers": "[\"Mainland China\", \"No\", \"No\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.3333333333333333, "avg_em": 0.3333333333333333, "avg_chrf": 33.333333333333336, "avg_bleu": 33.33333333333335}
{"id": "Wikivoyage_1:2191", "en": "All but a handful of countries have reported at least one case, with the highest numbers of reported cases in the United States, Spain, Italy, Germany, France, mainland China, Iran, and the United Kingdom.", "fr": "À quelques exceptions près, tous les pays ont rapporté au moins un cas, le nombre de cas déclarés étant le plus élevé aux États-Unis, en Espagne, en Italie, en Allemagne, en France, en Chine continentale, en Iran et au Royaume-Uni.", "perturbation": "alteration", "pert_fr": "À quelques exceptions près, aucun pays n'a rapporté de cas, le nombre de cas déclarés étant le plus bas aux États-Unis, en Espagne, en Italie, en Allemagne, en France, en Chine continentale, en Iran et au Royaume-Uni.", "bt_pert_fr": "With a few exceptions, no countries have reported cases, with the number of reported cases lowest in the United States, Spain, Italy, Germany, France, mainland China, Iran and the United Kingdom.", "questions": "[\"Which countries have reported at least one case of the virus?\", \"Which countries have the highest number of reported cases?\", \"What is the number of reported cases in the United States?\", \"What is the number of reported cases in Spain?\", \"What is the number of reported cases in Italy?\", \"What is the number of reported cases in Germany?\", \"What is the number of reported cases in France?\", \"What is the number of reported cases in mainland China?\", \"What is the number of reported cases in Iran?\", \"What is the number of reported cases in the United Kingdom?\"]", "answers": "[\"All countries except a few\", \"None\", \"Not specified\", \"Not specified\", \"Not specified\", \"Not specified\", \"Not specified\", \"Not specified\", \"Not specified\", \"Not specified\"]", "scores": [{"f1": 0.4444444444444445, "em": false, "chrf": 36.46403304208346, "bleu": 14.794015674776452}, {"f1": 0, "em": false, "chrf": 1.3020833333333335, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 89.11315536315534, "bleu": 49.99999999999999}, {"f1": 0.5, "em": false, "chrf": 89.11315536315534, "bleu": 49.99999999999999}, {"f1": 0.5, "em": false, "chrf": 89.11315536315534, "bleu": 49.99999999999999}, {"f1": 0.5, "em": false, "chrf": 89.11315536315534, "bleu": 49.99999999999999}, {"f1": 0.5, "em": false, "chrf": 89.11315536315534, "bleu": 49.99999999999999}, {"f1": 0.5, "em": false, "chrf": 89.11315536315534, "bleu": 49.99999999999999}, {"f1": 0.5, "em": false, "chrf": 89.11315536315534, "bleu": 49.99999999999999}, {"f1": 0.5, "em": false, "chrf": 89.11315536315534, "bleu": 49.99999999999999}], "avg_f1": 0.4444444444444445, "avg_em": 0.0, "avg_chrf": 75.06713592806595, "avg_bleu": 41.47940156747764}
{"id": "Wikivoyage_1:2192", "en": "Local transmission is established in many countries in all major inhabited regions of the world except some Pacific island nations.", "fr": "La transmission locale est avérée dans de nombreux pays de toutes les principales régions habitées du monde, à l’exception de certaines nations insulaires du Pacifique.", "perturbation": "alteration", "pert_fr": "La transmission locale n'est pas avérée dans de nombreux pays de toutes les principales régions habitées du monde, à l’exception de certaines nations insulaires du Pacifique.", "bt_pert_fr": "Local transmission is not documented in many countries in all major inhabited regions of the world, with the exception of some Pacific island nations.", "questions": "[\"In which countries is local transmission established?\", \"Are there any regions where local transmission is not established?\", \"Which major inhabited regions do not have local transmission?\", \"Which Pacific island nations do not have local transmission?\"]", "answers": "[\"Some Pacific island nations\", \"Yes\", \"All major inhabited regions of the world\", \"None\"]", "scores": [{"f1": 0, "em": false, "chrf": 11.739872201844179, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6, "em": false, "chrf": 78.58398848721635, "bleu": 30.213753973567677}, {"f1": 0, "em": false, "chrf": 5.067907444668007, "bleu": 0.0}], "avg_f1": 0.4, "avg_em": 0.25, "avg_chrf": 48.84794203343213, "avg_bleu": 32.55343849339193}
{"id": "Wikivoyage_1:2195", "en": "Many countries are experiencing a severe shortage of test kits, and the authorities have not been able to test everybody who is at high risk, so the real number of cases is probably much higher than the official one.", "fr": "De nombreux pays sont confrontés à une importante pénurie de kits de test, et les autorités n’ont pas été en mesure de tester toutes les personnes à haut risque, de sorte que le nombre réel de cas est probablement bien plus élevé que le nombre officiel.", "perturbation": "alteration", "pert_fr": "De nombreux pays sont confrontés à une importante abondance de kits de test, et les autorités ont été en mesure de tester toutes les personnes à haut risque, de sorte que le nombre réel de cas est probablement bien moins élevé que le nombre officiel.", "bt_pert_fr": "Many countries are facing a significant oversupply of test kits, and authorities have been able to test everyone at high risk, so the true number of cases is likely much lower than the official number.", "questions": "[\"Are many countries experiencing a severe shortage of test kits?\", \"Have authorities been able to test everybody who is at high risk?\", \"Is the real number of cases probably much higher than the official number?\"]", "answers": "[\"No\", \"Yes\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2196", "en": "Countries also differ in their testing and reporting practices, so comparisons of the number of reported cases do not tell the full story of how the epidemic has progressed in different areas.", "fr": "Les pays ont également adopté des méthodes de test et de comptage différentes, de sorte que la comparaison des nombres de cas rapportés ne permet pas de se faire une idée précise de la progression de l’épidémie dans différentes régions.", "perturbation": "alteration", "pert_fr": "Les pays n'ont pas adopté des méthodes de test et de comptage identiques, de sorte que la comparaison des nombres de cas rapportés permet de se faire une idée précise de la progression de l’épidémie dans différentes régions.", "bt_pert_fr": "Countries have not adopted identical testing and counting methods, so comparing the numbers of reported cases provides a clear picture of how the epidemic is progressing in different regions.", "questions": "[\"Do countries differ in their testing and reporting practices?\", \"Why do comparisons of the number of reported cases not tell the full story of how the epidemic has progressed in different areas?\"]", "answers": "[\"Yes\", \"Because countries have not adopted identical testing and counting methods\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4210526315789474, "em": false, "chrf": 46.9187242016869, "bleu": 11.868405219520975}], "avg_f1": 0.7105263157894737, "avg_em": 0.5, "avg_chrf": 73.45936210084345, "avg_bleu": 55.93420260976051}
{"id": "Wikivoyage_1:2198", "en": "The coronavirus is a relatively large virus, meaning it is not truly airborne: it will settle down in respiratory droplets.", "fr": "Le coronavirus est un virus d’une taille relativement grande, ce qui signifie qu’il n’est pas réellement aéroporté : il est présent dans les gouttelettes respiratoires.", "perturbation": "alteration", "pert_fr": "Le coronavirus est un virus d’une taille relativement petite, ce qui signifie qu’il est réellement aéroporté : il est présent dans les gouttelettes respiratoires.", "bt_pert_fr": "The coronavirus is a relatively small virus, which means it is truly airborne: it is present in respiratory droplets.", "questions": "[\"Is the coronavirus a relatively large virus?\", \"Does the coronavirus settle down in respiratory droplets?\", \"Is the coronavirus truly airborne?\"]", "answers": "[\"No\", \"No\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2199", "en": "Staying two metres (six feet) away from other people is usually enough to prevent transmission through this route.", "fr": "En maintenant une distance de deux mètres (six pieds) avec les autres, il est généralement possible d’éviter la transmission par cette voie.", "perturbation": "alteration", "pert_fr": "En maintenant une distance de deux mètres (six pieds) avec les autres, il est généralement impossible d’éviter la transmission par cette voie.", "bt_pert_fr": "By maintaining a distance of two meters (six feet) from others, it is generally impossible to avoid transmission by this route.", "questions": "[\"Is staying two metres (six feet) away from other people usually enough to prevent transmission through this route?\", \"Does the distance of two metres (six feet) from other people prevent transmission through this route?\", \"What distance is usually enough to prevent transmission through this route?\"]", "answers": "[\"No\", \"No\", \"two meters (six feet)\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.75, "em": false, "chrf": 66.55511155511157, "bleu": 35.35533905932737}], "avg_f1": 0.25, "avg_em": 0.0, "avg_chrf": 22.18503718503719, "avg_bleu": 11.78511301977579}
{"id": "Wikivoyage_1:2201", "en": "The SARS-CoV-2 virus may last on cardboard for up to 24 hours and on plastic for up to 3 days.", "fr": "Le virus SARS-Cov-2 peut survivre jusqu’à 24 heures sur du carton et jusqu’à 3 jours sur du plastique.", "perturbation": "alteration", "pert_fr": "Le virus SARS-Cov-2 peut disparaître jusqu’à 24 heures sur du carton et jusqu’à 3 jours sur du plastique.", "bt_pert_fr": "The SARS-Cov-2 virus can disappear for up to 24 hours on cardboard and up to 3 days on plastic.", "questions": "[\"How long can the SARS-CoV-2 virus last on cardboard?\", \"How long can the SARS-CoV-2 virus last on plastic?\"]", "answers": "[\"Up to 24 hours\", \"Up to 3 days\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikivoyage_1:2202", "en": "Transmission via the fecal–oral route may also be possible.", "fr": "Une transmission par voie oro-fécale serait également possible.", "perturbation": "alteration", "pert_fr": "Une transmission par voie oro-fécale ne serait pas possible.", "bt_pert_fr": "Transmission by the fecal-oral route would not be possible.", "questions": "[\"May transmission via the fecal–oral route be possible?\", \"Is fecal–oral transmission a possible route for the disease?\"]", "answers": "[\"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2203", "en": "Evidence suggests that COVID-19 is contagious even without symptoms, though to what extent is still being investigated.", "fr": "Des données probantes suggèrent que la COVID-19 est contagieuse même en l'absence de symptômes, bien que la mesure dans laquelle elle l’est soit encore à l’étude.", "perturbation": "alteration", "pert_fr": "Des données probantes suggèrent que la COVID-19 n'est pas contagieuse même en l'absence de symptômes, bien que la mesure dans laquelle elle l’est soit encore à l’étude.", "bt_pert_fr": "Evidence suggests that COVID-19 is not contagious even in the absence of symptoms, although the extent to which it is contagious is still being studied.", "questions": "[\"To what extent is COVID-19 contagious without symptoms?\", \"Is COVID-19 contagious without symptoms?\", \"How contagious is COVID-19 without symptoms?\"]", "answers": "[\"The extent is still being studied\", \"Yes\", \"The extent is still being studied\"]", "scores": [{"f1": 0.2222222222222222, "em": false, "chrf": 41.18611986008169, "bleu": 8.116697886877475}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.2222222222222222, "em": false, "chrf": 41.18611986008169, "bleu": 8.116697886877475}], "avg_f1": 0.48148148148148145, "avg_em": 0.3333333333333333, "avg_chrf": 60.79074657338779, "avg_bleu": 38.74446525791833}
{"id": "Wikivoyage_1:2204", "en": "Common symptoms include a fever, dry cough, and fatigue.", "fr": "Les symptômes courants comprennent la fièvre, une toux sèche et la fatigue.", "perturbation": "alteration", "pert_fr": "Les symptômes courants comprennent l'hypothermie, une toux sèche et la fatigue.", "bt_pert_fr": "Common symptoms include hypothermia, dry cough and fatigue.", "questions": "[\"What are the common symptoms of COVID-19?\", \"What is a common symptom of COVID-19?\", \"What is dry cough?\", \"What is fatigue?\", \"What is fever?\"]", "answers": "[\"Hypothermia, dry cough, and fatigue\", \"Hypothermia\", \"A common symptom of COVID-19\", \"A common symptom of COVID-19\", \"Not mentioned\"]", "scores": [{"f1": 0.8000000000000002, "em": false, "chrf": 73.35043830518609, "bleu": 66.87403049764218}, {"f1": 0, "em": false, "chrf": 10.30690537084399, "bleu": 0.0}, {"f1": 0.7499999999999999, "em": false, "chrf": 90.51297342902798, "bleu": 39.76353643835254}, {"f1": 0.7499999999999999, "em": false, "chrf": 90.51297342902798, "bleu": 39.76353643835254}, {"f1": 0, "em": false, "chrf": 4.385964912280701, "bleu": 0.0}], "avg_f1": 0.45999999999999996, "avg_em": 0.0, "avg_chrf": 53.81385108927335, "avg_bleu": 29.28022067486945}
{"id": "Wikivoyage_1:2205", "en": "Other less common symptoms include shortness of breath, a sore throat, headache, muscle pain, or sputum production.", "fr": "L’essoufflement, le mal de gorge, les maux de tête, les courbatures ou la production d’expectorations comptent parmi les autres symptômes moins courants.", "perturbation": "alteration", "pert_fr": "L’essoufflement, le mal de gorge, les maux de tête, les courbatures ou la suppression d’expectorations comptent parmi les autres symptômes moins courants.", "bt_pert_fr": "Other less common symptoms include shortness of breath, sore throat, headache, body aches, or passing sputum.", "questions": "[\"What are some other less common symptoms of the disease?\", \"Does shortness of breath occur as a less common symptom?\", \"Can a sore throat be a less common symptom?\", \"Is headache a less common symptom?\", \"Can muscle pain be a less common symptom?\", \"Is sputum production a less common symptom?\"]", "answers": "[\"Shortness of breath, sore throat, headache, body aches, or passing sputum\", \"Yes\", \"Yes\", \"Yes\", \"Yes\", \"Yes\"]", "scores": [{"f1": 0.7272727272727273, "em": false, "chrf": 64.22386943584172, "bleu": 49.616830003403635}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.9545454545454546, "avg_em": 0.8333333333333334, "avg_chrf": 94.03731157264029, "avg_bleu": 91.6028050005673}
{"id": "Wikivoyage_1:2207", "en": "Serious complications include pneumonia, acute respiratory distress syndrome, and multi-organ failure leading to disability or death.", "fr": "Les complications sévères incluent la pneumonie, le syndrome de détresse respiratoire aiguë et la défaillance multiviscérale entraînant une invalidité ou la mort.", "perturbation": "alteration", "pert_fr": "Les complications légères incluent la pneumonie, le syndrome de détresse respiratoire aiguë et la défaillance multiviscérale entraînant une invalidité ou la mort.", "bt_pert_fr": "Mild complications include pneumonia, acute respiratory distress syndrome, and multiple organ failure leading to disability or death.", "questions": "[\"What serious complications are associated with COVID-19?\", \"What are the complications that can lead to disability or death in COVID-19?\", \"Does pneumonia lead to serious complications in COVID-19?\", \"Does acute respiratory distress syndrome lead to serious complications in COVID-19?\", \"Does multi-organ failure lead to disability or death in COVID-19?\"]", "answers": "[\"Pneumonia, acute respiratory distress syndrome, and multiple organ failure\", \"Pneumonia, acute respiratory distress syndrome, and multiple organ failure\", \"Yes\", \"Yes\", \"Yes\"]", "scores": [{"f1": 0.823529411764706, "em": false, "chrf": 94.66667250743886, "bleu": 61.04735835807847}, {"f1": 0.823529411764706, "em": false, "chrf": 94.66667250743886, "bleu": 61.04735835807847}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.9294117647058824, "avg_em": 0.6, "avg_chrf": 97.86666900297556, "avg_bleu": 84.4189433432314}
{"id": "Wikivoyage_1:2209", "en": "Case fatality rate is estimated at 1-3% of infected individuals, most of whom are elderly with underlying health conditions.", "fr": "Le taux de létalité est estimé à 1 à 3 % des personnes infectées, dont la plupart sont des personnes âgées présentant des affections sous-jacentes.", "perturbation": "alteration", "pert_fr": "Le taux de guérison est estimé à 1 à 3 % des personnes infectées, dont la plupart sont des personnes âgées présentant des affections sous-jacentes.", "bt_pert_fr": "The recovery rate is estimated at 1-3% of those infected, most of whom are elderly people with underlying conditions.", "questions": "[\"What is the estimated case fatality rate for infected individuals?\", \"Which group of individuals accounts for most of the case fatality rate?\", \"Are elderly individuals with underlying health conditions more likely to have a high case fatality rate?\", \"What factors are associated with a higher case fatality rate in COVID-19 infections?\"]", "answers": "[\"1-3%\", \"Elderly people with underlying conditions\", \"Yes\", \"Underlying conditions\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7272727272727272, "em": false, "chrf": 54.618034659981504, "bleu": 20.801195378010608}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8, "em": false, "chrf": 66.48341103651549, "bleu": 42.88819424803536}], "avg_f1": 0.8818181818181818, "avg_em": 0.5, "avg_chrf": 80.27536142412424, "avg_bleu": 65.92234740651152}
{"id": "Wikivoyage_1:2210", "en": "The fatality rate is much higher for those over 70 but significantly lower for those under 40.", "fr": "Le taux de létalité est nettement plus élevé chez les plus de 70 ans, mais bien moins élevé chez les moins de 40 ans.", "perturbation": "alteration", "pert_fr": "Le taux de létalité est nettement moins élevé chez les plus de 70 ans, mais bien plus élevé chez les moins de 40 ans.", "bt_pert_fr": "The case fatality rate is significantly lower among those over 70, but much higher among those under 40.", "questions": "[\"Is the fatality rate higher for those over 70?\", \"Is the fatality rate lower for those under 40?\"]", "answers": "[\"No\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 50.0, "avg_bleu": 50.00000000000002}
{"id": "Wikivoyage_1:2211", "en": "Those most at risk of COVID-19 infection and serious complications are the elderly and those with weakened immune systems or underlying health conditions like cardiovascular disease, diabetes, hypertension, chronic respiratory disease, and cancer.", "fr": "Les personnes les plus à risque de développer une infection par le virus de la COVID-19 et des complications graves sont les personnes âgées et celles dont le système immunitaire est affaibli ou souffrant d'une affection sous-jacente comme une maladie cardiovasculaire, le diabète, l’hypertension, une maladie respiratoire chronique et un cancer.", "perturbation": "alteration", "pert_fr": "Les personnes les moins à risque de développer une infection par le virus de la COVID-19 et des complications graves sont les personnes âgées et celles dont le système immunitaire est affaibli ou souffrant d'une affection sous-jacente comme une maladie cardiovasculaire, le diabète, l’hypertension, une maladie respiratoire chronique et un cancer.", "bt_pert_fr": "People least at risk of developing infection with the COVID-19 virus and serious complications are older adults and those with weakened immune systems or underlying conditions such as cardiovascular disease, diabetes, hypertension, chronic respiratory disease and cancer.", "questions": "[\"Who are the most at risk of COVID-19 infection and serious complications?\", \"Why are the elderly at risk of COVID-19 infection and serious complications?\", \"Why are people with weakened immune systems at risk of COVID-19 infection and serious complications?\", \"Why are people with underlying health conditions like cardiovascular disease at risk of COVID-19 infection and serious complications?\", \"Why are people with underlying health conditions like diabetes at risk of COVID-19 infection and serious complications?\", \"Why are people with underlying health conditions like hypertension at risk of COVID-19 infection and serious complications?\", \"Why are people with underlying health conditions like chronic respiratory disease at risk of COVID-19 infection and serious complications?\", \"Why are people with underlying health conditions like cancer at risk of COVID-19 infection and serious complications?\"]", "answers": "[\"People with weakened immune systems or underlying conditions such as cardiovascular disease, diabetes, hypertension, chronic respiratory disease, and cancer\", \"Because they have weakened immune systems or underlying health conditions\", \"Because they have weakened immune systems\", \"Because they have underlying health conditions such as cardiovascular disease\", \"Because they have underlying health conditions such as diabetes\", \"Because they have underlying health conditions such as hypertension\", \"Because they have underlying health conditions such as chronic respiratory disease\", \"Because they have underlying health conditions such as cancer\"]", "scores": [{"f1": 0.7804878048780488, "em": false, "chrf": 80.6919853011527, "bleu": 58.57375508193743}, {"f1": 0.28571428571428575, "em": false, "chrf": 42.80962014775227, "bleu": 8.392229812593097}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8421052631578948, "em": false, "chrf": 89.12264580089422, "bleu": 58.14307369682194}, {"f1": 0.823529411764706, "em": false, "chrf": 86.31594317261467, "bleu": 61.04735835807847}, {"f1": 0.823529411764706, "em": false, "chrf": 87.32259598411038, "bleu": 61.04735835807847}, {"f1": 0.8571428571428572, "em": false, "chrf": 89.76823698802548, "bleu": 58.77283725105319}, {"f1": 0.823529411764706, "em": false, "chrf": 85.75011756703432, "bleu": 61.04735835807847}], "avg_f1": 0.7795048057734005, "avg_em": 0.125, "avg_chrf": 82.722643120198, "avg_bleu": 58.37799636458014}
{"id": "Wikivoyage_1:2212", "en": "Not many cases are reported in children and most of these are mild or moderate, though a significant fraction do get pneumonia.", "fr": "Peu de cas sont signalés chez les enfants, et la plupart d’entre eux sont légers à modérés, bien qu’une part significative développe une pneumonie.", "perturbation": "alteration", "pert_fr": "Beaucoup de cas sont signalés chez les adultes, et la plupart d’entre eux sont graves, bien qu’une part significative développe une pneumonie.", "bt_pert_fr": "Many cases are reported in adults, and most of them are serious, although a significant proportion develop pneumonia.", "questions": "[\"How many cases are reported in children?\", \"Are most cases in children mild or moderate?\", \"Do a significant fraction of children with COVID-19 get pneumonia?\"]", "answers": "[\"No information available\", \"No information available\", \"No information available\"]", "scores": [{"f1": 0, "em": false, "chrf": 13.711446638275907, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 15.408138032159908, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 4.901960784313726, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 11.340515151583181, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2213", "en": "Occupationally, health care workers have higher risk compared to others with clusters of disease among workers and in health care settings.", "fr": "Professionnellement, le personnel de santé présente un risque plus élevé par rapport aux autres, avec des clusters de maladie parmi les travailleurs et dans les établissements médicaux.", "perturbation": "alteration", "pert_fr": "Professionnellement, le personnel de santé présente un risque plus faible par rapport aux autres, avec des clusters de maladie parmi les travailleurs et dans les établissements médicaux.", "bt_pert_fr": "Professionally, healthcare workers are at lower risk compared to others, with clusters of illness among workers and in medical settings.", "questions": "[\"Do health care workers have a higher risk compared to others?\", \"Are there clusters of disease among health care workers?\", \"Are there clusters of disease in health care settings?\"]", "answers": "[\"No\", \"Yes\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6666666666666666, "avg_em": 0.6666666666666666, "avg_chrf": 66.66666666666667, "avg_bleu": 66.6666666666667}
{"id": "Wikivoyage_1:2214", "en": "The time between being exposed to the virus and the emergence of symptoms (incubation period) is typically between 2 and 14 days, though there has been one reported case in China where symptoms appeared 27 days after exposure.", "fr": "La durée entre l’exposition au virus et l’apparition des symptômes (période d’incubation) est généralement de 2 à 14 jours, même si pour un cas signalé en Chine, les symptômes sont apparus 27 jours après l’exposition.", "perturbation": "alteration", "pert_fr": "La durée entre l’exposition au virus et la disparition des symptômes (période d’incubation) est généralement de 2 à 14 jours, même si pour un cas signalé en Chine, les symptômes sont apparus 27 jours après l’exposition.", "bt_pert_fr": "The time between exposure to the virus and the disappearance of symptoms (incubation period) is generally 2 to 14 days, although for one case reported in China, symptoms appeared 27 days after exposure.", "questions": "[\"What is the typical incubation period for the virus?\", \"How long is the incubation period typically after exposure to the virus?\", \"Has there been a reported case where symptoms appeared more than 14 days after exposure?\", \"In what circumstances did symptoms appear 27 days after exposure?\", \"What is the range of the incubation period for the virus?\"]", "answers": "[\"The time between exposure to the virus and the disappearance of symptoms\", \"2 to 14 days\", \"Yes\", \"For one case reported in China\", \"2 to 14 days\"]", "scores": [{"f1": 0.761904761904762, "em": false, "chrf": 62.10809317838544, "bleu": 27.007097700389536}, {"f1": 0.6666666666666665, "em": false, "chrf": 28.024505186848785, "bleu": 27.534765745159184}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8333333333333334, "em": false, "chrf": 60.51910119111534, "bleu": 20.412414523193153}, {"f1": 0.6666666666666665, "em": false, "chrf": 28.024505186848785, "bleu": 27.534765745159184}], "avg_f1": 0.7857142857142857, "avg_em": 0.2, "avg_chrf": 55.73524094863967, "avg_bleu": 40.49780874278022}
{"id": "Wikivoyage_1:2216", "en": "There is evidence of transmission from people who don't have symptoms, although to what extent is still being investigated.", "fr": "Une transmission par des personnes asymptomatiques a été mise en évidence, mais l’ampleur de ce phénomène est encore à l’étude.", "perturbation": "alteration", "pert_fr": "Une transmission par des personnes symptomatiques a été mise en évidence, mais l’ampleur de ce phénomène est encore à l’étude.", "bt_pert_fr": "Transmission by symptomatic people has been demonstrated, but the extent of this phenomenon is still under study.", "questions": "[\"To what extent is transmission from people who don't have symptoms being investigated?\", \"Is there evidence of transmission from people who don't have symptoms?\"]", "answers": "[\"The extent of transmission from symptomatic people is still under study\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 16.56058419260541, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 8.280292096302706, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2218", "en": "Long-term effects for people who have recovered remain unclear, but there is evidence of reduced lung capacity in some recovered patients.", "fr": "Les effets à long terme chez les personnes ayant guéri ne sont toujours pas clairement établis, mais une réduction de la capacité pulmonaire a été mise en évidence chez certains patients guéris.", "perturbation": "alteration", "pert_fr": "Les effets à long terme chez les personnes n'ayant pas guéri ne sont toujours pas clairement établis, mais une augmentation de la capacité pulmonaire a été mise en évidence chez certains patients guéris.", "bt_pert_fr": "The long-term effects in those who have not recovered are still not clearly established, but an increase in lung capacity has been demonstrated in some recovered patients.", "questions": "[\"Are the long-term effects for people who have recovered clear?\", \"Is there evidence of reduced lung capacity in some recovered patients?\"]", "answers": "[\"No\", \"No\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 50.0, "avg_bleu": 50.00000000000002}
{"id": "Wikivoyage_1:2221", "en": "There is no established test assessing for the virus or antibodies in the blood, although tests are being developed.", "fr": "Il n’existe aucun test reconnu de dépistage du virus ou des anticorps dans le sang, bien que des tests soient en cours de développement.", "perturbation": "alteration", "pert_fr": "Il existe un test reconnu de dépistage du virus ou des anticorps dans le sang, bien que des tests soient en cours de développement.", "bt_pert_fr": "There is a recognized test for the virus or antibodies in the blood, although tests are under development.", "questions": "[\"Is there an established test assessing for the virus in the blood?\", \"Is there an established test assessing for antibodies in the blood?\", \"Are tests for the virus or antibodies in the blood currently being developed?\"]", "answers": "[\"Yes\", \"No\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6666666666666666, "avg_em": 0.6666666666666666, "avg_chrf": 66.66666666666667, "avg_bleu": 66.6666666666667}
{"id": "Wikivoyage_1:2222", "en": "There is no test to establish immunity to the virus.", "fr": "Il n’existe aucun test pour établir l’immunité au virus.", "perturbation": "alteration", "pert_fr": "Il existe un test pour établir l’immunité au virus.", "bt_pert_fr": "There is a test to establish immunity to the virus.", "questions": "[\"Is there a test to establish immunity to the virus?\"]", "answers": "[\"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2223", "en": "Many governments around the world have advised their citizens not to travel unnecessarily amid the pandemic.", "fr": "De nombreux gouvernements de par le monde ont conseillé à leurs citoyens de ne pas voyager sans raison valable pendant la pandémie.", "perturbation": "alteration", "pert_fr": "De nombreux gouvernements de par le monde ont conseillé à leurs citoyens de voyager sans raison valable pendant la pandémie.", "bt_pert_fr": "Many governments around the world have advised their citizens to travel without good reason during the pandemic.", "questions": "[\"Have governments around the world advised their citizens not to travel unnecessarily amid the pandemic?\", \"Which governments have advised their citizens not to travel unnecessarily amid the pandemic?\", \"What is the reason given by governments for advising citizens not to travel unnecessarily amid the pandemic?\"]", "answers": "[\"Yes\", \"Many governments around the world\", \"During the pandemic\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 84.90607844028708, "bleu": 31.947155212313625}, {"f1": 0.5, "em": false, "chrf": 55.514685469579284, "bleu": 49.99999999999999}], "avg_f1": 0.7222222222222222, "avg_em": 0.3333333333333333, "avg_chrf": 80.14025463662212, "avg_bleu": 60.64905173743788}
{"id": "Wikivoyage_1:2225", "en": "Particularly avoid cruise ship travel.", "fr": "Évitez particulièrement de partir en croisière.", "perturbation": "alteration", "pert_fr": "Préférez particulièrement de partir en croisière.", "bt_pert_fr": "Particularly prefer to go on a cruise.", "questions": "[\"Why should cruise ship travel be particularly avoided?\"]", "answers": "[\"It is not stated why cruise ship travel should be particularly avoided\"]", "scores": [{"f1": 0.45454545454545453, "em": false, "chrf": 59.56347537426513, "bleu": 14.323145079400492}], "avg_f1": 0.45454545454545453, "avg_em": 0.0, "avg_chrf": 59.56347537426513, "avg_bleu": 14.323145079400492}
{"id": "Wikivoyage_1:2226", "en": "Older travelers and those with underlying health conditions are most at risk and should avoid travel that puts them at risk, such as long plane flights, visits to crowded places, and especially cruises, even outside of severely affected areas.", "fr": "Les voyageurs âgés et ceux souffrant d'une affection sous-jacente sont les plus à risque et doivent éviter tout voyage qui les met en danger, notamment les longs vols, les visites de lieux très fréquentés et, en particulier, les croisières, même en dehors des régions gravement touchées.", "perturbation": "alteration", "pert_fr": "Les voyageurs jeunes et ceux ne souffrant d'aucune affection sous-jacente sont les moins à risque et doivent éviter tout voyage qui les met en danger, notamment les longs vols, les visites de lieux très fréquentés et, en particulier, les croisières, même en dehors des régions gravement touchées.", "bt_pert_fr": "Younger travelers and those without any underlying conditions are least at risk and should avoid any travel that puts them at risk, including long flights, visits to busy locations and, in particular, cruises, even outside of severely affected regions.", "questions": "[\"Are older travelers most at risk when traveling?\", \"Are people with underlying health conditions most at risk when traveling?\", \"Should older travelers avoid long plane flights?\", \"Should older travelers avoid visits to crowded places?\", \"Should older travelers avoid cruises?\", \"Should people with underlying health conditions avoid long plane flights?\", \"Should people with underlying health conditions avoid visits to crowded places?\", \"Should people with underlying health conditions avoid cruises?\", \"Should travelers avoid cruises even outside of severely affected areas?\"]", "answers": "[\"No\", \"Yes\", \"Yes\", \"Yes\", \"Yes\", \"Yes\", \"Yes\", \"Yes\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8888888888888888, "avg_em": 0.8888888888888888, "avg_chrf": 88.88888888888889, "avg_bleu": 88.88888888888893}
{"id": "Wikivoyage_1:2228", "en": "This means minimising contact with others by keeping a distance of six feet or two meters from them and avoiding gathering together in groups.", "fr": "Cela signifie limiter ses contacts avec les autres, en maintenant une distance de deux mètres ou six pieds avec eux et en évitant les rassemblements.", "perturbation": "alteration", "pert_fr": "Cela signifie multiplier ses contacts avec les autres, en réduisant une distance de deux mètres ou six pieds avec eux et en favorisant les rassemblements.", "bt_pert_fr": "This means increasing your contact with others, reducing a distance of two meters or six feet from them and encouraging gatherings.", "questions": "[\"What does minimising contact with others involve?\", \"What distance should be maintained from others to minimise contact?\", \"Why is avoiding gatherings in groups important?\", \"What is the recommended distance to keep from others to reduce contact?\"]", "answers": "[\"Reducing a distance of two meters or six feet from them and encouraging gatherings\", \"Two meters or six feet\", \"To reduce contact and minimize the risk of transmission\", \"Two meters or six feet\"]", "scores": [{"f1": 0.6206896551724138, "em": false, "chrf": 48.58516890620981, "bleu": 9.401936634847434}, {"f1": 0.6, "em": false, "chrf": 59.13653068064831, "bleu": 14.058533129758727}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6, "em": false, "chrf": 59.13653068064831, "bleu": 14.058533129758727}], "avg_f1": 0.7051724137931035, "avg_em": 0.25, "avg_chrf": 66.7145575668766, "avg_bleu": 34.37975072359123}
{"id": "Wikivoyage_1:2237", "en": "Drying your washed hands physically removes some germs from your skin (so don't skip that step, and don't share towels).", "fr": "Le séchage des mains lavées permet de physiquement éliminer certains germes de la peau (alors ne sautez pas cette étape et ne partagez pas les serviettes).", "perturbation": "alteration", "pert_fr": "Le séchage des mains sales permet de physiquement éliminer certains germes de la peau (alors ne sautez pas cette étape et ne partagez pas les serviettes).", "bt_pert_fr": "Drying dirty hands helps physically remove some germs from the skin (so don't skip this step or share towels).", "questions": "[\"Does drying your washed hands remove some germs from your skin?\", \"Should you skip the step of drying your hands after washing?\", \"Is it safe to share towels after washing your hands?\"]", "answers": "[\"Yes\", \"No\", \"No\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikivoyage_1:2238", "en": "If soap and water are not available, then use a &gt;60% alcohol-based hand sanitizer.", "fr": "En l’absence de savon et d’eau, utilisez une solution hydro-alcoolique &gt; 60 %.", "perturbation": "alteration", "pert_fr": "En présence de savon et d’eau, utilisez une solution hydro-alcoolique &gt; 60 %.", "bt_pert_fr": "In the presence of soap and water, use a hydro-alcoholic solution &gt; 60%.", "questions": "[\"What should be used if soap and water are not available?\", \"What is the required alcohol concentration in hand sanitizer?\", \"What is the minimum alcohol concentration needed in hand sanitizer?\"]", "answers": "[\"A hydro-alcoholic solution > 60%\", \"60%\", \"60%\"]", "scores": [{"f1": 0.25, "em": false, "chrf": 25.828078845271595, "bleu": 15.97357760615681}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.75, "avg_em": 0.6666666666666666, "avg_chrf": 75.2760262817572, "avg_bleu": 71.99119253538564}
{"id": "Wikivoyage_1:2239", "en": "Alcohol is a quick germ-killer, but it's not quite instant, so this still requires the same 20 seconds of rubbing your hands together, making sure that every single scrap of skin gets wet, and then you have to wait about another minute, for the alcohol to completely dry.", "fr": "L’alcool étant un germicide rapide, mais pas tout à fait instantané, il faut là encore se frotter les mains pendant 20 secondes, en veillant à humidifier tous les recoins de la peau, puis attendre une minute supplémentaire jusqu’à ce que l’alcool sèche complètement.", "perturbation": "alteration", "pert_fr": "L’alcool étant un germicide lent, mais pas tout à fait instantané, il faut là encore se frotter les mains pendant 20 secondes, en veillant à humidifier tous les recoins de la peau, puis attendre une minute supplémentaire jusqu’à ce que l’alcool sèche complètement.", "bt_pert_fr": "Alcohol being a slow, but not completely instantaneous, germicide, you must again rub your hands for 20 seconds, making sure to moisten all corners of the skin, then wait an additional minute until the alcohol dries completely.", "questions": "[\"How long does it take for alcohol to kill germs?\", \"Does alcohol kill germs instantly?\", \"How long should you rub your hands together with alcohol?\", \"How long should you wait after rubbing your hands with alcohol before it's effective?\", \"Does every part of the skin need to be wet when using alcohol?\", \"What is required for alcohol to completely dry and be effective?\"]", "answers": "[\"A slow, but not completely instantaneous\", \"No\", \"20 seconds\", \"An additional minute\", \"Yes\", \"Moistening all corners of the skin and waiting until the alcohol dries completely\"]", "scores": [{"f1": 0.2222222222222222, "em": false, "chrf": 10.758013402223751, "bleu": 8.116697886877475}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.3333333333333333, "em": false, "chrf": 26.250149632502573, "bleu": 27.516060407455225}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.23529411764705885, "em": false, "chrf": 46.78630687085429, "bleu": 4.456882760699064}], "avg_f1": 0.6318082788671023, "avg_em": 0.5, "avg_chrf": 63.96574498426344, "avg_bleu": 56.68160684250532}
{"id": "Wikivoyage_1:2242", "en": "Try to do this less, and try to wash your hands before touching your face.", "fr": "Essayez de le faire moins et de vous laver les mains avant de vous toucher le visage.", "perturbation": "alteration", "pert_fr": "Essayez de le faire plus et de vous laver les mains avant de vous toucher le visage.", "bt_pert_fr": "Try to do it more and wash your hands before touching your face.", "questions": "[\"How often should you do this?\", \"Should you wash your hands before touching your face?\"]", "answers": "[\"More\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 6.25, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 53.125, "avg_bleu": 50.00000000000002}
{"id": "Wikivoyage_1:2244", "en": "Cough and sneeze into your elbow or a tissue, and then immediately throw away the tissue and wash your hands.", "fr": "Toussez et éternuez dans le pli du coude ou un mouchoir, puis jetez le mouchoir et lavez-vous les mains immédiatement.", "perturbation": "alteration", "pert_fr": "Toussez et éternuez dans les mains ou un mouchoir, puis jetez le mouchoir et lavez-vous les mains immédiatement.", "bt_pert_fr": "Cough and sneeze into your hands or a tissue, then throw away the tissue and wash your hands immediately.", "questions": "[\"What should you do when you cough or sneeze?\", \"Should you cough and sneeze into your elbow or a tissue?\", \"What should you do after using a tissue?\", \"What should you do after coughing or sneezing into your elbow or a tissue?\"]", "answers": "[\"Cough and sneeze into your hands or a tissue, then throw away the tissue and wash your hands immediately\", \"You should cough and sneeze into your hands or a tissue\", \"Throw away the tissue\", \"Wash your hands immediately\"]", "scores": [{"f1": 0.9142857142857143, "em": false, "chrf": 79.72537134018368, "bleu": 58.471561557033894}, {"f1": 0, "em": false, "chrf": 8.928571428571429, "bleu": 0.0}, {"f1": 0.5714285714285715, "em": false, "chrf": 53.71484562266296, "bleu": 39.43223765116288}, {"f1": 0.8571428571428571, "em": false, "chrf": 82.48924839768235, "bleu": 59.460355750136046}], "avg_f1": 0.5857142857142857, "avg_em": 0.0, "avg_chrf": 56.214509197275106, "avg_bleu": 39.341038739583205}
{"id": "Wikivoyage_1:2245", "en": "Don't stand or sit near people who might be sick.", "fr": "Ne vous tenez pas et ne vous asseyez pas près de gens qui sont susceptibles d’être malades.", "perturbation": "alteration", "pert_fr": "Asseyez-vous et tenez-vous près de gens qui sont susceptibles d’être malades.", "bt_pert_fr": "Sit and be near people who may be sick.", "questions": "[\"Should you stand or sit near people who might be sick?\", \"Is it safe to stand or sit near people who might be sick?\"]", "answers": "[\"Sit\", \"It is not safe to stand near people who might be sick, but it is safe to sit near them\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 3.3783783783783785, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 1.6891891891891893, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2250", "en": "Clean objects and surfaces that a lot of people touch, such as doorknobs, phones, and television remotes with regular household cleaner.", "fr": "Nettoyez les objets et les surfaces que beaucoup de gens touchent, comme les poignées de porte, les téléphones et les télécommandes de télévision à l’aide d’un nettoyant ménager ordinaire.", "perturbation": "alteration", "pert_fr": "Salez les objets et les surfaces que peu de gens touchent, comme les poignées de porte, les téléphones et les télécommandes de télévision à l’aide d’un nettoyant ménager ordinaire.", "bt_pert_fr": "Dirty objects and surfaces that few people touch, like doorknobs, phones, and TV remotes using a regular household cleaner.", "questions": "[\"What should be cleaned regularly to reduce the risk of infection?\", \"What types of objects should be cleaned with household cleaner?\", \"What surfaces do people frequently touch that need regular cleaning?\", \"What is the recommended cleaner for cleaning doorknobs, phones, and television remotes?\"]", "answers": "[\"Dirty objects and surfaces that few people touch\", \"Doorknobs, phones, and TV remotes\", \"Doorknobs, phones, and TV remotes\", \"A regular household cleaner\"]", "scores": [{"f1": 0.625, "em": false, "chrf": 75.8064469841955, "bleu": 25.848657697858535}, {"f1": 0.8000000000000002, "em": false, "chrf": 64.31198830936708, "bleu": 42.7287006396234}, {"f1": 0.8000000000000002, "em": false, "chrf": 64.31198830936708, "bleu": 42.7287006396234}, {"f1": 0.5714285714285715, "em": false, "chrf": 94.16320622765005, "bleu": 31.947155212313625}], "avg_f1": 0.6991071428571429, "avg_em": 0.0, "avg_chrf": 74.64840745764494, "avg_bleu": 35.813303547354735}
{"id": "Wikivoyage_1:2252", "en": "Stay home when you are sick, and avoid contact with other people until your symptoms are gone.", "fr": "Restez chez vous si vous êtes malade et évitez tout contact avec les autres jusqu’à ce que vos symptômes aient disparu.", "perturbation": "alteration", "pert_fr": "Sortez chez les autres si vous êtes en bonne santé et multipliez tout contact avec les autres jusqu’à ce que vos symptômes apparaissent.", "bt_pert_fr": "Go out to others if you are in good health and increase all contact with others until your symptoms appear.", "questions": "[\"Why should you stay home when you are sick?\", \"What should you do to avoid contact with other people when you are sick?\", \"How long should you avoid contact with other people when you are sick?\"]", "answers": "[\"You should stay home when you are sick to avoid spreading symptoms to others\", \"You should avoid contact with other people when you are sick\", \"You should avoid contact with other people until your symptoms appear\"]", "scores": [{"f1": 0.1, "em": false, "chrf": 25.948536810098492, "bleu": 2.8398387225677895}, {"f1": 0.5000000000000001, "em": false, "chrf": 80.70976578280074, "bleu": 23.462350320528007}, {"f1": 0.25000000000000006, "em": false, "chrf": 54.53148618011501, "bleu": 7.495553473355842}], "avg_f1": 0.2833333333333334, "avg_em": 0.0, "avg_chrf": 53.72992959100475, "avg_bleu": 11.265914172150545}
{"id": "Wikivoyage_1:2253", "en": "Do not share personal items that come into contact with saliva, such as toothbrushes, eating utensils, drinks, water bottles, and towels.", "fr": "Ne partagez pas d’objets personnels qui entrent en contact avec la salive, comme les brosses à dents, les couverts, les boissons, les bouteilles d’eau et les serviettes.", "perturbation": "alteration", "pert_fr": "Partagez d’objets personnels qui entrent en contact avec la salive, comme les brosses à dents, les couverts, les boissons, les bouteilles d’eau et les serviettes.", "bt_pert_fr": "Share personal items that come into contact with saliva, such as toothbrushes, cutlery, drinks, water bottles and towels.", "questions": "[\"What personal items should not be shared?\", \"Which items that come into contact with saliva should not be shared?\", \"What examples of personal items that come into contact with saliva are mentioned?\", \"Should toothbrushes be shared?\", \"Should eating utensils be shared?\", \"Should drinks be shared?\", \"Should water bottles be shared?\", \"Should towels be shared?\"]", "answers": "[\"Personal items that come into contact with saliva\", \"Toothbrushes, cutlery, drinks, water bottles and towels\", \"Toothbrushes, cutlery, drinks, water bottles and towels\", \"No\", \"No\", \"No\", \"No\", \"No\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7999999999999999, "em": false, "chrf": 70.70959292825522, "bleu": 55.780028607687655}, {"f1": 0.7999999999999999, "em": false, "chrf": 70.70959292825522, "bleu": 55.780028607687655}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.95, "avg_em": 0.75, "avg_chrf": 92.67739823206381, "avg_bleu": 88.94500715192194}
{"id": "Wikivoyage_1:2254", "en": "The practice of serving yourself from a common plate with your own chopsticks, common in China, should be avoided.", "fr": "La pratique consistant à se servir dans une assiette commune à l’aide de baguettes, courante en Chine, doit être évitée.", "perturbation": "alteration", "pert_fr": "La pratique consistant à se servir dans une assiette commune à l’aide de baguettes, courante en Chine, doit être encouragée.", "bt_pert_fr": "The practice of serving oneself from a common plate using chopsticks, common in China, should be encouraged.", "questions": "[\"Should the practice of serving yourself from a common plate with your own chopsticks be avoided?\", \"Why should the practice of serving yourself from a common plate with your own chopsticks be avoided?\", \"Is the practice of serving yourself from a common plate with your own chopsticks common in China?\", \"What is the recommended practice regarding serving food from a common plate with chopsticks?\"]", "answers": "[\"No\", \"It should not be avoided because it is recommended\", \"Yes\", \"Serving oneself from a common plate using chopsticks\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.19999999999999998, "em": false, "chrf": 24.29436064231148, "bleu": 7.635362674858093}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.47058823529411764, "em": false, "chrf": 55.09588877240278, "bleu": 17.112717058426785}], "avg_f1": 0.4176470588235294, "avg_em": 0.25, "avg_chrf": 44.84756235367857, "avg_bleu": 31.18701993332123}
{"id": "Wikivoyage_1:2256", "en": "Avoid hugs, kisses, handshakes, fist bumps, and any other contact.", "fr": "Évitez les embrassades, la bise, les poignées de main, les poing-à-poing et tout autre contact.", "perturbation": "alteration", "pert_fr": "Pratiquez les embrassades, la bise, les poignées de main, les poing-à-poing et tout autre contact.", "bt_pert_fr": "Practice hugs, kisses, handshakes, fist-to-fist and other contact.", "questions": "[\"What types of physical contact should be avoided?\", \"Should hugs be avoided?\", \"Should kisses be avoided?\", \"Should handshakes be avoided?\", \"Should fist bumps be avoided?\", \"Should any other contact be avoided?\"]", "answers": "[\"None\", \"No\", \"No\", \"No\", \"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.6222480025121246, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.43704133375202076, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2257", "en": "If it's impossible to avoid contact, then wash your hands both before and after.", "fr": "S’il est impossible d’éviter un contact, lavez-vous les mains avant et après.", "perturbation": "alteration", "pert_fr": "S’il est impossible d’éviter un contact, salez-vous les mains avant et après.", "bt_pert_fr": "If contact cannot be avoided, salt your hands before and after.", "questions": "[\"Is it possible to avoid contact?\", \"Should you wash your hands before contact if it's impossible to avoid it?\", \"Should you wash your hands after contact if it's impossible to avoid it?\"]", "answers": "[\"No\", \"Yes\", \"Yes\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikivoyage_1:2258", "en": "It won't protect you from the coronavirus, but it will partially protect you from the flu, which remains a greater risk than COVID-19 in many areas.", "fr": "Cela ne vous protègera pas contre le coronavirus, mais vous protégera partiellement contre la grippe, qui pose toujours un plus grand risque que la COVID-19 dans de nombreuses régions.", "perturbation": "alteration", "pert_fr": "Cela vous protègera contre le coronavirus, mais vous ne protégera pas partiellement contre la grippe, qui pose toujours un plus grand risque que la COVID-19 dans de nombreuses régions.", "bt_pert_fr": "This will protect you against the coronavirus, but will not partially protect you against the flu, which still poses a greater risk than COVID-19 in many areas.", "questions": "[\"Will it protect you from the coronavirus?\", \"Will it partially protect you from the flu?\", \"Is the flu a greater risk than COVID-19 in many areas?\"]", "answers": "[\"Yes\", \"No\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.3333333333333333, "avg_em": 0.3333333333333333, "avg_chrf": 33.333333333333336, "avg_bleu": 33.33333333333335}
{"id": "Wikivoyage_1:2259", "en": "This also saves you from unnecessary worry if you get the flu and think it might be the coronavirus.", "fr": "Cela vous évite également de vous inquiéter inutilement si vous contractez la grippe et pensez qu’il s’agit peut-être du coronavirus.", "perturbation": "alteration", "pert_fr": "Cela vous oblige également à vous inquiéter inutilement si vous contractez la grippe et pensez qu’il s’agit peut-être du coronavirus.", "bt_pert_fr": "It also causes you to worry unnecessarily if you get the flu and think it might be the coronavirus.", "questions": "[\"Does getting the flu and thinking it might be the coronavirus cause unnecessary worry?\", \"Does thinking the flu might be the coronavirus lead to unnecessary worry?\", \"Is there a way to avoid unnecessary worry when getting the flu and considering it might be the coronavirus?\"]", "answers": "[\"Yes\", \"Yes\", \"Not specified in the sentence\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 6.116965925906505, "bleu": 0.0}], "avg_f1": 0.3333333333333333, "avg_em": 0.3333333333333333, "avg_chrf": 35.372321975302164, "avg_bleu": 33.33333333333335}
{"id": "Wikivoyage_1:2263", "en": "For those who are asymptomatic, the WHO does not recommend masks, though some national governments do.", "fr": "Pour les personnes asymptomatiques, l’OMS ne recommande pas les masques, bien que certains gouvernements nationaux le fassent.", "perturbation": "alteration", "pert_fr": "Pour les personnes asymptomatiques, l’OMS recommande les masques, bien que certains gouvernements nationaux ne le fassent pas.", "bt_pert_fr": "For asymptomatic people, the WHO recommends masks, although some national governments do not.", "questions": "[\"Does the WHO recommend masks for asymptomatic individuals?\", \"Do some national governments recommend masks for asymptomatic individuals?\"]", "answers": "[\"Yes\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2264", "en": "Wearing a mask of some kind is required in some countries and cities in an effort to reduce community transmission.", "fr": "Le port d’une forme quelconque de masque est obligatoire dans certains pays et villes dans le but de réduire la transmission communautaire.", "perturbation": "alteration", "pert_fr": "Le port d’une forme quelconque de masque est interdit dans certains pays et villes dans le but de réduire la transmission communautaire.", "bt_pert_fr": "Wearing any form of mask is banned in some countries and cities in an effort to reduce community transmission.", "questions": "[\"Is wearing a mask of some kind required in some countries and cities?\", \"What is the purpose of wearing a mask in some countries and cities?\", \"How does wearing a mask help reduce community transmission?\"]", "answers": "[\"No\", \"To reduce community transmission\", \"By banning the wearing of any form of mask, it limits the spread of the virus, thus helping to reduce community transmission\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.3333333333333333, "em": false, "chrf": 41.67735369788691, "bleu": 8.097785064266205}], "avg_f1": 0.4444444444444444, "avg_em": 0.3333333333333333, "avg_chrf": 47.2257845659623, "avg_bleu": 36.03259502142208}
{"id": "Wikivoyage_1:2265", "en": "There are worldwide shortages of surgical masks.", "fr": "Une pénurie de masques chirurgicaux sévit dans le monde entier.", "perturbation": "alteration", "pert_fr": "Une surabondance de masques chirurgicaux sévit dans le monde entier.", "bt_pert_fr": "A glut of surgical masks is plaguing the world.", "questions": "[\"Are there worldwide shortages of surgical masks?\"]", "answers": "[\"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2266", "en": "If you do wear a mask, make sure to use it correctly.", "fr": "Si vous portez un masque, veillez à l’utiliser correctement.", "perturbation": "alteration", "pert_fr": "Si vous portez un masque, veillez à ne pas l’utiliser correctement.", "bt_pert_fr": "If you wear a mask, be careful not to use it incorrectly.", "questions": "[\"What should you do if you wear a mask?\", \"How should you use a mask if you wear it?\"]", "answers": "[\"Be careful not to use it incorrectly\", \"Correctly\"]", "scores": [{"f1": 0.2, "em": false, "chrf": 53.86244657973577, "bleu": 6.567274736060395}, {"f1": 0, "em": false, "chrf": 51.139295453519075, "bleu": 0.0}], "avg_f1": 0.1, "avg_em": 0.0, "avg_chrf": 52.50087101662742, "avg_bleu": 3.2836373680301976}
{"id": "Wikivoyage_1:2267", "en": "The mask should cover your nose and mouth and fit without gaps.", "fr": "Le masque doit couvrir votre nez et votre bouche, et être bien ajusté, sans bâillements.", "perturbation": "alteration", "pert_fr": "Le masque ne doit pas couvrir votre nez et votre bouche, et être bien ajusté, sans bâillements.", "bt_pert_fr": "The mask should not cover your nose and mouth, and should fit snugly without gaping.", "questions": "[\"Should the mask cover your nose and mouth?\", \"Should the mask fit without gaps?\"]", "answers": "[\"No\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 50.0, "avg_bleu": 50.00000000000002}
{"id": "Wikivoyage_1:2268", "en": "Wash your hands before putting on the mask and avoid touching the mask while wearing it.", "fr": "Lavez-vous les mains avant de mettre le masque et évitez de le toucher lorsque vous le portez.", "perturbation": "alteration", "pert_fr": "Lavez-vous les mains après de mettre le masque et évitez de ne pas le toucher lorsque vous le portez.", "bt_pert_fr": "Wash your hands after putting on the mask and avoid touching it while wearing it.", "questions": "[\"Should you wash your hands before putting on a mask?\", \"Should you avoid touching the mask while wearing it?\"]", "answers": "[\"No\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 50.0, "avg_bleu": 50.00000000000002}
{"id": "Wikivoyage_1:2270", "en": "When the mask becomes damp, discard and replace it.", "fr": "Lorsque le masque devient humide, jetez-le et remplacez-le.", "perturbation": "alteration", "pert_fr": "Lorsque le masque devient sec, jetez-le et remplacez-le.", "bt_pert_fr": "When the mask becomes dry, throw it away and replace it.", "questions": "[\"When should a mask be discarded and replaced?\", \"What happens to a mask when it becomes damp?\", \"What should be done when a mask becomes damp?\"]", "answers": "[\"When the mask becomes dry\", \"Nothing is mentioned about what happens when a mask becomes damp\", \"Throw it away and replace it\"]", "scores": [{"f1": 0.75, "em": false, "chrf": 82.63043979281078, "bleu": 59.460355750136046}, {"f1": 0.30769230769230765, "em": false, "chrf": 46.46665472585897, "bleu": 8.392229812593097}, {"f1": 0.6, "em": false, "chrf": 56.995969024747836, "bleu": 30.213753973567677}], "avg_f1": 0.5525641025641025, "avg_em": 0.0, "avg_chrf": 62.0310211811392, "avg_bleu": 32.68877984543227}
{"id": "Wikivoyage_1:2272", "en": "Remember that masks are not a substitute for good hygiene: continue to wash your hands frequently.", "fr": "N’oubliez pas que les masques ne remplacent pas une bonne hygiène : continuez à vous laver les mains fréquemment.", "perturbation": "alteration", "pert_fr": "N’oubliez pas que les masques remplacent une bonne hygiène : arrêtez de vous laver les mains fréquemment.", "bt_pert_fr": "Remember that masks replace good hygiene: stop washing your hands frequently.", "questions": "[\"Should masks replace good hygiene?\", \"Is it necessary to continue washing hands frequently?\", \"Do masks provide adequate protection on their own?\", \"What should be done in addition to wearing masks?\"]", "answers": "[\"Yes\", \"No\", \"Not stated\", \"Stop washing your hands frequently\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 51.22950819672132, "bleu": 0.0}, {"f1": 0.6666666666666665, "em": false, "chrf": 79.4155220697142, "bleu": 39.76353643835254}], "avg_f1": 0.16666666666666663, "avg_em": 0.0, "avg_chrf": 32.66125756660888, "avg_bleu": 9.940884109588135}
{"id": "Wikivoyage_1:2273", "en": "Don't stock up on masks if you don't need them.", "fr": "Ne vous approvisionnez pas en masques si vous n’en avez pas besoin.", "perturbation": "alteration", "pert_fr": "Ne vous approvisionnez pas en masques si vous en avez besoin.", "bt_pert_fr": "Don’t stock up on masks if you need them.", "questions": "[\"Should you stock up on masks if you don't need them?\"]", "answers": "[\"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2276", "en": "Leave them for healthcare workers.", "fr": "Laissez-les aux professionnels de la santé.", "perturbation": "alteration", "pert_fr": "Laissez-les aux amateurs de la santé.", "bt_pert_fr": "Leave them to the health enthusiasts.", "questions": "[\"Who should leave them for?\" ]", "answers": "[\"Health enthusiasts\"]", "scores": [{"f1": 0, "em": false, "chrf": 26.000727213962506, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 26.000727213962506, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2281", "en": "At petrol/gas stations, use gloves or wipe down the handle with a disinfectant wipe if you can.", "fr": "Dans les stations-services, utilisez des gants ou essuyez la poignée à l’aide d’une lingette désinfectante dans la mesure du possible.", "perturbation": "alteration", "pert_fr": "Dans les stations-services, n'utilisez pas de gants ou essuyez la poignée à l’aide d’une lingette contaminante dans la mesure du possible.", "bt_pert_fr": "At gas stations, do not use gloves or wipe the handle with a contaminating wipe if possible.", "questions": "[\"Should gloves be used at petrol/gas stations?\", \"Is it recommended to wipe down the handle with a disinfectant wipe at petrol/gas stations?\"]", "answers": "[\"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2283", "en": "The U.S. and Canadian governments recommend avoiding travel by cruise ship.", "fr": "Les gouvernements américain et canadien recommandent d’éviter de voyager sur un paquebot de croisière.", "perturbation": "alteration", "pert_fr": "Les gouvernements américain et canadien recommandent de préférer de voyager sur un paquebot de croisière.", "bt_pert_fr": "The American and Canadian governments recommend that you prefer to travel on a cruise liner.", "questions": "[\"What do the U.S. and Canadian governments recommend regarding travel by cruise ship?\"]", "answers": "[\"To prefer traveling on a cruise liner\"]", "scores": [{"f1": 0.1818181818181818, "em": false, "chrf": 33.64954139647831, "bleu": 8.116697886877475}], "avg_f1": 0.1818181818181818, "avg_em": 0.0, "avg_chrf": 33.64954139647831, "avg_bleu": 8.116697886877475}
{"id": "Wikivoyage_1:2284", "en": "Infections spread easily on board, and medical care is limited.", "fr": "Les infections se propagent facilement à bord, et les services médicaux y sont limités.", "perturbation": "alteration", "pert_fr": "Les infections se propagent difficilement à bord, et les services médicaux y sont étendus.", "bt_pert_fr": "Infections spread with difficulty on board, and medical services are extensive.", "questions": "[\"How easily do infections spread on board?\", \"What is the situation regarding medical care on board?\"]", "answers": "[\"With difficulty\", \"Extensive\"]", "scores": [{"f1": 0, "em": false, "chrf": 6.578947368421052, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 9.361383442265796, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 7.970165405343424, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2286", "en": "Even cruise ships without confirmed cases have been denied permission to dock due to virus fears, and in the high-profile case of the Diamond Princess in Japan, hundreds of people were infected on the ship.", "fr": "Même les paquebots de croisière sans cas confirmés se sont vu refuser l’autorisation de mise à quai en raison des craintes suscitées par le virus et, dans le cas très médiatisé du Diamond Princess au Japon, des centaines de personnes ont été infectées à bord.", "perturbation": "alteration", "pert_fr": "Même les paquebots de croisière avec des cas confirmés se sont vu accorder l’autorisation de mise à quai en raison des espoirs suscités par le virus et, dans le cas très médiatisé du Diamond Princess au Japon, des centaines de personnes ont été guéries à bord.", "bt_pert_fr": "Even cruise ships with confirmed cases have been granted docking permission due to hopes raised by the virus and, in the high-profile case of the Diamond Princess in Japan, hundreds of people were cured on board.", "questions": "[\"Why have cruise ships without confirmed cases been denied permission to dock?\", \"How many people were infected on the Diamond Princess?\", \"What led to the denial of docking permission for cruise ships?\", \"What was the outcome of the Diamond Princess case in Japan?\"]", "answers": "[\"The sentence does not provide information on why cruise ships without confirmed cases have been denied permission to dock\", \"The sentence does not specify the number of people infected on the Diamond Princess\", \"Hopes raised by the virus led to the denial of docking permission for cruise ships\", \"Hundreds of people were cured on board\"]", "scores": [{"f1": 0.08695652173913043, "em": false, "chrf": 10.342202296533717, "bleu": 2.0244462660665508}, {"f1": 0.26666666666666666, "em": false, "chrf": 29.367063754676103, "bleu": 6.772997136689072}, {"f1": 0, "em": false, "chrf": 12.727229948198293, "bleu": 0.0}, {"f1": 0.7142857142857143, "em": false, "chrf": 62.262326743401466, "bleu": 43.47208719449914}], "avg_f1": 0.26697722567287785, "avg_em": 0.0, "avg_chrf": 28.674705685702396, "avg_bleu": 13.067382649313691}
{"id": "Wikivoyage_1:2287", "en": "If you believe you may be infected, call a hospital or local emergency medical services instead of going in person to avoid infecting others.", "fr": "Si vous pensez être infecté, appelez un hôpital ou les services d’aide médicale d’urgence locaux plutôt que de vous y rendre en personne, afin d’éviter d’infecter les autres.", "perturbation": "alteration", "pert_fr": "Si vous pensez ne pas être infecté, appelez un hôpital ou les services d’aide médicale d’urgence locaux plutôt que de vous y rendre en personne, afin d’éviter d’infecter les autres.", "bt_pert_fr": "If you think you are not infected, call a hospital or local emergency medical services rather than going there in person, to avoid infecting others.", "questions": "[\"Should you believe you may be infected, should you call a hospital or local emergency medical services instead of going in person to avoid infecting others?\"]", "answers": "[\"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2288", "en": "Mention your symptoms and travel history.", "fr": "Indiquez vos symptômes et l’historique de vos déplacements.", "perturbation": "alteration", "pert_fr": "Indiquez vos symptômes et l’historique de vos séjours.", "bt_pert_fr": "Indicate your symptoms and the history of your stays.", "questions": "[\"What symptoms should you mention?\", \"What about your travel history should you mention?\"]", "answers": "[\"Your symptoms\", \"Your history of stays\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5714285714285715, "em": false, "chrf": 41.92058220091961, "bleu": 18.99589214128981}], "avg_f1": 0.7857142857142858, "avg_em": 0.5, "avg_chrf": 70.96029110045981, "avg_bleu": 59.49794607064493}
{"id": "Wikivoyage_1:2291", "en": "On a plane, follow the same hygiene practices as anywhere else: wash hands frequently, or use alcohol-based hand sanitizer if it's not convenient to leave your seat, and avoid touching your face.", "fr": "En avion, adoptez les mêmes pratiques d’hygiène que partout ailleurs : lavez-vous les mains fréquemment ou utilisez une solution hydro-alcoolique s’il n’est pas pratique de quitter votre siège, et évitez de vous toucher le visage.", "perturbation": "alteration", "pert_fr": "En avion, adoptez les mêmes pratiques d'insalubrité que partout ailleurs : lavez-vous les mains rarement ou utilisez une solution hydro-alcoolique s’il est pratique de quitter votre siège, et évitez de ne pas vous toucher le visage.", "bt_pert_fr": "On a plane, adopt the same unsanitary practices as everywhere else: wash your hands rarely or use a hydro-alcoholic solution if it is practical to leave your seat, and avoid touching your face.", "questions": "[\"Should you wash your hands frequently on a plane?\", \"Should you use alcohol-based hand sanitizer on a plane?\", \"Is it recommended to avoid touching your face on a plane?\"]", "answers": "[\"No\", \"Yes\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6666666666666666, "avg_em": 0.6666666666666666, "avg_chrf": 66.66666666666667, "avg_bleu": 66.6666666666667}
{"id": "Wikivoyage_1:2293", "en": "Try to book a window seat, and avoid moving around the cabin during the flight.", "fr": "Essayez de réserver un siège côté hublot et évitez de vous déplacer dans la cabine pendant le vol.", "perturbation": "alteration", "pert_fr": "Essayez de réserver un siège côté couloir et évitez de vous déplacer dans la cabine pendant le vol.", "bt_pert_fr": "Try to reserve an aisle seat and avoid moving around the cabin during the flight.", "questions": "[\"Should you try to book a window seat?\", \"Should you avoid moving around the cabin during the flight?\"]", "answers": "[\"No\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 50.0, "avg_bleu": 50.00000000000002}
{"id": "Wikivoyage_1:2294", "en": "After washing your hands and before sitting down, use disinfectant wipes to wipe down the area around your seat.", "fr": "Après vous être lavé les mains et avant de vous asseoir, utilisez des lingettes désinfectantes pour essuyer la zone autour de votre siège.", "perturbation": "alteration", "pert_fr": "Après vous être lavé les mains et avant de vous asseoir, utilisez des lingettes infectantes pour essuyer la zone autour de votre siège.", "bt_pert_fr": "After washing your hands and before sitting down, use infective wipes to wipe down the area around your seat.", "questions": "[\"Should you use disinfectant wipes after washing your hands and before sitting down?\", \"What should you do after washing your hands and before sitting down?\", \"What is the recommended step to take after washing your hands and before sitting down?\"]", "answers": "[\"Yes\", \"Use infective wipes to wipe down the area around your seat\", \"Use infective wipes to wipe down the area around your seat\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.9, "em": false, "chrf": 78.0356344344703, "bleu": 78.25422900366438}, {"f1": 0.9, "em": false, "chrf": 78.0356344344703, "bleu": 78.25422900366438}], "avg_f1": 0.9333333333333332, "avg_em": 0.3333333333333333, "avg_chrf": 85.3570896229802, "avg_bleu": 85.50281933577627}
{"id": "Wikivoyage_1:2295", "en": "Wipe hard surfaces, and if your seat is leather you can wipe that too.", "fr": "Essuyez les surfaces dures et, si votre siège est en cuir, essuyez-le également.", "perturbation": "alteration", "pert_fr": "Essuyez les surfaces molles et, si votre siège est en cuir, ne l'essuyez pas.", "bt_pert_fr": "Wipe soft surfaces, and if your seat is leather, don't wipe it.", "questions": "[\"Should hard surfaces be wiped?\", \"Should a leather seat be wiped too?\"]", "answers": "[\"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2304", "en": "If a group of passengers is connecting from an area with a severe outbreak, the flight attendants may be able to seat them away from the rest of the passengers (and if you were recently in a high-risk area, consider telling the flight attendants for this reason).", "fr": "Si un groupe de passagers en correspondance provient d’une région touchée par une épidémie sévère, le personnel de cabine pourra peut-être les faire s'asseoir à l’écart du reste des passagers (et si vous vous êtes récemment rendu dans une région à haut risque, envisagez de le signaler au personnel de cabine pour cette raison).", "perturbation": "alteration", "pert_fr": "Si un groupe de passagers en correspondance provient d’une région épargnée par une épidémie sévère, le personnel de cabine pourra peut-être les faire s'asseoir au milieu du reste des passagers.", "bt_pert_fr": "If a group of connecting passengers is coming from an area without a severe outbreak, cabin crew may be able to seat them among the rest of the passengers.", "questions": "[\"Can flight attendants seat connecting passengers away from the rest of the passengers if the passengers are coming from an area with a severe outbreak?\", \"Should passengers who recently visited a high-risk area inform the flight attendants?\" ]", "answers": "[\"No\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 50.0, "avg_bleu": 50.00000000000002}
{"id": "Wikivoyage_1:2306", "en": "This is so that, if someone on the flight turns out to be infected, the authorities can track down the people who were sitting near them for testing or quarantine.", "fr": "Si un passager du vol est infecté, cette mesure permet aux autorités de retrouver les personnes assises à côté de lui pour les tester ou les mettre en quarantaine.", "perturbation": "alteration", "pert_fr": "Si un passager du vol n'est pas infecté, cette mesure permet aux autorités de retrouver les personnes assises à côté de lui pour les tester ou les mettre en quarantaine.", "bt_pert_fr": "If a passenger on the flight is not infected, this measure allows authorities to find the people sitting next to them for testing or quarantine.", "questions": "[\"Why is it important to track down people who were sitting near an infected individual on a flight?\", \"What action do authorities take if someone on the flight is found to be infected?\", \"What is the purpose of tracking people who sat near an infected individual on a flight?\"]", "answers": "[\"To identify individuals who may have been exposed to the infection\", \"They find the people sitting next to them for testing or quarantine\", \"To enable testing or quarantine of potentially exposed individuals\"]", "scores": [{"f1": 0.23076923076923075, "em": false, "chrf": 12.783338102883105, "bleu": 3.0307561627463224}, {"f1": 0.64, "em": false, "chrf": 59.91927899455135, "bleu": 30.040009257419577}, {"f1": 0.39999999999999997, "em": false, "chrf": 36.18796091230608, "bleu": 10.25262970250096}], "avg_f1": 0.42358974358974355, "avg_em": 0.0, "avg_chrf": 36.29685933658018, "avg_bleu": 14.44113170755562}
{"id": "Wikivoyage_1:2311", "en": "Mild symptoms may be relieved by taking paracetamol (acetaminophen).", "fr": "Les symptômes légers peuvent être soulagés par la prise de paracétamol (acétaminophène).", "perturbation": "alteration", "pert_fr": "Les symptômes graves peuvent être soulagés par la prise de paracétamol (acétaminophène).", "bt_pert_fr": "Severe symptoms may be relieved by taking paracetamol (acetaminophen).", "questions": "[\"Can mild symptoms be relieved by taking paracetamol (acetaminophen)?\" ]", "answers": "[\"Not specified\"]", "scores": [{"f1": 0, "em": false, "chrf": 13.88888888888889, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 13.88888888888889, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2312", "en": "If you are infected with COVID-19, countries will isolate you until several consecutive tests for COVID-19 are negative.", "fr": "Si vous êtes infecté par le virus de la COVID-19, les pays vous isoleront jusqu’à ce que plusieurs tests consécutifs de dépistage de la COVID-19 soient négatifs.", "perturbation": "alteration", "pert_fr": "Si vous êtes infecté par le virus de la COVID-19, les pays vous accueilleront jusqu’à ce que plusieurs tests consécutifs de dépistage de la COVID-19 soient négatifs.", "bt_pert_fr": "If you are infected with the COVID-19 virus, countries will accommodate you until several consecutive COVID-19 tests are negative.", "questions": "[\"Will countries isolate you if you are infected with COVID-19?\", \"How long will countries isolate you if you are infected with COVID-19?\", \"What condition must be met for countries to stop isolating you after being infected with COVID-19?\", \"What does it mean for several consecutive tests for COVID-19 to be negative?\"]", "answers": "[\"No\", \"Until several consecutive COVID-19 tests are negative\", \"Several consecutive COVID-19 tests must be negative\", \"It means that multiple tests taken in a row show no presence of the virus\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.9333333333333333, "em": false, "chrf": 77.98519760397939, "bleu": 28.98580955281284}, {"f1": 0.9333333333333333, "em": false, "chrf": 76.95939826579877, "bleu": 28.98580955281284}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7166666666666667, "avg_em": 0.25, "avg_chrf": 63.736148967444535, "avg_bleu": 39.492904776406434}
{"id": "Wikivoyage_1:2313", "en": "If you have been in close contact with someone infected with COVID-19, many countries will quarantine you for 14 days since the last exposure and monitor you for signs and symptoms.", "fr": "Si vous avez été en contact étroit avec une personne infectée par le virus de la COVID-19, de nombreux pays vous mettront en quarantaine pendant 14 jours à compter de la dernière exposition et vous placeront sous surveillance pour déceler les signes et symptômes.", "perturbation": "alteration", "pert_fr": "Si vous n'avez pas été en contact étroit avec une personne infectée par le virus de la COVID-19, de nombreux pays vous mettront en liberté pendant 14 jours à compter de la dernière exposition et vous placeront sous ignorance pour déceler les signes et symptômes.", "bt_pert_fr": "If you have not been in close contact with someone infected with the COVID-19 virus, many countries will release you for 14 days from last exposure and blind you for signs and symptoms.", "questions": "[\"Will you be quarantined if you have been in close contact with someone infected with COVID-19?\", \"How long is the quarantine period after close contact with someone infected with COVID-19?\", \"What do many countries monitor you for during quarantine after close contact with someone infected with COVID-19?\"]", "answers": "[\"Yes\", \"Not specified\", \"Signs and symptoms\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 4.62962962962963, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6666666666666666, "avg_em": 0.6666666666666666, "avg_chrf": 68.20987654320987, "avg_bleu": 66.6666666666667}
{"id": "Wikivoyage_1:2314", "en": "Some countries will also test you even if you don't have symptoms.", "fr": "Certains pays vous testeront également même si vous ne présentez aucun symptôme.", "perturbation": "alteration", "pert_fr": "Certains pays ne vous testeront pas même si vous présentez des symptômes.", "bt_pert_fr": "Some countries will not test you even if you have symptoms.", "questions": "[\"Will some countries test you even if you don't have symptoms?\"]", "answers": "[\"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2315", "en": "In many countries, the healthcare system has been stretched to the point of not being able to handle the sheer number of patients, and there is a chance you may be refused treatment due to the lack of available medical staff, supplies or equipment.", "fr": "Dans de nombreux pays, le système de santé a été mis à rude épreuve au point de ne pas être en mesure de prendre en charge le grand nombre de patients, et il se peut que vous vous voyiez refuser un traitement en raison du manque de personnel, fournitures et équipements médicaux.", "perturbation": "alteration", "pert_fr": "Dans de nombreux pays, le système de santé a été mis à rude épreuve au point d'être en mesure de prendre en charge le petit nombre de patients, et il se peut que vous vous voyiez accorder un traitement en raison du surplus de personnel, fournitures et équipements médicaux.", "bt_pert_fr": "In many countries, the healthcare system has been stretched beyond capacity to care for the small number of patients, and you may be denied treatment due to excess medical staff, supplies and equipment.", "questions": "[\"Has the healthcare system in many countries been stretched to the point of not being able to handle the sheer number of patients?\", \"May patients be refused treatment in many countries due to a lack of available medical staff?\", \"May patients be refused treatment in many countries due to a lack of available supplies?\", \"May patients be refused treatment in many countries due to a lack of available equipment?\"]", "answers": "[\"Yes\", \"Yes\", \"Yes\", \"Yes\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikivoyage_1:2317", "en": "Even more countries have imposed restrictions on arriving travelers, either barring entry (maybe with an exception for local citizens and permanent residents) or requiring you to be quarantined, typically for 14 days.", "fr": "Un plus grand nombre de pays encore a imposé des restrictions aux voyageurs à l’arrivée, soit en refusant l’entrée (sauf peut-être aux citoyens et résidents permanents du pays), soit en vous imposant une quarantaine, généralement de 14 jours.", "perturbation": "alteration", "pert_fr": "Un plus petit nombre de pays encore a imposé des restrictions aux voyageurs à l’arrivée, soit en refusant l’entrée (sauf peut-être aux citoyens et résidents permanents du pays), soit en vous imposant une quarantaine, généralement de 14 jours.", "bt_pert_fr": "An even smaller number of countries have imposed restrictions on arriving travelers, either by refusing entry (except perhaps to citizens and permanent residents of the country) or by requiring you to quarantine, usually for 14 days.", "questions": "[\"What countries have imposed restrictions on arriving travelers?\", \"Do any countries bar entry for arriving travelers?\", \"Are there exceptions to entry bans for arriving travelers?\", \"Do some countries require arriving travelers to be quarantined?\", \"How long is the typical quarantine period for arriving travelers?\"]", "answers": "[\"An even smaller number of countries\", \"Yes\", \"Yes\", \"Yes\", \"14 days\"]", "scores": [{"f1": 0.2222222222222222, "em": false, "chrf": 46.10382747740039, "bleu": 8.116697886877475}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8444444444444444, "avg_em": 0.8, "avg_chrf": 89.22076549548008, "avg_bleu": 81.62333957737553}
{"id": "Wikivoyage_1:2318", "en": "Even if a mandatory quarantine is not imposed, you may be asked to \"self-quarantine\" by staying at home and not interacting with other people.", "fr": "Même si une quarantaine obligatoire n’est pas imposée, il peut vous être demandé de vous mettre en « auto-quarantaine » en restant chez vous et en évitant toute interaction avec les autres.", "perturbation": "alteration", "pert_fr": "Même si une quarantaine obligatoire est imposée, il peut vous être demandé de vous mettre en « auto-liberté » en sortant chez vous et en favorisant toute interaction avec les autres.", "bt_pert_fr": "Even if a mandatory quarantine is imposed, you may be asked to enter into “self-freedom” by going out at home and encouraging any interaction with others.", "questions": "[\"What happens if a mandatory quarantine is not imposed?\", \"What does 'self-quarantine' involve?\", \"Is it possible to be asked to self-quarantine even without a mandatory quarantine?\", \"What actions are required during self-quarantine?\"]", "answers": "[\"Nothing is mentioned about what happens if a mandatory quarantine is not imposed\", \"Going out at home and encouraging any interaction with others\", \"Yes\", \"Going out at home and encouraging any interaction with others\"]", "scores": [{"f1": 0.07142857142857144, "em": false, "chrf": 28.047104363122116, "bleu": 2.426532257432171}, {"f1": 0.4210526315789474, "em": false, "chrf": 52.79720824530393, "bleu": 16.784459625186194}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4210526315789474, "em": false, "chrf": 52.79720824530393, "bleu": 16.784459625186194}], "avg_f1": 0.4783834586466166, "avg_em": 0.25, "avg_chrf": 58.41038021343249, "avg_bleu": 33.99886287695115}
{"id": "Wikivoyage_1:2319", "en": "The most severe restrictions are on travellers who have recently been to affected areas, but increasingly many countries are applying them to incoming travellers overall.", "fr": "Les restrictions les plus strictes concernent les voyageurs qui se trouvaient récemment dans des régions touchées mais, de plus en plus, de nombreux pays les appliquent à tous les voyageurs entrants.", "perturbation": "alteration", "pert_fr": "Les restrictions les moins strictes concernent les voyageurs qui se trouvaient récemment dans des régions touchées mais, de plus en plus, de nombreux pays les appliquent à tous les voyageurs entrants.", "bt_pert_fr": "The least stringent restrictions apply to travelers who were recently in affected regions, but increasingly many countries are applying them to all incoming travelers.", "questions": "[\"What type of travellers are subject to the most severe restrictions?\", \"Are restrictions on travellers being applied more broadly to incoming travellers overall?\"]", "answers": "[\"Travelers who were recently in affected regions\", \"No\"]", "scores": [{"f1": 0.39999999999999997, "em": false, "chrf": 50.59900772334539, "bleu": 7.492442692259767}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.19999999999999998, "avg_em": 0.0, "avg_chrf": 25.299503861672694, "avg_bleu": 3.7462213461298837}
{"id": "Wikivoyage_1:2321", "en": "What are the affected areas?", "fr": "Quelles sont les régions touchées ?", "perturbation": "alteration", "pert_fr": "Quelles sont les régions épargnées ?", "bt_pert_fr": "Which regions are spared?", "questions": "[\"Which areas are affected?\", \"What specific regions are impacted?\"]", "answers": "[\"None\", \"None\"]", "scores": [{"f1": 0, "em": false, "chrf": 1.8382352941176472, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 6.6980286738351245, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 4.268131983976386, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2322", "en": "Well, this is a fast-changing situation, and each country/region/organization has its own list of what areas are subject to restrictions.", "fr": "Il s’agit ici d’une situation évoluant rapidement, et chaque pays/région/organisation a sa propre liste de zones soumises à restrictions.", "perturbation": "alteration", "pert_fr": "Il s’agit ici d’une situation stagnante, et chaque pays/région/organisation a sa propre liste de zones soumises à restrictions.", "bt_pert_fr": "This is a stagnant situation, and each country/region/organization has its own list of restricted areas.", "questions": "[\"What areas are subject to restrictions in each country/region/organization?\", \"Does the list of restricted areas vary by country/region/organization?\", \"Is the list of restricted areas determined differently across countries/regions/organizations?\"]", "answers": "[\"Restricted areas\", \"Yes\", \"Yes\"]", "scores": [{"f1": 0.25, "em": false, "chrf": 25.894003416578432, "bleu": 6.7667641618306344}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.75, "avg_em": 0.6666666666666666, "avg_chrf": 75.29800113885948, "avg_bleu": 68.92225472061024}
{"id": "Wikivoyage_1:2323", "en": "The city of Wuhan is on every list and the rest of mainland China is on most.", "fr": "La ville de Wuhan figure sur toutes les listes, et le reste de la Chine continentale sur la plupart.", "perturbation": "alteration", "pert_fr": "La ville de Wuhan ne figure pas sur toutes les listes, et le reste de la Chine continentale sur la plupart.", "bt_pert_fr": "The city of Wuhan is not on all the lists, and the rest of mainland China is not on most.", "questions": "[\"Is the city of Wuhan on every list?\", \"Is the rest of mainland China on most lists?\"]", "answers": "[\"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2325", "en": "Some countries have imposed restrictions based on citizenship or residency from severely affected areas.", "fr": "Certains pays imposent des restrictions aux citoyens et résidents des zones sévèrement touchées.", "perturbation": "alteration", "pert_fr": "Certains pays imposent des libertés aux citoyens et résidents des zones sévèrement touchées.", "bt_pert_fr": "Some countries impose freedoms on citizens and residents of severely affected areas.", "questions": "[\"What restrictions have some countries imposed based on citizenship or residency from severely affected areas?\", \"Are there restrictions based on citizenship from severely affected areas in some countries?\", \"Are there restrictions based on residency from severely affected areas in some countries?\"]", "answers": "[\"None\", \"Yes\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 1.874900535780595, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6666666666666666, "avg_em": 0.6666666666666666, "avg_chrf": 67.29163351192686, "avg_bleu": 66.6666666666667}
{"id": "Wikivoyage_1:2326", "en": "A detailed list of entry restrictions is maintained by the IATA.", "fr": "Une liste détaillée des restrictions d’entrée est tenue à jour par l’IATA.", "perturbation": "alteration", "pert_fr": "Une liste détaillée des autorisations d’entrée est tenue à jour par l’IATA.", "bt_pert_fr": "A detailed list of entry authorizations is maintained by IATA.", "questions": "[\"Who maintains a detailed list of entry restrictions?\", \"What is maintained by the IATA?\"]", "answers": "[\"IATA\", \"A detailed list of entry authorizations\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 48.56912535268037, "bleu": 36.78794411714425}, {"f1": 0.8333333333333334, "em": false, "chrf": 68.52704548147278, "bleu": 75.98356856515926}], "avg_f1": 0.75, "avg_em": 0.0, "avg_chrf": 58.54808541707658, "avg_bleu": 56.385756341151755}
{"id": "Wikivoyage_1:2328", "en": "Keep up to date—the outbreak and the travel restrictions are changing rapidly.", "fr": "Tenez-vous au courant : l’épidémie et les restrictions de voyage évoluent rapidement.", "perturbation": "alteration", "pert_fr": "Tenez-vous au courant : l’épidémie et les restrictions de voyage régressent rapidement.", "bt_pert_fr": "Stay informed: the epidemic and travel restrictions are rapidly decreasing.", "questions": "[\"How quickly are the outbreak and travel restrictions changing?\", \"Are the outbreak and travel restrictions changing rapidly?\"]", "answers": "[\"Rapidly\", \"Yes\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikivoyage_1:2329", "en": "For travel in the near future, consider making refundable reservations in case the changing situation forces you to change your plans.", "fr": "Pour les voyages dans un avenir proche, envisagez d’effectuer des réservations remboursables pour le cas où l’évolution de la situation vous contraindrait à modifier vos plans.", "perturbation": "alteration", "pert_fr": "Pour les voyages dans un avenir proche, envisagez d’effectuer des réservations non remboursables pour le cas où l’évolution de la situation vous contraindrait à modifier vos plans.", "bt_pert_fr": "For trips in the near future, consider making non-refundable reservations in case developments force you to change your plans.", "questions": "[\"Should you make refundable reservations for travel in the near future?\", \"What should you consider when planning travel in the near future due to changing circumstances?\", \"Why is it advisable to make refundable reservations for travel in the near future?\"]", "answers": "[\"No\", \"Making non-refundable reservations\", \"Because changing circumstances might force you to change your plans\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 87.64075178058015, "bleu": 34.66806371753173}, {"f1": 0.9, "em": false, "chrf": 78.17477674145985, "bleu": 70.71067811865478}], "avg_f1": 0.5222222222222223, "avg_em": 0.0, "avg_chrf": 55.271842840679994, "avg_bleu": 35.12624727872884}
{"id": "Wikivoyage_1:2330", "en": "Avoid buying tickets with a connection in an affected area – even changing planes can make you subject to restrictions.", "fr": "Évitez d’acheter des billets avec une correspondance dans une région touchée : un simple changement d’avion peut vous soumettre à des restrictions.", "perturbation": "alteration", "pert_fr": "Évitez de ne pas acheter des billets avec une correspondance dans une région touchée : un simple changement d’avion peut vous soumettre à des restrictions.", "bt_pert_fr": "Avoid buying tickets with a connection in an affected region: a simple change of plane may subject you to restrictions.", "questions": "[\"Should you avoid buying tickets with a connection in an affected area?\", \"Does changing planes make you subject to restrictions?\", \"Is it necessary to avoid tickets with a connection in an affected area?\", \"Can changing planes result in being subject to travel restrictions?\"]", "answers": "[\"Yes\", \"Yes\", \"Yes\", \"Yes\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikivoyage_1:2332", "en": "You might also be delayed for hours upon arrival waiting for temperature checks and related procedures and paperwork, or even get quarantined for two weeks.", "fr": "Vous pouvez également être retardé des heures à l’arrivée pour les contrôles de température, et les procédures et formalités associées, voire être mis en quarantaine pendant deux semaines.", "perturbation": "alteration", "pert_fr": "Vous pouvez également être avancé des heures à l’arrivée pour les contrôles de température, et les procédures et formalités associées, voire être libéré pendant deux semaines.", "bt_pert_fr": "You may also be brought forward hours on arrival for temperature checks, and associated procedures and formalities, or even be released for two weeks.", "questions": "[\"May you be delayed for hours upon arrival waiting for temperature checks and related procedures and paperwork?\", \"Could you be quarantined for two weeks upon arrival?\", \"What procedures and paperwork are involved upon arrival?\", \"How long might you wait upon arrival for temperature checks and related procedures?\"]", "answers": "[\"No, you may be brought forward, not delayed\", \"Yes, you might be released for two weeks\", \"Temperature checks, and associated procedures and formalities\", \"Hours\"]", "scores": [{"f1": 0, "em": false, "chrf": 3.6231884057971016, "bleu": 0.0}, {"f1": 0.2222222222222222, "em": false, "chrf": 25.43537220755121, "bleu": 5.522397783539471}, {"f1": 0.7142857142857143, "em": false, "chrf": 69.20353665339286, "bleu": 30.739407647563215}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.48412698412698413, "avg_em": 0.25, "avg_chrf": 49.56552431668529, "avg_bleu": 34.065451357775686}
{"id": "Wikivoyage_1:2334", "en": "Even if you're nowhere near affected areas there's a risk that you'll have to stay at the destination longer than planned if you've shared a building or vessel with an infected person.", "fr": "Même si vous êtes très loin des régions touchées, vous risquez de devoir rester plus longtemps que prévu au lieu de destination si vous vous êtes trouvé dans le même bâtiment ou navire qu’une personne infectée.", "perturbation": "alteration", "pert_fr": "Même si vous êtes très près des régions touchées, vous risquez de devoir rester moins longtemps que prévu au lieu de destination si vous vous êtes trouvé dans le même bâtiment ou navire qu’une personne infectée.", "bt_pert_fr": "Even if you are very close to the affected areas, you may have to stay less than expected at your destination if you have been in the same building or ship as an infected person.", "questions": "[\"Is there a risk that you'll have to stay at the destination longer than planned if you've shared a building or vessel with an infected person?\", \"What factors increase the risk of having to stay at the destination longer than planned?\", \"Does sharing a building or vessel with an infected person affect the duration of stay at a destination?\"]", "answers": "[\"No\", \"Sharing a building or vessel with an infected person\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6666666666666666, "avg_em": 0.6666666666666666, "avg_chrf": 66.66666666666667, "avg_bleu": 66.6666666666667}
{"id": "Wikivoyage_1:2335", "en": "For example, in late February an Italian doctor on vacation in Costa Adeje (Canary Islands) was diagnosed with COVID-19, and as a result all the guests in the hotel he stayed at were quarantined.", "fr": "Fin février, par exemple, la COVID-19 a été diagnostiquée chez un médecin italien en vacances à Costa Adeje (îles Canaries) et, en conséquence, tous les clients de l’hôtel dans lequel il séjournait ont été mis en quarantaine.", "perturbation": "alteration", "pert_fr": "Fin février, par exemple, la COVID-19 n'a pas été diagnostiquée chez un médecin italien en vacances à Costa Adeje (îles Canaries) et, en conséquence, tous les clients de l’hôtel dans lequel il séjournait ont été libérés de la quarantaine.", "bt_pert_fr": "At the end of February, for example, COVID-19 was not diagnosed in an Italian doctor on vacation in Costa Adeje (Canary Islands) and, as a result, all guests of the hotel where he was staying were released from quarantine.", "questions": "[\"Was an Italian doctor diagnosed with COVID-19 in late February?\", \"Where was the Italian doctor on vacation in late February?\", \"What happened as a result of the Italian doctor being diagnosed with COVID-19?\", \"Were the guests in the hotel quarantined after the Italian doctor was diagnosed with COVID-19?\"]", "answers": "[\"No\", \"Costa Adeje (Canary Islands)\", \"All guests of the hotel where he was staying were released from quarantine\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4761904761904762, "em": false, "chrf": 50.175637246005486, "bleu": 8.51659301881964}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.36904761904761907, "avg_em": 0.25, "avg_chrf": 37.54390931150137, "avg_bleu": 27.12914825470492}
{"id": "Wikivoyage_1:2338", "en": "These include the temporary reintroduction of some border controls, restrictions on travel within the country, closing or limiting service at restaurants and other establishments, banning large public events, and in the most severe cases prohibiting people from leaving the house except for essential reasons.", "fr": "Celles-ci incluent la réintroduction temporaire de certains contrôles frontaliers, les restrictions sur les déplacements au sein du pays, la fermeture ou la limitation de l’activité des restaurants et d’autres établissements, l’interdiction des grands événements publics et, dans les cas les plus sévères, l’interdiction de quitter son domicile, sauf pour raisons essentielles.", "perturbation": "alteration", "pert_fr": "Celles-ci incluent la suppression temporaire de certains contrôles frontaliers, les restrictions sur les déplacements au sein du pays, l’ouverture ou l’extension de l’activité des restaurants et d’autres établissements, l’autorisation des grands événements publics et, dans les cas les moins sévères, la liberté de quitter son domicile, sans raisons particulières.", "bt_pert_fr": "These include the temporary removal of certain border controls, restrictions on travel within the country, the opening or expansion of the activity of restaurants and other establishments, the authorization of large public events and, in the least severe cases, the freedom to leave one's home, without particular reasons.", "questions": "[\"What temporary measures were reintroduced regarding border controls?\", \"What restrictions were placed on travel within the country?\", \"What measures were taken regarding the operation of restaurants and other establishments?\", \"What restrictions were imposed on large public events?\", \"What measures were implemented in the most severe cases regarding people's ability to leave their homes?\"]", "answers": "[\"the temporary removal of certain border controls\", \"restrictions on travel within the country\", \"the opening or expansion of the activity of restaurants and other establishments\", \"the authorization of large public events\", \"the freedom to leave one's home, without particular reasons\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 54.8587433378802, "bleu": 19.304869754804482}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5263157894736842, "em": false, "chrf": 62.221939346586375, "bleu": 27.77619034011791}, {"f1": 0.6666666666666665, "em": false, "chrf": 64.52413663566806, "bleu": 39.76353643835254}, {"f1": 0.11764705882352941, "em": false, "chrf": 23.48989379128577, "bleu": 4.8734989388136185}], "avg_f1": 0.5954592363261093, "avg_em": 0.2, "avg_chrf": 61.01894262228408, "avg_bleu": 38.34361909441772}
{"id": "Wikivoyage_1:2339", "en": "Beyond government restrictions, individual establishments are shutting their doors and cancelling events to try to reduce the spread of the virus.", "fr": "En plus des restrictions gouvernementales, des établissements individuels ferment leurs portes et annulent des événements afin d’essayer de réduire la propagation du virus.", "perturbation": "alteration", "pert_fr": "En plus des restrictions gouvernementales, des établissements individuels ouvrent leurs portes et organisent des événements afin d’essayer d’augmenter la propagation du virus.", "bt_pert_fr": "In addition to government restrictions, individual establishments are opening their doors and hosting events in an attempt to increase the spread of the virus.", "questions": "[\"Are individual establishments shutting their doors beyond government restrictions?\", \"Are events being cancelled by individual establishments beyond government restrictions?\", \"What measures are individual establishments taking beyond government restrictions to reduce the spread of the virus?\"]", "answers": "[\"No\", \"No\", \"Hosting events\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.25, "em": false, "chrf": 24.85520578929388, "bleu": 6.7667641618306344}], "avg_f1": 0.08333333333333333, "avg_em": 0.0, "avg_chrf": 8.285068596431293, "avg_bleu": 2.2555880539435447}
{"id": "Wikivoyage_1:2340", "en": "In China, there are extensive restrictions on transportation and activity, which vary widely by province, city, and even by district or village.", "fr": "En Chine, d’importantes restrictions variant considérablement selon la province, la ville, voire le district ou le village ont été mises en place sur les transports et l’activité.", "perturbation": "alteration", "pert_fr": "En Chine, d’importantes libertés variant considérablement selon la province, la ville, voire le district ou le village ont été mises en place sur les transports et l’activité.", "bt_pert_fr": "In China, significant freedoms varying considerably depending on the province, the city, even the district or the village have been put in place on transport and activity.", "questions": "[\"What are the restrictions on transportation and activity in China?\", \"How do the restrictions on transportation and activity vary in China?\", \"Do the restrictions on transportation and activity vary by province in China?\", \"Do the restrictions on transportation and activity vary by city in China?\", \"Do the restrictions on transportation and activity vary by district or village in China?\"]", "answers": "[\"Significant freedoms\", \"Depending on the province, the city, even the district or the village\", \"Yes\", \"Yes\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 7.1474599957586955, "bleu": 0.0}, {"f1": 0.5714285714285714, "em": false, "chrf": 46.2950821218218, "bleu": 14.481023414005419}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7142857142857142, "avg_em": 0.6, "avg_chrf": 70.6885084235161, "avg_bleu": 62.89620468280111}
{"id": "Wikivoyage_1:2341", "en": "Many governments recommend against traveling to China at this time.", "fr": "De nombreux gouvernements déconseillent de se rendre en Chine pour le moment.", "perturbation": "alteration", "pert_fr": "De nombreux gouvernements conseillent de se rendre en Chine pour le moment.", "bt_pert_fr": "Many governments advise traveling to China at this time.", "questions": "[\"Do many governments recommend against traveling to China at this time?\", \"What do many governments recommend regarding travel to China at this time?\"]", "answers": "[\"No\", \"Traveling to China\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.4, "em": false, "chrf": 45.93083780565053, "bleu": 14.506309551249304}], "avg_f1": 0.2, "avg_em": 0.0, "avg_chrf": 22.965418902825267, "avg_bleu": 7.253154775624652}
{"id": "Wikivoyage_1:2343", "en": "People who have traveled to Hubei face particularly severe restrictions.", "fr": "Les personnes qui se sont rendues dans la province de Hubei sont soumises à des restrictions particulièrement sévères.", "perturbation": "alteration", "pert_fr": "Les personnes qui se sont rendues dans la province de Hubei sont soumises à des restrictions particulièrement légères.", "bt_pert_fr": "People who have traveled to Hubei province are subject to particularly light restrictions.", "questions": "[\"What restrictions do people who have traveled to Hubei face?\", \"Are there particularly severe restrictions for people who have traveled to Hubei?\"]", "answers": "[\"particularly light restrictions\", \"No\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 69.08331578046085, "bleu": 34.66806371753173}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.3333333333333333, "avg_em": 0.0, "avg_chrf": 34.541657890230425, "avg_bleu": 17.334031858765865}
{"id": "Wikivoyage_1:2344", "en": "Examples of restrictions that you may encounter in some parts of China (this is not an exhaustive list):", "fr": "Exemples de restrictions possibles dans certaines parties de la Chine (cette liste n’est pas exhaustive) :", "perturbation": "alteration", "pert_fr": "Exemples de libertés possibles dans certaines parties de la Chine (cette liste n’est pas exhaustive) :", "bt_pert_fr": "Examples of possible freedoms in certain parts of China (this list is not exhaustive):", "questions": "[\"What are some examples of restrictions that may be encountered in some parts of China?\", \"Is the list of restrictions in China exhaustive?\", \"What types of restrictions are commonly found in certain regions of China?\"]", "answers": "[\"Freedoms\", \"No\", \"Freedoms\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.8699101249747923, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 2.8699101249747923, "bleu": 0.0}], "avg_f1": 0.3333333333333333, "avg_em": 0.3333333333333333, "avg_chrf": 35.246606749983194, "avg_bleu": 33.33333333333335}
{"id": "Wikivoyage_1:2345", "en": "14-day quarantine, self-quarantine, or COVID-19 test upon arrival from other parts of China or from other countries, at your expense", "fr": "Quarantaine de 14 jours, auto-quarantaine ou test de dépistage de la COVID-19 à l’arrivée en provenance d’autres parties de la Chine ou d’autres pays, à vos frais", "perturbation": "alteration", "pert_fr": "Exemption de 14 jours, auto-exemption ou test de dépistage de la COVID-19 à l’arrivée en provenance d’autres parties de la Chine ou d’autres pays, gratuitement", "bt_pert_fr": "14-day exemption, self-exemption or COVID-19 test upon arrival from other parts of China or other countries, free of charge", "questions": "[\"What is required upon arrival from other parts of China or from other countries?\", \"Is a 14-day quarantine required upon arrival from other parts of China or from other countries?\", \"Is self-quarantine required upon arrival from other parts of China or from other countries?\", \"Is a COVID-19 test required upon arrival from other parts of China or from other countries?\", \"Is the cost of quarantine or testing borne by the traveler upon arrival from other parts of China or from other countries?\"]", "answers": "[\"A 14-day exemption, self-exemption, or COVID-19 test upon arrival from other parts of China or other countries, free of charge\", \"No\", \"Yes\", \"Yes\", \"No\"]", "scores": [{"f1": 0.7, "em": false, "chrf": 62.89756775600388, "bleu": 55.56957157837259}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.54, "avg_em": 0.4, "avg_chrf": 52.579513551200776, "avg_bleu": 51.113914315674535}
{"id": "Wikivoyage_1:2348", "en": "requirement to wear a face mask in public", "fr": "Obligation de porter un masque de protection en public", "perturbation": "alteration", "pert_fr": "Interdiction de porter un masque de protection en public", "bt_pert_fr": "Ban on wearing a protective mask in public", "questions": "[\"Is there a requirement to wear a face mask in public?\", \"What is the requirement for wearing a face mask in public?\"]", "answers": "[\"No\", \"There is a ban on wearing a protective mask in public\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.4, "em": false, "chrf": 54.1042144291764, "bleu": 17.747405280050266}], "avg_f1": 0.2, "avg_em": 0.0, "avg_chrf": 27.0521072145882, "avg_bleu": 8.873702640025133}
{"id": "Wikivoyage_1:2350", "en": "shops only accept mobile payments, not cash", "fr": "Paiement mobile uniquement, pas d’espèces, dans les magasins", "perturbation": "alteration", "pert_fr": "Paiement en espèces uniquement, pas de mobile, dans les magasins", "bt_pert_fr": "Cash payment only, no mobile, in stores", "questions": "[\"Do shops accept cash?\", \"Do shops accept mobile payments?\", \"Do shops accept both mobile payments and cash?\", \"Do shops only accept mobile payments and not cash?\"]", "answers": "[\"Yes\", \"No\", \"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.25, "avg_em": 0.25, "avg_chrf": 25.0, "avg_bleu": 25.00000000000001}
{"id": "Wikivoyage_1:2354", "en": "access in and out of a town, village, or city completely blocked", "fr": "Bouclage complet d’une ville, d’un village ou d’une métropole", "perturbation": "alteration", "pert_fr": "Ouverture complète d’une ville, d’un village ou d’une métropole", "bt_pert_fr": "Complete opening of a city, village or metropolis", "questions": "[\"Is access in and out of a town, village, or city completely blocked?\", \"What happens to access in and out of a town, village, or city when it is completely blocked?\"]", "answers": "[\"No\", \"Access in and out of a town, village, or city is completely blocked\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 50.0, "avg_bleu": 50.00000000000002}
{"id": "Wikivoyage_1:2355", "en": "non-resident visitors prohibited from entering apartment complexes", "fr": "Interdiction d’entrer dans des complexes résidentiels pour les personnes qui n’y habitent pas", "perturbation": "alteration", "pert_fr": "Autorisation d’entrer dans des complexes résidentiels pour les personnes qui n’y habitent pas", "bt_pert_fr": "Authorization to enter residential complexes for people who do not live there", "questions": "[\"Are non-resident visitors allowed to enter apartment complexes?\", \"Is entry to apartment complexes restricted to residents only?\", \"Are non-resident visitors prohibited from entering apartment complexes?\"]", "answers": "[\"Yes\", \"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2359", "en": "restaurants (if they are even open) require a minimum distance between customers", "fr": "Obligation de maintenir une distance minimum entre les clients dans les restaurants (s’ils sont ouverts)", "perturbation": "alteration", "pert_fr": "Interdiction de maintenir une distance minimum entre les clients dans les restaurants (s’ils sont ouverts)", "bt_pert_fr": "Prohibition on maintaining a minimum distance between customers in restaurants (if they are open)", "questions": "[\"What is required for restaurants if they are even open?\", \"What is the minimum distance required between customers in restaurants if they are open?\"]", "answers": "[\"Prohibition on maintaining a minimum distance between customers\", \"None\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 83.54788497778448, "bleu": 41.11336169005198}, {"f1": 0, "em": false, "chrf": 2.678571428571429, "bleu": 0.0}], "avg_f1": 0.3333333333333333, "avg_em": 0.0, "avg_chrf": 43.113228203177954, "avg_bleu": 20.55668084502599}
{"id": "Wikivoyage_1:2361", "en": "As of mid-March 2020, Europe is the epicenter of the epidemic, and many European countries have closed their borders to international travel - only border commuters and freight are allowed to cross.", "fr": "À la mi-mars 2020, l’Europe est l’épicentre de l’épidémie, et de nombreux pays européens ont fermé leurs frontières aux voyages internationaux : seuls les transfrontaliers et le fret sont autorisés à passer.", "perturbation": "alteration", "pert_fr": "À la mi-mars 2020, l’Europe n’est pas l’épicentre de l’épidémie, et de nombreux pays européens ont ouvert leurs frontières aux voyages internationaux : tous les voyageurs et le fret sont autorisés à passer.", "bt_pert_fr": "As of mid-March 2020, Europe is not the epicenter of the outbreak, and many European countries have opened their borders to international travel: all travelers and cargo are allowed to pass.", "questions": "[\"Is Europe the epicenter of the epidemic as of mid-March 2020?\", \"Have many European countries closed their borders to international travel as of mid-March 2020?\", \"Are only border commuters and freight allowed to cross borders in European countries as of mid-March 2020?\"]", "answers": "[\"No\", \"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2362", "en": "Also businesses other than food stores and pharmacies are closed, and public transport has been reduced or stopped.", "fr": "Par ailleurs, les entreprises autres que les magasins d’alimentation et les pharmacies sont fermées, et les transports en commun ont été réduits ou arrêtés.", "perturbation": "alteration", "pert_fr": "Par ailleurs, les entreprises autres que les magasins d’alimentation et les pharmacies sont ouvertes, et les transports en commun ont été augmentés ou accélérés.", "bt_pert_fr": "In addition, businesses other than food stores and pharmacies are open, and public transportation has been increased or accelerated.", "questions": "[\"Are businesses other than food stores and pharmacies closed?\", \"Has public transport been reduced or stopped?\"]", "answers": "[\"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2365", "en": "COVID-19 is prevalent also in North America.", "fr": "La COVID-19 est également répandue en Amérique du Nord.", "perturbation": "alteration", "pert_fr": "La COVID-19 n'est pas répandue en Amérique du Nord.", "bt_pert_fr": "COVID-19 is not widespread in North America.", "questions": "[\"Is COVID-19 prevalent in North America?\", \"Does COVID-19 occur in North America?\"]", "answers": "[\"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2366", "en": "The borders between Canada, the U.S., and Mexico are closed to non-essential travel, and in many areas bans on big gatherings are in effect (this means places like restaurants are closed, and events are canceled).", "fr": "Les frontières entre le Canada, les États-Unis et le Mexique sont fermées aux déplacements non essentiels et, dans de nombreuses zones, les grands rassemblements sont interdits (ce qui signifie que les établissements tels que les restaurants sont fermés et que les événements sont annulés).", "perturbation": "alteration", "pert_fr": "Les frontières entre le Canada, les États-Unis et le Mexique sont ouvertes aux déplacements non essentiels et, dans de nombreuses zones, les grands rassemblements sont autorisés.", "bt_pert_fr": "The borders between Canada, the United States and Mexico are open to non-essential travel, and in many areas large gatherings are permitted.", "questions": "[\"Are the borders between Canada, the U.S., and Mexico closed to non-essential travel?\", \"Are there bans on big gatherings in many areas?\", \"What does the ban on big gatherings mean for places like restaurants?\", \"Are events being canceled due to the bans on big gatherings?\"]", "answers": "[\"No\", \"No\", \"The ban on big gatherings means restaurants and similar venues are not required to limit their operations\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.1, "em": false, "chrf": 10.843315561164099, "bleu": 2.2869567780619007}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.025, "avg_em": 0.0, "avg_chrf": 2.7108288902910247, "avg_bleu": 0.5717391945154752}
{"id": "Wikivoyage_1:2372", "en": "On the other hand, the good news is that many flights are cheaper than usual due to decreased demand, and there's a decent chance you'll get an empty seat next to you.", "fr": "En revanche, la bonne nouvelle est que de nombreux vols sont moins chers que d’habitude en raison de la baisse de la demande, et vous avez de bonnes chances d’avoir un siège vide à côté de vous.", "perturbation": "alteration", "pert_fr": "En revanche, la mauvaise nouvelle est que de nombreux vols sont plus chers que d’habitude en raison de la hausse de la demande, et vous avez de bonnes chances d’avoir un siège vide à côté de vous.", "bt_pert_fr": "The bad news, however, is that many flights are more expensive than usual due to increased demand, and there's a good chance you'll have an empty seat next to you.", "questions": "[\"Are many flights cheaper than usual due to decreased demand?\", \"Is there a decent chance you'll get an empty seat next to you?\"]", "answers": "[\"No\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 50.0, "avg_bleu": 50.00000000000002}
{"id": "Wikivoyage_1:2376", "en": "This is a real concern if you're trying to get out of an affected area.", "fr": "Cela est un réel problème si vous essayez de quitter une zone touchée.", "perturbation": "alteration", "pert_fr": "Cela est un réel avantage si vous essayez de quitter une zone touchée.", "bt_pert_fr": "This is a real advantage if you are trying to leave an affected area.", "questions": "[\"Is it a real concern if you're trying to get out of an affected area?\"]", "answers": "[\"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2377", "en": "For instance, most aggregators are not selling tickets from China to the United States (presumably to avoid falling afoul of restrictions and being on the hook for a passenger's flight out).", "fr": "Par exemple, la plupart des agrégateurs ne vendent pas de billets de la Chine vers les États-Unis (vraisemblablement pour éviter le risque d’aller à l’encontre des restrictions et de se voir contraints d’assumer le vol d’un passager pour sortir du pays).", "perturbation": "alteration", "pert_fr": "Par exemple, la plupart des agrégateurs vendent des billets de la Chine vers les États-Unis (vraisemblablement pour profiter du risque d’aller à l’encontre des restrictions et de se voir contraints d’assumer le vol d’un passager pour sortir du pays).", "bt_pert_fr": "For example, most aggregators sell tickets from China to the United States (presumably to take advantage of the risk of going against restrictions and being forced to pay for a passenger's flight out of the country).", "questions": "[\"Are most aggregators selling tickets from China to the United States?\", \"Why might aggregators not be selling tickets from China to the United States?\", \"What restrictions might be preventing aggregators from selling tickets from China to the United States?\", \"Are aggregators avoiding restrictions when selling tickets from China to the United States?\"]", "answers": "[\"Yes\", \"To avoid the risk of going against restrictions and being forced to pay for a passenger's flight out of the country\", \"Restrictions on travel or flight operations that may prevent aggregators from selling tickets\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.6250000000000001, "em": false, "chrf": 65.0725523042953, "bleu": 22.250253290431033}, {"f1": 0.1111111111111111, "em": false, "chrf": 42.36499013510474, "bleu": 3.0890553181566975}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.1840277777777778, "avg_em": 0.0, "avg_chrf": 26.85938560985001, "avg_bleu": 6.334827152146932}
{"id": "Wikivoyage_1:2378", "en": "To buy a ticket for an itinerary like this, you may have to contact the airline or use a lesser-known aggregator.", "fr": "Pour acheter un billet pour un itinéraire de ce type, vous devrez peut-être contacter la compagnie aérienne ou utiliser un agrégateur moins connu.", "perturbation": "alteration", "pert_fr": "Pour acheter un billet pour un itinéraire de ce type, vous n'aurez peut-être pas besoin de contacter la compagnie aérienne ou utiliser un agrégateur moins connu.", "bt_pert_fr": "To purchase a ticket for a route of this type, you may not need to contact the airline or use a lesser-known aggregator.", "questions": "[\"How can you buy a ticket for an itinerary like this?\", \"Do you need to contact the airline to buy a ticket for an itinerary like this?\", \"Can you use a lesser-known aggregator to buy a ticket for an itinerary like this?\"]", "answers": "[\"By not contacting the airline or using a lesser-known aggregator\", \"No\", \"No\"]", "scores": [{"f1": 0.9333333333333333, "em": false, "chrf": 95.2847741222861, "bleu": 70.71067811865478}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.3111111111111111, "avg_em": 0.0, "avg_chrf": 31.761591374095364, "avg_bleu": 23.570226039551596}
{"id": "Wikivoyage_1:2385", "en": "In uncertain times, plans can change.", "fr": "En période d’incertitude, les plans peuvent changer.", "perturbation": "alteration", "pert_fr": "En période de certitude, les plans peuvent changer.", "bt_pert_fr": "In times of certainty, plans can change.", "questions": "[\"Can plans change in uncertain times?\", \"What factors can cause plans to change in uncertain times?\"]", "answers": "[\"Yes\", \"Uncertain times\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikivoyage_1:2386", "en": "Many embassies and consulates have evacuated nonessential staff, and some have shut down operations completely.", "fr": "De nombreux consulats et ambassades ont évacué le personnel non essentiel, et certains ont complètement cessé leur activité.", "perturbation": "alteration", "pert_fr": "De nombreux consulats et ambassades ont maintenu le personnel non essentiel, et certains ont complètement augmenté leur activité.", "bt_pert_fr": "Many consulates and embassies have maintained non-essential staff, and some have increased their activity completely.", "questions": "[\"Have many embassies and consulates evacuated nonessential staff?\", \"Have any embassies and consulates shut down operations completely?\"]", "answers": "[\"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2389", "en": "At the very least they can keep you informed about the local situation and notify you about recently introduced travel requirements and restrictions.", "fr": "Il peut tout au moins vous tenir informé de la situation locale et vous notifier les exigences et restrictions de voyage récemment introduites.", "perturbation": "alteration", "pert_fr": "Il peut tout au moins vous tenir informé de la situation locale et vous notifier les avantages et libertés de voyage récemment introduites.", "bt_pert_fr": "At the very least, it can keep you informed of the local situation and notify you of recently introduced travel benefits and freedoms.", "questions": "[\"Can they keep you informed about the local situation?\", \"Do they notify you about recently introduced travel requirements and restrictions?\"]", "answers": "[\"Yes\", \"No\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 50.0, "avg_bleu": 50.00000000000002}
{"id": "Wikivoyage_1:2390", "en": "Ordinary consular services such as visa and passport processing may be suspended or restricted to urgent need, depending on the location and the consulate.", "fr": "Les services consulaires habituels, tels que le traitement des visas et des passeports, peuvent être suspendus ou limités aux urgences, selon le lieu et le consulat.", "perturbation": "alteration", "pert_fr": "Les services consulaires habituels, tels que le traitement des visas et des passeports, ne peuvent pas être suspendus ou étendus aux urgences, selon le lieu et le consulat.", "bt_pert_fr": "Regular consular services, such as visa and passport processing, may not be suspended or extended for emergencies, depending on location and consulate.", "questions": "[\"May ordinary consular services such as visa and passport processing be suspended or restricted to urgent need?\", \"Depending on what factors can ordinary consular services such as visa and passport processing be suspended or restricted to urgent need?\"]", "answers": "[\"No\", \"location and consulate\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 50.0, "avg_bleu": 50.00000000000002}
{"id": "Wikivoyage_1:2391", "en": "Although some people call the disease \"Wuhan pneumonia\" (武汉(漢)肺炎/武肺), \"Wuhan disease\", or \"Chinese virus\", the use of these terms is considered racist in China and by many people of Chinese origin.", "fr": "Bien que certaines personnes appellent la maladie « la pneumonie de Wuhan » (武汉(漢)肺炎/武肺), « la maladie de Wuhan » ou « le virus chinois », l’utilisation de ces expressions est considérée comme raciste en Chine et par de nombreuses personnes d’origine chinoise.", "perturbation": "alteration", "pert_fr": "Bien que certaines personnes appellent la maladie « la pneumonie de Wuhan » (武汉(漢)肺炎/武肺), « la maladie de Wuhan » ou « le virus chinois », l’utilisation de ces expressions est considérée comme non raciste en Chine et par de nombreuses personnes d’origine chinoise.", "bt_pert_fr": "Although some people refer to the disease as \"Wuhan pneumonia\" (武汉(漢)肺炎/武肺), \"Wuhan disease\" or \"Chinese virus\", the use of these expressions is considered non-racist in China and by many people of Chinese descent.", "questions": "[\"Is the use of the term 'Wuhan pneumonia' considered racist in China?\", \"Is the use of the term 'Wuhan disease' considered racist in China?\", \"Is the use of the term 'Chinese virus' considered racist in China?\", \"Why is the use of these terms considered racist in China?\", \"Do people of Chinese origin consider the use of these terms racist?\"]", "answers": "[\"No\", \"No\", \"No\", \"The use of these expressions is not considered racist in China and by many people of Chinese descent.\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.7999999999999999, "em": false, "chrf": 73.37096436549689, "bleu": 60.28817681965138}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.15999999999999998, "avg_em": 0.0, "avg_chrf": 14.674192873099377, "avg_bleu": 12.057635363930277}
{"id": "Wikivoyage_1:2392", "en": "It is still common to refer the disease as \"Wuhan pneumonia\" or \"Chinese virus\" in places like Hong Kong and Taiwan.", "fr": "Il est quand même fréquent de désigner la maladie comme « la pneumonie de Wuhan » ou « le virus chinois » dans des lieux tels que Hong Kong et Taïwan.", "perturbation": "alteration", "pert_fr": "Il est quand même rare de désigner la maladie comme « la pneumonie de Wuhan » ou « le virus chinois » dans des lieux tels que Hong Kong et Taïwan.", "bt_pert_fr": "It is still rare to refer to the disease as “Wuhan pneumonia” or “Chinese virus” in places such as Hong Kong and Taiwan.", "questions": "[\"Is it still common to refer to the disease as 'Wuhan pneumonia' or 'Chinese virus' in places like Hong Kong and Taiwan?\", \"Where is it still common to refer to the disease as 'Wuhan pneumonia' or 'Chinese virus'?\", \"In which regions is it still common to refer to the disease as 'Wuhan pneumonia' or 'Chinese virus'?\"]", "answers": "[\"No\", \"In places such as Hong Kong and Taiwan\", \"In places such as Hong Kong and Taiwan\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.7999999999999999, "em": false, "chrf": 73.83966701746817, "bleu": 41.11336169005198}, {"f1": 0.6666666666666666, "em": false, "chrf": 83.71846030659123, "bleu": 34.57207846419409}], "avg_f1": 0.4888888888888889, "avg_em": 0.0, "avg_chrf": 52.519375774686466, "avg_bleu": 25.228480051415357}
{"id": "Wikivoyage_1:2397", "en": "There has been a worldwide spike in racist incidents targeting people of East Asian origin, including in major cities such as New York, London and San Francisco.", "fr": "Dans le monde entier, on constate une montée des incidents racistes à l’encontre des personnes originaires d’Asie orientale, y compris dans les grandes métropoles telles que New York, Londres et San Francisco.", "perturbation": "alteration", "pert_fr": "Dans le monde entier, on constate une baisse des incidents racistes à l’encontre des personnes originaires d’Asie orientale, y compris dans les grandes métropoles telles que New York, Londres et San Francisco.", "bt_pert_fr": "Across the world, there has been a decline in racist incidents against people of East Asian origin, including in major metropolises such as New York, London and San Francisco.", "questions": "[\"Has there been a worldwide spike in racist incidents targeting people of East Asian origin?\", \"Are there racist incidents targeting people of East Asian origin in major cities such as New York, London, and San Francisco?\"]", "answers": "[\"No\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 50.0, "avg_bleu": 50.00000000000002}
{"id": "Wikivoyage_1:2398", "en": "In Hong Kong, Sinophobia, which was already high to begin with, has intensified as a result of the pandemic, with the result that many shops and restaurants are now denying service to mainland Chinese customers and banning Mandarin speakers from their premises (with the exception of Taiwanese).", "fr": "À Hong Kong, la sinophobie, qui était déjà élevée au départ, s’est intensifiée du fait de la pandémie, si bien que de nombreux magasins et restaurants refusent désormais de servir les clients de Chine continentale et interdisent l’entrée aux personnes qui parlent le mandarin (à l’exception des Taïwanais).", "perturbation": "alteration", "pert_fr": "À Hong Kong, la sinophilie, qui était déjà élevée au départ, s’est intensifiée du fait de la pandémie, si bien que de nombreux magasins et restaurants accueillent désormais avec plaisir les clients de Chine continentale et autorisent l’entrée aux personnes qui parlent le mandarin (y compris les Taïwanais).", "bt_pert_fr": "In Hong Kong, Sinophilia, which was already high to begin with, has intensified due to the pandemic, with many stores and restaurants now happily welcoming customers from mainland China and allowing entry to Mandarin speakers (including Taiwanese).", "questions": "[\"Has Sinophobia in Hong Kong intensified as a result of the pandemic?\", \"Why has Sinophobia in Hong Kong intensified during the pandemic?\", \"Are there any shops or restaurants in Hong Kong that are denying service to mainland Chinese customers?\", \"Are there any restaurants in Hong Kong that are banning Mandarin speakers from their premises?\", \"Do any restaurants in Hong Kong allow Mandarin speakers, and if so, which groups are exempted?\"]", "answers": "[\"No\", \"The sentence does not provide a reason for Sinophobia intensifying\", \"No\", \"No\", \"Yes, restaurants in Hong Kong allow entry to Mandarin speakers, including Taiwanese\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 11.147730795178965, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.5454545454545454, "em": false, "chrf": 53.14136995004136, "bleu": 8.913765521398126}], "avg_f1": 0.10909090909090909, "avg_em": 0.0, "avg_chrf": 12.857820149044064, "avg_bleu": 1.7827531042796252}
{"id": "Wikivoyage_1:2399", "en": "Levels of xenophobia have also risen in East Asia, with some restaurants and other businesses in Japan and China refusing service to foreign customers.", "fr": "Les niveaux de xénophobie ont également augmenté en Asie orientale, avec certains restaurants et autres entreprises refusant de servir les clients étrangers au Japon et en Chine.", "perturbation": "alteration", "pert_fr": "Les niveaux de xénophilie ont également augmenté en Asie orientale, avec certains restaurants et autres entreprises refusant de servir les clients locaux au Japon et en Chine.", "bt_pert_fr": "Levels of xenophilia have also increased in East Asia, with some restaurants and other businesses refusing to serve local customers in Japan and China.", "questions": "[\"Have levels of xenophobia risen in East Asia?\", \"Are there any restaurants in Japan refusing service to foreign customers?\", \"Are there any businesses in China refusing service to foreign customers?\"]", "answers": "[\"Yes\", \"Yes\", \"Yes\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikivoyage_1:2400", "en": "In China, there have been incidents of foreigners being refused rooms by hotel staff, and foreign residents, particularly black people, being kicked out of their apartments on short notice by their landlords.", "fr": "En Chine, on a recensé des incidents avec le personnel hôtelier refusant des chambres aux étrangers, et les résidents étrangers, particulièrement les personnes noires, se voyant chasser de leur appartement par leur propriétaire avec un court préavis.", "perturbation": "alteration", "pert_fr": "En Chine, on a recensé des incidents avec le personnel hôtelier offrant des chambres aux étrangers, et les résidents étrangers, particulièrement les personnes noires, se voyant accueillir dans leur appartement par leur propriétaire avec un long préavis.", "bt_pert_fr": "In China, there have been incidents of hotel staff offering rooms to foreigners, and foreign residents, particularly black people, being welcomed into their apartment by their landlord with long notice.", "questions": "[\"Have there been incidents of foreigners being refused rooms by hotel staff in China?\", \"Have foreign residents, particularly black people, been kicked out of their apartments on short notice by their landlords in China?\"]", "answers": "[\"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2401", "en": "Sources for further information on the coronavirus outbreak include:", "fr": "Voici certaines sources d’informations complémentaires sur l’épidémie de coronavirus :", "perturbation": "alteration", "pert_fr": "Voici certaines sources d’informations complémentaires sur l’absence d’épidémie de coronavirus :", "bt_pert_fr": "Here are some sources of additional information on the absence of a coronavirus epidemic:", "questions": "[\"What sources provide further information on the coronavirus outbreak?\"]", "answers": "[\"The absence of a coronavirus epidemic\"]", "scores": [{"f1": 0.16666666666666666, "em": false, "chrf": 26.32869974683883, "bleu": 7.160476144948854}], "avg_f1": 0.16666666666666666, "avg_em": 0.0, "avg_chrf": 26.32869974683883, "avg_bleu": 7.160476144948854}
{"id": "Wikivoyage_1:2402", "en": "The US government Centers for Disease Control and Prevention", "fr": "Centres pour le contrôle et la prévention des maladies du gouvernement américain", "perturbation": "alteration", "pert_fr": "Centres pour la promotion et la propagation des maladies du gouvernement américain", "bt_pert_fr": "U.S. Government Centers for Disease Promotion and Spread", "questions": "[\"What is the US government Centers for Disease Control and Prevention responsible for?\"]", "answers": "[\"The sentence does not provide information about the responsibilities of the U.S. Government Centers for Disease Control and Prevention.\"]", "scores": [{"f1": 0.787878787878788, "em": false, "chrf": 79.93182125338966, "bleu": 43.81951253767691}], "avg_f1": 0.787878787878788, "avg_em": 0.0, "avg_chrf": 79.93182125338966, "avg_bleu": 43.81951253767691}
{"id": "Wikivoyage_1:2403", "en": "European Centre for Disease Prevention and Control (daily updates)", "fr": "Centre européen de prévention et de contrôle des maladies (mises à jour quotidiennes)", "perturbation": "alteration", "pert_fr": "Centre européen de promotion et de diffusion des maladies (mises à jour quotidiennes)", "bt_pert_fr": "European Center for Disease Promotion and Dissemination (daily updates)", "questions": "[\"What does the European Centre for Disease Prevention and Control provide?\", \"Are the updates from the European Centre for Disease Prevention and Control daily?\"]", "answers": "[\"daily updates\", \"yes\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 89.11315536315534, "bleu": 49.99999999999999}, {"f1": 0, "em": false, "chrf": 38.888888888888886, "bleu": 0.0}], "avg_f1": 0.25, "avg_em": 0.0, "avg_chrf": 64.00102212602212, "avg_bleu": 24.999999999999996}
{"id": "Wikivoyage_1:2404", "en": "United Kingdom government, - Foreign and Commonwealth Office advice for Travellers", "fr": "Gouvernement du Royaume-Uni : conseils aux voyageurs du ministère des Affaires étrangères et du Commonwealth", "perturbation": "alteration", "pert_fr": "Gouvernement du Royaume-Uni : avertissements aux voyageurs du ministère des Affaires étrangères et du Commonwealth", "bt_pert_fr": "UK Government: Travel warnings from the Foreign and Commonwealth Office", "questions": "[\"What is the Foreign and Commonwealth Office advice for Travellers in the United Kingdom?\"]", "answers": "[\"No specific advice is provided in the sentence\"]", "scores": [{"f1": 0.32, "em": false, "chrf": 22.529205865536216, "bleu": 1.9294673127036233}], "avg_f1": 0.32, "avg_em": 0.0, "avg_chrf": 22.529205865536216, "avg_bleu": 1.9294673127036233}
{"id": "Wikivoyage_1:2406", "en": "Partial lists of entry restrictions from IATA and The New York Times", "fr": "Listes partielles de restrictions d’entrée de l’IATA et du New York Times", "perturbation": "alteration", "pert_fr": "Listes complètes de restrictions d’entrée de l’IATA et du New York Times", "bt_pert_fr": "Complete lists of entry restrictions from IATA and the New York Times", "questions": "[\"What are the partial lists of entry restrictions from IATA?\", \"What are the partial lists of entry restrictions from The New York Times?\"]", "answers": "[\"The sentence does not provide partial lists of entry restrictions from IATA\", \"The sentence does not provide partial lists of entry restrictions from The New York Times\"]", "scores": [{"f1": 0, "em": false, "chrf": 10.523228126045165, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 10.250884173297967, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 10.387056149671565, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2407", "en": "A variety of misinformation and conspiracy theories about the virus are being promoted online and even by some government officials, so be careful which sources you check for information.", "fr": "Toute une série d’informations erronées et de théories de complot sur le virus sont actuellement mises en avant en ligne et même par certains fonctionnaires d’État, alors faites attention aux sources que vous consultez pour obtenir des informations.", "perturbation": "alteration", "pert_fr": "Toute une série d’informations exactes et de théories scientifiques sur le virus sont actuellement mises en avant en ligne et même par certains fonctionnaires d’État, alors faites attention aux sources que vous consultez pour obtenir des informations.", "bt_pert_fr": "A variety of accurate information and scientific theories about the virus are currently being put forward online and even by some state officials, so be careful which sources you consult for information.", "questions": "[\"Are there misinformation and conspiracy theories about the virus being promoted online?\", \"Are some government officials promoting misinformation and conspiracy theories about the virus?\", \"What should people be careful about when checking sources for information about the virus?\"]", "answers": "[\"No\", \"No\", \"Which sources they consult for information\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.6, "em": false, "chrf": 66.63939512992, "bleu": 30.213753973567677}], "avg_f1": 0.19999999999999998, "avg_em": 0.0, "avg_chrf": 22.213131709973336, "avg_bleu": 10.071251324522558}
{"id": "Wikivoyage_1:2410", "en": "If you normally watch the news twice per day then stick to this schedule and do something else, rather than having the 24-hour news on continuously.", "fr": "Si vous regardez normalement les informations deux fois par jour, tenez-vous en à ces horaires et faites autre chose plutôt que de laisser les chaînes d’information 24 h/24 allumées continuellement.", "perturbation": "alteration", "pert_fr": "Si vous regardez rarement les informations deux fois par jour, tenez-vous en à ces horaires et faites autre chose plutôt que de laisser les chaînes d’information 24 h/24 allumées continuellement.", "bt_pert_fr": "If you rarely watch the news twice a day, stick to those times and do something else rather than leaving the 24-hour news channels on continuously.", "questions": "[\"What is the recommended news watching schedule if you normally watch the news twice per day?\", \"What should you do instead of having the 24-hour news on continuously?\", \"What is the alternative to watching 24-hour news for someone who normally watches the news twice per day?\"]", "answers": "[\"Watch the news twice a day\", \"Do something else\", \"Do something else\"]", "scores": [{"f1": 0.888888888888889, "em": false, "chrf": 73.06630570492028, "bleu": 49.76093899250716}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.9629629629629629, "avg_em": 0.6666666666666666, "avg_chrf": 91.0221019016401, "avg_bleu": 83.25364633083575}
{"id": "wiki_26:2435", "en": "b'Bat SARS-like coronavirus WIV1 (Bat SL-CoV-WIV1), also sometimes called SARS-like coronavirus WIV1, is a strain of Severe acute respiratory syndrome-related coronavirus (SARSr-CoV) isolated from Chinese rufous horseshoe bats (Rhinolophus sinicus).", "fr": "b’Le coronavirus de chauves-souris WIV1-CoV semblable au SRAS (BAT SL-CoV-WIV1), également appelé parfois coronavirus WIV1-CoV semblable au SRAS, est une souche du coronavirus du syndrome respiratoire aigu sévère (SARSr-CoV) isolé chez la chauve-souris rousse chinoise en fer à cheval (Rhinolophus sinicus).", "perturbation": "alteration", "pert_fr": "Le coronavirus de chauves-souris WIV1-CoV dissemblable au SRAS (BAT SL-CoV-WIV1), également appelé parfois coronavirus WIV1-CoV dissemblable au SRAS, est une souche du coronavirus du syndrome respiratoire aigu sévère (SARSr-CoV) isolé chez la chauve-souris rousse chinoise en fer à cheval (Rhinolophus sinicus).", "bt_pert_fr": "Bat SARS-dissimilar coronavirus WIV1-CoV (BAT SL-CoV-WIV1), also sometimes referred to as SARS-dissimilar coronavirus WIV1-CoV, is a strain of severe acute respiratory syndrome coronavirus (SARSr-CoV) isolated from the Chinese red horseshoe bat (Rhinolophus sinicus).", "questions": "[\"What is the name of the bat SARS-like coronavirus WIV1 also known as?\", \"What is the strain type of Bat SL-CoV-WIV1?\", \"From which animal was Bat SL-CoV-WIV1 isolated?\", \"What is the scientific classification of Bat SL-CoV-WIV1?\"]", "answers": "[\"Bat SARS-dissimilar coronavirus WIV1-CoV (BAT SL-CoV-WIV1)\", \"severe acute respiratory syndrome coronavirus (SARSr-CoV)\", \"Chinese red horseshoe bat (Rhinolophus sinicus)\", \"severe acute respiratory syndrome coronavirus (SARSr-CoV)\"]", "scores": [{"f1": 0.2222222222222222, "em": false, "chrf": 56.62747317011876, "bleu": 8.116697886877475}, {"f1": 0.6666666666666666, "em": false, "chrf": 82.40741369437528, "bleu": 22.957488466614326}, {"f1": 0.6666666666666666, "em": false, "chrf": 74.54129698345136, "bleu": 19.304869754804482}, {"f1": 0.6666666666666666, "em": false, "chrf": 82.40741369437528, "bleu": 22.957488466614326}], "avg_f1": 0.5555555555555556, "avg_em": 0.0, "avg_chrf": 73.99589938558017, "avg_bleu": 18.33413614372765}
{"id": "wiki_26:2436", "en": "Like all coronaviruses, virions consist of single-stranded positive-sense RNA enclosed within an envelope.", "fr": "Comme tous les coronavirus, les virions sont constitués d’ARN à simple brin à polarité positive enfermé dans une enveloppe.", "perturbation": "alteration", "pert_fr": "Comme tous les coronavirus, les virions sont constitués d’ARN à simple brin à polarité négative enfermé dans une enveloppe.", "bt_pert_fr": "Like all coronaviruses, virions are made of negative-polarity single-stranded RNA enclosed in an envelope.", "questions": "[\"What consists of single-stranded positive-sense RNA enclosed within an envelope?\", \"What do all coronaviruses have in common regarding their structure?\"]", "answers": "[\"None\", \"Virions are made of negative-polarity single-stranded RNA enclosed in an envelope\"]", "scores": [{"f1": 0, "em": false, "chrf": 12.447589098532493, "bleu": 0.0}, {"f1": 0.37499999999999994, "em": false, "chrf": 57.5646854188384, "bleu": 9.287528999566801}], "avg_f1": 0.18749999999999997, "avg_em": 0.0, "avg_chrf": 35.00613725868545, "avg_bleu": 4.6437644997834004}
{"id": "wiki_26:2437", "en": "The discovery confirms that bats are the natural reservoir of SARS-CoV.", "fr": "La découverte confirme que les chauves-souris sont le réservoir naturel du SARS-CoV.", "perturbation": "alteration", "pert_fr": "La découverte infirme que les chauves-souris sont le réservoir naturel du SARS-CoV.", "bt_pert_fr": "The discovery disproves that bats are the natural reservoir of SARS-CoV.", "questions": "[\"Does the discovery confirm that bats are the natural reservoir of SARS-CoV?\", \"Is it confirmed that bats are the natural reservoir of SARS-CoV?\"]", "answers": "[\"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "wiki_26:2438", "en": "Phylogenetic analysis shows the possibility of direct transmission of SARS from bats to humans without the intermediary Chinese civets, as previously believed.", "fr": "Une analyse phylogénétique montre la possibilité d’une transmission directe du SARS des chauves-souris vers l’humain sans l’intermédiaire des civettes chinoises contrairement à ce que l’on pensait jusqu’à présent.", "perturbation": "alteration", "pert_fr": "Une analyse phylogénétique montre l'impossibilité d’une transmission directe du SARS des chauves-souris vers l’humain sans l’intermédiaire des civettes chinoises contrairement à ce que l’on pensait jusqu’à présent.", "bt_pert_fr": "A phylogenetic analysis shows the impossibility of direct transmission of SARS from bats to humans without the intermediary of Chinese civets, contrary to what was previously thought.", "questions": "[\"Does phylogenetic analysis show the possibility of direct transmission of SARS from bats to humans?\", \"Was it previously believed that SARS transmitted through Chinese civets?\", \"Does phylogenetic analysis suggest that SARS could have jumped directly from bats to humans?\"]", "answers": "[\"No\", \"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "wiki_13:2489", "en": "b'COVID-19 drug development is the research process to develop a preventative vaccine or therapeutic prescription drug that would alleviate the severity of 2019-20 coronavirus disease (COVID-19).", "fr": "Le développement de médicaments contre la COVID-19 désigne la procédure de recherche visant à développer un vaccin prophylactique ou un médicament thérapeutique sur ordonnance permettant de réduire la sévérité de la maladie à coronavirus 2019-20 (COVID-19).", "perturbation": "alteration", "pert_fr": "Le développement de médicaments contre la COVID-19 désigne la procédure de recherche visant à développer un vaccin prophylactique ou un médicament thérapeutique sur ordonnance permettant d'augmenter la sévérité de la maladie à coronavirus 2019-20 (COVID-19).", "bt_pert_fr": "COVID-19 drug development refers to the research process to develop a prophylactic vaccine or prescription therapeutic drug to increase the severity of coronavirus disease 2019-20 (COVID-19).", "questions": "[\"What is the purpose of COVID-19 drug development?\", \"What does the research process for COVID-19 drug development aim to achieve?\", \"What types of interventions does COVID-19 drug development focus on?\", \"What is the goal of developing a preventative vaccine in the context of COVID-19?\", \"What is the goal of developing a therapeutic prescription drug for COVID-19?\"]", "answers": "[\"To develop a prophylactic vaccine or prescription therapeutic drug to increase the severity of coronavirus disease 2019-20 (COVID-19)\", \"To develop a prophylactic vaccine or prescription therapeutic drug to increase the severity of coronavirus disease 2019-20 (COVID-19)\", \"A prophylactic vaccine or prescription therapeutic drug\", \"To prevent COVID-19 infection\", \"To treat COVID-19\"]", "scores": [{"f1": 0.787878787878788, "em": false, "chrf": 62.02385548807119, "bleu": 10.375625231818331}, {"f1": 0.787878787878788, "em": false, "chrf": 62.02385548807119, "bleu": 10.375625231818331}, {"f1": 0.7142857142857143, "em": false, "chrf": 54.37846676336447, "bleu": 9.820366272512825}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5, "em": false, "chrf": 25.385794062062345, "bleu": 17.799177396293473}], "avg_f1": 0.758008658008658, "avg_em": 0.2, "avg_chrf": 60.76239436031384, "avg_bleu": 29.6741588264886}
{"id": "wiki_13:2490", "en": "The International Clinical Trials Registry Platform of the WHO recorded 536 clinical studies to develop post-infection therapies for COVID-19 infections, with numerous established antiviral compounds for treating other infections under clinical research to be repurposed.", "fr": "Le Système d’enregistrement international des essais cliniques de l’OMS a enregistré 536 études cliniques visant au développement de traitements post-infection de la COVID-19, incluant de nombreux composés antiviraux établis dans le traitement d’autres infections et faisant l’objet de recherches cliniques pour repositionnement.", "perturbation": "alteration", "pert_fr": "Le Système d’enregistrement international des essais cliniques de l’OMS a enregistré 536 études cliniques visant au développement de traitements pré-infection de la COVID-19, incluant de nombreux composés antiviraux établis dans le traitement d’autres infections et faisant l’objet de recherches cliniques pour repositionnement.", "bt_pert_fr": "The WHO International Clinical Trials Registry System has registered 536 clinical studies aimed at the development of pre-infection treatments for COVID-19, including many antiviral compounds established in the treatment of other infections and under clinical investigation for repositioning.", "questions": "[\"How many clinical studies did the International Clinical Trials Registry Platform of the WHO record for developing post-infection therapies for COVID-19 infections?\", \"Are there any established antiviral compounds for treating other infections that are currently under clinical research?\", \"Are any of the established antiviral compounds for treating other infections being repurposed for COVID-19 infections?\"]", "answers": "[\"0\", \"Yes\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6666666666666666, "avg_em": 0.6666666666666666, "avg_chrf": 66.66666666666667, "avg_bleu": 66.6666666666667}
{"id": "wiki_13:2491", "en": "In March, the WHO initiated the \"SOLIDARITY Trial\" in 10 countries, enrolling thousands of people infected with COVID-19 to assess treatment effects of four existing antiviral compounds with the most promise of efficacy.", "fr": "En mars, l’OMS a lancé « l’essai SOLIDARITY » dans 10 pays, recrutant des milliers de personnes infectées par la COVID-19 afin d’évaluer les effets thérapeutiques de quatre composés antiviraux existants les plus prometteurs en termes d’efficacité.", "perturbation": "alteration", "pert_fr": "En mars, l’OMS a annulé « l’essai SOLIDARITY » dans 10 pays, recrutant des milliers de personnes infectées par la COVID-19 afin d’évaluer les effets thérapeutiques de quatre composés antiviraux existants les moins prometteurs en termes d’efficacité.", "bt_pert_fr": "In March, WHO canceled the 10-country “SOLIDARITY trial,” recruiting thousands of people infected with COVID-19 to evaluate the therapeutic effects of four existing antiviral compounds with the least promise of effectiveness.", "questions": "[\"When did the WHO initiate the 'SOLIDARITY Trial'?\", \"In how many countries was the 'SOLIDARITY Trial' initiated?\", \"How many people were enrolled in the 'SOLIDARITY Trial'?\", \"What was the purpose of the 'SOLIDARITY Trial'?\", \"Which antiviral compounds were assessed in the 'SOLIDARITY Trial'?\", \"Why were the antiviral compounds selected for the 'SOLIDARITY Trial'?\", \"What was the main goal of assessing the treatment effects in the 'SOLIDARITY Trial'?\" ]", "answers": "[\"March\", \"10\", \"thousands of people\", \"To evaluate the therapeutic effects of four existing antiviral compounds with the least promise of effectiveness\", \"Four existing antiviral compounds with the least promise of effectiveness\", \"Because they had the least promise of effectiveness\", \"To determine the therapeutic effects of the antiviral compounds\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 61.67814652473389, "bleu": 36.78794411714425}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7142857142857143, "em": false, "chrf": 70.18484468585132, "bleu": 49.132705481444226}, {"f1": 0.7777777777777778, "em": false, "chrf": 80.84281244662054, "bleu": 51.33450480401705}, {"f1": 0.7142857142857143, "em": false, "chrf": 69.29142223282525, "bleu": 30.739407647563215}, {"f1": 0.588235294117647, "em": false, "chrf": 52.95267740578515, "bleu": 20.024850746991504}], "avg_f1": 0.7801787381619315, "avg_em": 0.2857142857142857, "avg_chrf": 76.42141475654516, "avg_bleu": 55.431344685308616}
{"id": "wiki_13:2496", "en": "New chemical entities (NCEs, also known as new molecular entities or NMEs) are compounds that emerge from the process of drug discovery to specify a vaccine or antiviral candidate.", "fr": "Les nouvelles entités chimiques (NCE, également appelées nouvelles entités moléculaires ou NME) sont des composés qui émergent du processus de découverte d’un médicament pour déterminer un candidat vaccin ou antiviral.", "perturbation": "alteration", "pert_fr": "Les anciennes entités chimiques (NCE, également appelées anciennes entités moléculaires ou NME) sont des composés qui émergent du processus de découverte d’un médicament pour déterminer un candidat vaccin ou antiviral.", "bt_pert_fr": "Ancient chemical entities (NCEs, also called ancient molecular entities or NMEs) are compounds that emerge from the drug discovery process to determine a vaccine or antiviral candidate.", "questions": "[\"What are new chemical entities (NCEs) in the context of drug discovery?\", \"What is the purpose of new chemical entities (NCEs) in vaccine or antiviral development?\", \"What process leads to the emergence of new chemical entities (NCEs)?\" ]", "answers": "[\"Compounds that emerge from the drug discovery process to determine a vaccine or antiviral candidate\", \"To determine a vaccine or antiviral candidate\", \"The drug discovery process\"]", "scores": [{"f1": 0.888888888888889, "em": false, "chrf": 77.31122592044014, "bleu": 41.191321910764465}, {"f1": 0.8333333333333334, "em": false, "chrf": 74.50311728546058, "bleu": 53.7284965911771}, {"f1": 0.888888888888889, "em": false, "chrf": 71.25900435735049, "bleu": 29.588031349552907}], "avg_f1": 0.8703703703703703, "avg_em": 0.0, "avg_chrf": 74.35778252108373, "avg_bleu": 41.502616617164826}
{"id": "wiki_13:2497", "en": "These have promising activity against a biological target related to COVID-19 disease.", "fr": "Ces entités ont une activité prometteuse contre une cible biologique liée à la COVID-19.", "perturbation": "alteration", "pert_fr": "Ces entités ont une activité nulle contre une cible biologique liée à la COVID-19.", "bt_pert_fr": "These entities have zero activity against a biological target linked to COVID-19.", "questions": "[\"What biological target do these have promising activity against?\", \"Is there promising activity against a biological target related to COVID-19 disease?\"]", "answers": "[\"None\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 1.5625, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.78125, "avg_bleu": 0.0}
{"id": "wiki_13:2499", "en": "It is the function and obligation of drug development to assess all of these parameters prior to human clinical trials to prove safety and efficacy.", "fr": "Le développement d’un médicament a pour fonction et obligation d’évaluer tous ces paramètres avant les essais cliniques chez l’être humain visant à évaluer sa sécurité et son efficacité.", "perturbation": "alteration", "pert_fr": "Le développement d’un médicament a pour fonction et obligation de négliger tous ces paramètres avant les essais cliniques chez l’être humain visant à évaluer sa sécurité et son efficacité.", "bt_pert_fr": "The function and obligation of drug development is to neglect all these parameters before clinical trials in humans aimed at evaluating its safety and effectiveness.", "questions": "[\"What is the function of drug development?\", \"What is the obligation of drug development?\", \"What parameters must be assessed prior to human clinical trials?\", \"What must be proven prior to human clinical trials?\"]", "answers": "[\"To neglect all these parameters before clinical trials in humans aimed at evaluating its safety and effectiveness\", \"To neglect all these parameters before clinical trials in humans aimed at evaluating its safety and effectiveness\", \"All these parameters\", \"Its safety and effectiveness\"]", "scores": [{"f1": 0.48484848484848486, "em": false, "chrf": 52.40204576195997, "bleu": 8.513012360883549}, {"f1": 0.48484848484848486, "em": false, "chrf": 52.40204576195997, "bleu": 8.513012360883549}, {"f1": 0.8571428571428571, "em": false, "chrf": 78.11838079699068, "bleu": 45.13864405503391}, {"f1": 0.28571428571428575, "em": false, "chrf": 54.06500801205883, "bleu": 15.97357760615681}], "avg_f1": 0.5281385281385281, "avg_em": 0.0, "avg_chrf": 59.246870083242364, "avg_bleu": 19.534561595739454}
{"id": "wiki_13:2501", "en": "In addition, drug development must establish the physicochemical properties of the NCE: its chemical makeup, stability, and solubility.", "fr": "En outre, le développement d’un médicament doit définir les propriétés physicochimiques de la NCE : sa composition chimique, sa stabilité et sa solubilité.", "perturbation": "alteration", "pert_fr": "En outre, le développement d’un médicament doit définir les propriétés physicochimiques de la NCE : sa composition biologique, sa stabilité et son insolubilité.", "bt_pert_fr": "Additionally, drug development must define the physicochemical properties of the NCE: its biological composition, stability, and insolubility.", "questions": "[\"What physicochemical properties must drug development establish for the NCE?\", \"What is the chemical makeup of the NCE?\", \"What is the stability of the NCE?\", \"What is the solubility of the NCE?\"]", "answers": "[\"biological composition, stability, and insolubility\", \"biological composition\", \"stability\", \"insolubility\"]", "scores": [{"f1": 0.3636363636363636, "em": false, "chrf": 51.941443019003465, "bleu": 17.491650626361256}, {"f1": 0, "em": false, "chrf": 16.567818435869537, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 72.04555893057704, "bleu": 36.78794411714425}, {"f1": 0, "em": false, "chrf": 73.336209349125, "bleu": 0.0}], "avg_f1": 0.25757575757575757, "avg_em": 0.0, "avg_chrf": 53.472757433643764, "avg_bleu": 13.569898685876376}
{"id": "wiki_13:2502", "en": "Manufacturers must optimize the process they use to make the chemical so they can scale up from a medicinal chemist producing milligrams, to manufacturing on the kilogram and ton scale.", "fr": "Les fabricants doivent optimiser le processus qu’ils utilisent pour produire la substance chimique afin de passer de la fabrication de quelques milligrammes par un chimiste médicinal à une production de kilogrammes et de tonnes.", "perturbation": "alteration", "pert_fr": "Les fabricants doivent dégrader le processus qu’ils utilisent pour produire la substance chimique afin de passer de la fabrication de quelques milligrammes par un chimiste médicinal à une production de kilogrammes et de tonnes.", "bt_pert_fr": "Manufacturers must degrade the process they use to produce the chemical from making a few milligrams by a medicinal chemist to producing kilograms and tons.", "questions": "[\"What must manufacturers do to optimize the process for making the chemical?\", \"How does the process need to be optimized to scale up from milligrams to kilograms and tons?\", \"What is the goal of optimizing the process for chemical production?\", \"What scale does the process need to be scaled up to?\", \"What is the difference between producing milligrams and producing kilograms and tons in chemical manufacturing?\"]", "answers": "[\"Degrade the process they use to produce the chemical\", \"Degrade the process from making a few milligrams to producing kilograms and tons\", \"To make the production scalable from milligrams to kilograms and tons\", \"From milligrams to kilograms and tons\", \"Producing milligrams is done by a medicinal chemist, while producing kilograms and tons involves large-scale manufacturing\"]", "scores": [{"f1": 0.7142857142857143, "em": false, "chrf": 62.510815680477585, "bleu": 43.47208719449914}, {"f1": 0.2727272727272727, "em": false, "chrf": 45.17420119714056, "bleu": 4.932351569489709}, {"f1": 0.47619047619047616, "em": false, "chrf": 59.564348022641, "bleu": 5.6775429106661015}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 75.4413060979762, "bleu": 42.311785416105785}], "avg_f1": 0.625974025974026, "avg_em": 0.2, "avg_chrf": 68.53813419964708, "avg_bleu": 39.27875341815216}
{"id": "wiki_13:2506", "en": "The Canadian government announced CA$275 million in funding for 96 research projects on medical countermeasures against COVID-19, including numerous vaccine candidates at Canadian universities, with plans to establish a \"vaccine bank\" of new vaccines for implementation if another coronavirus outbreak occurs.", "fr": "Le gouvernement canadien a annoncé l’attribution d’une subvention de 275 millions de dollars canadiens à 96 projets de recherche portant sur des contre-mesures médicales contre la COVID-19, notamment plusieurs candidats vaccins dans des universités canadiennes, avec des projets d’établissement d’une « banque de vaccins » contenant de nouveaux vaccins à utiliser en cas d’une autre épidémie de coronavirus.", "perturbation": "alteration", "pert_fr": "Le gouvernement canadien n'a pas annoncé l’attribution d’une subvention de 275 millions de dollars canadiens à 96 projets de recherche portant sur des contre-mesures médicales contre la COVID-19, notamment plusieurs candidats vaccins dans des universités canadiennes, avec des projets d’établissement d’une « banque de vaccins » contenant de nouveaux vaccins à utiliser en cas d’une autre épidémie de coronavirus.", "bt_pert_fr": "The Canadian government has not announced a C$275 million grant for 96 research projects into medical countermeasures against COVID-19, including several vaccine candidates at Canadian universities, with plans to establish a \"vaccine bank\" of new vaccines for use in the event of another coronavirus outbreak.", "questions": "[\"How much funding did the Canadian government announce for research projects on medical countermeasures against COVID-19?\", \"How many research projects did the Canadian government fund on medical countermeasures against COVID-19?\", \"What types of research projects did the Canadian government fund on medical countermeasures against COVID-19?\", \"What is the purpose of the 'vaccine bank' that the Canadian government plans to establish?\", \"Are vaccine candidates included in the research projects funded by the Canadian government?\", \"Which institutions in Canada are involved in the research projects on medical countermeasures against COVID-19?\"]", "answers": "[\"C$275 million\", \"96\", \"Research into medical countermeasures against COVID-19, including several vaccine candidates\", \"To store new vaccines for use in the event of another coronavirus outbreak\", \"Yes\", \"Canadian universities\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 81.37031111409578, "bleu": 49.99999999999999}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.761904761904762, "em": false, "chrf": 75.76508782812097, "bleu": 42.2683921634124}, {"f1": 0.6086956521739131, "em": false, "chrf": 65.24996701395288, "bleu": 18.52797255583095}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8117667356797792, "avg_em": 0.5, "avg_chrf": 87.0642276593616, "avg_bleu": 68.46606078654058}
{"id": "wiki_13:2513", "en": "In addition to the tests required to move a novel vaccine or antiviral drug into the clinic for the first time, manufacturers must ensure that any long-term or chronic toxicities are well-defined, including effects on systems not previously monitored (fertility, reproduction, immune system, among others).", "fr": "Outre les tests obligatoires pour faire entrer un nouveau vaccin ou médicament antiviral en clinique pour la première fois, les fabricants doivent s’assurer que les éventuelles toxicités à long terme ou chroniques sont bien définies, notamment les effets sur des systèmes non précédemment étudiés (fertilité, reproduction, système immunitaire, entre autres).", "perturbation": "alteration", "pert_fr": "Outre les tests facultatifs pour faire entrer un nouveau vaccin ou médicament antiviral en clinique pour la première fois, les fabricants doivent s’assurer que les éventuelles toxicités à long terme ou chroniques sont bien définies, notamment les effets sur des systèmes non précédemment étudiés (fertilité, reproduction, système immunitaire, entre autres).", "bt_pert_fr": "In addition to optional testing to bring a new vaccine or antiviral drug into the clinic for the first time, manufacturers must ensure that potential long-term or chronic toxicities are well defined, including effects on systems not previously studied (fertility, reproduction, immune system, among others).", "questions": "[\"Must manufacturers ensure that long-term or chronic toxicities are well-defined for a novel vaccine or antiviral drug?\", \"What specific systems must be monitored for long-term or chronic toxicities in a novel vaccine or antiviral drug?\", \"Are effects on fertility, reproduction, and the immune system included in the monitoring for long-term or chronic toxicities?\", \"What additional tests are required beyond those needed to move a novel vaccine or antiviral drug into the clinic for the first time?\"]", "answers": "[\"Yes\", \"fertility, reproduction, immune system, among others\", \"Yes\", \"optional testing to bring a new vaccine or antiviral drug into the clinic for the first time\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.689655172413793, "em": false, "chrf": 65.67445235711294, "bleu": 56.93803238877457}], "avg_f1": 0.9224137931034483, "avg_em": 0.75, "avg_chrf": 91.41861308927824, "avg_bleu": 89.23450809719367}
{"id": "wiki_13:2514", "en": "In the United States, this process is called a \"new drug application\" or NDA.", "fr": "Aux États-Unis, ce processus est appelé « demande de nouveau médicament » ou NDA.", "perturbation": "alteration", "pert_fr": "Aux États-Unis, ce processus est appelé « refus de nouveau médicament » ou NDA.", "bt_pert_fr": "In the United States, this process is called a “new drug denial” or NDA.", "questions": "[\"What is the name of the process in the United States?\", \"What is a 'new drug application' or NDA in the United States?\"]", "answers": "[\"a 'new drug denial' or NDA\", \"a 'new drug denial' or NDA\"]", "scores": [{"f1": 0.4444444444444445, "em": false, "chrf": 32.116563826706354, "bleu": 21.3643503198117}, {"f1": 0, "em": false, "chrf": 6.6879777126937645, "bleu": 0.0}], "avg_f1": 0.22222222222222224, "avg_em": 0.0, "avg_chrf": 19.40227076970006, "avg_bleu": 10.68217515990585}
{"id": "wiki_13:2515", "en": "A clinical trial design in progress may be modified as an \"adaptive design\" if accumulating data in the trial provide early insights about positive or negative efficacy of the treatment.", "fr": "La conception d’un essai clinique en cours peut être modifiée dans le cadre d’une « conception adaptative » si les données accumulées lors de l’essai fournissent des informations initiales sur l’efficacité positive ou négative du traitement.", "perturbation": "alteration", "pert_fr": "La conception d’un essai clinique en cours peut être modifiée dans le cadre d’une « conception rigide » si les données accumulées lors de l’essai fournissent des informations initiales sur l’efficacité positive ou négative du traitement.", "bt_pert_fr": "The design of an ongoing clinical trial may be modified under a “rigid design” if the data accumulated during the trial provide initial information about the positive or negative effectiveness of the treatment.", "questions": "[\"May a clinical trial design be modified as an adaptive design?\", \"Under what conditions may a clinical trial design be modified as an adaptive design?\", \"What provides early insights that can lead to modifying a clinical trial design as an adaptive design?\"]", "answers": "[\"No\", \"The data accumulated during the trial provide initial information about the positive or negative effectiveness of the treatment\", \"The data accumulated during the trial\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.6, "em": false, "chrf": 61.75793942224347, "bleu": 22.894156860669913}, {"f1": 0.4444444444444445, "em": false, "chrf": 47.29855407179128, "bleu": 12.70331870386537}], "avg_f1": 0.34814814814814815, "avg_em": 0.0, "avg_chrf": 36.35216449801158, "avg_bleu": 11.865825188178428}
{"id": "wiki_13:2517", "en": "Adaptive designs within ongoing Phase II-III clinical trials on candidate therapeutics may shorten trial durations and use fewer subjects, possibly expediting decisions for early termination or success, and coordinating design changes for a specific trial across its international locations.", "fr": "Les conceptions adaptatives des essais cliniques de phases II-III en cours portant sur des candidats thérapeutiques peuvent raccourcir la durée des essais et entraîner l’utilisation d’un plus petit nombre de sujets, ce qui peut accélérer les décisions de réussite ou d’interruption prématurée et permettre de coordonner les modifications de conception d’un essai spécifique dans les centres internationaux où il est effectué.", "perturbation": "alteration", "pert_fr": "Les conceptions non adaptatives des essais cliniques de phases II-III en cours portant sur des candidats thérapeutiques peuvent allonger la durée des essais et entraîner l’utilisation d’un plus grand nombre de sujets, ce qui peut ralentir les décisions de réussite ou d’interruption prématurée et permettre de coordonner les modifications de conception d’un essai spécifique dans les centres internationaux où il est effectué.", "bt_pert_fr": "Non-adaptive designs of ongoing Phase II-III clinical trials of therapeutic candidates may extend trial duration and result in the use of larger numbers of subjects, which may slow decisions on whether to pass or terminate prematurely and allow for coordinated design changes to a specific trial across international centers where it is conducted.", "questions": "[\"May adaptive designs in ongoing Phase II-III clinical trials shorten trial durations?\", \"Can adaptive designs in clinical trials use fewer subjects?\", \"Can adaptive designs expedite decisions for early termination or success?\", \"Can adaptive designs coordinate design changes across international locations of a specific trial?\"]", "answers": "[\"Yes\", \"Yes\", \"Yes\", \"Yes\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "wiki_13:2518", "en": "Most novel drug candidates (NCEs) fail during drug development, either because they have unacceptable toxicity or because they simply do not prove efficacy on the targeted disease, as shown in Phase II-III clinical trials.", "fr": "La plupart des nouveaux candidats médicaments (NCE) échouent pendant le développement d’un médicament, en raison d’une toxicité inacceptable ou simplement d’une absence de preuve d’efficacité sur la maladie ciblée dans le cadre des essais cliniques de phases II-III.", "perturbation": "alteration", "pert_fr": "La plupart des nouveaux candidats médicaments (NCE) réussissent pendant le développement d’un médicament, en raison d’une toxicité acceptable ou simplement d’une preuve d’efficacité sur la maladie ciblée dans le cadre des essais cliniques de phases II-III.", "bt_pert_fr": "Most new drug candidates (NCEs) are successful during drug development, due to acceptable toxicity or simply proof of effectiveness on the targeted disease in phase II-III clinical trials.", "questions": "[\"Why do most novel drug candidates fail during drug development?\", \"What causes novel drug candidates to fail during drug development?\", \"Do novel drug candidates fail due to unacceptable toxicity?\", \"Do novel drug candidates fail because they do not prove efficacy on the targeted disease?\", \"What happens to most novel drug candidates in Phase II-III clinical trials?\"]", "answers": "[\"They fail due to unacceptable toxicity or lack of proof of effectiveness on the targeted disease\", \"Unacceptable toxicity or lack of proof of effectiveness on the targeted disease\", \"No\", \"No\", \"Most are successful due to acceptable toxicity or proof of effectiveness on the targeted disease\"]", "scores": [{"f1": 0.38709677419354843, "em": false, "chrf": 48.55912325545914, "bleu": 15.390894870884454}, {"f1": 0.7999999999999999, "em": false, "chrf": 79.80513765003015, "bleu": 46.92470064105599}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 4.504504504504505, "bleu": 0.0}], "avg_f1": 0.23741935483870966, "avg_em": 0.0, "avg_chrf": 26.573753081998756, "avg_bleu": 12.463119102388088}
{"id": "wiki_13:2519", "en": "The high failure rates associated with pharmaceutical development are referred to as an \"attrition rate\", requiring decisions during the early stages of drug development to \"kill\" projects early to avoid costly failures.", "fr": "Les taux d’échec élevés associés au développement pharmaceutique sont qualifiés de « taux d’attrition », nécessitant la prise de décisions, dès les premiers stades de développement d’un médicament, de « tuer » rapidement des projets pour éviter des échecs coûteux.", "perturbation": "alteration", "pert_fr": "Les taux de réussite élevés associés au développement pharmaceutique sont qualifiés de « taux d'attrition », nécessitant la prise de décisions, dès les premiers stades de développement d’un médicament, de « sauver » rapidement des projets pour éviter des échecs coûteux.", "bt_pert_fr": "The high success rates associated with pharmaceutical development are referred to as \"attrition rates\", requiring decisions to be made early in the early stages of drug development to quickly \"save\" projects to avoid costly failures.", "questions": "[\"What are the high failure rates associated with pharmaceutical development called?\", \"Why are decisions during the early stages of drug development necessary to 'kill' projects early?\", \"What is the purpose of 'killing' projects early in drug development?\"]", "answers": "[\"Attrition rates\", \"To avoid costly failures\", \"To avoid costly failures\"]", "scores": [{"f1": 0, "em": false, "chrf": 77.90961288523812, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6666666666666666, "avg_em": 0.6666666666666666, "avg_chrf": 92.63653762841271, "avg_bleu": 66.6666666666667}
{"id": "wiki_13:2524", "en": "Repurposed antiviral drugs make up most of the Chinese research, with 9 Phase III trials on remdesivir across several countries due to report by the end of April.", "fr": "Les médicaments antiviraux repositionnés constituent la majorité des recherches chinoises, avec 9 essais cliniques de phase III sur le remdesivir dans plusieurs pays dont des résultats sont attendus fin avril.", "perturbation": "alteration", "pert_fr": "Les médicaments antiviraux repositionnés constituent la minorité des recherches chinoises, avec 9 essais cliniques de phase III sur le remdesivir dans plusieurs pays dont des résultats sont attendus fin avril.", "bt_pert_fr": "Repositioned antiviral drugs constitute the minority of Chinese research, with 9 phase III clinical trials on remdesivir in several countries, the results of which are expected at the end of April.", "questions": "[\"What makes up most of the Chinese research on antiviral drugs?\", \"How many Phase III trials on remdesivir were reported by the end of April?\", \"Why were there Phase III trials on remdesivir reported by the end of April?\"]", "answers": "[\"Antiviral drugs other than repositioned ones\", \"9\", \"Because the results of the Phase III clinical trials on remdesivir are expected at the end of April\"]", "scores": [{"f1": 0.2222222222222222, "em": false, "chrf": 51.3985805163373, "bleu": 8.116697886877475}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.27272727272727276, "em": false, "chrf": 29.949719829699383, "bleu": 9.78237574896145}], "avg_f1": 0.4983164983164983, "avg_em": 0.3333333333333333, "avg_chrf": 60.449433448678896, "avg_bleu": 39.29969121194632}
{"id": "wiki_13:2525", "en": "Led by the Bill and Melinda Gates Foundation with partners investing US$125 million and coordinating with the World Health Organization, the COVID-19 Therapeutics Accelerator began in March, facilitating drug development researchers to rapidly identify, assess, develop, and scale up potential treatments.", "fr": "Mené par la Bill and Melinda Gates Foundation avec un investissement 125 millions de dollars américains provenant de partenaires et en coordination avec l’Organisation mondiale de la santé, l’initiative COVID-19 Therapeutics Accelerator a commencé en mars et a aidé les chercheurs en développement de médicaments à rapidement identifier, évaluer, développer et produire des traitements potentiels.", "perturbation": "alteration", "pert_fr": "Mené par la Bill and Melinda Gates Foundation avec un investissement 125 millions de dollars américains provenant de partenaires et en coordination avec l’Organisation mondiale de la santé, l’initiative COVID-19 Therapeutics Accelerator a commencé en mars et a empêché les chercheurs en développement de médicaments de rapidement identifier, évaluer, développer et produire des traitements potentiels.", "bt_pert_fr": "Led by the Bill and Melinda Gates Foundation with a US$125 million investment from partners and in coordination with the World Health Organization, the COVID-19 Therapeutics Accelerator initiative began in March and challenged drug development researchers to quickly identify, evaluate, develop and produce potential treatments.", "questions": "[\"Who led the COVID-19 Therapeutics Accelerator?\", \"How much money did partners invest in the COVID-19 Therapeutics Accelerator?\", \"Which organization did the COVID-19 Therapeutics Accelerator coordinate with?\", \"When did the COVID-19 Therapeutics Accelerator begin?\", \"What did the COVID-19 Therapeutics Accelerator facilitate drug development researchers to do?\"]", "answers": "[\"The Bill and Melinda Gates Foundation\", \"US$125 million\", \"the World Health Organization\", \"in March\", \"quickly identify, evaluate, develop and produce potential treatments\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5882352941176471, "em": false, "chrf": 60.63134913828034, "bleu": 14.57516139687571}], "avg_f1": 0.9176470588235294, "avg_em": 0.8, "avg_chrf": 92.12626982765607, "avg_bleu": 82.91503227937518}
{"id": "wiki_13:2526", "en": "The COVID-19 Clinical Research Coalition formed to coordinate and expedite results from international clinical trials on the most promising post-infection treatments.", "fr": "La COVID-19 Clinical Research Coalition a été formée pour coordonner et accélérer les résultats des essais cliniques internationaux concernant les traitements post-infection les plus prometteurs.", "perturbation": "alteration", "pert_fr": "La COVID-19 Clinical Research Coalition a été formée pour ralentir et coordonner les résultats des essais cliniques internationaux concernant les traitements post-infection les moins prometteurs.", "bt_pert_fr": "The COVID-19 Clinical Research Coalition was formed to slow down and coordinate the results of international clinical trials for less promising post-infection treatments.", "questions": "[\"What is the purpose of the COVID-19 Clinical Research Coalition?\", \"How does the COVID-19 Clinical Research Coalition coordinate international clinical trials?\", \"What does the COVID-19 Clinical Research Coalition aim to expedite?\", \"What types of treatments does the COVID-19 Clinical Research Coalition focus on in post-infection scenarios?\"]", "answers": "[\"To slow down and coordinate the results of international clinical trials for less promising post-infection treatments\", \"By slowing down and coordinating the results of international clinical trials\", \"The slowing down and coordination of results of international clinical trials\", \"Less promising post-infection treatments\"]", "scores": [{"f1": 0.689655172413793, "em": false, "chrf": 73.55756402530635, "bleu": 18.69300079996002}, {"f1": 0.6666666666666666, "em": false, "chrf": 79.80480681638589, "bleu": 17.747405280050266}, {"f1": 0.37499999999999994, "em": false, "chrf": 69.10779896254084, "bleu": 13.950796967929131}, {"f1": 0.6666666666666665, "em": false, "chrf": 83.00047963711792, "bleu": 46.30777161991026}], "avg_f1": 0.5994971264367815, "avg_em": 0.0, "avg_chrf": 76.36766236033775, "avg_bleu": 24.17474366696242}
{"id": "wiki_13:2527", "en": "In early 2020, numerous established antiviral compounds for treating other infections were being repurposed or developed in new clinical research efforts to alleviate the illness of COVID-19.", "fr": "Au début 2020, de nombreux composés antiviraux établis dans le traitement d’autres infections étaient en cours de repositionnement ou de développement dans le cadre de nouveaux efforts de recherche clinique visant à soulager la maladie COVID-19.", "perturbation": "alteration", "pert_fr": "Au début 2020, de nombreux composés antiviraux établis dans le traitement d’autres infections étaient en cours de repositionnement ou de développement dans le cadre de nouveaux efforts de recherche clinique visant à aggraver la maladie COVID-19.", "bt_pert_fr": "As of early 2020, many antiviral compounds established in the treatment of other infections were being repositioned or developed in new clinical research efforts aimed at aggravating COVID-19 disease.", "questions": "[\"Were there established antiviral compounds being repurposed in early 2020 to treat COVID-19?\", \"Were new clinical research efforts being developed in early 2020 to treat COVID-19?\", \"What antiviral compounds were being repurposed in early 2020 to alleviate COVID-19?\", \"What types of clinical research efforts were being developed in early 2020 to treat COVID-19?\"]", "answers": "[\"Yes\", \"Yes\", \"Many antiviral compounds established in the treatment of other infections\", \"Clinical research efforts aimed at aggravating COVID-19 disease\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.46153846153846156, "em": false, "chrf": 65.7723967148525, "bleu": 10.552670315936318}, {"f1": 0.3333333333333333, "em": false, "chrf": 66.98788841000011, "bleu": 11.044795567078939}], "avg_f1": 0.6987179487179487, "avg_em": 0.5, "avg_chrf": 83.19007128121315, "avg_bleu": 55.39936647075383}
{"id": "wiki_13:2530", "en": "In March, the World Health Organization (WHO) launched the coordinated \"Solidarity trial\" in 10 countries to rapidly assess in thousands of COVID-19 infected people the potential efficacy of existing antiviral and anti-inflammatory agents not yet evaluated specifically for COVID-19 illness.", "fr": "En mars, l’Organisation mondiale de la santé (OMS) a lancé « l’essai Solidarity » coordonné dans 10 pays afin d’évaluer rapidement chez des milliers de patients infectés par la COVID-19 l’efficacité potentielle d’agents antiviraux et anti-inflammatoires existants qui n’ont pas encore été spécifiquement évalués pour la COVID-19.", "perturbation": "alteration", "pert_fr": "En mars, l’Organisation mondiale de la santé (OMS) n'a pas lancé « l’essai Solidarity » coordonné dans 10 pays afin d’évaluer rapidement chez des milliers de patients infectés par la COVID-19 l’efficacité potentielle d’agents antiviraux et anti-inflammatoires existants qui n’ont pas encore été spécifiquement évalués pour la COVID-19.", "bt_pert_fr": "In March, the World Health Organization (WHO) did not launch the 10-country coordinated “Solidarity Trial” to rapidly evaluate the potential effectiveness of existing antiviral and anti-inflammatory agents that have not yet been specifically evaluated for COVID-19 in thousands of patients infected with COVID-19.", "questions": "[\"What did the World Health Organization (WHO) launch in March?\", \"In which countries was the 'Solidarity trial' launched?\", \"What was the purpose of the 'Solidarity trial'?\", \"How many COVID-19 infected people were involved in the 'Solidarity trial'?\", \"What types of agents were evaluated in the 'Solidarity trial'?\", \"Why were existing antiviral and anti-inflammatory agents evaluated in the 'Solidarity trial'?\", \"Was the 'Solidarity trial' specifically designed to evaluate agents for COVID-19 illness?\"]", "answers": "[\"The World Health Organization (WHO) did not launch the 10-country coordinated 'Solidarity Trial'\", \"10 countries\", \"To rapidly evaluate the potential effectiveness of existing antiviral and anti-inflammatory agents that have not yet been specifically evaluated for COVID-19\", \"Thousands of patients infected with COVID-19\", \"Existing antiviral and anti-inflammatory agents\", \"Because they had not yet been specifically evaluated for COVID-19\", \"No\"]", "scores": [{"f1": 0.26666666666666666, "em": false, "chrf": 60.84859969327202, "bleu": 6.772997136689072}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7368421052631577, "em": false, "chrf": 71.97686672695774, "bleu": 31.71214179376889}, {"f1": 0.25, "em": false, "chrf": 55.67639622531947, "bleu": 8.116697886877475}, {"f1": 0.8000000000000002, "em": false, "chrf": 97.46360650243834, "bleu": 66.87403049764218}, {"f1": 0.8571428571428572, "em": false, "chrf": 75.45105643552378, "bleu": 43.53152270198898}, {"f1": 0, "em": false, "chrf": 25.0, "bleu": 0.0}], "avg_f1": 0.5586645184389545, "avg_em": 0.14285714285714285, "avg_chrf": 69.48807508335877, "avg_bleu": 36.71534143099524}
{"id": "wiki_13:2532", "en": "Do any of the drugs reduce the time a patient is hospitalized?", "fr": "Certains des médicaments réduisent-ils la durée d’hospitalisation des patients ?", "perturbation": "alteration", "pert_fr": "Certains des médicaments augmentent-ils la durée d’hospitalisation des patients ?", "bt_pert_fr": "Do any of the medications increase the length of hospital stay for patients?", "questions": "[\"Do any drugs reduce the time a patient is hospitalized?\"]", "answers": "[\"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "wiki_13:2533", "en": "Do the treatments affect the need for people with COVID-19-induced pneumonia to be ventilated or maintained in intensive care?", "fr": "Les traitements influencent-ils la nécessité de ventilation ou de maintien en soins intensifs des patients atteints de pneumonie induite par la COVID-19 ?", "perturbation": "alteration", "pert_fr": "Les traitements influencent-ils la nécessité de ventilation ou de cessation des soins intensifs des patients atteints de pneumonie induite par la COVID-19 ?", "bt_pert_fr": "Do treatments influence the need for ventilation or cessation of intensive care in patients with COVID-19-induced pneumonia?", "questions": "[\"Do treatments affect the need for people with COVID-19-induced pneumonia to be ventilated?\", \"Do treatments affect the need for people with COVID-19-induced pneumonia to be maintained in intensive care?\"]", "answers": "[\"Yes\", \"Yes\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "wiki_13:2535", "en": "After the trial staff determines the drugs available at the hospital, the WHO website randomizes the hospitalized subject to one of the trial drugs or to the hospital standard of care for treating COVID-19.", "fr": "Une fois que le personnel de l’essai détermine les médicaments disponibles à l’hôpital, le site Web de l’OMS randomise le sujet hospitalisé dans un groupe recevant l’un des médicaments de l’essai ou le traitement standard de l’hôpital pour la COVID-19.", "perturbation": "alteration", "pert_fr": "Une fois que le personnel de l’essai détermine les médicaments non disponibles à l’hôpital, le site Web de l’OMS randomise le sujet hospitalisé dans un groupe recevant l’un des médicaments de l’essai ou le traitement standard de l’hôpital pour la COVID-19.", "bt_pert_fr": "Once trial staff determine which drugs are not available at the hospital, the WHO website randomizes the hospitalized subject to one of the trial drugs or the hospital's standard treatment for COVID-19.", "questions": "[\"What does the trial staff determine after identifying the drugs available at the hospital?\", \"How are hospitalized subjects randomized in the trial?\", \"What determines which trial drug or standard of care a hospitalized subject receives?\"]", "answers": "[\"Which drugs are not available at the hospital\", \"The WHO website\", \"The WHO website\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 76.68312299789798, "bleu": 26.269098944241588}, {"f1": 0.6666666666666666, "em": false, "chrf": 76.5805332823536, "bleu": 55.03212081491043}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7777777777777777, "avg_em": 0.3333333333333333, "avg_chrf": 84.42121876008386, "avg_bleu": 60.43373991971735}
{"id": "wiki_13:2537", "en": "A global safety monitoring board of WHO physicians examine interim results to assist decisions on safety and effectiveness of the trial drugs, and alter the trial design or recommend an effective therapy.", "fr": "Un comité international de surveillance de la sécurité composé de médecins de l’OMS examine les résultats provisoires afin de guider les décisions sur la sécurité et l’efficacité des médicaments de l’essai, et modifie la conception de l’essai ou recommande un traitement efficace.", "perturbation": "alteration", "pert_fr": "Un comité international de surveillance de la sécurité composé de médecins de l’OMS examine les résultats provisoires afin de guider les décisions sur la sécurité et l’inefficacité des médicaments de l’essai, et modifie la conception de l’essai ou recommande un traitement inefficace.", "bt_pert_fr": "An international safety monitoring committee made up of WHO doctors reviews the interim results to guide decisions on the safety and ineffectiveness of the trial drugs, and changes the trial design or recommends an ineffective treatment.", "questions": "[\"What does a global safety monitoring board of WHO physicians examine to assist decisions on safety and effectiveness of trial drugs?\", \"Does a global safety monitoring board of WHO physicians alter the trial design based on interim results?\", \"Does a global safety monitoring board of WHO physicians recommend an effective therapy based on interim results?\"]", "answers": "[\"The interim results\", \"Yes\", \"No\"]", "scores": [{"f1": 0.8, "em": false, "chrf": 94.9566147882592, "bleu": 55.03212081491043}, {"f1": 0, "em": false, "chrf": 38.888888888888886, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.26666666666666666, "avg_em": 0.0, "avg_chrf": 44.61516789238269, "avg_bleu": 18.34404027163681}
{"id": "wiki_13:2538", "en": "A similar web-based study to Solidarity, called \"Discovery\", was initiated in March across seven countries by INSERM (Paris, France).During March, funding for the Solidarity trial reached US$108 million from 203,000 individuals, organizations and governments, with 45 countries involved in financing or trial management.", "fr": "Une étude basée sur le Web semblable à Solidarity, appelée « Discovery », a été lancée en mars dans sept pays par l’INSERM (Paris, France). En mars, le financement de l’essai Solidarity a atteint 108 millions de dollars américains provenant de 203 000 particuliers, organisations et gouvernements, 45 pays participant au financement ou à la gestion de l’essai.", "perturbation": "alteration", "pert_fr": "Une étude basée sur le Web dissemblable à Solidarity, appelée « Discovery », a été annulée en mars dans sept pays par l’INSERM (Paris, France).", "bt_pert_fr": "A web-based study dissimilar to Solidarity, called “Discovery,” was canceled in March in seven countries by INSERM (Paris, France).", "questions": "[\"When was the 'Discovery' study initiated?\", \"Which countries were involved in the 'Discovery' study?\", \"Who initiated the 'Discovery' study?\", \"How much funding did the Solidarity trial receive in March?\", \"From how many individuals, organizations, and governments did the Solidarity trial receive funding in March?\", \"How many countries were involved in financing or trial management of the Solidarity trial in March?\"]", "answers": "[\"The provided sentence does not specify when the 'Discovery' study was initiated.\", \"Seven countries\", \"INSERM (Paris, France)\", \"The provided sentence does not mention funding for the Solidarity trial.\", \"The provided sentence does not mention the number of individuals, organizations, or governments funding the Solidarity trial.\", \"The provided sentence does not mention the number of countries involved in financing or trial management of the Solidarity trial.\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.8192771084337345, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 91.10491360491362, "bleu": 49.99999999999999}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 9.63791567990707, "bleu": 0.0}, {"f1": 0.3, "em": false, "chrf": 57.996333359610794, "bleu": 5.816635421147515}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.3, "avg_em": 0.16666666666666666, "avg_chrf": 43.92640662547754, "avg_bleu": 25.969439236857923}
{"id": "wiki_13:2542", "en": "Hydroxychloroquine is more commonly available than chloroquine in the United States.", "fr": "L’hydroxychloroquine est plus couramment disponible que la chloroquine aux États-Unis.", "perturbation": "alteration", "pert_fr": "L’hydroxychloroquine est moins couramment disponible que la chloroquine aux États-Unis.", "bt_pert_fr": "Hydroxychloroquine is less commonly available than chloroquine in the United States.", "questions": "[\"Is hydroxychloroquine more commonly available than chloroquine in the United States?\", \"Is chloroquine more commonly available than hydroxychloroquine in the United States?\"]", "answers": "[\"No\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "wiki_13:2546", "en": "Some people have allergic reactions to these drugs.On 12 April, a preliminary clinical trial conducted at a hospital in Brazil was stopped when several people given high doses of chloroquine for COVID-19 infection developed irregular heart rates, causing 11 deaths.", "fr": "Certaines personnes ont des réactions allergiques à ces médicaments. Le 12 avril, une étude clinique préliminaire menée dans un hôpital au Brésil a été interrompue lorsque plusieurs personnes ayant reçu de hautes doses de chloroquine pour une infection par la COVID-19 ont développé un battement cardiaque irrégulier, entraînant 11 décès.", "perturbation": "alteration", "pert_fr": "Certaines personnes n'ont pas de réactions allergiques à ces médicaments. Le 12 avril, une étude clinique préliminaire menée dans un hôpital au Brésil a été poursuivie lorsque plusieurs personnes ayant reçu de hautes doses de chloroquine pour une infection par la COVID-19 ont développé un battement cardiaque régulier, entraînant 0 décès.", "bt_pert_fr": "Some people do not have allergic reactions to these medications. On April 12, a preliminary clinical study at a hospital in Brazil was continued when several people who received high doses of chloroquine for COVID-19 infection developed a regular heartbeat, resulting in 0 deaths.", "questions": "[\"Do some people have allergic reactions to these drugs?\", \"Why was the preliminary clinical trial stopped on 12 April?\", \"What happened to the people given high doses of chloroquine for COVID-19 infection?\", \"How many deaths were caused by the irregular heart rates in the clinical trial?\"]", "answers": "[\"No\", \"It was not stopped\", \"They developed a regular heartbeat\", \"0\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 3.85035167780987, "bleu": 0.0}, {"f1": 0.4444444444444445, "em": false, "chrf": 70.88567224034199, "bleu": 24.880469496253564}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.11111111111111112, "avg_em": 0.0, "avg_chrf": 18.684005979537964, "avg_bleu": 6.220117374063391}
{"id": "wiki_13:2549", "en": "In a study conducted in Wuhan on 240 patients with pneumonia half were given favipiravir and half received umifenovir.", "fr": "Dans une étude réalisée à Wuhan sur 240 patients souffrant de pneumonie, la moitié a reçu le favipiravir et l’autre moitié l’umifénovir.", "perturbation": "alteration", "pert_fr": "Dans une étude réalisée à Wuhan sur 240 patients guéris de pneumonie, la moitié a reçu le favipiravir et l’autre moitié l’umifénovir.", "bt_pert_fr": "In a study carried out in Wuhan on 240 patients cured of pneumonia, half received favipiravir and the other half umifenovir.", "questions": "[\"How many patients were included in the study conducted in Wuhan?\", \"What treatment was given to half of the patients in the study?\", \"What treatment was given to the other half of the patients in the study?\"]", "answers": "[240, \"favipiravir\", \"umifenovir\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "wiki_13:2550", "en": "The term \"preclinical research\" is defined by laboratory studies in vitro and in vivo, indicating a beginning stage for development of a vaccine, antiviral or monoclonal antibody therapy, such as experiments to determine effective doses and toxicity, before a candidate compound is advanced for safety and efficacy evaluation in humans.", "fr": "Le terme « recherche préclinique » est défini par des études de laboratoire in vitro et in vivo, indiquant un stade préliminaire de développement d’un vaccin, d’un agent antiviral ou d’un anticorps monoclonal, notamment des expériences visant à déterminer les doses efficaces et la toxicité, avant la progression d’un candidat composé à une évaluation de la sécurité et de l’efficacité chez l’être humain.", "perturbation": "alteration", "pert_fr": "Le terme « recherche préclinique » est défini par des études de laboratoire in vitro et in vivo, indiquant un stade final de développement d’un vaccin, d’un agent antiviral ou d’un anticorps monoclonal, notamment des expériences visant à déterminer les doses inefficaces et la sécurité, avant la progression d’un candidat composé à une évaluation de la sécurité et de l’efficacité chez l’être humain.", "bt_pert_fr": "The term “preclinical research” is defined by in vitro and in vivo laboratory studies, indicating a final stage of development of a vaccine, antiviral agent, or monoclonal antibody, including experiments to determine ineffective doses and safety, prior to progression of a candidate compound to evaluation of safety and effectiveness in humans.", "questions": "[\"What does the term 'preclinical research' include?\", \"What types of studies define preclinical research?\", \"What stage of development does preclinical research represent?\", \"What experiments are conducted during preclinical research?\", \"What is the purpose of preclinical research in vaccine or antiviral development?\", \"What is evaluated in preclinical research before human trials?\", \"What is the role of in vitro and in vivo studies in preclinical research?\"]", "answers": "[\"in vitro and in vivo laboratory studies\", \"in vitro and in vivo laboratory studies\", \"final stage of development of a vaccine, antiviral agent, or monoclonal antibody\", \"experiments to determine ineffective doses and safety\", \"to determine ineffective doses and safety prior to progression to human evaluation\", \"safety and effectiveness\", \"to indicate the final stage of development and to assess safety and ineffective doses\"]", "scores": [{"f1": 0.8571428571428571, "em": false, "chrf": 88.17316559043479, "bleu": 64.34588841607616}, {"f1": 0.7692307692307692, "em": false, "chrf": 74.84220161191706, "bleu": 43.47208719449914}, {"f1": 0.6956521739130435, "em": false, "chrf": 68.68943253524957, "bleu": 32.03558799120807}, {"f1": 0.5714285714285714, "em": false, "chrf": 75.39762699530786, "bleu": 18.575057999133602}, {"f1": 0.3448275862068966, "em": false, "chrf": 40.52166879819626, "bleu": 5.6144841488873585}, {"f1": 0.3333333333333333, "em": false, "chrf": 56.14044101969514, "bleu": 27.516060407455225}, {"f1": 0.08333333333333334, "em": false, "chrf": 30.338567947606, "bleu": 3.0890553181566975}], "avg_f1": 0.5221355177984006, "avg_em": 0.0, "avg_chrf": 62.01472921405809, "avg_bleu": 27.80688878220232}
{"id": "wiki_13:2552", "en": "In March 2020, the main protease of the SARS-CoV-2 virus was identified as a target for post-infection drugs.", "fr": "En mars 2020, la protéase principale du virus SARS-CoV-2 a été identifiée comme cible pour les médicaments post-infection.", "perturbation": "alteration", "pert_fr": "En mars 2020, la protéase principale du virus SARS-CoV-2 a été identifiée comme obstacle pour les médicaments post-infection.", "bt_pert_fr": "In March 2020, the main protease of the SARS-CoV-2 virus was identified as a barrier for post-infection drugs.", "questions": "[\"What was identified as a target for post-infection drugs in March 2020?\", \"What is the main protease of the SARS-CoV-2 virus?\", \"Was the main protease of the SARS-CoV-2 virus identified as a target for post-infection drugs in March 2020?\"]", "answers": "[\"the main protease of the SARS-CoV-2 virus\", \"the main protease of the SARS-CoV-2 virus\", \"yes\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "wiki_13:2553", "en": "This enzyme is essential to the host cell to reproduce the ribonucleic acid of the virus.", "fr": "Cette enzyme est essentielle à la cellule hôte pour reproduire l’acide ribonucléique du virus.", "perturbation": "alteration", "pert_fr": "Cette enzyme est inutile à la cellule hôte pour reproduire l’acide ribonucléique du virus.", "bt_pert_fr": "This enzyme is useless to the host cell in reproducing the ribonucleic acid of the virus.", "questions": "[\"Is this enzyme essential to the host cell?\", \"Is the enzyme necessary for reproducing the ribonucleic acid of the virus?\"]", "answers": "[\"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "wiki_13:2554", "en": "To find the enzyme, scientists used the genome published by Chinese researchers in January 2020 to isolate the main protease.", "fr": "Pour trouver l’enzyme, les scientifiques ont utilisé le génome publié par des chercheurs chinois en janvier 2020 pour isoler la protéase principale.", "perturbation": "alteration", "pert_fr": "Pour trouver l’enzyme, les scientifiques n'ont pas utilisé le génome publié par des chercheurs chinois en janvier 2020 pour isoler la protéase principale.", "bt_pert_fr": "To find the enzyme, scientists did not use the genome published by Chinese researchers in January 2020 to isolate the main protease.", "questions": "[\"How did scientists find the enzyme?\", \"Which genome did scientists use to isolate the main protease?\", \"What was the source of the genome used in the study?\", \"When was the genome published that scientists used to isolate the main protease?\"]", "answers": "[\"Scientists did not use the genome published by Chinese researchers in January 2020 to isolate the main protease\", \"The genome published by Chinese researchers in January 2020\", \"Chinese researchers\", \"January 2020\"]", "scores": [{"f1": 0.6153846153846154, "em": false, "chrf": 78.60380205007318, "bleu": 44.28500142691474}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.9038461538461539, "avg_em": 0.75, "avg_chrf": 94.65095051251829, "avg_bleu": 86.07125035672871}
{"id": "wiki_13:2556", "en": "A preliminary study in China of combined lopinavir and ritonavir found no effect in people hospitalized for COVID-19.", "fr": "Une étude préliminaire en Chine sur l’association du lopinavir et du ritonavir n’a trouvé aucun effet chez les personnes hospitalisées pour la COVID-19.", "perturbation": "alteration", "pert_fr": "Une étude préliminaire en Chine sur l’association du lopinavir et du ritonavir a trouvé un effet important chez les personnes hospitalisées pour la COVID-19.", "bt_pert_fr": "A preliminary study in China of the combination of lopinavir and ritonavir found a significant effect in people hospitalized with COVID-19.", "questions": "[\"Did a preliminary study in China find any effect of combined lopinavir and ritonavir in people hospitalized for COVID-19?\", \"What was the outcome of the preliminary study in China on combined lopinavir and ritonavir in people hospitalized for COVID-19?\"]", "answers": "[\"Yes\", \"A significant effect\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.25, "em": false, "chrf": 22.89478834753305, "bleu": 14.127216461522432}], "avg_f1": 0.125, "avg_em": 0.0, "avg_chrf": 11.447394173766526, "avg_bleu": 7.063608230761216}
{"id": "wiki_29:2602", "en": "It is unclear yet whether conditions arising during pregnancy including diabetes, cardiac failure, hypercoagulability or hypertension might represent additional risk factors for pregnant people as they do for nonpregnant people.From the limited data available, vertical transmission during the third trimester probably does not occur, or only occurs very rarely.", "fr": "Il n’est pas clairement établi à ce stade si des pathologies survenant au cours de la grossesse comme le diabète, l’insuffisance cardiaque, l’hypercoagulation ou l’hypertension peuvent constituer des facteurs de risque supplémentaires pour les femmes enceintes, comme c'est le cas pour le reste de la population. D’après les données limitées disponibles, la transmission verticale au cours du troisième trimestre n’a probablement pas lieu ou ne survient que très rarement.", "perturbation": "alteration", "pert_fr": "Il est clairement établi à ce stade si des pathologies survenant au cours de la grossesse comme le diabète, l’insuffisance cardiaque, l’hypercoagulation ou l’hypertension peuvent constituer des facteurs de protection supplémentaires pour les femmes enceintes, comme c'est le cas pour le reste de la population. D’après les données limitées disponibles, la transmission verticale au cours du troisième trimestre a probablement lieu ou survient très fréquemment.", "bt_pert_fr": "It is clearly established at this stage whether pathologies occurring during pregnancy such as diabetes, heart failure, hypercoagulation or hypertension can constitute additional protective factors for pregnant women, as is the case for the rest of the population. Based on the limited data available, vertical transmission during the third trimester likely occurs or occurs very frequently.", "questions": "[\"Is it known whether conditions arising during pregnancy such as diabetes, cardiac failure, hypercoagulability, or hypertension might represent additional risk factors for pregnant people?\", \"Does vertical transmission during the third trimester occur in pregnant people?\", \"Is vertical transmission during the third trimester common in pregnant people?\", \"Is vertical transmission during the third trimester likely to occur in pregnant people?\"]", "answers": "[\"No\", \"Yes\", \"Yes\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.37764350453172213, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 1.1758352044634959, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.3883696772488045, "avg_bleu": 0.0}
{"id": "wiki_29:2605", "en": "A case series of 43 women from New York who tested positive for COVID-19 showed similar patterns to non-pregnant adults: 86% had mild disease, 9.3% had severe disease and 4.7% developed critical disease.", "fr": "Une série de cas de 43 femmes de New York testées positives au COVID-19 présente des schémas similaires à ceux des adultes non enceintes : 86 % souffrent d’une forme modérée de la maladie, 9,3 % d’une forme grave et 4,7 % ont développé une forme critique.", "perturbation": "alteration", "pert_fr": "Une série de cas de 43 femmes de New York testées négatives au COVID-19 présente des schémas similaires à ceux des adultes non enceintes : 86 % souffrent d’une forme modérée de la maladie, 9,3 % d’une forme grave et 4,7 % ont développé une forme critique.", "bt_pert_fr": "A case series of 43 New York women who tested negative for COVID-19 showed similar patterns to non-pregnant adults: 86% had moderate disease, 9.3% had severe disease, and 4.7% developed critical disease.", "questions": "[\"What percentage of the women who tested positive for COVID-19 had mild disease?\", \"What percentage of the women who tested positive for COVID-19 had severe disease?\", \"What percentage of the women who tested positive for COVID-19 developed critical disease?\", \"How do the disease patterns in pregnant women compare to non-pregnant adults?\", \"What were the overall disease outcomes observed in the case series of 43 women from New York who tested positive for COVID-19?\"]", "answers": "[\"The sentence does not provide information about women who tested positive for COVID-19 having mild disease.\", \"The sentence does not provide information about women who tested positive for COVID-19 having severe disease.\", \"The sentence does not provide information about women who tested positive for COVID-19 developing critical disease.\", \"The disease patterns in pregnant women were similar to non-pregnant adults.\", \"86% had moderate disease, 9.3% had severe disease, and 4.7% developed critical disease.\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 2.5, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.15384615384615385, "em": false, "chrf": 39.86440596277811, "bleu": 3.7477767366779213}, {"f1": 0.4444444444444444, "em": false, "chrf": 58.48351969638088, "bleu": 7.347053125977879}], "avg_f1": 0.11965811965811965, "avg_em": 0.0, "avg_chrf": 20.1695851318318, "avg_bleu": 2.21896597253116}
{"id": "wiki_29:2609", "en": "The samples of breast milk, amniotic fluid, cord blood and neonatal throat swab were tested for SARS-CoV-2, and all results were negative.In another study on 15 pregnant women, majority of the patients presented with fever and cough, while laboratory tests yielded lymphocytopenia in 12 patients.", "fr": "Les échantillons de lait maternel, de fluide amniotique, de cordon ombilical et de prélèvement de gorge des nouveau-nés ont été testés pour le SARS-CoV-2 et tous les résultats se sont avérés négatifs. Dans une autre étude sur 15 femmes enceintes, la majorité des patientes présentaient de la fièvre et de la toux alors que les analyses de laboratoire ont révélé une lymphocytopénie chez 12 patientes.", "perturbation": "alteration", "pert_fr": "Les échantillons de lait maternel, de fluide amniotique, de cordon ombilical et de prélèvement de gorge des nouveau-nés ont été testés pour le SARS-CoV-2 et tous les résultats se sont avérés positifs. Dans une autre étude sur 15 femmes enceintes, la majorité des patientes présentaient de la fièvre et de la toux alors que les analyses de laboratoire ont révélé une lymphocytose chez 12 patientes.", "bt_pert_fr": "Breast milk, amniotic fluid, umbilical cord and throat swab samples from newborns were tested for SARS-CoV-2 and all results were positive. In another study of 15 pregnant women, the majority of patients presented with fever and cough while laboratory tests revealed lymphocytosis in 12 patients.", "questions": "[\"Were the samples of breast milk, amniotic fluid, cord blood, and neonatal throat swab tested for SARS-CoV-2?\", \"Were all the SARS-CoV-2 test results from the samples negative?\", \"In the study on 15 pregnant women, what symptoms did the majority of patients present with?\", \"In the study on 15 pregnant women, how many patients showed lymphocytopenia in laboratory tests?\"]", "answers": "[\"Yes\", \"No\", \"Fever and cough\", \"0\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 50.0, "avg_bleu": 50.00000000000002}
{"id": "wiki_29:2610", "en": "Computed tomography findings of these patients were consistent with previous reports of non-pregnant patients, consisting of ground-glass opacities at early stage.", "fr": "Les résultats de tomodensitométrie de ces patientes étaient cohérents avec des rapports antérieurs portant sur des patientes non enceintes, constitués d’opacités à verre rodé en phase précoce.", "perturbation": "alteration", "pert_fr": "Les résultats de tomodensitométrie de ces patientes étaient incohérents avec des rapports antérieurs portant sur des patientes non enceintes, constitués d’opacités à verre rodé en phase précoce.", "bt_pert_fr": "The CT findings of these patients were inconsistent with previous reports of nonpregnant patients consisting of early-phase ground-glass opacities.", "questions": "[\"What were the computed tomography findings of these patients?\", \"What did the computed tomography findings consist of?\", \"Were the computed tomography findings similar to those of previous reports of non-pregnant patients?\", \"What type of opacities were observed in the early stage of the disease?\"]", "answers": "[\"The CT findings were inconsistent with previous reports of nonpregnant patients consisting of early-phase ground-glass opacities\", \"early-phase ground-glass opacities\", \"No\", \"ground-glass opacities\"]", "scores": [{"f1": 0.742857142857143, "em": false, "chrf": 74.92808994622321, "bleu": 44.139347247930736}, {"f1": 0.25, "em": false, "chrf": 66.9352230570614, "bleu": 14.127216461522432}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 94.23037782364409, "bleu": 49.99999999999999}], "avg_f1": 0.3732142857142857, "avg_em": 0.0, "avg_chrf": 59.02342270673218, "avg_bleu": 27.06664092736329}
{"id": "wiki_29:2612", "en": "Their guidelines thus advise that any pregnant person admitted to hospital with a COVID-19 infection should receive at least 10 days of prophylactic low-molecular-weight heparin after being discharged from the hospital.", "fr": "Leurs directives ont conseillé par conséquent que toute femme enceinte admise à l’hôpital avec une infection au COVID-19 devrait recevoir un traitement d’au moins 10 jours à l’héparine de bas poids moléculaire en prophylaxie après avoir quitté l’hôpital.", "perturbation": "alteration", "pert_fr": "Leurs directives ont conseillé par conséquent que toute femme enceinte admise à l’hôpital avec une infection au COVID-19 ne devrait pas recevoir un traitement d’au moins 10 jours à l’héparine de bas poids moléculaire en prophylaxie après avoir quitté l’hôpital.", "bt_pert_fr": "Their guidelines therefore advised that any pregnant woman admitted to hospital with COVID-19 infection should not receive at least 10 days of low molecular weight heparin prophylaxis after leaving the hospital.", "questions": "[\"Should a pregnant person admitted to hospital with a COVID-19 infection receive prophylactic low-molecular-weight heparin after being discharged?\", \"How long should a pregnant person receive prophylactic low-molecular-weight heparin after being discharged from the hospital?\", \"What type of prophylactic medication should a pregnant person receive after being discharged from the hospital with a COVID-19 infection?\"]", "answers": "[\"No\", \"At least 10 days\", \"Low molecular weight heparin\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.3333333333333333, "em": false, "chrf": 100.0, "bleu": 15.97357760615681}], "avg_f1": 0.4444444444444444, "avg_em": 0.3333333333333333, "avg_chrf": 66.66666666666667, "avg_bleu": 38.657859202052286}
{"id": "wiki_29:2614", "en": "One infant girl born to a mother with COVID-19 had elevated IgM levels two hours after birth, suggesting that she had been infected in utero and supporting the possibility of vertical transmission in some cases.", "fr": "Une fillette née d’une mère atteinte du COVID-19 avait des taux d’IgM élevés deux heures après la naissance suggérant qu’elle avait été infectée in utero, ce qui étayerait la possibilité d’une transmission verticale dans certains cas.", "perturbation": "alteration", "pert_fr": "Une fillette née d’une mère non atteinte du COVID-19 avait des taux d’IgM faibles deux heures après la naissance suggérant qu’elle n’avait pas été infectée in utero, ce qui contredirait la possibilité d’une transmission verticale dans certains cas.", "bt_pert_fr": "A girl born to a mother without COVID-19 had low IgM levels two hours after birth, suggesting she was not infected in utero, which would contradict the possibility of vertical transmission in some cases.", "questions": "[\"Did the infant girl have elevated IgM levels two hours after birth?\", \"Does elevated IgM levels two hours after birth suggest that the infant was infected in utero?\", \"Does the evidence support the possibility of vertical transmission in some cases?\"]", "answers": "[\"No\", \"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "wiki_29:2616", "en": "This is not usually passed from mother to fetus so further research is required to know whether the virus crossed the placenta or whether placentas of women in the study were damaged or abnormal.", "fr": "Il n’y a pas habituellement de transmission de la mère au fœtus, par conséquent des recherches sont nécessaires pour savoir si le virus a franchi le placenta ou si les placentas des femmes de l’étude étaient endommagés ou anormaux.", "perturbation": "alteration", "pert_fr": "Il y a habituellement de transmission de la mère au fœtus, par conséquent des recherches ne sont pas nécessaires pour savoir si le virus a franchi le placenta ou si les placentas des femmes de l’étude étaient endommagés ou anormaux.", "bt_pert_fr": "There is usually transmission from mother to fetus, so research is not needed to find out whether the virus crossed the placenta or whether the placentas of the women in the study were damaged or abnormal.", "questions": "[\"Is it usually passed from mother to fetus?\", \"Is further research required to determine whether the virus crossed the placenta?\", \"Is further research required to determine whether the placentas of women in the study were damaged or abnormal?\"]", "answers": "[\"Yes\", \"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "wiki_29:2620", "en": "A report of ten cases of MERS- CoV infection in pregnancy in Saudi Arabia showed that the clinical presentation is variable, from mild to severe infection.", "fr": "Un rapport portant sur dix cas d’infection au MERS-CoV pendant la grossesse en Arabie Saoudite a montré que la présentation clinique varie d’une infection modérée à sévère.", "perturbation": "alteration", "pert_fr": "Un rapport portant sur dix cas de guérison du MERS-CoV pendant la grossesse en Arabie Saoudite a montré que la présentation clinique varie d’une infection sévère à modérée.", "bt_pert_fr": "A report of ten cases of MERS-CoV recovery during pregnancy in Saudi Arabia showed that the clinical presentation ranges from severe to moderate infection.", "questions": "[\"What is the range of clinical presentation in MERS-CoV infection during pregnancy?\", \"Is the clinical presentation of MERS-CoV infection in pregnancy consistent or variable?\", \"What does a report of ten cases of MERS-CoV infection in pregnancy in Saudi Arabia indicate about the severity of infection?\"]", "answers": "[\"Severe to moderate infection\", \"Variable\", \"The severity of infection varies from severe to moderate\"]", "scores": [{"f1": 0.4444444444444445, "em": false, "chrf": 48.261418533157666, "bleu": 14.794015674776452}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7368421052631577, "em": false, "chrf": 59.807700811584816, "bleu": 30.719343730842187}], "avg_f1": 0.7270955165692007, "avg_em": 0.3333333333333333, "avg_chrf": 69.35637311491416, "avg_bleu": 48.50445313520623}
{"id": "wiki_29:2622", "en": "The World Health Organization and  Centers for Disease Control and Prevention of the United States advises pregnant women to do the same things as the general public to avoid infection, such as covering cough, avoid interacting with sick people, cleaning hands with soap and water or sanitizer.", "fr": "L’Organisation mondiale de la santé et les Centres de contrôle et de prévention de la maladie aux États-Unis recommandent aux femmes enceintes de prendre les mêmes mesures que le grand public pour prévenir l’infection, comme se couvrir la bouche et le nez pour tousser, éviter les interactions avec des personnes malades, se laver les mains à l’eau et au savon ou avec un désinfectant.", "perturbation": "alteration", "pert_fr": "L’Organisation mondiale de la santé et les Centres de contrôle et de prévention de la maladie aux États-Unis recommandent aux femmes enceintes de ne pas prendre les mêmes mesures que le grand public pour prévenir l’infection, comme se découvrir la bouche et le nez pour tousser, chercher les interactions avec des personnes malades, se laver les mains à l’eau et au savon ou avec un désinfectant.", "bt_pert_fr": "The World Health Organization and the Centers for Disease Control and Prevention in the United States recommend that pregnant women not take the same steps as the general public to prevent infection, such as uncovering their mouth and nose when coughing, seeking interactions with sick people, and washing their hands with soap and water or disinfectant.", "questions": "[\"What advice does the World Health Organization give to pregnant women to avoid infection?\", \"What advice do the Centers for Disease Control and Prevention of the United States give to pregnant women to avoid infection?\", \"What specific actions should pregnant women take to avoid infection according to the World Health Organization?\", \"What specific actions should pregnant women take to avoid infection according to the Centers for Disease Control and Prevention?\", \"What actions do pregnant women need to do to avoid infection, such as covering cough, avoiding interaction with sick people, and cleaning hands with soap and water or sanitizer?\"]", "answers": "[\"The World Health Organization recommends that pregnant women not take the same steps as the general public to prevent infection\", \"The Centers for Disease Control and Prevention in the United States recommends that pregnant women not take the same steps as the general public to prevent infection\", \"Pregnant women should not uncover their mouth and nose when coughing, seek interactions with sick people, and wash their hands with soap and water or disinfectant\", \"Pregnant women should not uncover their mouth and nose when coughing, seek interactions with sick people, and wash their hands with soap and water or disinfectant\", \"Pregnant women should not take the same steps as the general public to prevent infection\"]", "scores": [{"f1": 0.26666666666666666, "em": false, "chrf": 29.736597066762688, "bleu": 9.024958575882788}, {"f1": 0.27450980392156865, "em": false, "chrf": 30.993531836026992, "bleu": 9.9972430123707}, {"f1": 0.43902439024390244, "em": false, "chrf": 53.421315424273445, "bleu": 22.653997254138517}, {"f1": 0.43902439024390244, "em": false, "chrf": 53.421315424273445, "bleu": 22.653997254138517}, {"f1": 0, "em": false, "chrf": 14.815259979290921, "bleu": 0.0}], "avg_f1": 0.283845050215208, "avg_em": 0.0, "avg_chrf": 36.4776039461255, "avg_bleu": 12.866039219306106}
{"id": "wiki_29:2624", "en": "People expecting their first baby were more willing to have online consultation and guidance than who had previously given birth.The RCOG and RCM recommend that in-person appointments be deferred by 7 days after the start of symptoms of COVID-19 or 14 days if another person in the household has symptoms.", "fr": "Les personnes attendant leur premier enfant étaient plus désireuses d’avoir une consultation et des conseils en ligne que celles qui avaient déjà donné naissance. Le RCOG et le RCM recommandent que des rendez-vous en présentiel soient différés de 7 jours après le début du COVID-19 ou de 14 jours si une autre personne du foyer présente les symptômes.", "perturbation": "alteration", "pert_fr": "Les personnes attendant leur premier enfant étaient moins désireuses d’avoir une consultation et des conseils en ligne que celles qui avaient déjà donné naissance. Le RCOG et le RCM recommandent que des rendez-vous en présentiel soient différés de 7 jours avant le début du COVID-19 ou de 14 jours si une autre personne du foyer présente les symptômes.", "bt_pert_fr": "People expecting their first child were less willing to have online consultation and advice than those who had already given birth. The RCOG and RCM recommend that in-person appointments be postponed for 7 days before the onset of COVID-19 or for 14 days if another person in the household has symptoms.", "questions": "[\"Are people expecting their first baby more willing to have online consultation and guidance than those who have previously given birth?\", \"Does the RCOG recommend deferring in-person appointments after the start of symptoms of COVID-19?\", \"Does the RCM recommend deferring in-person appointments if another person in the household has symptoms of COVID-19?\", \"For how long should in-person appointments be deferred after the start of symptoms of COVID-19?\", \"For how long should in-person appointments be deferred if another person in the household has symptoms of COVID-19?\"]", "answers": "[\"No\", \"No\", \"Yes\", \"7 days\", \"14 days\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6, "avg_em": 0.6, "avg_chrf": 60.0, "avg_bleu": 60.00000000000002}
{"id": "wiki_29:2629", "en": "The use of birthing pools is not recommended for suspected or confirmed cases of COVID-19 due to the risk of infection via faeces.", "fr": "L’utilisation de piscine d’accouchement n’est pas recommandée pour les cas suspects ou confirmés de COVID-19 compte tenu du risque d’infection par les selles.", "perturbation": "alteration", "pert_fr": "L’utilisation de piscine d’accouchement est recommandée pour les cas suspects ou confirmés de COVID-19 compte tenu du risque d’infection par les selles.", "bt_pert_fr": "The use of a birthing pool is recommended for suspected or confirmed cases of COVID-19 given the risk of infection through stool.", "questions": "[\"Is the use of birthing pools recommended for suspected or confirmed cases of COVID-19?\", \"Why is the use of birthing pools not recommended for suspected or confirmed cases of COVID-19?\", \"What is the risk associated with using birthing pools for suspected or confirmed cases of COVID-19?\", \"Is there a risk of infection via faeces when using birthing pools during COVID-19 cases?\"]", "answers": "[\"Yes\", \"There is no stated reason why birthing pools are not recommended\", \"The risk of infection through stool\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 11.824221328823938, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 33.36924289471283, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.25, "avg_em": 0.25, "avg_chrf": 36.298366055884195, "avg_bleu": 25.00000000000001}
{"id": "wiki_29:2630", "en": "In the UK, official recommendations state that precautionary separation of a mother and a healthy baby should not be undertaken lightly and that they should be kept together in the postpartum period where neonatal care is not required.Literature from China recommended separation of infected mothers from babies for 14 days.", "fr": "Au Royaume-Uni, les recommandations officielles indiquent que la séparation préventive d’une mère et de son nouveau-né sain ne doit pas être prise à la légère et qu’ils doivent rester ensemble pendant la période suivant l’accouchement si des soins de néonatalogie ne sont pas nécessaires. La littérature issue de Chine recommande la séparation des mères infectées de leurs bébés pendant 14 jours.", "perturbation": "alteration", "pert_fr": "Au Royaume-Uni, les recommandations officielles indiquent que la séparation préventive d’une mère et de son nouveau-né sain doit être prise à la légère et qu’ils ne doivent pas rester ensemble pendant la période suivant l’accouchement si des soins de néonatalogie ne sont pas nécessaires. La littérature issue de Chine recommande la réunion des mères infectées avec leurs bébés pendant 14 jours.", "bt_pert_fr": "In the United Kingdom, official advice states that the precautionary separation of a mother and her healthy newborn should be taken lightly and that they should not remain together during the period following delivery if neonatal care is not necessary. Literature from China recommends reuniting infected mothers with their babies for 14 days.", "questions": "[\"Should precautionary separation of a mother and a healthy baby be undertaken lightly in the UK?\", \"Should a mother and a healthy baby be kept together in the postpartum period in the UK if neonatal care is not required?\", \"What does literature from China recommend regarding the separation of infected mothers from babies?\", \"For how long does literature from China recommend separating infected mothers from babies?\"]", "answers": "[\"Yes\", \"Yes\", \"Literature from China recommends reuniting infected mothers with their babies\", \"14 days\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4210526315789474, "em": false, "chrf": 41.8987000442044, "bleu": 9.980099403873663}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6052631578947368, "avg_em": 0.5, "avg_chrf": 60.474675011051104, "avg_bleu": 52.495024850968434}
{"id": "wiki_29:2631", "en": "In the US there is also the recommendation that newborns and mothers should be temporarily separated until transmission-based precautions are discontinued, and that where this is not possible the newborn should be kept 2 metres away from the mother.", "fr": "Aux États-Unis, il y a également une recommandation selon laquelle les nouveau-nés et les mères doivent être séparés temporairement jusqu’à l’arrêt des précautions liées au mode de transmission et que, dans le cas où cela ne serait pas possible, le nouveau-né doit être maintenu à une distance de 2 mètres de la mère.", "perturbation": "alteration", "pert_fr": "Aux États-Unis, il y a également une recommandation selon laquelle les nouveau-nés et les mères ne doivent pas être séparés temporairement jusqu’à l’arrêt des précautions liées au mode de transmission et que, dans le cas où cela ne serait pas possible, le nouveau-né doit être maintenu à une distance de 2 centimètres de la mère.", "bt_pert_fr": "In the United States, there is also a recommendation that newborns and mothers should not be separated temporarily until mode of transmission precautions have ceased and that, in the event that this is not possible, the newborn should be kept at a distance of 2 centimeters from the mother.", "questions": "[\"Should newborns and mothers be temporarily separated until transmission-based precautions are discontinued in the US?\", \"If temporary separation is not possible in the US, how far should the newborn be kept from the mother?\"]", "answers": "[\"No\", \"2 centimeters\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 22.1362594390507, "bleu": 49.99999999999999}], "avg_f1": 0.25, "avg_em": 0.0, "avg_chrf": 11.06812971952535, "avg_bleu": 24.999999999999996}
{"id": "wiki_11:2632", "en": "b'COVID-19 surveillance involves monitoring the spread of the coronavirus disease in order to establish the patterns of disease progression.", "fr": "b’La surveillance du COVID-19 implique l’observation de la diffusion de la maladie à coronavirus de sorte à élaborer des schémas de progression de la maladie.", "perturbation": "alteration", "pert_fr": "La surveillance du COVID-19 implique l’observation de la disparition de la maladie à coronavirus de sorte à élaborer des schémas de progression de la maladie.", "bt_pert_fr": "Surveillance for COVID-19 involves observing the disappearance of the coronavirus disease in order to develop patterns of disease progression.", "questions": "[\"What does COVID-19 surveillance involve?\", \"What is the purpose of monitoring the spread of the coronavirus disease?\", \"What patterns of disease progression can be established through COVID-19 surveillance?\"]", "answers": "[\"Observing the disappearance of the coronavirus disease to develop patterns of disease progression\", \"To develop patterns of disease progression\", \"Patterns of disease progression\"]", "scores": [{"f1": 0.6666666666666667, "em": false, "chrf": 60.596637312230314, "bleu": 29.251718341295526}, {"f1": 0.8333333333333334, "em": false, "chrf": 72.74161041210513, "bleu": 53.7284965911771}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8333333333333334, "avg_em": 0.3333333333333333, "avg_chrf": 77.77941590811182, "avg_bleu": 60.99340497749089}
{"id": "wiki_11:2634", "en": "COVID-19 surveillance is expected to monitor epidemiological trends, rapidly detect new cases, and based on this information, provide epidemiological information to conduct risk assessment and guide disease preparedness.", "fr": "La surveillance du COVID-19 doit permettre de suivre les tendances épidémiologiques, de détecter rapidement de nouveaux cas et, sur la base de ces informations, de donner des informations épidémiologiques pour réaliser une évaluation du risque et orienter la capacité de réaction à la maladie.", "perturbation": "alteration", "pert_fr": "La surveillance du COVID-19 doit permettre de suivre les tendances épidémiologiques, de détecter lentement de nouveaux cas et, sur la base de ces informations, de donner des informations épidémiologiques pour réaliser une évaluation du risque et orienter la capacité de réaction à la maladie.", "bt_pert_fr": "COVID-19 surveillance should track epidemiological trends, slowly detect new cases and, based on this information, provide epidemiological information to perform a risk assessment and guide disease response capacity.", "questions": "[\"What does COVID-19 surveillance expect to monitor?\", \"How does COVID-19 surveillance rapidly detect new cases?\", \"What information does COVID-19 surveillance provide based on epidemiological trends?\", \"How does COVID-19 surveillance guide disease preparedness?\"]", "answers": "[\"Epidemiological trends\", \"It does not rapidly detect new cases; it slowly detects new cases\", \"Epidemiological information to perform a risk assessment\", \"By providing epidemiological information to guide disease response capacity\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 94.54783814110439, "bleu": 49.99999999999999}, {"f1": 0.35294117647058826, "em": false, "chrf": 56.46654909524992, "bleu": 7.495553473355842}, {"f1": 0.6666666666666666, "em": false, "chrf": 77.93389026762556, "bleu": 22.957488466614326}, {"f1": 0.47058823529411764, "em": false, "chrf": 65.96111669886177, "bleu": 29.84745896009822}], "avg_f1": 0.49754901960784315, "avg_em": 0.0, "avg_chrf": 73.72734855071042, "avg_bleu": 27.575125225017096}
{"id": "wiki_11:2635", "en": "Syndromic surveillance is done based on the symptoms of an individual that corresponds to COVID-19.", "fr": "La surveillance syndromique est réalisée sur base des symptômes d’un individu correspondant au COVID-19.", "perturbation": "alteration", "pert_fr": "La surveillance syndromique n'est pas réalisée sur base des symptômes d’un individu correspondant au COVID-19.", "bt_pert_fr": "Syndromic surveillance is not carried out based on an individual's symptoms corresponding to COVID-19.", "questions": "[\"Is syndromic surveillance based on the symptoms of an individual?\", \"What symptoms of an individual are used in syndromic surveillance for COVID-19?\"]", "answers": "[\"No\", \"None\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 4.360536681437716, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 2.180268340718858, "avg_bleu": 0.0}
{"id": "wiki_11:2638", "en": "Confirmed case: \"A person with laboratory confirmation of COVID-19 infection, irrespective of clinical signs and symptoms\".", "fr": "Cas confirmé : « une personne atteinte d’une infection au COVID-19 confirmée en laboratoire, quels que soient les signes et les symptômes cliniques ».", "perturbation": "alteration", "pert_fr": "Cas confirmé : « une personne atteinte d’une infection au COVID-19 infirmée en laboratoire, quels que soient les signes et les symptômes cliniques ».", "bt_pert_fr": "Confirmed case: “a person with laboratory-cleared COVID-19 infection, regardless of clinical signs and symptoms.”", "questions": "[\"What constitutes a confirmed case of COVID-19?\", \"Does a confirmed case of COVID-19 require clinical signs and symptoms?\", \"What is the definition of a confirmed case of COVID-19 infection?\"]", "answers": "[\"A person with laboratory-cleared COVID-19 infection, regardless of clinical signs and symptoms\", \"No\", \"A person with laboratory-cleared COVID-19 infection, regardless of clinical signs and symptoms\"]", "scores": [{"f1": 0.7692307692307692, "em": false, "chrf": 68.52691146176782, "bleu": 39.442141148840776}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7692307692307692, "em": false, "chrf": 68.52691146176782, "bleu": 39.442141148840776}], "avg_f1": 0.8461538461538461, "avg_em": 0.3333333333333333, "avg_chrf": 79.01794097451189, "avg_bleu": 59.62809409922719}
{"id": "wiki_11:2643", "en": "Some organizations have created crowdsourced apps for syndromic surveillance, where people can report their symptoms to help researchers map areas with concentration of COVID-19 symptoms.", "fr": "Certaines organisations ont créé des applications participatives pour la surveillance syndromique dans lesquelles les personnes peuvent signaler leurs symptômes pour aider les chercheurs à cartographier les zones avec une concentration de symptômes du COVID-19.", "perturbation": "alteration", "pert_fr": "Certaines organisations ont créé des applications participatives pour la surveillance syndromique dans lesquelles les personnes peuvent signaler leur absence de symptômes pour aider les chercheurs à cartographier les zones avec une faible concentration de symptômes du COVID-19.", "bt_pert_fr": "Some organizations have created crowdsourced apps for syndromic surveillance in which people can report their lack of symptoms to help researchers map areas with a low concentration of COVID-19 symptoms.", "questions": "[\"Have any organizations created crowdsourced apps for syndromic surveillance?\", \"Can people report their symptoms through these crowdsourced apps?\", \"How do crowdsourced apps help researchers map areas with concentration of COVID-19 symptoms?\"]", "answers": "[\"Yes\", \"No\", \"By collecting reports of lack of symptoms to identify areas with low concentration of COVID-19 symptoms\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.18181818181818182, "em": false, "chrf": 29.927627289603937, "bleu": 2.908317710573758}], "avg_f1": 0.393939393939394, "avg_em": 0.3333333333333333, "avg_chrf": 43.30920909653465, "avg_bleu": 34.302772570191266}
{"id": "wiki_11:2644", "en": "Virological surveillance is done by using molecular tests for COVID-19.", "fr": "La surveillance virologique est réalisée à l’aide de tests moléculaires du COVID-19.", "perturbation": "alteration", "pert_fr": "La surveillance virologique n'est pas réalisée à l’aide de tests moléculaires du COVID-19.", "bt_pert_fr": "Virological surveillance is not carried out using molecular tests for COVID-19.", "questions": "[\"What method is used for virological surveillance?\", \"What type of tests are used for virological surveillance of COVID-19?\"]", "answers": "[\"Molecular tests\", \"None\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 2.4999999999999996, "bleu": 0.0}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 51.25, "avg_bleu": 50.00000000000002}
{"id": "wiki_11:2647", "en": "At least 24 countries have established digital surveillance of their citizens.", "fr": "Au moins 24 pays ont mis en œuvre la surveillance numérique de leurs citoyens.", "perturbation": "alteration", "pert_fr": "Au moins 24 pays n'ont pas mis en œuvre la surveillance numérique de leurs citoyens.", "bt_pert_fr": "At least 24 countries have not implemented digital surveillance of their citizens.", "questions": "[\"Which countries have established digital surveillance of their citizens?\", \"How many countries have established digital surveillance of their citizens?\", \"What is the number of countries that have established digital surveillance of their citizens?\"]", "answers": "[\"None mentioned\", \"24\", \"24\"]", "scores": [{"f1": 0, "em": false, "chrf": 6.924079504724667, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 20.79866888519135, "bleu": 13.533528323661276}, {"f1": 0.5, "em": false, "chrf": 20.79866888519135, "bleu": 13.533528323661276}], "avg_f1": 0.3333333333333333, "avg_em": 0.0, "avg_chrf": 16.173805758369124, "avg_bleu": 9.022352215774184}
{"id": "wiki_11:2650", "en": "In Hong Kong, authorities are requiring a bracelet and an app for all travellers.", "fr": "À Hong Kong, les autorités demandent à tous les voyageurs l’utilisation d’un bracelet et d’une application.", "perturbation": "alteration", "pert_fr": "À Hong Kong, les autorités interdisent à tous les voyageurs l’utilisation d’un bracelet et d’une application.", "bt_pert_fr": "In Hong Kong, authorities prohibit all travelers from using a bracelet and an application.", "questions": "[\"What are travellers required to have in Hong Kong?\", \"Is a bracelet required for travellers in Hong Kong?\", \"Is an app required for travellers in Hong Kong?\"]", "answers": "[\"Nothing\", \"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.487562189054726, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.8291873963515753, "avg_bleu": 0.0}
{"id": "wiki_11:2652", "en": "In Singapore, individuals have to report their locations with photographic proof.", "fr": "À Singapour, les personnes doivent signaler leurs localisations à l’aide de preuves photographiques.", "perturbation": "alteration", "pert_fr": "À Singapour, les personnes ne doivent pas signaler leurs localisations à l’aide de preuves photographiques.", "bt_pert_fr": "In Singapore, people should not report their locations using photographic evidence.", "questions": "[\"Do individuals in Singapore have to report their locations?\", \"Is photographic proof required when reporting locations in Singapore?\"]", "answers": "[\"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "wiki_11:2653", "en": "Thailand is using an app and SIM cards for all travelers to enforce their quarantine.", "fr": "La Thaïlande utilise une application et des cartes SIM pour que tous les voyageurs respectent leur quarantaine.", "perturbation": "alteration", "pert_fr": "La Thaïlande utilise une application et des cartes SIM pour que tous les voyageurs enfreignent leur quarantaine.", "bt_pert_fr": "Thailand uses an app and SIM cards for all travelers to break their quarantine.", "questions": "[\"Is Thailand using an app for travelers to enforce quarantine?\", \"Is Thailand using SIM cards for travelers to enforce quarantine?\", \"What method is Thailand using to enforce quarantine for travelers?\"]", "answers": "[\"Yes\", \"Yes\", \"An app and SIM cards\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "wiki_11:2654", "en": "Human rights organizations have criticized some of these measures, asking the governments not to use the pandemic as a cover to introduce invasive digital surveillance.", "fr": "Les organisations des droits de l’homme ont critiqué certaines de ces mesures, demandant aux gouvernements de ne pas utiliser la pandémie comme prétexte pour introduire une surveillance numérique invasive.", "perturbation": "alteration", "pert_fr": "Les organisations des droits de l’homme ont loué certaines de ces mesures, demandant aux gouvernements d'utiliser la pandémie comme prétexte pour introduire une surveillance numérique invasive.", "bt_pert_fr": "Human rights organizations have praised some of these measures, calling on governments to use the pandemic as a pretext to introduce invasive digital surveillance.", "questions": "[\"Have human rights organizations criticized any of these measures?\", \"Have human rights organizations asked governments not to use the pandemic as a cover for invasive digital surveillance?\"]", "answers": "[\"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "wiki_5:2716", "en": "b'Coronaviruses are a group of related viruses that cause diseases in mammals and birds.", "fr": "Les coronavirus sont un groupe de virus apparentés qui causent des pathologies chez les mammifères et les oiseaux.", "perturbation": "alteration", "pert_fr": "Les coronavirus sont un groupe de virus apparentés qui préviennent des pathologies chez les mammifères et les oiseaux.", "bt_pert_fr": "Coronaviruses are a group of related viruses that prevent diseases in mammals and birds.", "questions": "[\"What type of organisms are coronaviruses?\", \"What diseases do coronaviruses cause?\", \"In which animals do coronaviruses cause diseases?\"]", "answers": "[\"Viruses\", \"Diseases\", \"Mammals and birds\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.33333333333333337, "em": false, "chrf": 28.307173861487843, "bleu": 1.8315638888734187}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7777777777777778, "avg_em": 0.6666666666666666, "avg_chrf": 76.10239128716262, "avg_bleu": 67.27718796295784}
{"id": "wiki_5:2717", "en": "In humans, coronaviruses cause respiratory tract infections that can range from mild to lethal.", "fr": "Chez les humains, les coronavirus provoquent des infections des voies respiratoires qui peuvent varier de modérées à létales.", "perturbation": "alteration", "pert_fr": "Chez les humains, les coronavirus provoquent des infections des voies respiratoires qui peuvent varier de létales à modérées.", "bt_pert_fr": "In humans, coronaviruses cause respiratory tract infections that can range from lethal to moderate.", "questions": "[\"Can coronaviruses cause mild respiratory tract infections in humans?\", \"Can coronaviruses cause lethal respiratory tract infections in humans?\", \"What range of respiratory tract infections can coronaviruses cause in humans?\"]", "answers": "[\"Yes\", \"Yes\", \"From lethal to moderate\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.75, "em": false, "chrf": 38.99067234768779, "bleu": 21.02241038134286}], "avg_f1": 0.9166666666666666, "avg_em": 0.6666666666666666, "avg_chrf": 79.66355744922926, "avg_bleu": 73.67413679378099}
{"id": "wiki_5:2721", "en": "Coronaviruses constitute the subfamily Orthocoronavirinae, in the family Coronaviridae, order Nidovirales, and realm Riboviria.", "fr": "Les coronavirus constituent la sous-famille des Orthocoronavirinae, dans la famille des Coronaviridae, l’ordre des Nidovirales et le domaine des Riboviria.", "perturbation": "alteration", "pert_fr": "Les coronavirus constituent la sous-famille des Orthocoronavirinae, dans la famille des Bactériidae, l’ordre des Nidovirales et le domaine des Riboviria.", "bt_pert_fr": "Coronaviruses constitute the subfamily Orthocoronavirinae, in the family Bactériidae, the order Nidovirales and the domain Riboviria.", "questions": "[\"Which subfamily do coronaviruses belong to?\", \"Which family do coronaviruses belong to?\", \"Which order do coronaviruses belong to?\", \"Which realm do coronaviruses belong to?\"]", "answers": "[\"Orthocoronavirinae\", \"Bactériidae\", \"Nidovirales\", \"Riboviria\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 19.888021975687824, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.75, "avg_em": 0.75, "avg_chrf": 79.97200549392196, "avg_bleu": 75.00000000000003}
{"id": "wiki_5:2722", "en": "They are enveloped viruses with a positive-sense single-stranded RNA genome and a nucleocapsid of helical symmetry.", "fr": "Ce sont des virus enveloppés à génome d’ARN à simple brin de sens positif et un nucléocapside à symétrie hélicoïdale.", "perturbation": "alteration", "pert_fr": "Ce sont des virus enveloppés à génome d’ADN à double brin de sens négatif et un nucléocapside à symétrie hélicoïdale.", "bt_pert_fr": "They are enveloped viruses with a negative-sense double-stranded DNA genome and a nucleocapsid with helical symmetry.", "questions": "[\"What type of viruses are they?\", \"What does their genome consist of?\", \"What is the structure of their nucleocapsid?\"]", "answers": "[\"Enveloped viruses\", \"A negative-sense double-stranded DNA genome\", \"Helical symmetry\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4000000000000001, "em": false, "chrf": 57.72436206259736, "bleu": 12.70331870386537}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7999999999999999, "avg_em": 0.6666666666666666, "avg_chrf": 85.90812068753246, "avg_bleu": 70.90110623462182}
{"id": "wiki_5:2726", "en": "In the 1940s, two more animal coronaviruses, mouse hepatitis virus (MHV) and transmissible gastroenteritis virus (TGEV), were isolated.Human coronaviruses were discovered in the 1960s.", "fr": "Dans les années 40, deux autres coronavirus d’origine animale, le virus de l'hépatite murine (VHM) et le virus de la gastroentérite transmissible (VGET), ont été isolés. Les coronavirus humains ont été découverts dans les années 60.", "perturbation": "alteration", "pert_fr": "Dans les années 40, deux autres coronavirus d’origine animale, le virus de l'hépatite murine (VHM) et le virus de la gastroentérite transmissible (VGET), n'ont pas été isolés. Les coronavirus humains ont été découverts dans les années 60.", "bt_pert_fr": "In the 1940s, two other coronaviruses of animal origin, murine hepatitis virus (MHV) and transmissible gastroenteritis virus (TSV), were not isolated. Human coronaviruses were discovered in the 1960s.", "questions": "[\"When were two more animal coronaviruses, mouse hepatitis virus (MHV) and transmissible gastroenteritis virus (TGEV), isolated?\", \"When were human coronaviruses discovered?\"]", "answers": "[\"In the 1940s\", \"In the 1960s\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "wiki_5:2727", "en": "The earliest ones studied were from human patients with the common cold, which were later named human coronavirus 229E and human coronavirus OC43.", "fr": "Les premiers coronavirus étudiés étaient issus de patients humains présentant un rhume commun ; ils ont ensuite été appelés coronavirus humain 229E et coronavirus humain OC43.", "perturbation": "alteration", "pert_fr": "Les derniers coronavirus étudiés étaient issus de patients humains présentant un rhume rare ; ils ont ensuite été appelés coronavirus humain 229E et coronavirus humain OC43.", "bt_pert_fr": "The latest coronaviruses studied came from human patients with a rare cold; they were later called human coronavirus 229E and human coronavirus OC43.", "questions": "[\"What were the earliest ones studied?\", \"What were the earliest ones studied from?\", \"What were the earliest ones studied named?\", \"What are human coronavirus 229E and human coronavirus OC43?\", \"What were the human coronavirus 229E and human coronavirus OC43 originally identified from?\"]", "answers": "[\"The latest coronaviruses studied\", \"human patients with a rare cold\", \"human coronavirus 229E and human coronavirus OC43\", \"the latest coronaviruses studied\", \"human patients with a rare cold\"]", "scores": [{"f1": 0.26666666666666666, "em": false, "chrf": 22.66953088133457, "bleu": 3.300991086751251}, {"f1": 0.8000000000000002, "em": false, "chrf": 66.48518935984066, "bleu": 42.7287006396234}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.3333333333333333, "em": false, "chrf": 58.969291299214, "bleu": 27.516060407455225}, {"f1": 0.8000000000000002, "em": false, "chrf": 66.48518935984066, "bleu": 42.7287006396234}], "avg_f1": 0.64, "avg_em": 0.2, "avg_chrf": 62.921840180045976, "avg_bleu": 43.25489055469066}
{"id": "wiki_5:2732", "en": "The name refers to the characteristic appearance of virions (the infective form of the virus) by electron microscopy, which have a fringe of large, bulbous surface projections creating an image reminiscent of a crown or of a solar corona.", "fr": "Ce nom se réfère à l’apparence caractéristique des virions (la forme infectieuse du virus) au microscope électronique, ces derniers possédant une frange de projections superficielles larges et bulbeuses qui donne une image rappelant la couronne solaire.", "perturbation": "alteration", "pert_fr": "Ce nom se réfère à l’apparence caractéristique des virions (la forme infectieuse du virus) au microscope électronique, ces derniers possédant une frange de projections superficielles étroites et plates qui donne une image rappelant la couronne solaire.", "bt_pert_fr": "This name refers to the characteristic appearance of virions (the infectious form of the virus) under the electron microscope, the latter having a fringe of narrow and flat surface projections which gives an image reminiscent of the solar corona.", "questions": "[\"What does the name refer to?\", \"What is the characteristic appearance of virions by electron microscopy?\", \"What do the large, bulbous surface projections on virions look like?\", \"Why does the name resemble a crown or a solar corona?\"]", "answers": "[\"the characteristic appearance of virions (the infectious form of the virus) under the electron microscope\", \"the latter having a fringe of narrow and flat surface projections\", \"The large, bulbous surface projections on virions are not mentioned in the sentence\", \"Because the surface projections give an image reminiscent of the solar corona\"]", "scores": [{"f1": 0.6956521739130435, "em": false, "chrf": 82.4098780878447, "bleu": 32.03558799120807}, {"f1": 0.5, "em": false, "chrf": 58.18231372401277, "bleu": 13.485111859503684}, {"f1": 0, "em": false, "chrf": 19.117084593180415, "bleu": 0.0}, {"f1": 0.6956521739130435, "em": false, "chrf": 62.981078287461536, "bleu": 19.457849455649992}], "avg_f1": 0.47282608695652173, "avg_em": 0.0, "avg_chrf": 55.67258867312486, "avg_bleu": 16.244637326590436}
{"id": "wiki_5:2735", "en": "The envelope of the virus in electron micrographs appears as a distinct pair of electron dense shells.The viral envelope consists of a lipid bilayer where the membrane (M), envelope (E) and spike (S) structural proteins are anchored.", "fr": "L’enveloppe du virus sous microscope électronique ressemble à une paire distincte de coquilles denses en électron. L’enveloppe virale est constituée d’une bicouche lipidique où sont ancrées les protéines structurales de la membrane (M), de l’enveloppe (E) et de la spicule (S).", "perturbation": "alteration", "pert_fr": "L’enveloppe du virus sous microscope électronique ressemble à une paire indistincte de coquilles creuses en électron. L’enveloppe virale est constituée d’une bicouche lipidique où sont ancrées les protéines structurales de la membrane (M), de l’enveloppe (E) et de la spicule (S).", "bt_pert_fr": "The virus envelope under an electron microscope looks like an indistinct pair of hollow electron shells. The viral envelope is made up of a lipid bilayer where the structural proteins of the membrane (M), envelope (E) and spike (S) are anchored.", "questions": "[\"What does the envelope of the virus appear as in electron micrographs?\", \"What consists of the viral envelope?\", \"What structural proteins are anchored in the viral envelope?\"]", "answers": "[\"An indistinct pair of hollow electron shells\", \"A lipid bilayer\", \"M, E, and S\"]", "scores": [{"f1": 0.5714285714285714, "em": false, "chrf": 64.74745306546991, "bleu": 15.619699684601283}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7272727272727273, "em": false, "chrf": 9.137060035042065, "bleu": 17.946048174042403}], "avg_f1": 0.7662337662337663, "avg_em": 0.3333333333333333, "avg_chrf": 57.961504366837325, "avg_bleu": 44.521915952881244}
{"id": "wiki_5:2737", "en": "Coronaviruses contain a positive-sense, single-stranded RNA genome.", "fr": "Les coronavirus contiennent un virus à ARN à simple brin de sens positif.", "perturbation": "alteration", "pert_fr": "Les coronavirus contiennent un virus à ARN à simple brin de sens négatif.", "bt_pert_fr": "Coronaviruses contain a negative-sense, single-stranded RNA virus.", "questions": "[\"What type of genome do coronaviruses contain?\", \"What is the structure of the coronavirus genome?\", \"Does the coronavirus genome have a positive-sense, single-stranded RNA structure?\"]", "answers": "[\"Negative-sense, single-stranded RNA\", \"Negative-sense, single-stranded RNA\", \"No\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 85.39806978887438, "bleu": 55.03212081491043}, {"f1": 0.6666666666666666, "em": false, "chrf": 85.39806978887438, "bleu": 55.03212081491043}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.4444444444444444, "avg_em": 0.0, "avg_chrf": 56.932046525916256, "avg_bleu": 36.68808054327362}
{"id": "wiki_5:2738", "en": "The genome size for coronaviruses ranges from 26.4 to 31.7 kilobases.", "fr": "La taille du génome des coronavirus varie de 26,4 à 31,7 kilobases.", "perturbation": "alteration", "pert_fr": "La taille du génome des coronavirus varie de 26,4 à 31,7 métabases.", "bt_pert_fr": "The genome size of coronaviruses ranges from 26.4 to 31.7 metabases.", "questions": "[\"What is the range of genome size for coronaviruses?\", \"How large is the genome of coronaviruses?\"]", "answers": "[\"26.4 to 31.7 metabases\", \"26.4 to 31.7 metabases\"]", "scores": [{"f1": 0.75, "em": false, "chrf": 53.11368778280543, "bleu": 59.460355750136046}, {"f1": 0.75, "em": false, "chrf": 53.11368778280543, "bleu": 59.460355750136046}], "avg_f1": 0.75, "avg_em": 0.0, "avg_chrf": 53.11368778280543, "avg_bleu": 59.460355750136046}
{"id": "wiki_5:2741", "en": "The replicase/transcriptase polyprotein self cleaves to form nonstructural proteins.The later reading frames encode the four major structural proteins: spike, envelope, membrane, and nucleocapsid.", "fr": "La polyprotéine réplicase/transcriptase s’autoclive pour former des protéines non structurales. Les cadres de lecture ultérieurs codent les quatre principales protéines structurales : spicule, enveloppe, membrane et nucléocapside.", "perturbation": "alteration", "pert_fr": "La polyprotéine réplicase/transcriptase ne s’autoclive pas pour former des protéines structurales. Les cadres de lecture ultérieurs codent les quatre principales protéines non structurales : spicule, enveloppe, membrane et nucléocapside.", "bt_pert_fr": "Polyprotein replicase/transcriptase does not self-cleave to form structural proteins. Later reading frames encode the four major nonstructural proteins: spike, envelope, membrane, and nucleocapsid.", "questions": "[\"How does the replicase/transcriptase polyprotein self-cleave?\", \"What proteins are encoded by the later reading frames?\", \"What are the four major structural proteins encoded by the later reading frames?\"]", "answers": "[\"It does not self-cleave\", \"Spike, envelope, membrane, and nucleocapsid\", \"Spike, envelope, membrane, and nucleocapsid\"]", "scores": [{"f1": 0, "em": false, "chrf": 9.240175380842649, "bleu": 0.0}, {"f1": 0.5333333333333333, "em": false, "chrf": 56.48671154062145, "bleu": 24.601580968354597}, {"f1": 0.8000000000000002, "em": false, "chrf": 97.00713223542921, "bleu": 66.87403049764218}], "avg_f1": 0.4444444444444445, "avg_em": 0.0, "avg_chrf": 54.24467305229777, "avg_bleu": 30.491870488665594}
{"id": "wiki_5:2742", "en": "Interspersed between these reading frames are the reading frames for the accessory proteins.", "fr": "Entre ces cadres de lecture se trouvent les cadres de lecture des protéines accessoires.", "perturbation": "alteration", "pert_fr": "Entre ces cadres de lecture se trouvent les cadres de lecture des protéines essentielles.", "bt_pert_fr": "Between these reading frames are the reading frames of essential proteins.", "questions": "[\"What are interspersed between the reading frames?\", \"What reading frames are associated with accessory proteins?\"]", "answers": "[\"The reading frames of essential proteins\", \"None\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 61.40255680302723, "bleu": 32.46679154750989}, {"f1": 0, "em": false, "chrf": 2.5337837837837838, "bleu": 0.0}], "avg_f1": 0.3333333333333333, "avg_em": 0.0, "avg_chrf": 31.968170293405507, "avg_bleu": 16.233395773754946}
{"id": "wiki_5:2743", "en": "The number of accessory proteins and their function is unique depending on the specific coronavirus.", "fr": "Le nombre de protéines accessoires et leur fonction sont uniques en fonction du coronavirus spécifique.", "perturbation": "alteration", "pert_fr": "Le nombre de protéines accessoires et leur fonction sont communes en fonction du coronavirus spécifique.", "bt_pert_fr": "The number of accessory proteins and their function are common depending on the specific coronavirus.", "questions": "[\"What is unique depending on the specific coronavirus?\", \"What is unique about the function of accessory proteins?\"]", "answers": "[\"The number of accessory proteins\", \"Nothing is unique about the function of accessory proteins\"]", "scores": [{"f1": 0.7692307692307693, "em": false, "chrf": 66.5181183898031, "bleu": 54.88116360940266}, {"f1": 0.4615384615384615, "em": false, "chrf": 58.79579638382181, "bleu": 20.556680845025987}], "avg_f1": 0.6153846153846154, "avg_em": 0.0, "avg_chrf": 62.65695738681246, "avg_bleu": 37.71892222721432}
{"id": "wiki_5:2744", "en": "Infection begins when the viral spike (S) glycoprotein attaches to its complementary host cell receptor.", "fr": "L’infection commence lorsque la glycoprotéine virale à spicule (S) s’attache à son récepteur hôte complémentaire.", "perturbation": "alteration", "pert_fr": "L’infection commence lorsque la glycoprotéine virale à spicule (S) se détache de son récepteur hôte complémentaire.", "bt_pert_fr": "Infection begins when the viral spike (S) glycoprotein detaches from its complementary host receptor.", "questions": "[\"What attaches to the host cell receptor during infection?\", \"What is the viral component that attaches to the host cell receptor?\", \"What is the role of the viral spike (S) glycoprotein in infection?\"]", "answers": "[\"The viral spike (S) glycoprotein\", \"The viral spike (S) glycoprotein\", \"It detaches from its complementary host receptor\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5333333333333333, "em": false, "chrf": 63.219937870130416, "bleu": 22.772101321113862}], "avg_f1": 0.8444444444444444, "avg_em": 0.6666666666666666, "avg_chrf": 87.73997929004348, "avg_bleu": 74.25736710703798}
{"id": "wiki_5:2747", "en": "The host ribosome translates the initial overlapping open reading frame of the virus genome and forms a long polyprotein.", "fr": "Le ribosome hôte convertit le cadre de lecture ouvert initial se chevauchant du génome viral et forme une longue polyprotéine.", "perturbation": "alteration", "pert_fr": "Le ribosome hôte convertit le cadre de lecture ouvert initial non se chevauchant du génome viral et forme une courte polyprotéine.", "bt_pert_fr": "The host ribosome converts the initial non-overlapping open reading frame of the viral genome and forms a short polyprotein.", "questions": "[\"What does the host ribosome translate from the virus genome?\", \"What is formed when the host ribosome translates the initial overlapping open reading frame of the virus genome?\"]", "answers": "[\"The initial non-overlapping open reading frame\", \"A short polyprotein\"]", "scores": [{"f1": 0.6666666666666667, "em": false, "chrf": 71.19649537230852, "bleu": 23.04318198457308}, {"f1": 0.6666666666666666, "em": false, "chrf": 63.49605133839024, "bleu": 34.66806371753173}], "avg_f1": 0.6666666666666667, "avg_em": 0.0, "avg_chrf": 67.34627335534938, "avg_bleu": 28.855622851052406}
{"id": "wiki_5:2748", "en": "The polyprotein has its own proteases which cleave the polyprotein into multiple nonstructural proteins.", "fr": "La polyprotéine dispose de sa propre protéase qui clive la polyprotéine en de multiples protéines non structurales.", "perturbation": "alteration", "pert_fr": "La polyprotéine dispose de sa propre protéase qui assemble la polyprotéine en de multiples protéines structurales.", "bt_pert_fr": "The polyprotein has its own protease which assembles the polyprotein into multiple structural proteins.", "questions": "[\"Does the polyprotein have its own proteases?\", \"Do the proteases of the polyprotein cleave the polyprotein into multiple nonstructural proteins?\"]", "answers": "[\"Yes\", \"Yes\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "wiki_5:2752", "en": "The other nonstructural proteins in the complex assist in the replication and transcription process.", "fr": "Les autres protéines non structurales du complexe assistent le processus de réplication et de transcription.", "perturbation": "alteration", "pert_fr": "Les autres protéines non structurales du complexe gênent le processus de réplication et de transcription.", "bt_pert_fr": "The other non-structural proteins in the complex interfere with the process of replication and transcription.", "questions": "[\"What role do the other nonstructural proteins in the complex play?\", \"How do the other nonstructural proteins assist in the replication and transcription process?\"]", "answers": "[\"Interfere with the process of replication and transcription\", \"They do not assist; instead, they interfere with the process of replication and transcription\"]", "scores": [{"f1": 0.6153846153846153, "em": false, "chrf": 71.83148817023928, "bleu": 26.269098944241588}, {"f1": 0.1111111111111111, "em": false, "chrf": 9.731677632830031, "bleu": 3.0890553181566975}], "avg_f1": 0.3632478632478632, "avg_em": 0.0, "avg_chrf": 40.781582901534655, "avg_bleu": 14.679077131199143}
{"id": "wiki_5:2753", "en": "The exoribonuclease nonstructural protein, for instance, provides extra fidelity to replication by providing a proofreading function which the RNA-dependent RNA polymerase lacks.One of the main functions of the complex is to replicate the viral genome.", "fr": "La protéine non structurale exoribonucléase, par exemple, apporte une fidélité supplémentaire dans la réplication en fournissant une fonction de relecture dont manque l’ARN polymérase ARN dépendante. L’une des fonctions principales du complexe est la réplication du génome viral.", "perturbation": "alteration", "pert_fr": "La protéine non structurale exoribonucléase, par exemple, apporte une infidélité supplémentaire dans la réplication en fournissant une fonction de relecture dont manque l’ARN polymérase ARN dépendante. L’une des fonctions principales du complexe est la dégradation du génome viral.", "bt_pert_fr": "The nonstructural protein exoribonuclease, for example, provides additional infidelity in replication by providing a proofreading function that RNA-dependent RNA polymerase lacks. One of the main functions of the complex is the degradation of the viral genome.", "questions": "[\"What is the function of the exoribonuclease nonstructural protein?\", \"How does the exoribonuclease nonstructural protein provide extra fidelity to replication?\", \"What function does the RNA-dependent RNA polymerase lack?\", \"What is one of the main functions of the complex?\"]", "answers": "[\"The proofreading function\", \"By providing a proofreading function that RNA-dependent RNA polymerase lacks\", \"A proofreading function\", \"The degradation of the viral genome\"]", "scores": [{"f1": 0.30769230769230765, "em": false, "chrf": 32.69362641504505, "bleu": 5.33657305117355}, {"f1": 0.6153846153846153, "em": false, "chrf": 80.71102991422693, "bleu": 29.84745896009822}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4444444444444445, "em": false, "chrf": 47.609728046538805, "bleu": 21.3643503198117}], "avg_f1": 0.5918803418803419, "avg_em": 0.25, "avg_chrf": 65.2535960939527, "avg_bleu": 39.137095582770876}
{"id": "wiki_5:2756", "en": "The other important function of the complex is to transcribe the viral genome.", "fr": "L'autre fonction importante du complexe est la réplication du génome viral.", "perturbation": "alteration", "pert_fr": "L'autre fonction importante du complexe est la suppression du génome viral.", "bt_pert_fr": "The other important function of the complex is the suppression of the viral genome.", "questions": "[\"What is the other important function of the complex?\", \"What is the function of the complex in transcribing the viral genome?\"]", "answers": "[\"The suppression of the viral genome\", \"None\"]", "scores": [{"f1": 0.4444444444444445, "em": false, "chrf": 44.41888556280673, "bleu": 21.3643503198117}, {"f1": 0, "em": false, "chrf": 1.7687752471668161, "bleu": 0.0}], "avg_f1": 0.22222222222222224, "avg_em": 0.0, "avg_chrf": 23.09383040498677, "avg_bleu": 10.68217515990585}
{"id": "wiki_5:2758", "en": "This is followed by the transcription of these negative-sense subgenomic RNA molecules to their corresponding positive-sense mRNAs.", "fr": "Ceci est suivi par la transcription de ces molécules d'ARN subgénomique de sens négatif en leurs ARNm de sens positif correspondants.", "perturbation": "alteration", "pert_fr": "Ceci est suivi par la transcription de ces molécules d'ARN subgénomique de sens positif en leurs ARNm de sens négatif correspondants.", "bt_pert_fr": "This is followed by transcription of these positive-sense subgenomic RNA molecules into their corresponding negative-sense mRNAs.", "questions": "[\"What happens after the negative-sense subgenomic RNA molecules are present?\", \"What is the process by which negative-sense subgenomic RNA molecules are converted to positive-sense mRNAs?\"]", "answers": "[\"Transcription of these positive-sense subgenomic RNA molecules into their corresponding negative-sense mRNAs\", \"The sentence does not describe the conversion of negative-sense subgenomic RNA molecules to positive-sense mRNAs; it describes the transcription of positive-sense RNA molecules into negative-sense mRNAs, which is the opposite of what is asked.\"]", "scores": [{"f1": 0.8, "em": false, "chrf": 87.95786871737296, "bleu": 18.63640680706656}, {"f1": 0, "em": false, "chrf": 20.6472160758712, "bleu": 0.0}], "avg_f1": 0.4, "avg_em": 0.0, "avg_chrf": 54.30254239662208, "avg_bleu": 9.31820340353328}
{"id": "wiki_5:2759", "en": "The replicated positive-sense genomic RNA becomes the genome of the progeny viruses.", "fr": "L'ARN génomique de sens positif répliqué devient le génome des virus descendants.", "perturbation": "alteration", "pert_fr": "L'ARN génomique de sens négatif répliqué devient le génome des virus descendants.", "bt_pert_fr": "The replicated negative-sense genomic RNA becomes the genome of the progeny viruses.", "questions": "[\"What becomes the genome of the progeny viruses?\", \"What is the replicated positive-sense genomic RNA turned into?\"]", "answers": "[\"The replicated negative-sense genomic RNA\", \"None\"]", "scores": [{"f1": 0.20000000000000004, "em": false, "chrf": 25.565870750349433, "bleu": 10.682175159905853}, {"f1": 0, "em": false, "chrf": 3.6057692307692304, "bleu": 0.0}], "avg_f1": 0.10000000000000002, "avg_em": 0.0, "avg_chrf": 14.585819990559331, "avg_bleu": 5.3410875799529265}
{"id": "wiki_5:2760", "en": "The mRNAs are gene transcripts of the last third of the virus genome after the initial overlapping reading frame.", "fr": "Les ARNm sont des transcrits géniques du dernier tiers du génome, qui suit les cadres de lecture initiaux se chevauchant.", "perturbation": "alteration", "pert_fr": "Les ARNm ne sont pas des transcrits géniques du premier tiers du génome, qui suit les cadres de lecture initiaux se chevauchant.", "bt_pert_fr": "mRNAs are not gene transcripts from the first third of the genome, which follows the initial overlapping reading frames.", "questions": "[\"What are the mRNAs in the virus genome?\", \"What part of the virus genome do the mRNAs originate from?\", \"Where are the mRNAs transcribed from in the virus genome?\", \"What is the origin of the mRNAs in the virus genome?\"]", "answers": "[\"mRNAs are not gene transcripts from the first third of the genome\", \"the first third of the genome\", \"the first third of the genome\", \"the first third of the genome\"]", "scores": [{"f1": 0.34782608695652173, "em": false, "chrf": 36.622580156023425, "bleu": 7.39343948260436}, {"f1": 0.39999999999999997, "em": false, "chrf": 21.454616441043527, "bleu": 6.143836690366869}, {"f1": 0.39999999999999997, "em": false, "chrf": 21.454616441043527, "bleu": 6.143836690366869}, {"f1": 0.39999999999999997, "em": false, "chrf": 21.454616441043527, "bleu": 6.143836690366869}], "avg_f1": 0.3869565217391304, "avg_em": 0.0, "avg_chrf": 25.2466073697885, "avg_bleu": 6.456237388426242}
{"id": "wiki_5:2763", "en": "The viral structural proteins S, E, and M move along the secretory pathway into the Golgi intermediate compartment.", "fr": "Les protéines structurales virales S, E et M se déplacent le long de la voie de sécrétion dans le compartiment intermédiaire de Golgi.", "perturbation": "alteration", "pert_fr": "Les protéines structurales virales S, E et M restent le long de la voie de sécrétion dans le compartiment intermédiaire de Golgi.", "bt_pert_fr": "The viral structural proteins S, E, and M remain along the secretory pathway in the Golgi intermediate compartment.", "questions": "[\"Which viral structural proteins move along the secretory pathway into the Golgi intermediate compartment?\", \"Do the viral structural proteins S, E, and M move along the secretory pathway into the Golgi intermediate compartment?\"]", "answers": "[\"S, E, and M\", \"Yes\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "wiki_5:2764", "en": "There, the M proteins direct most protein-protein interactions required for assembly of viruses following its binding to the nucleocapsid.", "fr": "Là, les protéines M dirigent la plupart des interactions protéine-protéine nécessaires à l'assemblage des virus après sa liaison à la nucléocapside.", "perturbation": "alteration", "pert_fr": "Là, les protéines M dirigent la plupart des interactions protéine-protéine inutiles à l'assemblage des virus après sa liaison à la nucléocapside.", "bt_pert_fr": "There, M proteins direct most of the protein-protein interactions unnecessary for virus assembly after its binding to the nucleocapsid.", "questions": "[\"What role do M proteins play in the assembly of viruses?\", \"How do M proteins direct protein-protein interactions during virus assembly?\", \"What is the function of M proteins after they bind to the nucleocapsid?\"]", "answers": "[\"M proteins direct most of the protein-protein interactions unnecessary for virus assembly after its binding to the nucleocapsid\", \"M proteins direct protein-protein interactions that are unnecessary for virus assembly\", \"To direct most of the protein-protein interactions unnecessary for virus assembly\"]", "scores": [{"f1": 0.56, "em": false, "chrf": 66.16095408984474, "bleu": 13.380161378318954}, {"f1": 0.26666666666666666, "em": false, "chrf": 65.42209223368988, "bleu": 7.495553473355842}, {"f1": 0.7368421052631577, "em": false, "chrf": 73.03369808226819, "bleu": 22.957488466614326}], "avg_f1": 0.5211695906432748, "avg_em": 0.0, "avg_chrf": 68.20558146860094, "avg_bleu": 14.611067772763041}
{"id": "wiki_5:2766", "en": "The interaction of the coronavirus spike protein with its complement host cell receptor is central in determining the tissue tropism, infectivity, and species range of the virus.", "fr": "L’interaction du spicule du coronavirus avec le récepteur de la cellule hôte complémentaire est essentielle dans la détermination du tropisme tissulaire, de l’infectivité et de la variété d’espèces du virus.", "perturbation": "alteration", "pert_fr": "L’interaction du spicule du coronavirus avec le récepteur de la cellule hôte non complémentaire est essentielle dans la détermination du tropisme tissulaire, de l’infectivité et de la variété d’espèces du virus.", "bt_pert_fr": "The interaction of the coronavirus spike with the noncomplementary host cell receptor is essential in determining the tissue tropism, infectivity, and species variety of the virus.", "questions": "[\"What determines the tissue tropism, infectivity, and species range of the virus?\", \"How does the interaction of the coronavirus spike protein with its host cell receptor influence virus characteristics?\"]", "answers": "[\"The interaction of the coronavirus spike with the noncomplementary host cell receptor\", \"It is essential in determining the tissue tropism, infectivity, and species variety of the virus\"]", "scores": [{"f1": 0.8181818181818182, "em": false, "chrf": 76.44481754924973, "bleu": 44.30006936196753}, {"f1": 0.6956521739130435, "em": false, "chrf": 73.78628025220553, "bleu": 34.38931217657843}], "avg_f1": 0.7569169960474309, "avg_em": 0.0, "avg_chrf": 75.11554890072763, "avg_bleu": 39.34469076927298}
{"id": "wiki_5:2767", "en": "The SARS coronavirus, for example, infects human cells by attaching to the angiotensin-converting enzyme 2 (ACE2) receptor.", "fr": "Le coronavirus du SRAS, par exemple, infecte les cellules humaines en se liant au récepteur de l’enzyme de conversion de l’angiotensine 2 (ACE2).", "perturbation": "alteration", "pert_fr": "Le coronavirus du SRAS, par exemple, protège les cellules humaines en se liant au récepteur de l’enzyme de conversion de l’angiotensine 2 (ACE2).", "bt_pert_fr": "The SARS coronavirus, for example, protects human cells by binding to the angiotensin-converting enzyme 2 (ACE2) receptor.", "questions": "[\"How does the SARS coronavirus infect human cells?\", \"What receptor does the SARS coronavirus attach to in human cells?\", \"What is the role of the angiotensin-converting enzyme 2 (ACE2) receptor in SARS coronavirus infection?\"]", "answers": "[\"By binding to the angiotensin-converting enzyme 2 (ACE2) receptor\", \"The angiotensin-converting enzyme 2 (ACE2) receptor\", \"It serves as the receptor that the SARS coronavirus binds to in order to infect human cells\"]", "scores": [{"f1": 0.875, "em": false, "chrf": 85.76941372276401, "bleu": 70.71067811865478}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666665, "em": false, "chrf": 65.33407100319246, "bleu": 26.518122980477767}], "avg_f1": 0.8472222222222222, "avg_em": 0.3333333333333333, "avg_chrf": 83.70116157531884, "avg_bleu": 65.74293369971086}
{"id": "wiki_5:2768", "en": "The scientific name for coronavirus is Orthocoronavirinae or Coronavirinae.", "fr": "Le nom scientifique du coronavirus est Orthocoronavirinae ou Coronavirinae.", "perturbation": "alteration", "pert_fr": "Le nom scientifique du coronavirus est Antiorthocoronavirinae ou Coronavirinae.", "bt_pert_fr": "The scientific name of the coronavirus is Antiorthocoronavirinae or Coronavirinae.", "questions": "[\"What is the scientific name for coronavirus?\", \"Is the scientific name for coronavirus Orthocoronavirinae or Coronavirinae?\"]", "answers": "[\"Antiorthocoronavirinae or Coronavirinae\", \"Coronavirinae\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 94.23268202989364, "bleu": 55.03212081491043}, {"f1": 0, "em": false, "chrf": 6.666666666666667, "bleu": 0.0}], "avg_f1": 0.3333333333333333, "avg_em": 0.0, "avg_chrf": 50.449674348280155, "avg_bleu": 27.516060407455214}
{"id": "wiki_5:2769", "en": "Coronaviruses belong to the family of Coronaviridae, order Nidovirales, and realm Riboviria.", "fr": "Les coronavirus appartiennent à la famille des Coronaviridae, à l’ordre des Nidovirales et au domaine des Riboviria.", "perturbation": "alteration", "pert_fr": "Les coronavirus n'appartiennent pas à la famille des Coronaviridae, à l’ordre des Nidovirales et au domaine des Riboviria.", "bt_pert_fr": "Coronaviruses do not belong to the family Coronaviridae, the order Nidovirales and the domain Riboviria.", "questions": "[\"To which family do coronaviruses belong?\", \"To which order do coronaviruses belong?\", \"To which realm do coronaviruses belong?\"]", "answers": "[\"The family Coronaviridae\", \"The order Nidovirales\", \"The domain Riboviria\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 85.1846725103534, "bleu": 27.516060407455225}, {"f1": 0.5, "em": false, "chrf": 83.87393801293894, "bleu": 27.516060407455225}, {"f1": 0.5, "em": false, "chrf": 77.80553357915268, "bleu": 27.516060407455225}], "avg_f1": 0.5, "avg_em": 0.0, "avg_chrf": 82.28804803414833, "avg_bleu": 27.516060407455225}
{"id": "wiki_5:2773", "en": "The most recent common ancestor (MRCA) of all coronaviruses is estimated to have existed as recently as 8000 BCE, although some models place the common ancestor as far back as 55 million years or more, implying long term coevolution with bat and avian species.", "fr": "On estime que le plus récent ancêtre commun (MRCA) de tous les coronavirus a existé 8 000 ans avant notre ère, bien que certains modèles placent l’ancêtre commun il y a 55 millions d’années ou plus, ce qui implique une coévolution à long terme au sein des espèces de chauves-souris et d’oiseaux.", "perturbation": "alteration", "pert_fr": "On estime que le plus récent ancêtre commun (MRCA) de tous les coronavirus n'a pas existé 8 000 ans avant notre ère, bien que certains modèles placent l’ancêtre commun il y a 55 millions d’années ou plus, ce qui implique une coévolution à long terme au sein des espèces de chauves-souris et d’oiseaux.", "bt_pert_fr": "The most recent common ancestor (MRCA) of all coronaviruses is estimated to have existed no earlier than 8,000 BCE, although some models place the common ancestor 55 million years ago or more, implying long-term coevolution within bat and bird species.", "questions": "[\"When is the most recent common ancestor (MRCA) of all coronaviruses estimated to have existed?\", \"What is the range of estimated times for the most recent common ancestor (MRCA) of all coronaviruses?\", \"Does the most recent common ancestor (MRCA) of all coronaviruses imply long-term coevolution with bat and avian species?\", \"What does the estimation of the MRCA's existence suggest about the coevolution of coronaviruses with bat and avian species?\"]", "answers": "[\"No earlier than 8,000 BCE\", \"From 8,000 BCE to 55 million years ago\", \"Yes\", \"It suggests long-term coevolution within bat and bird species\"]", "scores": [{"f1": 0.4000000000000001, "em": false, "chrf": 33.11258925582815, "bleu": 21.3643503198117}, {"f1": 0.631578947368421, "em": false, "chrf": 58.527337032346615, "bleu": 46.76143972269792}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7777777777777778, "em": false, "chrf": 79.4341955391427, "bleu": 36.88939732334405}], "avg_f1": 0.7023391812865497, "avg_em": 0.25, "avg_chrf": 67.76853045682937, "avg_bleu": 51.253796841463426}
{"id": "wiki_5:2774", "en": "The most recent common ancestor of the alphacoronavirus line has been placed at about 2400 BCE, the betacoronavirus line at 3300 BCE, the gammacoronavirus line at 2800 BCE, and the deltacoronavirus line at about 3000 BCE.", "fr": "Le plus récent ancêtre commun de la lignée de l’alphacoronavirus a été positionné environ 2 400 ans avant notre ère, la lignée des bêtacoronavirus environ 3 300 ans avant notre ère, la lignée des gammacoronavirus environ 2 800 ans avant notre ère et la lignée des deltacoronavirus environ 3 000 ans avant notre ère.", "perturbation": "alteration", "pert_fr": "Le plus récent ancêtre commun de la lignée de l’alphacoronavirus a été positionné environ 2 400 ans après notre ère, la lignée des bêtacoronavirus environ 3 300 ans après notre ère, la lignée des gammacoronavirus environ 2 800 ans après notre ère et la lignée des deltacoronavirus environ 3 000 ans après notre ère.", "bt_pert_fr": "The most recent common ancestor of the alphacoronavirus lineage was positioned around 2400 years CE, the betacoronavirus lineage around 3300 years CE, the gammacoronavirus lineage around 2800 years CE, and the deltacoronavirus lineage around 3000 years CE.", "questions": "[\"When was the most recent common ancestor of the alphacoronavirus line placed?\", \"When was the most recent common ancestor of the betacoronavirus line placed?\", \"When was the most recent common ancestor of the gammacoronavirus line placed?\", \"When was the most recent common ancestor of the deltacoronavirus line placed?\"]", "answers": "[\"around 2400 years CE\", \"around 3300 years CE\", \"around 2800 years CE\", \"around 3000 years CE\"]", "scores": [{"f1": 0.28571428571428575, "em": false, "chrf": 23.18338745251934, "bleu": 15.97357760615681}, {"f1": 0.3333333333333333, "em": false, "chrf": 27.072394386590144, "bleu": 15.97357760615681}, {"f1": 0.3333333333333333, "em": false, "chrf": 27.072394386590144, "bleu": 15.97357760615681}, {"f1": 0.28571428571428575, "em": false, "chrf": 23.18338745251934, "bleu": 15.97357760615681}], "avg_f1": 0.30952380952380953, "avg_em": 0.0, "avg_chrf": 25.127890919554744, "avg_bleu": 15.97357760615681}
{"id": "wiki_5:2775", "en": "The large number of host bat and avian species, and their global range, has enabled extensive evolution and dissemination of coronaviruses.Many human coronavirus have their origin in bats.", "fr": "Le grand nombre d’espèces de chauves-souris et d’oiseaux hôtes et leur répartition mondiale ont permis une évolution et une dissémination importantes des coronavirus. De nombreux coronavirus humains trouvent leur origine chez les chauves-souris.", "perturbation": "alteration", "pert_fr": "Le petit nombre d’espèces de chauves-souris et d’oiseaux hôtes et leur répartition locale ont permis une évolution et une dissémination faibles des coronavirus. De nombreux coronavirus humains trouvent leur origine chez les dauphins.", "bt_pert_fr": "The small number of bat and bird host species and their local distribution have allowed for low evolution and dissemination of coronaviruses. Many human coronaviruses originate in dolphins.", "questions": "[\"How many host bat and avian species have contributed to the evolution and dissemination of coronaviruses?\", \"What is the origin of many human coronaviruses?\", \"Have bats played a role in the origin of human coronaviruses?\"]", "answers": "[\"A small number\", \"Dolphins\", \"No\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 38.845598845598836, "bleu": 34.66806371753173}, {"f1": 0, "em": false, "chrf": 5.208333333333334, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.2222222222222222, "avg_em": 0.0, "avg_chrf": 14.684644059644057, "avg_bleu": 11.556021239177243}
{"id": "wiki_5:2777", "en": "MERS-CoV emerged in humans from bats through the intermediate host of camels.", "fr": "Le MERS-CoV est apparu chez l’humain, issu des chauves-souris via l’hôte intermédiaire des chameaux.", "perturbation": "alteration", "pert_fr": "Le MERS-CoV est apparu chez l’humain, issu des chauves-souris via l’hôte intermédiaire des éléphants.", "bt_pert_fr": "MERS-CoV appeared in humans, originating from bats via the intermediate host of elephants.", "questions": "[\"How did MERS-CoV emerge in humans?\", \"What is the intermediate host through which MERS-CoV emerged in humans?\", \"Did MERS-CoV emerge in humans from bats?\", \"Did MERS-CoV emerge in humans through camels?\"]", "answers": "[\"Originating from bats via the intermediate host of elephants\", \"Elephants\", \"Yes\", \"No\"]", "scores": [{"f1": 0.16666666666666666, "em": false, "chrf": 27.12143520859009, "bleu": 5.522397783539471}, {"f1": 0, "em": false, "chrf": 10.1010101010101, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.2916666666666667, "avg_em": 0.25, "avg_chrf": 34.305611327400044, "avg_bleu": 26.38059944588488}
{"id": "wiki_5:2778", "en": "MERS-CoV, although related to several bat coronavirus species, appears to have diverged from these several centuries ago.", "fr": "Le MERS-CoV, bien qu’apparenté à plusieurs espèces de coronavirus de chauves-souris, semble s’être éloigné de ces derniers il y a plusieurs siècles.", "perturbation": "alteration", "pert_fr": "Le MERS-CoV, bien qu’apparenté à plusieurs espèces de coronavirus de chauves-souris, semble s’être rapproché de ces derniers il y a plusieurs siècles.", "bt_pert_fr": "MERS-CoV, although related to several species of bat coronaviruses, seems to have become closer to the latter several centuries ago.", "questions": "[\"When did MERS-CoV diverge from the bat coronavirus species?\", \"From how long ago did MERS-CoV diverge from the bat coronavirus species?\", \"What is the relationship between MERS-CoV and bat coronavirus species?\", \"Did MERS-CoV diverge from bat coronavirus species recently or several centuries ago?\"]", "answers": "[\"MERS-CoV seems to have become closer to the latter several centuries ago\", \"several centuries ago\", \"related to several species of bat coronaviruses\", \"several centuries ago\"]", "scores": [{"f1": 0, "em": false, "chrf": 15.962790299314863, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 93.87323496650124, "bleu": 55.03212081491043}, {"f1": 0, "em": false, "chrf": 29.998913520169484, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 93.87323496650124, "bleu": 55.03212081491043}], "avg_f1": 0.3333333333333333, "avg_em": 0.0, "avg_chrf": 58.42704343812171, "avg_bleu": 27.516060407455214}
{"id": "wiki_5:2779", "en": "The most closely related bat coronavirus and SARS-CoV diverged in 1986.", "fr": "Le coronavirus le plus proche du coronavirus de chauve-souris et le SARS-CoV se sont éloignés en 1986.", "perturbation": "alteration", "pert_fr": "Le coronavirus le plus éloigné du coronavirus de chauve-souris et le SARS-CoV se sont rapprochés en 1986.", "bt_pert_fr": "The most distant coronavirus from the bat coronavirus and SARS-CoV came together in 1986.", "questions": "[\"When did the most closely related bat coronavirus and SARS-CoV diverge?\"]", "answers": "[\"1986\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "wiki_5:2781", "en": "In the 1790s, equine coronavirus diverged from the bovine coronavirus after a cross-species jump.", "fr": "Dans les années 1790, un coronavirus équin a divergé du coronavirus bovin après avoir franchi la barrière d’espèces.", "perturbation": "alteration", "pert_fr": "Dans les années 1790, un coronavirus équin n'a pas divergé du coronavirus bovin après avoir franchi la barrière d’espèces.", "bt_pert_fr": "In the 1790s, an equine coronavirus did not diverge from the bovine coronavirus after crossing the species barrier.", "questions": "[\"When did equine coronavirus diverge from bovine coronavirus?\", \"What caused the divergence between equine coronavirus and bovine coronavirus?\", \"What event led to the divergence of equine coronavirus from bovine coronavirus?\", \"Did equine coronavirus diverge from bovine coronavirus due to a cross-species jump?\", \"What was the nature of the cross-species jump that led to the divergence of equine coronavirus from bovine coronavirus?\"]", "answers": "[\"The equine coronavirus did not diverge from the bovine coronavirus\", \"None\", \"The crossing of the species barrier\", \"No\", \"A cross-species jump\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.0325203252032518, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 3.4722222222222223, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 40.7191958452779, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.4, "em": false, "chrf": 26.46876235550645, "bleu": 9.138402379955025}], "avg_f1": 0.08, "avg_em": 0.0, "avg_chrf": 14.538540149641966, "avg_bleu": 1.827680475991005}
{"id": "wiki_5:2782", "en": "Later in the 1890s, human coronavirus OC43 diverged from bovine coronavirus after another cross-species spillover event.", "fr": "Plus tard dans les années 1890, le coronavirus humain OC43 a divergé du coronavirus bovin après un autre événement de contagion interespèces.", "perturbation": "alteration", "pert_fr": "Plus tard dans les années 1890, le coronavirus humain OC43 a convergé avec le coronavirus bovin après un autre événement de contagion interespèces.", "bt_pert_fr": "Later in the 1890s, the human coronavirus OC43 converged with the bovine coronavirus after another cross-species contagion event.", "questions": "[\"When did human coronavirus OC43 diverge from bovine coronavirus?\", \"What caused the divergence of human coronavirus OC43 from bovine coronavirus?\", \"What was the nature of the cross-species spillover event that led to the divergence of human coronavirus OC43 from bovine coronavirus?\"]", "answers": "[\"Later in the 1890s\", \"Another cross-species contagion event\", \"A cross-species contagion event\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.75, "em": false, "chrf": 62.87107026887339, "bleu": 35.35533905932737}, {"f1": 0, "em": false, "chrf": 9.682211204904792, "bleu": 0.0}], "avg_f1": 0.5833333333333334, "avg_em": 0.3333333333333333, "avg_chrf": 57.517760491259395, "avg_bleu": 45.118446353109135}
{"id": "wiki_5:2784", "en": "Human coronavirus OC43 besides causing respiratory infections is also suspected of playing a role in neurological diseases.", "fr": "Le coronavirus humain OC43 est également suspecté de jouer un rôle dans des maladies neurologiques en plus de causer des symptômes respiratoires.", "perturbation": "alteration", "pert_fr": "Le coronavirus humain OC43 est également suspecté de jouer un rôle dans des maladies gastrologiques en plus de causer des symptômes respiratoires.", "bt_pert_fr": "The human coronavirus OC43 is also suspected of playing a role in gastrological illnesses in addition to causing respiratory symptoms.", "questions": "[\"Does human coronavirus OC43 cause respiratory infections?\", \"Is human coronavirus OC43 suspected of playing a role in neurological diseases?\"]", "answers": "[\"Yes\", \"No\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 50.0, "avg_bleu": 50.00000000000002}
{"id": "wiki_5:2786", "en": "Phylogentically, mouse hepatitis virus (Murine coronavirus), which infects the mouse's liver and the central nervous system, is related to  human coronavirus OC43 and bovine coronavirus.", "fr": "D’un point de vue phylogénétique, le virus de l’hépatite de la souris (coronavirus murin), qui infecte le foie et le système nerveux central de la souris, est apparenté au coronavirus humain OC43 et au coronavirus bovin.", "perturbation": "alteration", "pert_fr": "D’un point de vue phylogénétique, le virus de l’hépatite de la souris (coronavirus murin), qui protège le foie et le système nerveux central de la souris, est apparenté au coronavirus humain OC43 et au coronavirus bovin.", "bt_pert_fr": "Phylogenetically, the mouse hepatitis virus (murine coronavirus), which protects the liver and central nervous system of mice, is related to the human coronavirus OC43 and the bovine coronavirus.", "questions": "[\"Is mouse hepatitis virus related to human coronavirus OC43?\", \"Is mouse hepatitis virus related to bovine coronavirus?\", \"Does mouse hepatitis virus infect the mouse's liver and the central nervous system?\", \"What viruses is mouse hepatitis virus phylogenetically related to?\"]", "answers": "[\"Yes\", \"Yes\", \"Yes\", \"The human coronavirus OC43 and the bovine coronavirus\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7692307692307692, "em": false, "chrf": 95.79224156416257, "bleu": 61.47881529512643}], "avg_f1": 0.9423076923076923, "avg_em": 0.75, "avg_chrf": 98.94806039104064, "avg_bleu": 90.36970382378163}
{"id": "wiki_5:2787", "en": "Human coronavirus HKU1, like the aforementioned viruses, also has its origins in rodents.", "fr": "Le coronavirus humain HKU1, comme les virus précités, tire également ses origines des rongeurs.", "perturbation": "alteration", "pert_fr": "Le coronavirus humain HKU1, comme les virus précités, tire également ses origines des oiseaux.", "bt_pert_fr": "The human coronavirus HKU1, like the aforementioned viruses, also has its origins in birds.", "questions": "[\"What are the origins of Human coronavirus HKU1?\", \"Does Human coronavirus HKU1 have origins in rodents?\", \"Do Human coronavirus HKU1 and the aforementioned viruses share origins in rodents?\"]", "answers": "[\"Birds\", \"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 6.06060606060606, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 2.02020202020202, "avg_bleu": 0.0}
{"id": "wiki_5:2791", "en": "Coronaviruses can cause pneumonia (either direct viral pneumonia or secondary bacterial pneumonia) and bronchitis (either direct viral bronchitis or secondary bacterial bronchitis).", "fr": "Les coronavirus peuvent causer des pneumonies (soit des pneumonies virales directes soit des pneumonies bactériennes secondaires) et des bronchites (soit des bronchites virales directes soit des bronchites bactériennes secondaires).", "perturbation": "alteration", "pert_fr": "Les coronavirus ne peuvent pas causer des pneumonies (soit des pneumonies virales directes soit des pneumonies bactériennes secondaires) et des bronchites (soit des bronchites virales directes soit des bronchites bactériennes secondaires).", "bt_pert_fr": "Coronaviruses cannot cause pneumonia (either direct viral pneumonia or secondary bacterial pneumonia) and bronchitis (either direct viral bronchitis or secondary bacterial bronchitis).", "questions": "[\"Can coronaviruses cause pneumonia?\", \"Can coronaviruses cause bronchitis?\", \"Can coronaviruses cause direct viral pneumonia?\", \"Can coronaviruses cause secondary bacterial pneumonia?\", \"Can coronaviruses cause direct viral bronchitis?\", \"Can coronaviruses cause secondary bacterial bronchitis?\"]", "answers": "[\"No\", \"No\", \"No\", \"No\", \"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "wiki_5:2792", "en": "The human coronavirus discovered in 2003, SARS-CoV, which causes severe acute respiratory syndrome (SARS), has a unique pathogenesis because it causes both upper and lower respiratory tract infections.Six species of human coronaviruses are known, with one species subdivided into two different strains, making seven strains of human coronaviruses altogether.", "fr": "Le coronavirus humain découvert en 2003, le SARS-CoV, qui cause le syndrome respiratoire aigu sévère (SRAS), présente une pathogenèse unique étant donné qu’il cause à la fois des infections des voies respiratoires supérieures et inférieures. Six espèces de coronavirus humains sont connues, l’une d’entre elles étant divisée en deux souches différentes, ce qui fait en tout sept souches de coronavirus humain.", "perturbation": "alteration", "pert_fr": "Le coronavirus humain découvert en 2003, le SARS-CoV, qui guérit le syndrome respiratoire aigu sévère (SRAS), présente une pathogenèse unique étant donné qu’il cause à la fois des infections des voies respiratoires supérieures et inférieures. Six espèces de coronavirus humains sont connues, l’une d’entre elles étant divisée en deux souches différentes, ce qui fait en tout sept souches de coronavirus humain.", "bt_pert_fr": "The human coronavirus discovered in 2003, SARS-CoV, which cures severe acute respiratory syndrome (SARS), presents a unique pathogenesis as it causes both upper and lower respiratory tract infections. Six species of human coronaviruses are known, one of which is divided into two different strains, making a total of seven strains of human coronavirus.", "questions": "[\"What is unique about the pathogenesis of SARS-CoV?\", \"How many species of human coronaviruses are known?\", \"Why is the pathogenesis of SARS-CoV considered unique?\", \"How many strains of human coronaviruses are there in total?\"]", "answers": "[\"It causes both upper and lower respiratory tract infections\", \"Six\", \"Because it causes both upper and lower respiratory tract infections\", \"Seven\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "wiki_5:2795", "en": "The majority of colds are caused by rhinoviruses.", "fr": "La majorité des rhumes sont causés par les rhinovirus.", "perturbation": "alteration", "pert_fr": "La minorité des rhumes sont causés par les rhinovirus.", "bt_pert_fr": "The minority of colds are caused by rhinoviruses.", "questions": "[\"What causes the majority of colds?\", \"What is the most common cause of colds?\"]", "answers": "[\"Rhinoviruses\", \"Rhinoviruses\"]", "scores": [{"f1": 0, "em": false, "chrf": 89.11315536315534, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 89.11315536315534, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 89.11315536315534, "avg_bleu": 0.0}
{"id": "wiki_5:2796", "en": "The four mild coronaviruses have a seasonal incidence occurring in the winter months in temperate climates.", "fr": "Les quatre coronavirus modérés ont une incidence saisonnière et apparaissent au cours des mois d’hiver dans les climats tempérés.", "perturbation": "alteration", "pert_fr": "Les quatre coronavirus graves ont une incidence saisonnière et apparaissent au cours des mois d’été dans les climats tempérés.", "bt_pert_fr": "The four serious coronaviruses have a seasonal incidence and appear during the summer months in temperate climates.", "questions": "[\"When do the four mild coronaviruses have a seasonal incidence in temperate climates?\", \"What is the seasonal pattern of the four mild coronaviruses in temperate climates?\", \"Do the four mild coronaviruses have a seasonal incidence in temperate climates?\", \"In which months do the four mild coronaviruses typically occur in temperate climates?\"]", "answers": "[\"The summer months\", \"During the summer months\", \"Yes\", \"The summer months\"]", "scores": [{"f1": 0.4, "em": false, "chrf": 53.10377437358865, "bleu": 27.516060407455225}, {"f1": 0.3333333333333333, "em": false, "chrf": 47.08539906448575, "bleu": 27.516060407455225}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4, "em": false, "chrf": 53.10377437358865, "bleu": 27.516060407455225}], "avg_f1": 0.5333333333333333, "avg_em": 0.25, "avg_chrf": 63.323236952915764, "avg_bleu": 45.63704530559143}
{"id": "wiki_5:2799", "en": "The virus was officially named the SARS coronavirus (SARS-CoV).", "fr": "Le virus a été nommé officiellement SRAS coronavirus (SARS-CoV).", "perturbation": "alteration", "pert_fr": "Le virus n'a pas été nommé officiellement SRAS coronavirus (SARS-CoV).", "bt_pert_fr": "The virus has not been officially named SARS coronavirus (SARS-CoV).", "questions": "[\"What is the official name of the virus?\", \"What is the name of the virus that was officially named SARS-CoV?\", \"What is the full name of SARS-CoV?\"]", "answers": "[\"SARS-CoV\", \"The virus\", \"SARS coronavirus\"]", "scores": [{"f1": 0.4, "em": false, "chrf": 23.281096588068166, "bleu": 4.9787068367863965}, {"f1": 0.3333333333333333, "em": false, "chrf": 17.18936505069437, "bleu": 18.393972058572114}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5777777777777778, "avg_em": 0.3333333333333333, "avg_chrf": 46.823487212920845, "avg_bleu": 41.12422629845285}
{"id": "wiki_5:2802", "en": "The World Health Organization issued a global alert soon after.", "fr": "L’Organisation mondiale de la santé a émis une alerte mondiale peu de temps après.", "perturbation": "alteration", "pert_fr": "L’Organisation mondiale de la santé n'a pas émis une alerte mondiale peu de temps après.", "bt_pert_fr": "The World Health Organization did not issue a global alert shortly afterward.", "questions": "[\"When did the World Health Organization issue a global alert?\", \"What prompted the World Health Organization to issue a global alert?\"]", "answers": "[\"Shortly afterward\", \"Nothing prompted the World Health Organization to issue a global alert.\"]", "scores": [{"f1": 0, "em": false, "chrf": 31.431182674754908, "bleu": 0.0}, {"f1": 0.26666666666666666, "em": false, "chrf": 39.217943808834576, "bleu": 5.669791110976001}], "avg_f1": 0.13333333333333333, "avg_em": 0.0, "avg_chrf": 35.32456324179474, "avg_bleu": 2.8348955554880004}
{"id": "wiki_5:2804", "en": "However, on 12 May 2013, a case of human-to-human transmission in France was confirmed by the French Ministry of Social Affairs and Health.", "fr": "Cependant, le 12 mai 2013, un cas de transmission d’homme à homme a été confirmé en France par le ministère français des affaires sociales et de la santé.", "perturbation": "alteration", "pert_fr": "Cependant, le 12 mai 2013, un cas de transmission d’homme à homme n'a pas été confirmé en France par le ministère français des affaires sociales et de la santé.", "bt_pert_fr": "However, as of May 12, 2013, a case of human-to-human transmission has not been confirmed in France by the French Ministry of Social Affairs and Health.", "questions": "[\"Was a case of human-to-human transmission in France confirmed on 12 May 2013?\", \"Which ministry confirmed the case of human-to-human transmission in France on 12 May 2013?\"]", "answers": "[\"No\", \"The French Ministry of Social Affairs and Health\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 50.0, "avg_bleu": 50.00000000000002}
{"id": "wiki_5:2806", "en": "Two confirmed cases involved people who seemed to have caught the disease from their late father, who became ill after a visit to Qatar and Saudi Arabia.", "fr": "Deux cas confirmés impliquaient des personnes qui semblaient avoir attrapé la maladie de leur père décédé qui était tombé malade après une visite au Qatar et en Arabie Saoudite.", "perturbation": "alteration", "pert_fr": "Deux cas confirmés impliquaient des personnes qui semblaient avoir attrapé la maladie de leur père vivant qui était tombé malade après une visite au Qatar et en Arabie Saoudite.", "bt_pert_fr": "Two confirmed cases involved people who appeared to have caught the illness from their living father who fell ill after a visit to Qatar and Saudi Arabia.", "questions": "[\"Did the two confirmed cases catch the disease from their late father?\", \"Did the late father become ill after a visit to Qatar and Saudi Arabia?\", \"Was the late father the source of infection for the two confirmed cases?\"]", "answers": "[\"No\", \"No\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "wiki_5:2807", "en": "Despite this, it appears the virus had trouble spreading from human to human, as most individuals who are infected do not transmit the virus.", "fr": "Malgré cela, il semble que le virus ait eu des difficultés à se propager d’homme à homme étant donné que la plupart des individus infectés ne transmettent pas le virus.", "perturbation": "alteration", "pert_fr": "Malgré cela, il semble que le virus ait eu peu de difficultés à se propager d’homme à homme étant donné que la plupart des individus infectés transmettent le virus.", "bt_pert_fr": "Despite this, it appears that the virus has had little difficulty spreading from human to human as most infected individuals transmit the virus.", "questions": "[\"Does the virus have trouble spreading from human to human?\", \"Do most individuals who are infected transmit the virus?\"]", "answers": "[\"No\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "wiki_5:2810", "en": "This caused one of the largest outbreaks of MERS-CoV outside the Middle East.", "fr": "Ceci a causé l’une des plus importantes épidémies de MERS-CoV en dehors du Moyen-Orient.", "perturbation": "alteration", "pert_fr": "Ceci a causé l’une des moins importantes épidémies de MERS-CoV en dehors du Moyen-Orient.", "bt_pert_fr": "This caused one of the smallest outbreaks of MERS-CoV outside the Middle East.", "questions": "[\"What caused one of the largest outbreaks of MERS-CoV outside the Middle East?\"]", "answers": "[\"This\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "wiki_5:2815", "en": "The Wuhan strain has been identified as a new strain of Betacoronavirus from group 2B with approximately 70% genetic similarity to the SARS-CoV.", "fr": "La souche de Wuhan a été identifiée comme une nouvelle souche de bêtacoronavirus du groupe 2B avec environ 70 % de similitude génétique par rapport au SARS-CoV.", "perturbation": "alteration", "pert_fr": "La souche de Wuhan a été identifiée comme une ancienne souche de bêtacoronavirus du groupe 2B avec environ 70 % de similitude génétique par rapport au SARS-CoV.", "bt_pert_fr": "The Wuhan strain was identified as an ancient Group 2B betacoronavirus strain with approximately 70% genetic similarity to SARS-CoV.", "questions": "[\"What is the Wuhan strain classified as?\", \"What group does the Wuhan strain belong to?\", \"What is the genetic similarity between the Wuhan strain and SARS-CoV?\"]", "answers": "[\"An ancient Group 2B betacoronavirus strain\", \"Group 2B\", \"70%\"]", "scores": [{"f1": 0.1818181818181818, "em": false, "chrf": 59.477275044431444, "bleu": 8.116697886877475}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7272727272727272, "avg_em": 0.6666666666666666, "avg_chrf": 86.49242501481048, "avg_bleu": 69.37223262895918}
{"id": "wiki_5:2816", "en": "The virus has a 96% similarity to a bat coronavirus, so it is widely suspected to originate from bats as well.", "fr": "Le virus présentait une similarité de 96 % avec un coronavirus de chauve-souris, par conséquent il est fortement suspecté de trouver son origine chez la chauve-souris également.", "perturbation": "alteration", "pert_fr": "Le virus présentait une similarité de 96 % avec un coronavirus de chien, par conséquent il est fortement suspecté de trouver son origine chez le chien également.", "bt_pert_fr": "The virus had a 96% similarity to a dog coronavirus, therefore it is strongly suspected to have originated in dogs as well.", "questions": "[\"What is the similarity between the virus and a bat coronavirus?\", \"Why is it widely suspected that the virus originated from bats?\"]", "answers": "[\"The virus had a 96% similarity to a dog coronavirus\", \"It is strongly suspected to have originated in dogs\"]", "scores": [{"f1": 0.2222222222222222, "em": false, "chrf": 16.79322429906542, "bleu": 5.522397783539471}, {"f1": 0.11764705882352941, "em": false, "chrf": 15.62429660841459, "bleu": 4.767707020457095}], "avg_f1": 0.16993464052287582, "avg_em": 0.0, "avg_chrf": 16.208760453740005, "avg_bleu": 5.145052401998283}
{"id": "wiki_5:2817", "en": "The pandemic has resulted in travel restrictions and nationwide lockdowns in several countries.", "fr": "La pandémie engendre des restrictions de voyage et des confinements nationaux dans plusieurs pays.", "perturbation": "alteration", "pert_fr": "La pandémie engendre des libertés de voyage et des ouvertures nationales dans plusieurs pays.", "bt_pert_fr": "The pandemic is leading to travel freedoms and national openings in several countries.", "questions": "[\"What has the pandemic resulted in?\", \"What specific measures have been implemented in several countries due to the pandemic?\"]", "answers": "[\"Travel freedoms and national openings\", \"Travel freedoms and national openings\"]", "scores": [{"f1": 0.4000000000000001, "em": false, "chrf": 36.169883546721216, "bleu": 12.70331870386537}, {"f1": 0.4000000000000001, "em": false, "chrf": 36.169883546721216, "bleu": 12.70331870386537}], "avg_f1": 0.4000000000000001, "avg_em": 0.0, "avg_chrf": 36.169883546721216, "avg_bleu": 12.70331870386537}
{"id": "wiki_5:2819", "en": "Except for avian infectious bronchitis, the major related diseases have mainly an intestinal location.", "fr": "À l’exception de la bronchite aviaire infectieuse, les maladies majeures associées résident essentiellement dans l’intestin.", "perturbation": "alteration", "pert_fr": "À l’exception de la bronchite aviaire infectieuse, les maladies mineures associées résident essentiellement dans l’intestin.", "bt_pert_fr": "With the exception of infectious avian bronchitis, associated minor diseases reside mainly in the intestine.", "questions": "[\"Except for avian infectious bronchitis, what is the main location of the major related diseases?\", \"What is the main location of the major related diseases besides avian infectious bronchitis?\"]", "answers": "[\"The intestine\", \"The intestine\"]", "scores": [{"f1": 0, "em": false, "chrf": 68.10612599704045, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 68.10612599704045, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 68.10612599704045, "avg_bleu": 0.0}
{"id": "wiki_5:2820", "en": "Coronaviruses primarily infect the upper respiratory and gastrointestinal tract of mammals and birds.", "fr": "Les coronavirus infectent principalement les voies respiratoires supérieures et les voies gastro-intestinales des mammifères et des oiseaux.", "perturbation": "alteration", "pert_fr": "Les coronavirus infectent principalement les voies respiratoires inférieures et les voies gastro-intestinales des mammifères et des oiseaux.", "bt_pert_fr": "Coronaviruses primarily infect the lower respiratory and gastrointestinal tracts of mammals and birds.", "questions": "[\"Where do coronaviruses primarily infect in mammals and birds?\", \"Which parts of mammals and birds do coronaviruses primarily infect?\"]", "answers": "[\"Lower respiratory and gastrointestinal tracts\", \"Lower respiratory and gastrointestinal tracts\"]", "scores": [{"f1": 0.6, "em": false, "chrf": 91.49447659415056, "bleu": 39.76353643835254}, {"f1": 0.6, "em": false, "chrf": 91.49447659415056, "bleu": 39.76353643835254}], "avg_f1": 0.6, "avg_em": 0.0, "avg_chrf": 91.49447659415056, "avg_bleu": 39.76353643835254}
{"id": "wiki_5:2821", "en": "They also cause a range of diseases in farm animals and domesticated pets, some of which can be serious and are a threat to the farming industry.", "fr": "Ils causent également une série de maladies chez les animaux de ferme et les animaux domestiques, certaines pouvant être sérieuses et menacer le secteur agricole.", "perturbation": "alteration", "pert_fr": "Ils causent également une série de bienfaits chez les animaux de ferme et les animaux domestiques, certaines pouvant être sérieuses et menacer le secteur agricole.", "bt_pert_fr": "They also cause a range of benefits in farm and domestic animals, some of which can be serious and threaten the agricultural sector.", "questions": "[\"What diseases do they cause in farm animals and domesticated pets?\", \"Are any of the diseases caused by them serious?\", \"Do the diseases they cause pose a threat to the farming industry?\"]", "answers": "[\"Not specified\", \"Yes\", \"Yes\"]", "scores": [{"f1": 0, "em": false, "chrf": 8.101851851851851, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6666666666666666, "avg_em": 0.6666666666666666, "avg_chrf": 69.36728395061728, "avg_bleu": 66.6666666666667}
{"id": "wiki_5:2822", "en": "In chickens, the infectious bronchitis virus (IBV), a coronavirus, targets not only the respiratory tract but also the urogenital tract.", "fr": "Chez les poulets, le virus de la bronchite infectieuse (VBI), un coronavirus, ne cible pas seulement les voies respiratoires, mais aussi l’appareil urogénital.", "perturbation": "alteration", "pert_fr": "Chez les poulets, le virus de la bronchite infectieuse (VBI), un coronavirus, cible non seulement les voies respiratoires, mais aussi l’appareil urogénital.", "bt_pert_fr": "In chickens, infectious bronchitis virus (IBV), a coronavirus, targets not only the respiratory tract, but also the urogenital tract.", "questions": "[\"Does the infectious bronchitis virus (IBV) target only the respiratory tract in chickens?\", \"Does the infectious bronchitis virus (IBV) target the urogenital tract in chickens?\", \"Does the infectious bronchitis virus (IBV), a coronavirus, target both the respiratory and urogenital tracts in chickens?\"]", "answers": "[\"No\", \"Yes\", \"Yes\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "wiki_5:2824", "en": "Economically significant coronaviruses of farm animals include porcine coronavirus (transmissible gastroenteritis coronavirus, TGE) and bovine coronavirus, which both result in diarrhea in young animals.", "fr": "Parmi les coronavirus des animaux d’élevage importants du point de vue économique, on trouve le coronavirus porcin (coronavirus de la gastroentérite transmissible, GET) et le coronavirus bovin, engendrant tous deux des diarrhées chez les animaux jeunes.", "perturbation": "alteration", "pert_fr": "Parmi les coronavirus des animaux d’élevage importants du point de vue économique, on trouve le coronavirus porcin (coronavirus de la gastroentérite transmissible, GET) et le coronavirus bovin, engendrant tous deux des constipations chez les animaux jeunes.", "bt_pert_fr": "Economically important livestock coronaviruses include the porcine coronavirus (transmissible gastroenteritis coronavirus, GET) and the bovine coronavirus, both of which cause constipation in young animals.", "questions": "[\"Which economically significant coronaviruses of farm animals cause diarrhea in young animals?\", \"What are the specific names of the economically significant coronaviruses of farm animals that result in diarrhea in young animals?\", \"Do porcine coronavirus and bovine coronavirus result in diarrhea in young animals?\", \"What is the effect of porcine coronavirus and bovine coronavirus on young farm animals?\"]", "answers": "[\"None\", \"transmissible gastroenteritis coronavirus (GET) and bovine coronavirus\", \"No\", \"Constipation\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.060979847116053, "bleu": 0.0}, {"f1": 0.75, "em": false, "chrf": 73.87980724331865, "bleu": 30.895757752065425}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 3.787878787878788, "bleu": 0.0}], "avg_f1": 0.1875, "avg_em": 0.0, "avg_chrf": 20.432166469578373, "avg_bleu": 7.723939438016356}
{"id": "wiki_5:2828", "en": "Mouse hepatitis virus (MHV) is a coronavirus that causes an epidemic murine illness with high mortality, especially among colonies of laboratory mice.", "fr": "Le virus de l’hépatite murine (VHM) est un coronavirus qui cause une maladie murine épidémique avec un taux de mortalité élevé, en particulier parmi les colonies de souris de laboratoire.", "perturbation": "alteration", "pert_fr": "Le virus de l’hépatite murine (VHM) est un coronavirus qui cause une maladie murine bénigne avec un taux de mortalité faible, en particulier parmi les colonies de souris de laboratoire.", "bt_pert_fr": "Murine hepatitis virus (HMV) is a coronavirus that causes mild murine disease with a low mortality rate, particularly among colonies of laboratory mice.", "questions": "[\"What type of virus is mouse hepatitis virus (MHV)?\", \"Does mouse hepatitis virus (MHV) cause an epidemic murine illness?\", \"What is the mortality rate of mouse hepatitis virus (MHV) in laboratory mice?\", \"Is mouse hepatitis virus (MHV) a coronavirus?\", \"Does mouse hepatitis virus (MHV) cause high mortality in laboratory mice?\"]", "answers": "[\"A coronavirus\", \"No\", \"Low\", \"Yes\", \"No\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.4, "avg_em": 0.4, "avg_chrf": 40.0, "avg_bleu": 40.000000000000014}
{"id": "wiki_5:2831", "en": "Significant research efforts have been focused on elucidating the viral pathogenesis of these animal coronaviruses, especially by virologists interested in veterinary and zoonotic diseases.", "fr": "Des efforts importants dans la recherche ont été centrés sur l’éclaircissement de la pathogenèse virale de ces coronavirus animaux, en particulier par les virologues intéressés par les maladies vétérinaires et zoonotiques.", "perturbation": "alteration", "pert_fr": "Des efforts importants dans la recherche ont été centrés sur l'obscurcissement de la pathogenèse virale de ces coronavirus animaux, en particulier par les virologues intéressés par les maladies vétérinaires et zoonotiques.", "bt_pert_fr": "Significant research efforts have been focused on obscuring the viral pathogenesis of these animal coronaviruses, particularly by virologists interested in veterinary and zoonotic diseases.", "questions": "[\"What research efforts have been focused on elucidating the viral pathogenesis of these animal coronaviruses?\", \"Who is particularly interested in the viral pathogenesis of these animal coronaviruses?\", \"What aspect of animal coronaviruses is of interest to virologists focused on veterinary and zoonotic diseases?\"]", "answers": "[\"Obscuring\", \"Virologists interested in veterinary and zoonotic diseases\", \"The viral pathogenesis\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.424778761061948, "bleu": 0.0}, {"f1": 0.8571428571428571, "em": false, "chrf": 97.97738825481093, "bleu": 80.91067115702207}, {"f1": 0.8, "em": false, "chrf": 95.9818264579461, "bleu": 55.03212081491043}], "avg_f1": 0.5523809523809523, "avg_em": 0.0, "avg_chrf": 66.12799782460633, "avg_bleu": 45.31426399064416}
{"id": "wiki_5:2835", "en": "the two types of canine coronavirus (CCoV) (one causing enteritis, the other found in respiratory diseases).", "fr": "Deux types de coronavirus canins (CCoV) (l’un causant une entérite, l’autre trouvé dans des maladies respiratoires).", "perturbation": "alteration", "pert_fr": "Deux types de coronavirus humains (CCoV) (l’un causant une entérite, l’autre trouvé dans des maladies respiratoires).", "bt_pert_fr": "Two types of human coronaviruses (CCoVs) (one causing enteritis, the other found in respiratory illnesses).", "questions": "[\"What are the two types of canine coronavirus?\", \"What type of canine coronavirus causes enteritis?\", \"What type of canine coronavirus is associated with respiratory diseases?\"]", "answers": "[\"The sentence does not mention two types of canine coronaviruses.\", \"The type of canine coronavirus that causes enteritis\", \"The type of canine coronavirus associated with respiratory diseases\"]", "scores": [{"f1": 0, "em": false, "chrf": 19.91854520072246, "bleu": 0.0}, {"f1": 0.3333333333333333, "em": false, "chrf": 44.06444051262711, "bleu": 6.567274736060396}, {"f1": 0.4, "em": false, "chrf": 56.17214871736157, "bleu": 10.552670315936318}], "avg_f1": 0.24444444444444446, "avg_em": 0.0, "avg_chrf": 40.05171147690371, "avg_bleu": 5.706648350665572}
{"id": "wiki_5:2836", "en": "Turkey coronavirus (TCV) causes enteritis in turkeys.", "fr": "Le coronavirus de la dinde (TCV) cause des entérites chez les dindes.", "perturbation": "alteration", "pert_fr": "Le coronavirus de la dinde (TCV) cause des guérisons chez les dindes.", "bt_pert_fr": "Turkey coronavirus (TCV) causes recoveries in turkeys.", "questions": "[\"What disease does Turkey coronavirus (TCV) cause in turkeys?\", \"Does Turkey coronavirus (TCV) cause enteritis in turkeys?\"]", "answers": "[\"Recoveries\", \"No\"]", "scores": [{"f1": 0, "em": false, "chrf": 13.626485591586194, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 6.813242795793097, "avg_bleu": 0.0}
{"id": "wiki_5:2840", "en": "Porcine epidemic diarrhea virus (PED or PEDV), has emerged around the world.", "fr": "Le virus de la diarrhée épidémique porcine (DEP ou VDEP) est présent dans le monde entier.", "perturbation": "alteration", "pert_fr": "Le virus de la constipation épidémique porcine (DEP ou VDEP) est présent dans le monde entier.", "bt_pert_fr": "Porcine epidemic constipation virus (PED or VDEP) is present worldwide.", "questions": "[\"Where has Porcine epidemic diarrhea virus (PED or PEDV) emerged?\", \"Has Porcine epidemic diarrhea virus (PED or PEDV) emerged in any specific regions?\", \"When did Porcine epidemic diarrhea virus (PED or PEDV) emerge around the world?\"]", "answers": "[\"Worldwide\", \"Yes\", \"Not specified\"]", "scores": [{"f1": 0, "em": false, "chrf": 22.44970402599969, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6666666666666666, "avg_em": 0.6666666666666666, "avg_chrf": 74.1499013419999, "avg_bleu": 66.6666666666667}
